sample	id	disease_type	case_id	submitter_id	primary_site	alcohol_history.exposures	race.demographic	gender.demographic	ethnicity.demographic	vital_status.demographic	age_at_index.demographic	days_to_birth.demographic	year_of_birth.demographic	year_of_death.demographic	primary_site.project	project_id.project	disease_type.project	name.project	name.program.project	tissue_source_site_id.tissue_source_site	code.tissue_source_site	name.tissue_source_site	project.tissue_source_site	bcr_id.tissue_source_site	days_to_death.demographic	entity_submitter_id.annotations	notes.annotations	submitter_id.annotations	classification.annotations	entity_id.annotations	created_datetime.annotations	annotation_id.annotations	entity_type.annotations	updated_datetime.annotations	case_id.annotations	state.annotations	category.annotations	status.annotations	case_submitter_id.annotations	synchronous_malignancy.diagnoses	ajcc_pathologic_stage.diagnoses	days_to_diagnosis.diagnoses	last_known_disease_status.diagnoses	tissue_or_organ_of_origin.diagnoses	days_to_last_follow_up.diagnoses	age_at_diagnosis.diagnoses	primary_diagnosis.diagnoses	prior_malignancy.diagnoses	year_of_diagnosis.diagnoses	prior_treatment.diagnoses	ajcc_staging_system_edition.diagnoses	ajcc_pathologic_t.diagnoses	morphology.diagnoses	ajcc_pathologic_n.diagnoses	ajcc_pathologic_m.diagnoses	classification_of_tumor.diagnoses	icd_10_code.diagnoses	site_of_resection_or_biopsy.diagnoses	tumor_grade.diagnoses	progression_or_recurrence.diagnoses	age_at_earliest_diagnosis.diagnoses.xena_derived	age_at_earliest_diagnosis_in_years.diagnoses.xena_derived	treatment_id.treatments.diagnoses	submitter_id.treatments.diagnoses	treatment_type.treatments.diagnoses	treatment_or_therapy.treatments.diagnoses	created_datetime.treatments.diagnoses	updated_datetime.treatments.diagnoses	state.treatments.diagnoses	sample_type_id.samples	tumor_descriptor.samples	sample_id.samples	sample_type.samples	composition.samples	days_to_collection.samples	initial_weight.samples	preservation_method.samples	pathology_report_uuid.samples	oct_embedded.samples	specimen_type.samples	is_ffpe.samples	tissue_type.samples
TCGA-DD-A73C-01A	79f9331c-9e00-4277-a9d1-7c848e132134	Adenomas and Adenocarcinomas	79f9331c-9e00-4277-a9d1-7c848e132134	TCGA-DD-A73C	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	65.0	-23782.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	701.0	23782.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23782.0	65.15616438356165	['41c6f756-0233-59de-95f1-f6dd7ece852c', '9332be3b-e934-535a-bf92-ea19d78e0782']	['TCGA-DD-A73C_treatment_1', 'TCGA-DD-A73C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:37.101106-05:00', '']	['2019-07-31T21:04:39.208735-05:00', '2019-07-31T21:04:39.208735-05:00']	['released', 'released']	01	Primary	2473ff5a-9cd4-4695-b5f3-36a30e2a04a1	Primary Tumor	Not Reported	288.0	160.0	Unknown	FE051CD7-9C34-4A45-934C-DD8BB00C717A	false	Solid Tissue	False	Tumor
TCGA-5C-AAPD-01A	7a6162a4-1166-4310-84cd-ffc2b06f124c	Adenomas and Adenocarcinomas	7a6162a4-1166-4310-84cd-ffc2b06f124c	TCGA-5C-AAPD	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	61.0	-22552.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	994ff94f-5d44-5de6-908b-dea33dca2a3d	5C	Cureline	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	20.0	22552.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2013.0	No	7th	T2	8180/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22552.0	61.78630136986301	['b879fc6b-ec0a-565a-a0c3-73672f6349ef', 'bce4cef7-e2a3-58bc-88db-8eb85d49ded9']	['TCGA-5C-AAPD_treatment_1', 'TCGA-5C-AAPD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:39.558011-05:00', '']	['2019-07-31T21:04:42.654942-05:00', '2019-07-31T21:04:42.654942-05:00']	['released', 'released']	01	Primary	6f980585-e803-448a-9492-951c782e36cd	Primary Tumor	Not Reported	55.0	140.0	OCT	E4DB31C4-89F3-4D8D-A32E-B42C599904E1	true	Solid Tissue	False	Tumor
TCGA-ZS-A9CE-01A	7bdc5f86-4d7d-4f1f-bc23-ab51fa9fb947	Adenomas and Adenocarcinomas	7bdc5f86-4d7d-4f1f-bc23-ab51fa9fb947	TCGA-ZS-A9CE	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	79.0	-29051.0	1932.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33a38997-77be-52dc-b79d-890d8d4b792b	ZS	Tayside Tissue Bank	Liver hepatocellular carcinoma	NCH																Not Reported	Stage II	0.0	not reported	Liver	1241.0	29051.0	Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29051.0	79.59178082191781	['50e5b3ac-c3f9-5ca6-b3e0-1fae2eee1c85', '63114e37-7023-573b-9b67-8e2afd74ab25']	['TCGA-ZS-A9CE_treatment_1', 'TCGA-ZS-A9CE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:46.813505-05:00', '']	['2019-07-31T21:04:52.181675-05:00', '2019-07-31T21:04:52.181675-05:00']	['released', 'released']	01	Primary	12076740-d690-48ac-9630-5105ac239111	Primary Tumor	Not Reported	967.0	10.0	OCT	35A87F65-19F9-4C03-8A82-FFBF2C3C568A	true	Solid Tissue	False	Tumor
TCGA-HP-A5N0-01A	7f8e25d4-6021-4327-96ab-79b6fcc97a24	Adenomas and Adenocarcinomas	7f8e25d4-6021-4327-96ab-79b6fcc97a24	TCGA-HP-A5N0	Liver and intrahepatic bile ducts	Not Reported	not reported	female	not reported	Dead	90.0	-32120.0			Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	b521e8d8-2b93-5a14-9fd0-ece883fd1327	HP	Ontario Institute for Cancer Research (OICR)	Liver hepatocellular carcinoma	NCH	752.0															No		0.0	not reported	Liver		32120.0	Hepatocellular carcinoma, clear cell type	no		No	6th	TX	8174/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	32120.0	88.0	['4a881f1c-0d78-53f3-a948-82fa287965dc', 'fc85888f-381c-55fd-954b-bbbad6f9b85e']	['TCGA-HP-A5N0_treatment_1', 'TCGA-HP-A5N0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:56.387360-05:00', '']	['2019-07-31T21:05:05.134633-05:00', '2019-07-31T21:05:05.134633-05:00']	['released', 'released']	01	Primary	26dc1e14-4925-4258-8e46-1d52dfdd1b4f	Primary Tumor	Not Reported		350.0	Unknown	0221A6F3-34F5-407E-8548-B62F27F66FCE	false	Solid Tissue	False	Tumor
TCGA-DD-AAVQ-01A	80e7742f-abbe-4f11-b4e4-c999dc1bd459	Adenomas and Adenocarcinomas	80e7742f-abbe-4f11-b4e4-c999dc1bd459	TCGA-DD-AAVQ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	38.0	-13911.0	1969.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2728.0	13911.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	13911.0	38.11232876712329	['99befad3-7d2f-5b9d-8771-d38067963aa8', 'eab0ab83-f532-587f-b77a-729ca78237f1']	['TCGA-DD-AAVQ_treatment', 'TCGA-DD-AAVQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:08.436556-05:00']	['2019-07-31T21:05:19.797777-05:00', '2019-07-31T21:05:19.797777-05:00']	['released', 'released']	01	Primary	9fefeef1-1d0b-4fef-a46a-6017c8f746a5	Primary Tumor	Not Reported	2464.0	80.0	OCT	A58E32BF-829C-48AB-BC80-919A295D78D5	true	Solid Tissue	False	Tumor
TCGA-DD-A1E9-11A	8153a862-0790-4a33-80db-ed47fedcd4ef	Adenomas and Adenocarcinomas	8153a862-0790-4a33-80db-ed47fedcd4ef	TCGA-DD-A1E9	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	70.0	-25808.0	1932.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2759.0															No	Stage I	0.0	not reported	Liver		25808.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25808.0	70.7068493150685	['15319954-3dfe-5ebc-aa9c-cf5b252ba6f8', 'c5e2522d-c8c5-5581-9304-0e08e7f67d57']	['TCGA-DD-A1E9_treatment_1', 'TCGA-DD-A1E9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:10.841143-05:00', '']	['2019-07-31T21:05:22.760303-05:00', '2019-07-31T21:05:22.760303-05:00']	['released', 'released']	11	Not Applicable	786c9b43-92d7-4d5e-8c86-e96f5759fd34	Solid Tissue Normal	Not Reported	3234.0	120.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-A1E9-01A	8153a862-0790-4a33-80db-ed47fedcd4ef	Adenomas and Adenocarcinomas	8153a862-0790-4a33-80db-ed47fedcd4ef	TCGA-DD-A1E9	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	70.0	-25808.0	1932.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2759.0															No	Stage I	0.0	not reported	Liver		25808.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25808.0	70.7068493150685	['15319954-3dfe-5ebc-aa9c-cf5b252ba6f8', 'c5e2522d-c8c5-5581-9304-0e08e7f67d57']	['TCGA-DD-A1E9_treatment_1', 'TCGA-DD-A1E9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:10.841143-05:00', '']	['2019-07-31T21:05:22.760303-05:00', '2019-07-31T21:05:22.760303-05:00']	['released', 'released']	01	Primary	966c4541-84d4-4a4f-9bb9-209431b620c7	Primary Tumor	Not Reported	3234.0	100.0	OCT	07CF8AAC-8A8A-4E4C-BBDA-EDCD78608723	true	Solid Tissue	False	Tumor
TCGA-DD-AAVR-01A	834cff01-3c12-42fa-abbe-ae0ae168c568	Adenomas and Adenocarcinomas	834cff01-3c12-42fa-abbe-ae0ae168c568	TCGA-DD-AAVR	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	44.0	-16157.0	1963.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2513.0	16157.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16157.0	44.26575342465753	['3cf561fa-15d8-5bad-beaa-fc1b09b267c6', '9730cb66-15fa-50d8-b669-257c5f6982fb']	['TCGA-DD-AAVR_treatment', 'TCGA-DD-AAVR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:20.509118-05:00']	['2019-07-31T21:05:34.377867-05:00', '2019-07-31T21:05:34.377867-05:00']	['released', 'released']	01	Primary	afa9379a-fb68-4153-9327-411007f223eb	Primary Tumor	Not Reported	2355.0	40.0	OCT	9CD3E7C0-EC70-4204-A919-0C5A33D8B4D9	true	Solid Tissue	False	Tumor
TCGA-G3-A6UC-01A	87aa894e-7676-40b7-9557-6541446d8cea	Adenomas and Adenocarcinomas	87aa894e-7676-40b7-9557-6541446d8cea	TCGA-G3-A6UC	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	65.0	-23793.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																Not Reported	Stage IIIB	0.0	not reported	Liver	671.0	23793.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23793.0	65.18630136986302	['0453c968-1b70-5fe6-aaf6-5c7a3306ee5b', '475b233f-cb4d-5b10-b149-a7dcb14f1fab']	['TCGA-G3-A6UC_treatment_1', 'TCGA-G3-A6UC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:37.439768-05:00', '']	['2019-07-31T21:05:56.034984-05:00', '2019-07-31T21:05:56.034984-05:00']	['released', 'released']	01	Primary	00c2eeb7-b822-4dbd-a127-98aad0c0f184	Primary Tumor	Not Reported	266.0	410.0	OCT	08415C4C-C645-4911-BA53-6E562E562FD4	true	Solid Tissue	False	Tumor
TCGA-BC-A10T-11A	8a9cde9a-c38c-423e-bc14-354ee26468c9	Adenomas and Adenocarcinomas	8a9cde9a-c38c-423e-bc14-354ee26468c9	TCGA-BC-A10T	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	76.0	-27944.0	1924.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	837.0															No		0.0	not reported	Liver		27944.0	Hepatocellular carcinoma, NOS	no	2000.0	No	5th	T4	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27944.0	76.55890410958904	['5c94c953-a5e4-5236-8451-963da8869e50', 'ec94462e-96ad-5074-aac3-43b5e8e835aa']	['TCGA-BC-A10T_treatment', 'TCGA-BC-A10T_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:53.474309-05:00']	['2019-07-31T21:06:17.655580-05:00', '2019-07-31T21:06:17.655580-05:00']	['released', 'released']	11	Not Applicable	055e602f-5d95-432d-afcc-627f1f032464	Solid Tissue Normal	Not Reported	3660.0	480.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A10T-01A	8a9cde9a-c38c-423e-bc14-354ee26468c9	Adenomas and Adenocarcinomas	8a9cde9a-c38c-423e-bc14-354ee26468c9	TCGA-BC-A10T	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	76.0	-27944.0	1924.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	837.0															No		0.0	not reported	Liver		27944.0	Hepatocellular carcinoma, NOS	no	2000.0	No	5th	T4	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27944.0	76.55890410958904	['5c94c953-a5e4-5236-8451-963da8869e50', 'ec94462e-96ad-5074-aac3-43b5e8e835aa']	['TCGA-BC-A10T_treatment', 'TCGA-BC-A10T_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:53.474309-05:00']	['2019-07-31T21:06:17.655580-05:00', '2019-07-31T21:06:17.655580-05:00']	['released', 'released']	01	Primary	d2f6cea0-ecec-49f1-a851-e332e79ce098	Primary Tumor	Not Reported	3660.0	1000.0	Unknown	D8103C33-F303-4D97-81AF-CC3D06E79285	false	Solid Tissue	False	Tumor
TCGA-4R-AA8I-01A	91a0c8cd-4f23-4569-8e5c-e5442f7af530	Adenomas and Adenocarcinomas	91a0c8cd-4f23-4569-8e5c-e5442f7af530	TCGA-4R-AA8I	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	66.0	-24279.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d6b695e-3dee-583e-9540-9c6d2435cfb5	4R	Duke University	Liver hepatocellular carcinoma	NCH	262.0															Not Reported	Stage II	0.0	not reported	Liver	216.0	24279.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24279.0	66.51780821917808	['43a8b049-317c-5ff6-850a-cda56eab5c5c', '7c93346b-5383-582f-9d80-a701838a8530']	['TCGA-4R-AA8I_treatment', 'TCGA-4R-AA8I_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:13.604101-05:00']	['2019-07-31T21:06:42.125040-05:00', '2019-07-31T21:06:42.125040-05:00']	['released', 'released']	01	Primary	d01bd9b6-1f1e-48de-a8e4-caa975d31f03	Primary Tumor	Not Reported	43.0	210.0	OCT	1898901D-903B-48F4-B378-41144929245D	true	Solid Tissue	False	Tumor
TCGA-DD-AADI-01A	97472e71-66eb-434b-81b0-d727765f44cb	Adenomas and Adenocarcinomas	97472e71-66eb-434b-81b0-d727765f44cb	TCGA-DD-AADI	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	43.0	-15928.0	1968.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1085.0	15928.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	15928.0	43.63835616438356	['0c4bbe53-88b5-59e6-8407-8189c8e5bfde', '11e52765-8b08-515f-9d79-4421a47b0fb4']	['TCGA-DD-AADI_treatment', 'TCGA-DD-AADI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:33.978421-05:00']	['2019-07-31T21:07:05.797486-05:00', '2019-07-31T21:07:05.797486-05:00']	['released', 'released']	01	Primary	49b874c4-a313-4678-ab43-3e4fa8bf97b7	Primary Tumor	Not Reported	819.0	10.0	OCT	BA182F06-3BFF-417C-B6EE-D9FFA9B25054	true	Solid Tissue	False	Tumor
TCGA-G3-A5SL-01A	9a56d8a8-dadd-442e-bc09-732cd619aef7	Adenomas and Adenocarcinomas	9a56d8a8-dadd-442e-bc09-732cd619aef7	TCGA-G3-A5SL	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	70.0	-25671.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	621.0	25671.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	25671.0	70.33150684931506	['148c8e4c-ee3d-5526-bd95-d92cafdcedb8', 'd6b3bab4-5aae-517f-9560-9399cc5d8e45']	['TCGA-G3-A5SL_treatment', 'TCGA-G3-A5SL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:38.985285-05:00']	['2019-07-31T21:07:11.206625-05:00', '2019-07-31T21:07:11.206625-05:00']	['released', 'released']	01	Primary	5af5519d-73ee-481b-a47c-06f54dbd372f	Primary Tumor	Not Reported	236.0	220.0	OCT	7DB1AFB2-69C9-4277-904E-4CF9CBAE8360	true	Solid Tissue	False	Tumor
TCGA-2Y-A9H3-01A	9b69d7f9-38eb-48e1-bdc0-a092a53bc709	Adenomas and Adenocarcinomas	9b69d7f9-38eb-48e1-bdc0-a092a53bc709	TCGA-2Y-A9H3	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Alive	45.0	-16443.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1516.0	16443.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	16443.0	45.04931506849315	['16a1c699-da5b-5f3a-a2bf-5c8b7312254c', '9a33c592-f976-5c75-a337-102c3f1cbc73']	['TCGA-2Y-A9H3_treatment', 'TCGA-2Y-A9H3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:43.843367-05:00']	['2019-07-31T21:07:16.661299-05:00', '2019-07-31T21:07:16.661299-05:00']	['released', 'released']	01	Primary	28fe46e4-b049-4892-9f57-deed8e4f4fc8	Primary Tumor	Not Reported	1309.0	90.0	OCT	83E9C775-EE1D-4763-A448-BB677FC01FA0	true	Solid Tissue	False	Tumor
TCGA-ED-A7PY-01A	a396e048-5aa0-4d71-96bd-7f4fdf6934aa	Adenomas and Adenocarcinomas	a396e048-5aa0-4d71-96bd-7f4fdf6934aa	TCGA-ED-A7PY	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	20.0	-7556.0	1993.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	390.0	7556.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	7556.0	20.7013698630137	['22fd35dd-f118-5484-b055-08dd736a1618', '49febf45-716f-5d78-a67a-d02abfa0ba42']	['TCGA-ED-A7PY_treatment', 'TCGA-ED-A7PY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:24:02.166403-05:00']	['2019-07-31T21:07:37.134942-05:00', '2019-07-31T21:07:37.134942-05:00']	['released', 'released']	01	Primary	7c611dd6-6237-45f6-ae24-50bfa63d7835	Primary Tumor	Not Reported	83.0	1380.0	OCT	B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C	true	Solid Tissue	False	Tumor
TCGA-RC-A6M6-01A	a62f065e-7491-493a-87b3-d213cd87091d	Adenomas and Adenocarcinomas	a62f065e-7491-493a-87b3-d213cd87091d	TCGA-RC-A6M6	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	75.0	-27649.0	1936.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	9.0	27649.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	27649.0	75.75068493150685	['3164f294-e6d4-50c7-b7ae-40975e9de1fb', 'fbce4137-8c46-58f7-baa2-5550e4ca8393']	['TCGA-RC-A6M6_treatment_1', 'TCGA-RC-A6M6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:24:12.739974-05:00', '']	['2019-07-31T21:07:49.922926-05:00', '2019-07-31T21:07:49.922926-05:00']	['released', 'released']	01	Primary	9dc8f8f5-bfec-48df-9ce8-ee9526c6a4d8	Primary Tumor	Not Reported	748.0	110.0	OCT	210AAA2E-0B18-4C08-815D-BC523FF2A7D5	true	Solid Tissue	False	Tumor
TCGA-DD-A4NS-01A	a6a3f07c-ced4-451b-b2e5-c93e4ed622c1	Adenomas and Adenocarcinomas	a6a3f07c-ced4-451b-b2e5-c93e4ed622c1	TCGA-DD-A4NS	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	61.0	-22638.0	1944.0	2011.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2456.0															No	Stage I	0.0	not reported	Liver		22638.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22638.0	62.02191780821918	['21255b2e-46d3-5293-9317-a7dc144f4fd4', '2e4b65de-7bc8-50b7-9790-c4201ea23652']	['TCGA-DD-A4NS_treatment', 'TCGA-DD-A4NS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:24:17.617711-05:00']	['2019-07-31T21:07:55.954463-05:00', '2019-07-31T21:07:55.954463-05:00']	['released', 'released']	01	Primary	fbab0003-7e83-46d4-a265-c19f9b183292	Primary Tumor	Not Reported	2596.0	140.0	OCT	97CA96D5-990E-41F9-949D-CCCCFFB78CBD	true	Solid Tissue	False	Tumor
TCGA-MI-A75C-01A	a6c0def6-7649-485a-a679-50dafb5eade5	Adenomas and Adenocarcinomas	a6c0def6-7649-485a-a679-50dafb5eade5	TCGA-MI-A75C	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	64.0	-23441.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2b1c1097-fa63-5d15-b5d3-c54f5eacb9c8	MI	BLN - Baylor	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	291.0	23441.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23441.0	64.22191780821917	['15a3047f-4bae-56ee-9259-04451671a960', '97c5f2d8-e17b-599d-94a5-cdbae27f14f5']	['TCGA-MI-A75C_treatment', 'TCGA-MI-A75C_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:24:22.503486-05:00']	['2019-07-31T21:08:02.181836-05:00', '2019-07-31T21:08:02.181836-05:00']	['released', 'released']	01	Primary	db785f76-45d8-49b5-af40-57b01eebcc1b	Primary Tumor	Not Reported	573.0	40.0	OCT	D32D0307-8132-4492-9431-51C9C71DD7A1	true	Solid Tissue	False	Tumor
TCGA-DD-A3A4-11A	ab35c9f9-3040-424d-a89f-dff3a1365bc6	Adenomas and Adenocarcinomas	ab35c9f9-3040-424d-a89f-dff3a1365bc6	TCGA-DD-A3A4	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	37.0	-13739.0	1961.0	1999.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	612.0															No	Stage IIIA	0.0	not reported	Liver		13739.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	13739.0	37.64109589041096	['2a67254d-799c-5ee3-888b-a94a2d7e25e8', 'ab6fa8bb-d0f1-5877-9de2-cfc015ac1c0e']	['TCGA-DD-A3A4_treatment', 'TCGA-DD-A3A4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:24:34.739163-05:00']	['2019-07-31T21:08:18.771925-05:00', '2019-07-31T21:08:18.771925-05:00']	['released', 'released']	11	Not Applicable	0e4ced27-5d8e-4c6f-bb6e-583d5ef4d5a1	Solid Tissue Normal	Not Reported	4776.0	240.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A3A4-01A	ab35c9f9-3040-424d-a89f-dff3a1365bc6	Adenomas and Adenocarcinomas	ab35c9f9-3040-424d-a89f-dff3a1365bc6	TCGA-DD-A3A4	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	37.0	-13739.0	1961.0	1999.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	612.0															No	Stage IIIA	0.0	not reported	Liver		13739.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	13739.0	37.64109589041096	['2a67254d-799c-5ee3-888b-a94a2d7e25e8', 'ab6fa8bb-d0f1-5877-9de2-cfc015ac1c0e']	['TCGA-DD-A3A4_treatment', 'TCGA-DD-A3A4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:24:34.739163-05:00']	['2019-07-31T21:08:18.771925-05:00', '2019-07-31T21:08:18.771925-05:00']	['released', 'released']	01	Primary	8bcc5576-c437-4ea7-a914-d4b465c8d5dd	Primary Tumor	Not Reported	4776.0	160.0	Unknown	C755324B-9B82-4319-BDD8-EB8A24107AAC	false	Solid Tissue	False	Tumor
TCGA-RC-A7SK-01A	acfd58eb-c546-49c3-a846-684f22428219	Adenomas and Adenocarcinomas	acfd58eb-c546-49c3-a846-684f22428219	TCGA-RC-A7SK	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	59.0	-21814.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	472.0	21814.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21814.0	59.76438356164383	['9ff497c4-f5ee-5cde-855d-372576a640fb', 'c18a6cb4-ae37-5a85-914e-bb1982047ded']	['TCGA-RC-A7SK_treatment_1', 'TCGA-RC-A7SK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:42.127230-05:00', '']	['2019-07-31T21:08:28.106247-05:00', '2019-07-31T21:08:28.106247-05:00']	['released', 'released']	01	Primary	97c393d9-bb30-4504-8621-fd7827b6cd16	Primary Tumor	Not Reported	232.0	40.0	OCT	5C08444C-DD26-44C1-BDF3-E6E581126F38	true	Solid Tissue	False	Tumor
TCGA-UB-AA0U-01A	ae8d4b34-d40a-482d-9d45-23242843df00	Adenomas and Adenocarcinomas	ae8d4b34-d40a-482d-9d45-23242843df00	TCGA-UB-AA0U	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	60.0	-21985.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	327.0	21985.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21985.0	60.23287671232877	['69cd6ef5-3ec7-51d1-81d8-7edfa3b68734', 'f45e1a55-bebe-5e3a-a421-2a4f83f68dfa']	['TCGA-UB-AA0U_treatment', 'TCGA-UB-AA0U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:24:47.031068-05:00']	['2019-07-31T21:08:33.839792-05:00', '2019-07-31T21:08:33.839792-05:00']	['released', 'released']	01	Primary	e1af89c8-f9ab-4599-a1f5-c7145d40378e	Primary Tumor	Not Reported	18.0	730.0	OCT	00C0CD33-615E-47A6-8CEF-EE3A67F277D3	true	Solid Tissue	False	Tumor
TCGA-DD-A113-11A	aeb17d2b-fa8c-4989-bf3a-d2c74b785455	Adenomas and Adenocarcinomas	aeb17d2b-fa8c-4989-bf3a-d2c74b785455	TCGA-DD-A113	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20188.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2425.0	20188.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20188.0	55.30958904109589	['45b4c855-7106-5443-8d8b-9ea54487c01d', 'b6c5c4dd-1297-5411-a868-a52f0f6e5d0a']	['TCGA-DD-A113_treatment_1', 'TCGA-DD-A113_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:52.008980-05:00', '']	['2019-07-31T21:08:40.048906-05:00', '2019-07-31T21:08:40.048906-05:00']	['released', 'released']	11	Not Applicable	2378318c-5cf4-419f-ac5c-64d40cb7e753	Solid Tissue Normal	Not Reported	1650.0	240.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A113-01A	aeb17d2b-fa8c-4989-bf3a-d2c74b785455	Adenomas and Adenocarcinomas	aeb17d2b-fa8c-4989-bf3a-d2c74b785455	TCGA-DD-A113	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20188.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2425.0	20188.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20188.0	55.30958904109589	['45b4c855-7106-5443-8d8b-9ea54487c01d', 'b6c5c4dd-1297-5411-a868-a52f0f6e5d0a']	['TCGA-DD-A113_treatment_1', 'TCGA-DD-A113_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:52.008980-05:00', '']	['2019-07-31T21:08:40.048906-05:00', '2019-07-31T21:08:40.048906-05:00']	['released', 'released']	01	Primary	546f37ab-fbfe-404e-b24f-0aa8201b8ec7	Primary Tumor	Not Reported	1650.0	110.0	Unknown	F0D7BCB4-D3C3-491A-BDE2-8E77E77F1655	false	Solid Tissue	False	Tumor
TCGA-DD-AAVX-01A	afcb9708-92b3-4727-9c0d-63e7ff22d87b	Adenomas and Adenocarcinomas	afcb9708-92b3-4727-9c0d-63e7ff22d87b	TCGA-DD-AAVX	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	38.0	-14016.0	1970.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1718.0	14016.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	14016.0	38.4	['03c1b88d-7ca4-5480-844d-1f77ccbb9205', '8af9c87c-0f3c-5ae2-9e48-480d224385c1']	['TCGA-DD-AAVX_treatment_1', 'TCGA-DD-AAVX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'yes']	['2019-04-28T13:24:58.888224-05:00', '']	['2019-07-31T21:08:49.311726-05:00', '2019-07-31T21:08:49.311726-05:00']	['released', 'released']	01	Primary	512f703d-14cb-4e9f-9356-4a6d8325caba	Primary Tumor	Not Reported	2039.0	50.0	OCT	C62E123A-5AFC-47FA-AE6A-E16C22ACD374	true	Solid Tissue	False	Tumor
TCGA-2Y-A9HB-01A	b181b591-269c-4e48-b681-243d28772025	Adenomas and Adenocarcinomas	b181b591-269c-4e48-b681-243d28772025	TCGA-2Y-A9HB	Liver and intrahepatic bile ducts	Not Reported	not reported	male	hispanic or latino	Alive	66.0	-24359.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	260.0	24359.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24359.0	66.73698630136987	['b270b0dc-6845-56bf-bab3-61d85ef2a194', 'be6c54dc-0af3-5f33-a911-231fe1ad94e0']	['TCGA-2Y-A9HB_treatment', 'TCGA-2Y-A9HB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:03.669157-05:00']	['2019-07-31T21:08:54.995771-05:00', '2019-07-31T21:08:54.995771-05:00']	['released', 'released']	01	Primary	055fc79d-b598-4dd6-8fc4-a7accb86d90a	Primary Tumor	Not Reported	497.0	80.0	OCT	B5784B06-665F-4DA3-A3EF-CF98A84B2FB7	true	Solid Tissue	False	Tumor
TCGA-DD-A73A-01A	b6c0266a-cf34-464a-808d-1d3c28dc90f2	Adenomas and Adenocarcinomas	b6c0266a-cf34-464a-808d-1d3c28dc90f2	TCGA-DD-A73A	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	71.0	-26136.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	728.0	26136.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26136.0	71.6054794520548	['6e50612e-6e2b-5505-bc65-70bd996185a4', '7f585b6b-408b-567a-a389-051b2bd6e267']	['TCGA-DD-A73A_treatment', 'TCGA-DD-A73A_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:18.495626-05:00']	['2019-07-31T21:09:13.441371-05:00', '2019-07-31T21:09:13.441371-05:00']	['released', 'released']	01	Primary	51a910ec-5097-4f8e-b520-b574e23f33df	Primary Tumor	Not Reported	287.0	60.0	Unknown	CAFC4E06-D637-463A-BBC8-D3B5E608204D	false	Solid Tissue	False	Tumor
TCGA-ED-A66X-01A	b75ca9e4-a474-4960-9343-c8e9524cd096	Adenomas and Adenocarcinomas	b75ca9e4-a474-4960-9343-c8e9524cd096	TCGA-ED-A66X	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	35.0	-12947.0	1978.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	406.0	12947.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	12947.0	35.47123287671233	['73a40823-65b8-5e75-aa94-2092eeb978af', 'e5c646c9-fdf7-5762-8169-572d9d668330']	['TCGA-ED-A66X_treatment_1', 'TCGA-ED-A66X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:20.956019-05:00', '']	['2019-07-31T21:09:16.751824-05:00', '2019-07-31T21:09:16.751824-05:00']	['released', 'released']	01	Primary	c46cc628-1a71-4a9a-9111-8c78f89694f8	Primary Tumor	Not Reported	89.0	2190.0	OCT	F83A9A75-387A-4A66-9817-084A8E633E37	true	Solid Tissue	False	Tumor
TCGA-EP-A26S-11A	b7d6621c-8bce-4a01-8588-9d7761d9372b	Adenomas and Adenocarcinomas	b7d6621c-8bce-4a01-8588-9d7761d9372b	TCGA-EP-A26S	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	70.0	-25677.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	608.0	25677.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	25677.0	70.34794520547945	['a2de1238-94b5-5d52-8181-80bdcc58079f', 'a5240fac-a33a-5f14-b927-0d6ea82002ae']	['TCGA-EP-A26S_treatment', 'TCGA-EP-A26S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:23.603057-05:00']	['2019-07-31T21:09:19.405964-05:00', '2019-07-31T21:09:19.405964-05:00']	['released', 'released']	11	Not Applicable	5e0097a1-7d93-48b7-aad7-5f6c7af55596	Solid Tissue Normal	Not Reported	91.0	1140.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EP-A26S-01A	b7d6621c-8bce-4a01-8588-9d7761d9372b	Adenomas and Adenocarcinomas	b7d6621c-8bce-4a01-8588-9d7761d9372b	TCGA-EP-A26S	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	70.0	-25677.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	608.0	25677.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	25677.0	70.34794520547945	['a2de1238-94b5-5d52-8181-80bdcc58079f', 'a5240fac-a33a-5f14-b927-0d6ea82002ae']	['TCGA-EP-A26S_treatment', 'TCGA-EP-A26S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:23.603057-05:00']	['2019-07-31T21:09:19.405964-05:00', '2019-07-31T21:09:19.405964-05:00']	['released', 'released']	01	Primary	a0b2ff38-e6bf-4f27-98ab-5cf924b0e236	Primary Tumor	Not Reported	91.0	520.0	Unknown	078A6815-B1E3-47F5-A49B-C06B7D47F5E8	false	Solid Tissue	False	Tumor
TCGA-DD-A4NN-01A	b96b7620-5506-4def-aff2-5e888eaf3ea5	Adenomas and Adenocarcinomas	b96b7620-5506-4def-aff2-5e888eaf3ea5	TCGA-DD-A4NN	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	56.0	-20548.0	1948.0	2006.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	899.0															No	Stage I	0.0	not reported	Liver		20548.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20548.0	56.295890410958904	['3de976b0-3dc8-5c8f-a3de-aa7e9d29c52f', '68113f4d-71d3-538d-b222-720f2bf15b39']	['TCGA-DD-A4NN_treatment_1', 'TCGA-DD-A4NN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:32.352763-05:00', '']	['2019-07-31T21:09:28.742728-05:00', '2019-07-31T21:09:28.742728-05:00']	['released', 'released']	01	Primary	423590e6-7496-40ee-8b1d-99986366ebc8	Primary Tumor	Not Reported	3053.0	240.0	OCT	16053CE8-B3B1-4925-AEAA-5B118E1C2E45	true	Solid Tissue	False	Tumor
TCGA-DD-A4NE-01A	bce25281-502e-4599-9679-32dc8462ffb1	Adenomas and Adenocarcinomas	bce25281-502e-4599-9679-32dc8462ffb1	TCGA-DD-A4NE	Liver and intrahepatic bile ducts	Not Reported	white	female	hispanic or latino	Dead	75.0	-27549.0	1936.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	660.0															No	Stage IIIA	0.0	not reported	Liver		27549.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27549.0	75.47671232876712	['7bd3324d-385f-5504-b51b-e81bcb704989', '8faa87df-3c49-56e7-aefd-1609e9eb8623']	['TCGA-DD-A4NE_treatment', 'TCGA-DD-A4NE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:41.978536-05:00']	['2019-07-31T21:09:40.540402-05:00', '2019-07-31T21:09:40.540402-05:00']	['released', 'released']	01	Primary	c8cb1326-7ab9-4e3d-bdc9-9ce42715dac7	Primary Tumor	Not Reported	631.0	200.0	OCT	8E3E5E19-6A21-44B1-B000-F90EA27F6EE0	true	Solid Tissue	False	Tumor
TCGA-DD-A39Y-01A	bed1d731-e382-4b80-9604-e6dd68d9c0ab	Adenomas and Adenocarcinomas	bed1d731-e382-4b80-9604-e6dd68d9c0ab	TCGA-DD-A39Y	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	67.0	-24769.0	1935.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	171.0															No	Stage I	0.0	not reported	Liver		24769.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	24769.0	67.86027397260274	['88ea69f5-8fe0-5bd8-9fd3-7fc9005447d3', 'fe4bd31b-c3ce-512c-b85a-a5e47c086a71']	['TCGA-DD-A39Y_treatment_1', 'TCGA-DD-A39Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:52.367765-05:00', '']	['2019-07-31T21:09:52.264126-05:00', '2019-07-31T21:09:52.264126-05:00']	['released', 'released']	01	Primary	5c9a03b5-3bbe-4377-b837-20cc178a9c2c	Primary Tumor	Not Reported	3530.0	220.0	Unknown	2674265B-6B9D-49B3-9BD2-DF4E77AD4B26	false	Solid Tissue	False	Tumor
TCGA-DD-A4NA-01A	bee9d6c8-948f-4b76-97ca-b985064249ef	Adenomas and Adenocarcinomas	bee9d6c8-948f-4b76-97ca-b985064249ef	TCGA-DD-A4NA	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24603.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIC	0.0	not reported	Liver	1008.0	24603.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T2	8170/3	N1	M0	not reported	C22.0	Liver	Not Reported	not reported	24603.0	67.40547945205479	['90064261-b8e2-570d-ae3f-0a300ecab86f', '9d0a5984-75a0-5ae3-a763-f3f4e768804c']	['TCGA-DD-A4NA_treatment_1', 'TCGA-DD-A4NA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:54.787171-05:00', '']	['2019-07-31T21:09:55.526648-05:00', '2019-07-31T21:09:55.526648-05:00']	['released', 'released']	01	Primary	1e7c53f1-dfb6-4a50-bd83-f8062b1306f2	Primary Tumor	Not Reported	1198.0	110.0	OCT	48C11C04-947E-4954-9687-DF275D897F79	true	Solid Tissue	False	Tumor
TCGA-DD-A4NQ-01A	c05720fe-19c1-4cff-819b-6806b26fc312	Adenomas and Adenocarcinomas	c05720fe-19c1-4cff-819b-6806b26fc312	TCGA-DD-A4NQ	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Dead	60.0	-22111.0	1947.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	373.0															No	Stage II	0.0	not reported	Liver		22111.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22111.0	60.57808219178082	['2538d6a7-3b72-5732-997d-559c32528dc6', '526e6e48-680a-525e-a053-cdb711230c7e']	['TCGA-DD-A4NQ_treatment_1', 'TCGA-DD-A4NQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:25:59.615795-05:00', '']	['2019-07-31T21:10:02.012420-05:00', '2019-07-31T21:10:02.012420-05:00']	['released', 'released']	01	Primary	1e18c64b-42c7-424b-bd32-a1e7797f28a7	Primary Tumor	Not Reported	2030.0	120.0	OCT	D79DB738-2DA3-43F6-898C-4A212964FA03	true	Solid Tissue	False	Tumor
TCGA-DD-A4ND-01A	c0bf9278-9cbb-4361-b4d8-ab172b67e276	Adenomas and Adenocarcinomas	c0bf9278-9cbb-4361-b4d8-ab172b67e276	TCGA-DD-A4ND	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20782.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	2746.0	20782.0	Hepatocellular carcinoma, NOS	yes	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20782.0	56.93698630136986	['3e1ab4b2-f8cf-55d7-bd33-9f7b67de1d18', 'd71168cd-8d9b-5132-b0df-28752fd410d9']	['TCGA-DD-A4ND_treatment', 'TCGA-DD-A4ND_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:01.998968-05:00']	['2019-07-31T21:10:05.074149-05:00', '2019-07-31T21:10:05.074149-05:00']	['released', 'released']	01	Primary	4282039e-396b-44d8-b4ec-ac14c46ddef6	Primary Tumor	Not Reported	2088.0	140.0	OCT	64D878AE-DEEA-4C56-854C-3774038E2914	true	Solid Tissue	False	Tumor
TCGA-ED-A4XI-01A	c52abac9-07da-4b3d-bf8a-2161cacf9682	Adenomas and Adenocarcinomas	c52abac9-07da-4b3d-bf8a-2161cacf9682	TCGA-ED-A4XI	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	58.0	-21497.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	819.0	21497.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21497.0	58.895890410958906	['1ddd225f-712b-5b6e-87a4-31276cd2cae0', 'df2104bc-01b5-56d4-ad5c-52e912677d9c']	['TCGA-ED-A4XI_treatment_1', 'TCGA-ED-A4XI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:14.003554-05:00', '']	['2019-07-31T21:10:20.888520-05:00', '2019-07-31T21:10:20.888520-05:00']	['released', 'released']	01	Primary	25eb5afd-e7a6-4f3c-82b4-a3de1f8f9be1	Primary Tumor	Not Reported	70.0	2000.0	OCT	40130FAC-455F-49B7-A97E-CFFED2202925	true	Solid Tissue	False	Tumor
TCGA-LG-A6GG-01A	c618da6d-3c66-4a6a-8832-3526a3b75410	Adenomas and Adenocarcinomas	c618da6d-3c66-4a6a-8832-3526a3b75410	TCGA-LG-A6GG	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	79.0	-28871.0	1934.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ef6a28c0-1733-5c00-be40-0ea911305be8	LG	Hartford Hospital	Liver hepatocellular carcinoma	NCH																Not Reported	Stage II	0.0	not reported	Liver	387.0	28871.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28871.0	79.0986301369863	['4d1b37ee-01fd-5145-8848-1ab507e09597', '6fe0674b-d337-5cc1-8132-67a443930c31']	['TCGA-LG-A6GG_treatment', 'TCGA-LG-A6GG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:16.469340-05:00']	['2019-07-31T21:10:23.792111-05:00', '2019-07-31T21:10:23.792111-05:00']	['released', 'released']	01	Primary	18000b40-b2e5-4c32-81fe-c7c208e99f33	Primary Tumor	Not Reported	35.0	1140.0	OCT	A7F1EA5C-5797-42D1-AD35-E2E529B26409	true	Solid Tissue	False	Tumor
TCGA-G3-A3CJ-01A	cb8f3c76-da86-4a1d-977c-44ab399b342a	Adenomas and Adenocarcinomas	cb8f3c76-da86-4a1d-977c-44ab399b342a	TCGA-G3-A3CJ	Liver and intrahepatic bile ducts	Not Reported	american indian or alaska native	male	not hispanic or latino	Alive	52.0	-19305.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	594.0	19305.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19305.0	52.89041095890411	['1e4318ab-281e-5d03-956a-dae3562b6649', '20aca155-207b-55bc-b0f7-117d8cf8d4bf']	['TCGA-G3-A3CJ_treatment', 'TCGA-G3-A3CJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:26:33.821415-05:00']	['2019-07-31T21:10:44.681175-05:00', '2019-07-31T21:10:44.681175-05:00']	['released', 'released']	01	Primary	a8ab7daf-079d-458b-ad09-a99306384864	Primary Tumor	Not Reported	113.0	20.0	Unknown	191868C4-3299-4E65-9DB2-C8C43CB83963	false	Solid Tissue	False	Tumor
TCGA-ED-A7XP-01A	cca827ca-0066-497d-83dc-477f3b08ea6d	Adenomas and Adenocarcinomas	cca827ca-0066-497d-83dc-477f3b08ea6d	TCGA-ED-A7XP	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	53.0	-19504.0	1960.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	400.0	19504.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19504.0	53.43561643835616	['b71423de-7ea6-5c77-8831-824645f34a8d', 'dcfd483b-b984-5d2f-908e-5a032c70db71']	['TCGA-ED-A7XP_treatment', 'TCGA-ED-A7XP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:38.532654-05:00']	['2019-07-31T21:10:50.215536-05:00', '2019-07-31T21:10:50.215536-05:00']	['released', 'released']	01	Primary	cbdaac78-7866-47b0-bbde-62e1b84b96d7	Primary Tumor	Not Reported	62.0	780.0	OCT	70432A18-BDAF-465D-9311-66E37E3F941E	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GV-01A	d1aa9c1a-d732-48c0-b669-8a14e0397344	Adenomas and Adenocarcinomas	d1aa9c1a-d732-48c0-b669-8a14e0397344	TCGA-2Y-A9GV	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	54.0	-20011.0	1953.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	2532.0															Not Reported	Stage I	0.0	not reported	Liver		20011.0	Hepatocellular carcinoma, NOS	yes	2007.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20011.0	54.824657534246576	['1c1d8a99-8591-5ab8-94e1-a2476114508e', 'feb37c5f-1ccd-59c2-8464-2337aac3dc92']	['TCGA-2Y-A9GV_treatment', 'TCGA-2Y-A9GV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:26:55.734028-05:00']	['2019-07-31T21:11:11.398363-05:00', '2019-07-31T21:11:11.398363-05:00']	['released', 'released']	01	Primary	cb3afdac-4a19-4d95-bd96-42a1fa5be795	Primary Tumor	Not Reported	2431.0	120.0	OCT	4979AF79-CF92-4D6C-87FD-158C87B5F059	true	Solid Tissue	False	Tumor
TCGA-G3-A5SM-01A	d397e70f-c174-4656-9b7e-5e4c00754410	Adenomas and Adenocarcinomas	d397e70f-c174-4656-9b7e-5e4c00754410	TCGA-G3-A5SM	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	58.0	-21236.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	520.0	21236.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	21236.0	58.18082191780822	['68be2dde-1693-5ea6-8265-31f936e33e39', 'dfc7d4f6-9ecb-5ac2-8f61-b495afa7f928']	['TCGA-G3-A5SM_treatment_1', 'TCGA-G3-A5SM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:58.107166-05:00', '']	['2019-07-31T21:11:14.399885-05:00', '2019-07-31T21:11:14.399885-05:00']	['released', 'released']	01	Primary	8313a442-e572-476a-b96f-565b105834ea	Primary Tumor	Not Reported	111.0	160.0	OCT	791E29AD-22A6-402E-978C-69407C6B748F	true	Solid Tissue	False	Tumor
TCGA-RC-A6M5-01A	d504ee30-6955-4a7b-9311-55ad3decadd5	Adenomas and Adenocarcinomas	d504ee30-6955-4a7b-9311-55ad3decadd5	TCGA-RC-A6M5	Liver and intrahepatic bile ducts	Not Reported	white	female	not reported	Alive	20.0	-7634.0	1992.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage IVA	0.0	not reported	Liver	15.0	7634.0	Hepatocellular carcinoma, fibrolamellar	no	2012.0	No	7th	T1	8171/3	N1	M0	not reported	C22.0	Liver	Not Reported	not reported	7634.0	20.915068493150685	['35b7cc94-52cb-592d-a8f0-0e55d41497e6', '5c6fa26c-fbad-5b74-ba2a-ced42361b7a9']	['TCGA-RC-A6M5_treatment', 'TCGA-RC-A6M5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:27:05.247836-05:00']	['2019-07-31T21:11:23.276218-05:00', '2019-07-31T21:11:23.276218-05:00']	['released', 'released']	01	Primary	60914737-d016-4c0d-bc54-f5fbfde78adb	Primary Tumor	Not Reported	484.0	50.0	OCT	CFE4CEBF-2B23-4ABD-8F50-2B7C4A432AA6	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GX-01A	d6c2c6ce-3483-4fe5-aef6-e40419f728cf	Adenomas and Adenocarcinomas	d6c2c6ce-3483-4fe5-aef6-e40419f728cf	TCGA-2Y-A9GX	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	68.0	-24963.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2442.0	24963.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24963.0	68.3917808219178	['1e44f05d-8f42-5c0b-b87a-0a99b0fecb1c', '2f02c3f4-4311-57ca-88f3-cf6d2287f346']	['TCGA-2Y-A9GX_treatment_1', 'TCGA-2Y-A9GX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:15.135172-05:00', '']	['2019-07-31T21:11:35.412092-05:00', '2019-07-31T21:11:35.412092-05:00']	['released', 'released']	01	Primary	481741ac-d3ae-4e1f-92ee-18d382017605	Primary Tumor	Not Reported	2365.0	90.0	OCT	92541202-F81A-428F-8EF5-19A7C82CC31F	true	Solid Tissue	False	Tumor
TCGA-G3-AAUZ-01A	d74ddbe2-5860-40b1-9bd8-99cc50f3392d	Adenomas and Adenocarcinomas	d74ddbe2-5860-40b1-9bd8-99cc50f3392d	TCGA-G3-AAUZ	Liver and intrahepatic bile ducts	Not Reported	not reported	male	hispanic or latino	Alive	48.0	-17760.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	480.0	17760.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17760.0	48.657534246575345	['20404099-49eb-541e-8d51-abbb7a38e2ed', 'a51872a0-b5b4-5c3b-8a72-00f7f3c05d1f']	['TCGA-G3-AAUZ_treatment_1', 'TCGA-G3-AAUZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:17.506938-05:00', '']	['2019-07-31T21:11:38.335547-05:00', '2019-07-31T21:11:38.335547-05:00']	['released', 'released']	01	Primary	7c4e023a-de49-4a4a-b4cf-26731b5650b2	Primary Tumor	Not Reported	168.0	210.0	OCT	09055681-FB0F-4960-86A0-5D6EBD08FAED	true	Solid Tissue	False	Tumor
TCGA-DD-A39V-01A	dd056692-4e2a-4e45-a4d0-357af9754f0e	Adenomas and Adenocarcinomas	dd056692-4e2a-4e45-a4d0-357af9754f0e	TCGA-DD-A39V	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	77.0	-28254.0	1923.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	643.0															No	Stage II	0.0	not reported	Liver		28254.0	Hepatocellular carcinoma, NOS	no	2000.0	No	5th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28254.0	77.40821917808219	['9ce3806d-9bb0-568c-90af-7a567b000301', 'bc8e0b1e-fdb1-5f3c-ba17-2b9850f7a49e']	['TCGA-DD-A39V_treatment', 'TCGA-DD-A39V_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:27:27.424412-05:00']	['2019-07-31T21:11:50.195507-05:00', '2019-07-31T21:11:50.195507-05:00']	['released', 'released']	01	Primary	23fcd37f-a46a-4f99-944e-aed930b009f7	Primary Tumor	Not Reported	4180.0	180.0	Unknown	AB7EF7A1-F8F1-404A-BF15-2CC53F63C033	false	Solid Tissue	False	Tumor
TCGA-DD-A39V-11A	dd056692-4e2a-4e45-a4d0-357af9754f0e	Adenomas and Adenocarcinomas	dd056692-4e2a-4e45-a4d0-357af9754f0e	TCGA-DD-A39V	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	77.0	-28254.0	1923.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	643.0															No	Stage II	0.0	not reported	Liver		28254.0	Hepatocellular carcinoma, NOS	no	2000.0	No	5th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28254.0	77.40821917808219	['9ce3806d-9bb0-568c-90af-7a567b000301', 'bc8e0b1e-fdb1-5f3c-ba17-2b9850f7a49e']	['TCGA-DD-A39V_treatment', 'TCGA-DD-A39V_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:27:27.424412-05:00']	['2019-07-31T21:11:50.195507-05:00', '2019-07-31T21:11:50.195507-05:00']	['released', 'released']	11	Not Applicable	bee5bcfe-cbfd-4cfc-8214-dc83f557c678	Solid Tissue Normal	Not Reported	4180.0	140.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A4NL-01A	e0067280-2722-46f2-a5a8-352c77b47e38	Adenomas and Adenocarcinomas	e0067280-2722-46f2-a5a8-352c77b47e38	TCGA-DD-A4NL	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	46.0	-16874.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1711.0	16874.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16874.0	46.23013698630137	['04079283-0bf6-5e10-8c27-6c08f838f8a2', 'ce9f0ab5-2f25-51b8-8db6-ba44d5d76ba5']	['TCGA-DD-A4NL_treatment', 'TCGA-DD-A4NL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:34.547272-05:00']	['2019-07-31T21:11:59.114796-05:00', '2019-07-31T21:11:59.114796-05:00']	['released', 'released']	01	Primary	ae09a90d-e285-44c1-993d-75b9aa7749c4	Primary Tumor	Not Reported	1896.0	80.0	OCT	54C7EDE1-EDBE-44A4-A3BE-FD639D6891DA	true	Solid Tissue	False	Tumor
TCGA-CC-A7IF-01A	e0674b82-2fba-421e-be62-58efd0348d44	Adenomas and Adenocarcinomas	e0674b82-2fba-421e-be62-58efd0348d44	TCGA-CC-A7IF	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	59.0	-21845.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	649.0															No	Stage IIIA	0.0	not reported	Liver	0.0	21845.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21845.0	59.84931506849315	['36fcee46-6cfb-5834-8684-0aa3d00ca2d2', '6539de10-6bb6-5231-832f-540c48544310']	['TCGA-CC-A7IF_treatment', 'TCGA-CC-A7IF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:39.581484-05:00']	['2019-07-31T21:12:05.744473-05:00', '2019-07-31T21:12:05.744473-05:00']	['released', 'released']	01	Primary	85bf24dd-ed33-4b46-9739-1994ae3a2c91	Primary Tumor	Not Reported	236.0	380.0	OCT	4CD1A49C-2243-4F21-BF19-EB6F069D431E	true	Solid Tissue	False	Tumor
TCGA-CC-A7IJ-01A	e610a644-0504-445a-bba1-4bae360de4c1	Adenomas and Adenocarcinomas	e610a644-0504-445a-bba1-4bae360de4c1	TCGA-CC-A7IJ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	56.0	-20751.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	382.0	20751.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20751.0	56.85205479452055	['c4647594-e428-508f-b119-8c93aa311adc', 'fbf8ed40-f21f-5991-a766-ec0f57a7cf02']	['TCGA-CC-A7IJ_treatment', 'TCGA-CC-A7IJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:49.200552-05:00']	['2019-07-31T21:12:17.880178-05:00', '2019-07-31T21:12:17.880178-05:00']	['released', 'released']	01	Primary	23d951c1-92e2-4b6b-b716-ff5829e28303	Primary Tumor	Not Reported	168.0	270.0	OCT	0FF7D013-EAEC-4406-B314-0ECEA7B59E69	true	Solid Tissue	False	Tumor
TCGA-DD-AACI-01A	e6fa354e-ada7-41e0-8c8b-38520a5e6601	Adenomas and Adenocarcinomas	e6fa354e-ada7-41e0-8c8b-38520a5e6601	TCGA-DD-AACI	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	69.0	-25236.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1618.0	25236.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25236.0	69.13972602739726	['422a3610-551f-500c-b6fd-6500ee29b4fa', 'c3f85da6-43d0-5f0a-aef2-1cbbfb14c1e3']	['TCGA-DD-AACI_treatment', 'TCGA-DD-AACI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T09:25:15.879891-05:00']	['2019-07-31T16:14:11.319247-05:00', '2019-07-31T16:14:11.319247-05:00']	['released', 'released']	01	Primary	3df80a55-0381-48a9-acb0-58bcf702e209	Primary Tumor	Not Reported	1870.0	320.0	OCT	54CDEB1D-8CF9-4723-9A7D-CD9DFEDFD659	true	Solid Tissue	False	Tumor
TCGA-CC-A7IK-01A	eba5208b-404a-45df-9133-31ff122e7fc0	Adenomas and Adenocarcinomas	eba5208b-404a-45df-9133-31ff122e7fc0	TCGA-CC-A7IK	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	59.0	-21552.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	262.0															No	Stage IIIA	0.0	not reported	Liver	0.0	21552.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21552.0	59.04657534246575	['4b202c15-5027-5fa9-9fca-43b75bacb584', '7314da94-d917-5069-afa4-9115ee2930ad']	['TCGA-CC-A7IK_treatment', 'TCGA-CC-A7IK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:54.539919-05:00']	['2019-07-31T21:12:23.528188-05:00', '2019-07-31T21:12:23.528188-05:00']	['released', 'released']	01	Primary	9ae951fb-97e7-42d2-bb74-a490e22583ee	Primary Tumor	Not Reported	163.0	470.0	OCT	6944ABF0-8C64-48D5-920A-6FA6DAC8A57B	true	Solid Tissue	False	Tumor
TCGA-G3-AAV1-01A	ee6d81bf-0470-4652-aff0-d85f6ab67626	Adenomas and Adenocarcinomas	ee6d81bf-0470-4652-aff0-d85f6ab67626	TCGA-G3-AAV1	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	51.0	-18973.0	1962.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	359.0															No	Stage IIIC	0.0	not reported	Liver		18973.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18973.0	51.98082191780822	['17b79e7f-c95d-537d-93ce-a2a9dd0d72a8', '4458f978-6407-5e27-84de-b9aa7519e9b5']	['TCGA-G3-AAV1_treatment', 'TCGA-G3-AAV1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:03.958454-05:00']	['2019-07-31T21:12:36.372968-05:00', '2019-07-31T21:12:36.372968-05:00']	['released', 'released']	01	Primary	ad535210-07ee-41a5-b9f7-8548e41df779	Primary Tumor	Not Reported	146.0	470.0	OCT	0124A3C7-B294-464E-831D-3E4738E3F305	true	Solid Tissue	False	Tumor
TCGA-G3-AAV3-01A	efc865fd-7c74-4361-9d7a-eef923dbcd24	Adenomas and Adenocarcinomas	efc865fd-7c74-4361-9d7a-eef923dbcd24	TCGA-G3-AAV3	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21449.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	412.0	21449.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21449.0	58.76438356164383	['2ff44133-dd20-59b1-9391-acbee5798790', 'bff0b07f-ad69-5e9d-9c45-07b04f84148e']	['TCGA-G3-AAV3_treatment_1', 'TCGA-G3-AAV3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:28:08.941753-05:00', '']	['2019-07-31T21:12:42.491473-05:00', '2019-07-31T21:12:42.491473-05:00']	['released', 'released']	01	Primary	b0d2fd7c-04e8-459b-80ee-e7f786f163d1	Primary Tumor	Not Reported	98.0	150.0	OCT	275E9EDA-413F-40BE-943C-9521F8CC297A	true	Solid Tissue	False	Tumor
TCGA-DD-AAEB-01A	f0ece8e2-a6b0-4ed9-a613-d2fbb20e51b1	Adenomas and Adenocarcinomas	f0ece8e2-a6b0-4ed9-a613-d2fbb20e51b1	TCGA-DD-AAEB	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	60.0	-22121.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	478.0	22121.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22121.0	60.605479452054794	['471bdcfc-9125-51fa-94a2-586a0a7c7d35', '69bba14e-55e1-58dc-81bf-2f10966a78c0']	['TCGA-DD-AAEB_treatment_1', 'TCGA-DD-AAEB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:28:11.300723-05:00', '']	['2019-07-31T21:12:45.496434-05:00', '2019-07-31T21:12:45.496434-05:00']	['released', 'released']	01	Primary	a89b7843-1c53-4d0c-977f-9674bfa717f1	Primary Tumor	Not Reported	468.0	70.0	OCT	E991576A-60BD-4C11-9B4E-EA43F19D06C3	true	Solid Tissue	False	Tumor
TCGA-MI-A75H-01A	f3f6ba92-c68f-4313-99f4-0281272e02b6	Adenomas and Adenocarcinomas	f3f6ba92-c68f-4313-99f4-0281272e02b6	TCGA-MI-A75H	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	77.0	-28371.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2b1c1097-fa63-5d15-b5d3-c54f5eacb9c8	MI	BLN - Baylor	Liver hepatocellular carcinoma	NCH																Not Reported		0.0	not reported	Liver	747.0	28371.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th		8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	28371.0	77.72876712328767	['188f8e84-29f7-561f-bdc5-36f724d08afd', '1d42a256-f16a-5f0e-b41b-7fcac0b50055']	['TCGA-MI-A75H_treatment', 'TCGA-MI-A75H_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:16.105426-05:00']	['2019-07-31T21:12:51.569846-05:00', '2019-07-31T21:12:51.569846-05:00']	['released', 'released']	01	Primary	637339c3-46aa-4e37-82c8-09ef2b18cf9c	Primary Tumor	Not Reported	287.0	30.0	OCT	57959509-A138-4131-BE87-9A77ED365702	true	Solid Tissue	False	Tumor
TCGA-G3-A25V-01A	f435ec00-0db8-46b4-96bf-890a9d931df3	Adenomas and Adenocarcinomas	f435ec00-0db8-46b4-96bf-890a9d931df3	TCGA-G3-A25V	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	68.0	-25144.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	860.0	25144.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25144.0	68.88767123287671	['369e78ec-0ed5-5810-bc93-db8f9c14c332', '9565a3d4-b366-5020-b9ba-f865b61fc545']	['TCGA-G3-A25V_treatment', 'TCGA-G3-A25V_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:18.361103-05:00']	['2019-07-31T21:12:54.556941-05:00', '2019-07-31T21:12:54.556941-05:00']	['released', 'released']	01	Primary	634ab666-0845-4b62-a2a1-abd408d8b829	Primary Tumor	Not Reported	223.0	100.0	Unknown	F52224B9-1FAF-4F71-B017-22AAEBA8F75D	false	Solid Tissue	False	Tumor
TCGA-CC-A9FS-01A	f661a921-2e59-424b-a145-e22664b73728	Adenomas and Adenocarcinomas	f661a921-2e59-424b-a145-e22664b73728	TCGA-CC-A9FS	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	55.0	-20157.0	1958.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	211.0	20157.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20157.0	55.224657534246575	['aa01512f-972c-5282-b30c-a59eff6695a6', 'd6500501-e95e-5b53-a358-b43624cf3f13']	['TCGA-CC-A9FS_treatment', 'TCGA-CC-A9FS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:23.150354-05:00']	['2019-07-31T21:13:00.520110-05:00', '2019-07-31T21:13:00.520110-05:00']	['released', 'released']	01	Primary	729ca3a4-1c6b-4c84-b4ce-150bb21d631d	Primary Tumor	Not Reported	142.0	190.0	OCT	F47FE6A0-1095-45DD-8CEF-33363FA9F52F	true	Solid Tissue	False	Tumor
TCGA-DD-AACF-01A	635aad0b-9c47-4564-821f-c00ddb280d53	Adenomas and Adenocarcinomas	635aad0b-9c47-4564-821f-c00ddb280d53	TCGA-DD-AACF	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	68.0	-25172.0	1940.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	365.0															No	Stage I	0.0	not reported	Liver		25172.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25172.0	68.96438356164384	['a0de0050-b8d6-5164-b294-2a698953a268', 'cbc910f9-3bf3-5d23-8ea7-b53d4145b768']	['TCGA-DD-AACF_treatment', 'TCGA-DD-AACF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:31.443934-05:00']	['2019-07-31T21:03:17.058609-05:00', '2019-07-31T21:03:17.058609-05:00']	['released', 'released']	01	Primary	0a4ceca6-6ac5-416e-bdb9-4ef957f5f9ee	Primary Tumor	Not Reported	1952.0	210.0	OCT	57E9FFF0-F926-4793-AF09-691BDA2248C9	true	Solid Tissue	False	Tumor
TCGA-BC-A10Y-01A	6533648f-1353-4253-b65b-d472aacf5751	Adenomas and Adenocarcinomas	6533648f-1353-4253-b65b-d472aacf5751	TCGA-BC-A10Y	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	76.0	-28049.0	1926.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	711.0															No		0.0	not reported	Liver		28049.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T4	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	28049.0	76.84657534246575	['89d4bc1a-701f-5aad-8ccb-bda6d52686bb', 'dd54ffb7-b816-53ce-a9bd-f767f245ba95']	['TCGA-BC-A10Y_treatment_1', 'TCGA-BC-A10Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:36.285854-05:00', '']	['2019-07-31T21:03:23.552576-05:00', '2019-07-31T21:03:23.552576-05:00']	['released', 'released']	01	Primary	06ba5a5e-1718-4208-9811-8a157a520645	Primary Tumor	Not Reported	2961.0	340.0	Unknown	20CD1D6D-C4ED-43AD-9FCD-0A683FD96C6E	false	Solid Tissue	False	Tumor
TCGA-BC-A10Y-11A	6533648f-1353-4253-b65b-d472aacf5751	Adenomas and Adenocarcinomas	6533648f-1353-4253-b65b-d472aacf5751	TCGA-BC-A10Y	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	76.0	-28049.0	1926.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	711.0															No		0.0	not reported	Liver		28049.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T4	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	28049.0	76.84657534246575	['89d4bc1a-701f-5aad-8ccb-bda6d52686bb', 'dd54ffb7-b816-53ce-a9bd-f767f245ba95']	['TCGA-BC-A10Y_treatment_1', 'TCGA-BC-A10Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:36.285854-05:00', '']	['2019-07-31T21:03:23.552576-05:00', '2019-07-31T21:03:23.552576-05:00']	['released', 'released']	11	Not Applicable	297d707f-df19-4e78-9008-b2f568068eb4	Solid Tissue Normal	Not Reported	2961.0	160.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A119-01A	66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c	Adenomas and Adenocarcinomas	66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c	TCGA-DD-A119	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	40.0	-14613.0	1963.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	223.0															No	Stage IV	0.0	not reported	Liver		14613.0	Hepatocellular carcinoma, NOS	no	2003.0	No	6th	T3a	8170/3	N0	M1	not reported	C22.0	Liver	Not Reported	not reported	14613.0	40.035616438356165	['139cc8d8-a15c-5dd1-b748-1fcb553a93bc', '48d48758-76ce-5818-98de-1f403edce635']	['TCGA-DD-A119_treatment', 'TCGA-DD-A119_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:20:43.661162-05:00']	['2019-07-31T21:03:32.670168-05:00', '2019-07-31T21:03:32.670168-05:00']	['released', 'released']	01	Primary	7f290198-d88f-465c-8b83-d48bdaa57b4b	Primary Tumor	Not Reported	2738.0	160.0	Unknown	F8B8C948-933A-4B28-A0D1-98166C9B16EF	false	Solid Tissue	False	Tumor
TCGA-DD-A119-11A	66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c	Adenomas and Adenocarcinomas	66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c	TCGA-DD-A119	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	40.0	-14613.0	1963.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	223.0															No	Stage IV	0.0	not reported	Liver		14613.0	Hepatocellular carcinoma, NOS	no	2003.0	No	6th	T3a	8170/3	N0	M1	not reported	C22.0	Liver	Not Reported	not reported	14613.0	40.035616438356165	['139cc8d8-a15c-5dd1-b748-1fcb553a93bc', '48d48758-76ce-5818-98de-1f403edce635']	['TCGA-DD-A119_treatment', 'TCGA-DD-A119_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:20:43.661162-05:00']	['2019-07-31T21:03:32.670168-05:00', '2019-07-31T21:03:32.670168-05:00']	['released', 'released']	11	Not Applicable	d9735f12-76c0-4f95-9ce5-91ca885862b4	Solid Tissue Normal	Not Reported	2738.0	210.0	Unknown		false	Solid Tissue	False	Normal
TCGA-CC-5258-01A	6a93206a-c25c-4e45-b0ba-0a21bd8253b6	Adenomas and Adenocarcinomas	6a93206a-c25c-4e45-b0ba-0a21bd8253b6	TCGA-CC-5258	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	48.0	-17586.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	129.0															No	Stage II	0.0	not reported	Liver	0.0	17586.0	Hepatocellular carcinoma, NOS	no	2010.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17586.0	48.18082191780822	['35bbfaed-f33b-5617-93d7-5001fb936365', 'ecfceeea-3526-5e6b-a2bb-aec642c87df6']	['TCGA-CC-5258_treatment_1', 'TCGA-CC-5258_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:55.909893-05:00', '']	['2019-07-31T21:03:47.973076-05:00', '2019-07-31T21:03:47.973076-05:00']	['released', 'released']	01	Primary	d928ac5d-960f-4ebe-8826-0e03b55dc34e	Primary Tumor	Not Reported	147.0	1700.0	OCT	F63EEB94-37AE-43FC-97B9-8EBF328C2134	true	Solid Tissue	False	Tumor
TCGA-DD-A1EG-11A	6c79f64b-63fe-46f5-bf7b-77208231b0f2	Adenomas and Adenocarcinomas	6c79f64b-63fe-46f5-bf7b-77208231b0f2	TCGA-DD-A1EG	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	76.0	-28108.0	1931.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1372.0															No	Stage I	0.0	not reported	Liver		28108.0	Hepatocellular carcinoma, NOS	no	2007.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	28108.0	77.00821917808219	['5755a41a-7d49-54ee-9bb1-59aa3b05e3be', '96b8deb2-528f-548e-802b-35bfa7ee06fc']	['TCGA-DD-A1EG_treatment_1', 'TCGA-DD-A1EG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:20:58.310688-05:00', '']	['2019-07-31T21:03:50.678620-05:00', '2019-07-31T21:03:50.678620-05:00']	['released', 'released']	11	Not Applicable	47e4251c-0035-411a-b2dc-ddbae8ee757a	Solid Tissue Normal	Not Reported	1386.0	170.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-A1EG-01A	6c79f64b-63fe-46f5-bf7b-77208231b0f2	Adenomas and Adenocarcinomas	6c79f64b-63fe-46f5-bf7b-77208231b0f2	TCGA-DD-A1EG	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	76.0	-28108.0	1931.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1372.0															No	Stage I	0.0	not reported	Liver		28108.0	Hepatocellular carcinoma, NOS	no	2007.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	28108.0	77.00821917808219	['5755a41a-7d49-54ee-9bb1-59aa3b05e3be', '96b8deb2-528f-548e-802b-35bfa7ee06fc']	['TCGA-DD-A1EG_treatment_1', 'TCGA-DD-A1EG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:20:58.310688-05:00', '']	['2019-07-31T21:03:50.678620-05:00', '2019-07-31T21:03:50.678620-05:00']	['released', 'released']	01	Primary	e8b59658-06c6-46b7-b51f-ed52de0c403e	Primary Tumor	Not Reported	1386.0	20.0	OCT	D3F371AB-487A-47A8-8EE7-2D27D62FE482	true	Solid Tissue	False	Tumor
TCGA-DD-AACB-01A	6d2e8bc2-ca86-41c1-ae49-289e20fce758	Adenomas and Adenocarcinomas	6d2e8bc2-ca86-41c1-ae49-289e20fce758	TCGA-DD-AACB	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	74.0	-27103.0	1934.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2324.0	27103.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27103.0	74.25479452054795	['252e00db-54b4-5121-843c-38aaadd48b48', 'b017d09d-58bb-5365-9d62-8a7bb93fb585']	['TCGA-DD-AACB_treatment', 'TCGA-DD-AACB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T09:25:13.615201-05:00']	['2019-07-31T16:14:08.192108-05:00', '2019-07-31T16:14:08.192108-05:00']	['released', 'released']	01	Primary	b6104862-f135-46a7-86a4-1e12b96386e6	Primary Tumor	Not Reported	2045.0	410.0	OCT	40E83F82-43B5-426D-A120-2F2F597332C6	true	Solid Tissue	False	Tumor
TCGA-G3-AAV0-01A	6e657705-8579-433b-af7a-b6155b599518	Adenomas and Adenocarcinomas	6e657705-8579-433b-af7a-b6155b599518	TCGA-G3-AAV0	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	58.0	-21249.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	476.0	21249.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21249.0	58.21643835616438	['14fce117-0011-5135-a2a9-5cce0b7c0734', 'c096181e-22ac-5914-a05c-adf7b27d4ca3']	['TCGA-G3-AAV0_treatment_1', 'TCGA-G3-AAV0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T09:12:48.556882-05:00', '']	['2019-07-31T15:58:31.161786-05:00', '2019-07-31T15:58:31.161786-05:00']	['released', 'released']	01	Primary	d4862074-e347-4318-a4a4-bf1878ead618	Primary Tumor	Not Reported	163.0	350.0	OCT	07528302-2925-4767-A47C-FE4EBA621202	true	Solid Tissue	False	Tumor
TCGA-BC-A10Z-11A	709f1e4d-f5e8-4a0b-8254-23f037f4bae7	Adenomas and Adenocarcinomas	709f1e4d-f5e8-4a0b-8254-23f037f4bae7	TCGA-BC-A10Z	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	62.0	-22913.0	1941.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	34.0															No	Stage I	0.0	not reported	Liver		22913.0	Hepatocellular carcinoma, NOS	no	2003.0	No	6th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	22913.0	62.775342465753425	['19a30c64-abf7-560f-a1e1-e06e2109bb17', '8f281926-ea8f-552c-bdd2-5be8ab9604d8']	['TCGA-BC-A10Z_treatment_1', 'TCGA-BC-A10Z_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:07.396438-05:00', '']	['2019-07-31T21:04:03.546345-05:00', '2019-07-31T21:04:03.546345-05:00']	['released', 'released']	11	Not Applicable	91614e15-a2e1-4025-9974-7802db70a6f3	Solid Tissue Normal	Not Reported	2652.0	160.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A10Z-01A	709f1e4d-f5e8-4a0b-8254-23f037f4bae7	Adenomas and Adenocarcinomas	709f1e4d-f5e8-4a0b-8254-23f037f4bae7	TCGA-BC-A10Z	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	62.0	-22913.0	1941.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	34.0															No	Stage I	0.0	not reported	Liver		22913.0	Hepatocellular carcinoma, NOS	no	2003.0	No	6th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	22913.0	62.775342465753425	['19a30c64-abf7-560f-a1e1-e06e2109bb17', '8f281926-ea8f-552c-bdd2-5be8ab9604d8']	['TCGA-BC-A10Z_treatment_1', 'TCGA-BC-A10Z_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:07.396438-05:00', '']	['2019-07-31T21:04:03.546345-05:00', '2019-07-31T21:04:03.546345-05:00']	['released', 'released']	01	Primary	a758e425-e4f9-4b71-86f0-f82f4331055d	Primary Tumor	Not Reported	2652.0	160.0	Unknown	427BA175-823D-4C68-B659-D53CFEB5EA45	false	Solid Tissue	False	Tumor
TCGA-EP-A2KC-01A	71681db9-fa90-4fe1-a497-67d501eb75f0	Adenomas and Adenocarcinomas	71681db9-fa90-4fe1-a497-67d501eb75f0	TCGA-EP-A2KC	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	62.0	-22677.0	1949.0	2011.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH	19.0															No	Stage I	0.0	not reported	Liver		22677.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22677.0	62.12876712328767	['3039de9d-6bfc-5b3b-a2d8-5ab493e1f2e2', '56b5c69a-0b7a-5c70-bd89-9d5a4a13e08e']	['TCGA-EP-A2KC_treatment', 'TCGA-EP-A2KC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:17.035350-05:00']	['2019-07-31T21:04:15.421183-05:00', '2019-07-31T21:04:15.421183-05:00']	['released', 'released']	01	Primary	e3e1e85e-585f-4a19-b972-6119f1e39237	Primary Tumor	Not Reported	30.0	260.0	Unknown	F45A4E99-3856-4455-BF21-B767A0A4FA82	false	Solid Tissue	False	Tumor
TCGA-BC-A69H-01A	79df037c-7d37-4e6c-a654-57708a4f87aa	Adenomas and Adenocarcinomas	79df037c-7d37-4e6c-a654-57708a4f87aa	TCGA-BC-A69H	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	64.0	-23380.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	444.0	23380.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	23380.0	64.05479452054794	['77ce5f92-5d6d-5e2e-8adc-d2e92a587588', 'f387b93d-3888-5086-861c-fe763466cea5']	['TCGA-BC-A69H_treatment_1', 'TCGA-BC-A69H_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:34.564441-05:00', '']	['2019-07-31T21:04:36.397148-05:00', '2019-07-31T21:04:36.397148-05:00']	['released', 'released']	01	Primary	7b0389ae-8b72-4e9a-ac52-802a384a14a3	Primary Tumor	Not Reported	94.0	610.0	Unknown	AE56DFF8-AF71-4217-A491-8F78543E186D	false	Solid Tissue	False	Tumor
TCGA-CC-A5UC-01A	7e589ee1-ffcc-448a-a275-829ca26a597e	Adenomas and Adenocarcinomas	7e589ee1-ffcc-448a-a275-829ca26a597e	TCGA-CC-A5UC	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	63.0	-23156.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	347.0															No	Stage IIIA	0.0	not reported	Liver	0.0	23156.0	Hepatocellular carcinoma, NOS	no	2012.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23156.0	63.441095890410956	['9818f9ce-06eb-5179-b557-0d143b4abe34', 'a1bf42ac-bd1c-5edc-8f48-faa01247f329']	['TCGA-CC-A5UC_treatment', 'TCGA-CC-A5UC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:54.053680-05:00']	['2019-07-31T21:05:01.056042-05:00', '2019-07-31T21:05:01.056042-05:00']	['released', 'released']	01	Primary	f83ace1a-16f0-4d9a-89cc-077fbaa69d0c	Primary Tumor	Not Reported	99.0	210.0	OCT	21B4A68D-F76C-49BB-81D7-423E957852E1	true	Solid Tissue	False	Tumor
TCGA-ZS-A9CF-02A	7fe5e2d9-c514-47bc-8387-3f940f7a822d	Adenomas and Adenocarcinomas	7fe5e2d9-c514-47bc-8387-3f940f7a822d	TCGA-ZS-A9CF	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	64.0	-23510.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33a38997-77be-52dc-b79d-890d8d4b792b	ZS	Tayside Tissue Bank	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2412.0	23510.0	Hepatocellular carcinoma, NOS	no	2008.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23510.0	64.41095890410959	['02ff719e-c5a6-5404-a5ff-ed0d79f331d9', '820c7baf-6e82-535e-8372-65cb956a5753']	['TCGA-ZS-A9CF_treatment', 'TCGA-ZS-A9CF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:01.189228-05:00']	['2019-07-31T21:05:10.895528-05:00', '2019-07-31T21:05:10.895528-05:00']	['released', 'released']	02	Recurrence	922ac7c8-f72f-412f-9245-16348a6b4551	Recurrent Tumor	Not Reported	2217.0	30.0	Unknown	5D79D370-F174-4CCB-AF64-5617EBF352BE	false	Solid Tissue	False	Tumor
TCGA-ZS-A9CF-01A	7fe5e2d9-c514-47bc-8387-3f940f7a822d	Adenomas and Adenocarcinomas	7fe5e2d9-c514-47bc-8387-3f940f7a822d	TCGA-ZS-A9CF	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	64.0	-23510.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33a38997-77be-52dc-b79d-890d8d4b792b	ZS	Tayside Tissue Bank	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2412.0	23510.0	Hepatocellular carcinoma, NOS	no	2008.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23510.0	64.41095890410959	['02ff719e-c5a6-5404-a5ff-ed0d79f331d9', '820c7baf-6e82-535e-8372-65cb956a5753']	['TCGA-ZS-A9CF_treatment', 'TCGA-ZS-A9CF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:01.189228-05:00']	['2019-07-31T21:05:10.895528-05:00', '2019-07-31T21:05:10.895528-05:00']	['released', 'released']	01	Primary	b5eb7e48-6f6c-4485-ba52-6430518192b4	Primary Tumor	Not Reported	2217.0	30.0	Unknown	B6FCD13D-3DC8-4997-A5A3-3C5D71728436	false	Solid Tissue	False	Tumor
TCGA-DD-A1EA-01A	8052c374-9435-4588-b970-68565c56dbb7	Adenomas and Adenocarcinomas	8052c374-9435-4588-b970-68565c56dbb7	TCGA-DD-A1EA	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	68.0	-24925.0	1934.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2415.0	24925.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24925.0	68.28767123287672	['88e4f571-e177-57cc-94ca-45876b4c50b4', 'a3b49d60-3ad8-51bd-b08f-03af99c9a423']	['TCGA-DD-A1EA_treatment', 'TCGA-DD-A1EA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:06.016970-05:00']	['2019-07-31T21:05:16.827138-05:00', '2019-07-31T21:05:16.827138-05:00']	['released', 'released']	01	Primary	ad574b69-318d-449a-ad7d-78de9de5a042	Primary Tumor	Not Reported	3298.0	80.0	OCT	0B2D3D3C-78CC-4DB7-9A8C-92BF05CFB68B	true	Solid Tissue	False	Tumor
TCGA-DD-A73F-01A	870c86e7-d6e1-4f9d-bb0b-bd1c66d6bcde	Adenomas and Adenocarcinomas	870c86e7-d6e1-4f9d-bb0b-bd1c66d6bcde	TCGA-DD-A73F	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28234.0	1933.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1085.0	28234.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	28234.0	77.35342465753425	['46fbdc06-7500-556a-9b62-9c186a8c2cc6', 'fd52f9d1-0c50-5053-9a2a-7c3068930a65']	['TCGA-DD-A73F_treatment_1', 'TCGA-DD-A73F_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:27.799288-05:00', '']	['2019-07-31T21:05:43.712314-05:00', '2019-07-31T21:05:43.712314-05:00']	['released', 'released']	01	Primary	a15cf382-8456-4096-96a6-f211dea6ba78	Primary Tumor	Not Reported	975.0	250.0	Unknown	2FCC867C-91AD-40B3-8046-FFB84BDD2EA7	false	Solid Tissue	False	Tumor
TCGA-ED-A97K-01A	8778dc9e-a7db-4464-a8af-11addb5e441a	Adenomas and Adenocarcinomas	8778dc9e-a7db-4464-a8af-11addb5e441a	TCGA-ED-A97K	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	54.0	-20073.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	6.0	20073.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2013.0	No	7th	T3a	8180/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20073.0	54.99452054794521	['342d61a9-506c-502d-867e-08b0125e7695', 'f46f6d7b-45bd-5b2f-99f5-46ec6242a59b']	['TCGA-ED-A97K_treatment_1', 'TCGA-ED-A97K_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'no']	['2019-04-28T13:22:32.540383-05:00', '']	['2019-07-31T21:05:49.920958-05:00', '2019-07-31T21:05:49.920958-05:00']	['released', 'released']	01	Primary	6b015154-d6c7-4aa4-b631-45439cecfb97	Primary Tumor	Not Reported	92.0	1650.0	OCT	518E0619-1C4F-475C-904E-009300CF1768	true	Solid Tissue	False	Tumor
TCGA-DD-A3A1-11A	877b9f6b-9b34-40ed-933f-8fef204edf21	Adenomas and Adenocarcinomas	877b9f6b-9b34-40ed-933f-8fef204edf21	TCGA-DD-A3A1	Liver and intrahepatic bile ducts	Not Reported	not reported	male	not reported	Dead	65.0	-24046.0	1936.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	233.0															No	Stage IIIA	0.0	not reported	Liver		24046.0	Hepatocellular carcinoma, NOS	no	2001.0	No	5th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24046.0	65.87945205479453	['5a4fc3a9-7086-575c-8a92-018f730fd31b', 'e898b5c8-acba-5e06-bad8-6ca6db03ac44']	['TCGA-DD-A3A1_treatment_1', 'TCGA-DD-A3A1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:34.942331-05:00', '']	['2019-07-31T21:05:52.883560-05:00', '2019-07-31T21:05:52.883560-05:00']	['released', 'released']	11	Not Applicable	118cbeed-8dee-4253-9850-f2ba7e589a0d	Solid Tissue Normal	Not Reported	3753.0	180.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A3A1-01A	877b9f6b-9b34-40ed-933f-8fef204edf21	Adenomas and Adenocarcinomas	877b9f6b-9b34-40ed-933f-8fef204edf21	TCGA-DD-A3A1	Liver and intrahepatic bile ducts	Not Reported	not reported	male	not reported	Dead	65.0	-24046.0	1936.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	233.0															No	Stage IIIA	0.0	not reported	Liver		24046.0	Hepatocellular carcinoma, NOS	no	2001.0	No	5th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24046.0	65.87945205479453	['5a4fc3a9-7086-575c-8a92-018f730fd31b', 'e898b5c8-acba-5e06-bad8-6ca6db03ac44']	['TCGA-DD-A3A1_treatment_1', 'TCGA-DD-A3A1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:34.942331-05:00', '']	['2019-07-31T21:05:52.883560-05:00', '2019-07-31T21:05:52.883560-05:00']	['released', 'released']	01	Primary	fb5cca74-f88a-410f-9220-503cd644c002	Primary Tumor	Not Reported	3753.0	240.0	Unknown	EAB38F5C-4399-48DE-A4F5-18B7CB982689	false	Solid Tissue	False	Tumor
TCGA-DD-A4NG-01A	89791f8f-dc06-4a04-b166-afbfd6cf53de	Adenomas and Adenocarcinomas	89791f8f-dc06-4a04-b166-afbfd6cf53de	TCGA-DD-A4NG	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	77.0	-28234.0	1934.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	802.0															No	Stage IIIA	0.0	not reported	Liver	445.0	28234.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3a	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28234.0	77.35342465753425	['9a0525fb-9e06-5e24-8c84-885b3edccc6d', 'c0e96cf2-5bee-5eb4-a685-3da7c7ce70c1']	['TCGA-DD-A4NG_treatment_1', 'TCGA-DD-A4NG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:42.036417-05:00', '']	['2019-07-31T21:06:01.892290-05:00', '2019-07-31T21:06:01.892290-05:00']	['released', 'released']	01	Primary	38507edd-dfb4-4931-9895-2c0482bd4555	Primary Tumor	Not Reported	629.0	280.0	OCT	4E4F148F-7C70-43DE-802E-271078BDFB4F	true	Solid Tissue	False	Tumor
TCGA-DD-AADG-01A	89d1261c-6d93-4298-a2af-b5ff52be0cb6	Adenomas and Adenocarcinomas	89d1261c-6d93-4298-a2af-b5ff52be0cb6	TCGA-DD-AADG	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	70.0	-25887.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	1145.0	25887.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25887.0	70.92328767123287	['1a151bf3-c874-5aad-aff6-aa9578863fc1', 'bdaa042c-8c47-573d-992a-6d6b607f93b2']	['TCGA-DD-AADG_treatment_1', 'TCGA-DD-AADG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:46.676028-05:00', '']	['2019-07-31T21:06:07.529448-05:00', '2019-07-31T21:06:07.529448-05:00']	['released', 'released']	01	Primary	1acafc42-0ee1-405c-af15-c71581ff6d69	Primary Tumor	Not Reported	862.0	80.0	OCT	E6130559-E3EA-4010-9031-071D55816383	true	Solid Tissue	False	Tumor
TCGA-DD-AACV-01A	8e79ea29-787e-4a33-8465-9891776f47ed	Adenomas and Adenocarcinomas	8e79ea29-787e-4a33-8465-9891776f47ed	TCGA-DD-AACV	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	53.0	-19660.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1531.0	19660.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19660.0	53.863013698630134	['6f71e462-7db6-538f-8968-81f8a0df757d', '9534432f-5dce-529e-b8be-138825b11a85']	['TCGA-DD-AACV_treatment', 'TCGA-DD-AACV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:58.534619-05:00']	['2019-07-31T21:06:23.831150-05:00', '2019-07-31T21:06:23.831150-05:00']	['released', 'released']	01	Primary	e37b6eaa-e3e8-4268-ae61-7a571488f519	Primary Tumor	Not Reported	1231.0	40.0	OCT	9BC1D204-8E33-4E30-94B7-6AE5E6484AD2	true	Solid Tissue	False	Tumor
TCGA-DD-AAVV-01A	915f531b-8448-41c7-9dfb-9c83062b906e	Adenomas and Adenocarcinomas	915f531b-8448-41c7-9dfb-9c83062b906e	TCGA-DD-AAVV	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	56.0	-20751.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2455.0	20751.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20751.0	56.85205479452055	['3362c47f-03c1-5430-a68b-a39e5c212d8e', '34112f34-2e0c-5714-a700-922ec228fe37']	['TCGA-DD-AAVV_treatment_1', 'TCGA-DD-AAVV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:06.012957-05:00', '']	['2019-07-31T21:06:33.380628-05:00', '2019-07-31T21:06:33.380628-05:00']	['released', 'released']	01	Primary	4e04e745-d37e-4412-9995-fae0927b6140	Primary Tumor	Not Reported	2513.0	70.0	OCT	5F24D049-6BE5-403B-9E5A-399921814C68	true	Solid Tissue	False	Tumor
TCGA-DD-AACJ-01A	93afbfa1-4d03-4105-8dda-b095f0ab308a	Adenomas and Adenocarcinomas	93afbfa1-4d03-4105-8dda-b095f0ab308a	TCGA-DD-AACJ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	75.0	-27528.0	1933.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2102.0	27528.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27528.0	75.41917808219178	['2c51dbef-64d8-5ff0-964d-49bc5fa16469', '747a33cd-9e51-5952-8eed-937d9626f1bf']	['TCGA-DD-AACJ_treatment_1', 'TCGA-DD-AACJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:16.232721-05:00', '']	['2019-07-31T21:06:45.284746-05:00', '2019-07-31T21:06:45.284746-05:00']	['released', 'released']	01	Primary	24b87b32-13c6-4f3c-8dd1-775b15f5654b	Primary Tumor	Not Reported	1835.0	380.0	OCT	2CD482F0-0882-4A61-9B40-1D7B3DBC625E	true	Solid Tissue	False	Tumor
TCGA-EP-A12J-11A	959918d7-cb84-4745-a72f-d138176b1ecb	Adenomas and Adenocarcinomas	959918d7-cb84-4745-a72f-d138176b1ecb	TCGA-EP-A12J	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	62.0	-22997.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	570.0	22997.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22997.0	63.00547945205479	['2501df72-8136-5508-960f-5f682d7e16e9', 'b07ac05e-d44a-590f-b9df-06141eb194c2']	['TCGA-EP-A12J_treatment_1', 'TCGA-EP-A12J_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:26.154208-05:00', '']	['2019-07-31T21:06:56.855120-05:00', '2019-07-31T21:06:56.855120-05:00']	['released', 'released']	11	Not Applicable	1a528b30-2444-4d9f-a6d6-1c43a175cbba	Solid Tissue Normal	Not Reported	59.0	410.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EP-A12J-01A	959918d7-cb84-4745-a72f-d138176b1ecb	Adenomas and Adenocarcinomas	959918d7-cb84-4745-a72f-d138176b1ecb	TCGA-EP-A12J	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	62.0	-22997.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	570.0	22997.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22997.0	63.00547945205479	['2501df72-8136-5508-960f-5f682d7e16e9', 'b07ac05e-d44a-590f-b9df-06141eb194c2']	['TCGA-EP-A12J_treatment_1', 'TCGA-EP-A12J_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:26.154208-05:00', '']	['2019-07-31T21:06:56.855120-05:00', '2019-07-31T21:06:56.855120-05:00']	['released', 'released']	01	Primary	9d2fd2fd-b53a-4dbd-ace1-278e53f629af	Primary Tumor	Not Reported	59.0	300.0	Unknown	CC7D4052-0068-425B-A5C3-873059716D44	false	Solid Tissue	False	Tumor
TCGA-DD-AADO-01A	9f056388-7529-4fd1-af11-c82cc350f51c	Adenomas and Adenocarcinomas	9f056388-7529-4fd1-af11-c82cc350f51c	TCGA-DD-AADO	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	55.0	-20139.0	1958.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	453.0	20139.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20139.0	55.175342465753424	['1ee63291-9b5d-5817-b4ba-ba608adab663', '7f85ae82-ebd5-5f73-9294-fc39bdf11f00']	['TCGA-DD-AADO_treatment_1', 'TCGA-DD-AADO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:48.718521-05:00', '']	['2019-07-31T21:07:22.261159-05:00', '2019-07-31T21:07:22.261159-05:00']	['released', 'released']	01	Primary	dff1bb71-01ee-480e-83c9-98abafe60d2e	Primary Tumor	Not Reported	155.0	20.0	OCT	7A832B85-3B55-44E5-AC66-35DBADADEAEC	true	Solid Tissue	False	Tumor
TCGA-DD-AAVS-01A	9fc30c21-2c78-4843-a658-fe84a64b8fad	Adenomas and Adenocarcinomas	9fc30c21-2c78-4843-a658-fe84a64b8fad	TCGA-DD-AAVS	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	56.0	-20586.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1823.0	20586.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20586.0	56.4	['cfdb5ea1-0bdc-5d21-ac75-222ba8a3ecac', 'fd3a0556-8f6d-5500-acdc-9481f0588b1c']	['TCGA-DD-AAVS_treatment', 'TCGA-DD-AAVS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:51.044821-05:00']	['2019-07-31T21:07:24.982911-05:00', '2019-07-31T21:07:24.982911-05:00']	['released', 'released']	01	Primary	8a8c8e2f-36fd-4fa4-8b45-f92607f26845	Primary Tumor	Not Reported	2201.0	60.0	OCT	5F714C34-BB01-49D1-B41C-C64DE8D0EC0E	true	Solid Tissue	False	Tumor
TCGA-DD-AAE6-01A	a61f823b-9164-4bd6-92f4-0a8d8ff0f55e	Adenomas and Adenocarcinomas	a61f823b-9164-4bd6-92f4-0a8d8ff0f55e	TCGA-DD-AAE6	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	59.0	-21764.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	141.0	21764.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21764.0	59.62739726027397	['04afe9bc-c4df-5405-9afe-26574822790c', 'd472d406-e51d-5a90-85cc-fce9d0b2172a']	['TCGA-DD-AAE6_treatment', 'TCGA-DD-AAE6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:24:10.271719-05:00']	['2019-07-31T21:07:46.929102-05:00', '2019-07-31T21:07:46.929102-05:00']	['released', 'released']	01	Primary	99cc40c9-d05e-4b6b-ac17-1524d2adf79b	Primary Tumor	Not Reported	399.0	80.0	OCT	1B3F62E9-8E87-43FA-AEA8-00C89D678F8F	true	Solid Tissue	False	Tumor
TCGA-G3-AAV6-01A	a6733fa1-030a-45ed-9c24-0e64164d4998	Adenomas and Adenocarcinomas	a6733fa1-030a-45ed-9c24-0e64164d4998	TCGA-G3-AAV6	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	53.0	-19556.0	1960.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	65.0															No	Stage IIIA	0.0	not reported	Liver		19556.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19556.0	53.57808219178082	['382c5e0d-87e6-5ef6-9fc5-792ddc317c26', '6f50de72-1cc6-587e-9a2d-cfdbff8e9c11']	['TCGA-G3-AAV6_treatment_1', 'TCGA-G3-AAV6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:15.177046-05:00', '']	['2019-07-31T21:07:52.739927-05:00', '2019-07-31T21:07:52.739927-05:00']	['released', 'released']	01	Primary	df60f0b3-aa75-41ac-9921-fe3bbc3998eb	Primary Tumor	Not Reported	24.0	360.0	OCT	AEA78B89-B8C2-457C-B524-87C19B685C03	true	Solid Tissue	False	Tumor
TCGA-ED-A82E-01A	a96b67ba-6180-4b80-8792-877860421ca0	Adenomas and Adenocarcinomas	a96b67ba-6180-4b80-8792-877860421ca0	TCGA-ED-A82E	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	60.0	-22234.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	408.0	22234.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22234.0	60.915068493150685	['b39f9eba-670e-565a-b986-183c9e6e7116', 'f7af8469-90ad-538f-ae2b-aa538780c0e4']	['TCGA-ED-A82E_treatment_1', 'TCGA-ED-A82E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:30.022236-05:00', '']	['2019-07-31T21:08:10.864104-05:00', '2019-07-31T21:08:10.864104-05:00']	['released', 'released']	01	Primary	f05898c4-ee50-4a7b-8504-1cbb6f7b1e41	Primary Tumor	Not Reported	78.0	1320.0	OCT	2FE90807-3C01-4956-B565-A5A18A08C93C	true	Solid Tissue	False	Tumor
TCGA-DD-AAC9-01A	ac6a1e0c-dba0-4b21-b12b-a501ed796bec	Adenomas and Adenocarcinomas	ac6a1e0c-dba0-4b21-b12b-a501ed796bec	TCGA-DD-AAC9	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18911.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	347.0	18911.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18911.0	51.81095890410959	['20b21ab7-f9bf-5fb8-8776-f4a03156bdaa', 'c6618598-9de9-57bf-a3c7-792157d79480']	['TCGA-DD-AAC9_treatment', 'TCGA-DD-AAC9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:24:39.862702-05:00']	['2019-07-31T21:08:25.176505-05:00', '2019-07-31T21:08:25.176505-05:00']	['released', 'released']	01	Primary	d657ebda-3f44-4dee-8963-88dd5c4f5002	Primary Tumor	Not Reported	2069.0	130.0	OCT	A993CEA3-6AA2-4CE7-A9EC-8318B1377E99	true	Solid Tissue	False	Tumor
TCGA-UB-A7MB-01A	af1e56af-410c-4cad-a4e8-1c6937f1a350	Adenomas and Adenocarcinomas	af1e56af-410c-4cad-a4e8-1c6937f1a350	TCGA-UB-A7MB	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	24.0	-8951.0	1989.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	601.0	8951.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	8951.0	24.523287671232875	['23640b8c-827c-547b-b5f0-a28882b27cc9', 'ee0af280-0b2c-5afc-8293-87fc41a1b56e']	['TCGA-UB-A7MB_treatment', 'TCGA-UB-A7MB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:24:54.207645-05:00']	['2019-07-31T21:08:43.256142-05:00', '2019-07-31T21:08:43.256142-05:00']	['released', 'released']	01	Primary	110dc5cc-bfe1-427d-87ef-037b719bf96f	Primary Tumor	Not Reported	176.0	140.0	OCT	8B239487-4D0E-45EF-84EB-F61B23C42FE7	true	Solid Tissue	False	Tumor
TCGA-QA-A7B7-01A	b0952fd6-62ee-44ef-9a2a-e5262ed4721a	Adenomas and Adenocarcinomas	b0952fd6-62ee-44ef-9a2a-e5262ed4721a	TCGA-QA-A7B7	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	48.0	-17636.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	73b91143-060e-5d8f-8183-b5dff41350b0	QA	Emory University	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	94.0	17636.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	17636.0	48.31780821917808	['493da4da-97b5-5214-8298-f2ba922ac332', 'bf095257-ede1-5aa0-9ef4-6f9d402bfd1a']	['TCGA-QA-A7B7_treatment', 'TCGA-QA-A7B7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:01.280949-05:00']	['2019-07-31T21:08:52.167265-05:00', '2019-07-31T21:08:52.167265-05:00']	['released', 'released']	01	Primary	82d635ac-27d1-4aad-bc9c-d52885345163	Primary Tumor	Not Reported	27.0	80.0	OCT	20257CE0-FCFF-41B4-B9A3-47397B147ED8	true	Solid Tissue	False	Tumor
TCGA-CC-A7IL-01A	b54df65f-8a6b-4405-9918-90d53418804c	Adenomas and Adenocarcinomas	b54df65f-8a6b-4405-9918-90d53418804c	TCGA-CC-A7IL	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	61.0	-22319.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	278.0															No	Stage IIIA	0.0	not reported	Liver	0.0	22319.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22319.0	61.14794520547945	['61b29ace-425b-5b5d-a182-2dafe0b69ff4', '6252ba36-c1e2-5cf8-acc3-387735196c1d']	['TCGA-CC-A7IL_treatment_1', 'TCGA-CC-A7IL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:13.523846-05:00', '']	['2019-07-31T21:09:07.103151-05:00', '2019-07-31T21:09:07.103151-05:00']	['released', 'released']	01	Primary	1445b31d-812d-4ddf-8965-0a970b9ea562	Primary Tumor	Not Reported	161.0	230.0	OCT	2C629C1E-6849-47F6-B9B4-A97BC0453EFF	true	Solid Tissue	False	Tumor
TCGA-YA-A8S7-01A	bb2069d3-e699-4a8a-bb61-b3c28b98a66b	Adenomas and Adenocarcinomas	bb2069d3-e699-4a8a-bb61-b3c28b98a66b	TCGA-YA-A8S7	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Dead	68.0	-25188.0	1944.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	f9d27424-561d-5b8b-9351-bc1e1cb59caa	YA	Spectrum Health	Liver hepatocellular carcinoma	NCH	412.0															No	Stage IIIA	0.0	not reported	Liver		25188.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T3a	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	25188.0	69.00821917808219	['42777ab3-c8f5-5d78-82d5-7402a68eab8c', 'c6a9c5d2-fbbc-54a4-975e-2bea0eb331c0']	['TCGA-YA-A8S7_treatment', 'TCGA-YA-A8S7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:25:37.300500-05:00']	['2019-07-31T21:09:34.751656-05:00', '2019-07-31T21:09:34.751656-05:00']	['released', 'released']	01	Primary	ae98b44c-15ab-4534-8ecc-274d4784ae4f	Primary Tumor	Not Reported	383.0	160.0	Unknown	CFF98B7F-C09E-441D-BE5F-48A06036735B	false	Solid Tissue	False	Tumor
TCGA-2Y-A9H6-01A	bc3502bc-bbf6-44f2-a1f4-d1567819aefb	Adenomas and Adenocarcinomas	bc3502bc-bbf6-44f2-a1f4-d1567819aefb	TCGA-2Y-A9H6	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24982.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	357.0	24982.0	Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24982.0	68.44383561643835	['b6df23f0-21ee-5b7f-a4ce-db883f3c60a1', 'deb8ee2d-67ac-50e9-9f0c-199030face37']	['TCGA-2Y-A9H6_treatment_1', 'TCGA-2Y-A9H6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:39.771610-05:00', '']	['2019-07-31T21:09:37.842035-05:00', '2019-07-31T21:09:37.842035-05:00']	['released', 'released']	01	Primary	9bf4058e-e487-4033-88d9-4951f47afe4c	Primary Tumor	Not Reported	982.0	100.0	OCT	0B39CB6A-D208-4128-AB46-50C7DB072865	true	Solid Tissue	False	Tumor
TCGA-DD-AAVY-01A	c36f9ffe-515b-4895-b82a-aadc49fe3016	Adenomas and Adenocarcinomas	c36f9ffe-515b-4895-b82a-aadc49fe3016	TCGA-DD-AAVY	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	56.0	-20709.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	1970.0	20709.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20709.0	56.73698630136986	['2e5e9eab-d14b-54af-86ec-fbaa532a9605', '395eba24-b8c0-5393-80a8-e447ccff93ff']	['TCGA-DD-AAVY_treatment', 'TCGA-DD-AAVY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:04.172473-05:00']	['2019-07-31T21:10:07.986954-05:00', '2019-07-31T21:10:07.986954-05:00']	['released', 'released']	01	Primary	ddc48731-4b43-4122-9e19-9be1e072ac2c	Primary Tumor	Not Reported	1826.0	40.0	OCT	ADDCC231-66AE-4136-AAEC-DCA3DA1C4159	true	Solid Tissue	False	Tumor
TCGA-BW-A5NQ-01A	c7f1b389-aec7-4993-8afb-b7a56064f8fc	Adenomas and Adenocarcinomas	c7f1b389-aec7-4993-8afb-b7a56064f8fc	TCGA-BW-A5NQ	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	63.0	-23353.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	0e691470-b18b-5803-9e4a-ee2cfbaae7b4	BW	St. Joseph's Medical Center-(MD)	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	0.0	23353.0	Hepatocellular carcinoma, NOS	yes	2010.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23353.0	63.98082191780822	['b3fe93ae-31a9-5816-a9d0-b052100b0c4d', 'c88606b6-e730-50a2-a4c8-c09e7770dafb']	['TCGA-BW-A5NQ_treatment', 'TCGA-BW-A5NQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:26:23.796827-05:00']	['2019-07-31T21:10:32.803941-05:00', '2019-07-31T21:10:32.803941-05:00']	['released', 'released']	01	Primary	c8ffe03a-62c3-4b47-9dea-cb3377f59abb	Primary Tumor	Not Reported	1022.0	160.0	Unknown	D56121DE-22A7-44D8-97EF-E33D395ABAF9	false	Solid Tissue	False	Tumor
TCGA-DD-AADU-01A	cf358fb8-866c-4780-a550-d6c1c30b8c63	Adenomas and Adenocarcinomas	cf358fb8-866c-4780-a550-d6c1c30b8c63	TCGA-DD-AADU	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	60.0	-21940.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	554.0	21940.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21940.0	60.10958904109589	['4ab1375b-d4b4-539e-be0b-3f3218fc29df', '832f1dcc-cdf8-5436-b2ff-dcbbbe4a9371']	['TCGA-DD-AADU_treatment_1', 'TCGA-DD-AADU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:48.301106-05:00', '']	['2019-07-31T21:11:02.538476-05:00', '2019-07-31T21:11:02.538476-05:00']	['released', 'released']	01	Primary	8566dfb0-570b-4540-b4cd-eaec48cc27fd	Primary Tumor	Not Reported	280.0	30.0	OCT	5135A7C0-6CA4-404E-9649-E7B664EDD1B8	true	Solid Tissue	False	Tumor
TCGA-2Y-A9H2-01A	cf7f0473-eaf3-4259-a68e-475a782fc84c	Adenomas and Adenocarcinomas	cf7f0473-eaf3-4259-a68e-475a782fc84c	TCGA-2Y-A9H2	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23653.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1731.0	23653.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	23653.0	64.8027397260274	['617037ba-4b94-534e-9e4c-13cc7f17649a', 'b927f96d-5176-5df5-a2e2-ab02124739a4']	['TCGA-2Y-A9H2_treatment', 'TCGA-2Y-A9H2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:50.778116-05:00']	['2019-07-31T21:11:05.344529-05:00', '2019-07-31T21:11:05.344529-05:00']	['released', 'released']	01	Primary	10eb3f76-4d00-4b1d-8697-ee5306f2cc8e	Primary Tumor	Not Reported	1443.0	80.0	OCT	4C19CF84-5E30-4854-A084-F6EE53A80543	true	Solid Tissue	False	Tumor
TCGA-CC-A8HS-01A	d18cd259-267e-47b5-9353-ad3454e048a0	Adenomas and Adenocarcinomas	d18cd259-267e-47b5-9353-ad3454e048a0	TCGA-CC-A8HS	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	18.0	-6617.0	1995.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	300.0															No	Stage IIIC	0.0	not reported	Liver	0.0	6617.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N1	M0	not reported	C22.0	Liver	Not Reported	not reported	6617.0	18.12876712328767	['4dd42c93-6ae2-58e9-99a7-bc85e1c429ef', '6c09a1b0-38fe-523d-a13f-9709f3916c49']	['TCGA-CC-A8HS_treatment', 'TCGA-CC-A8HS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:53.201692-05:00']	['2019-07-31T21:11:08.311811-05:00', '2019-07-31T21:11:08.311811-05:00']	['released', 'released']	01	Primary	41ca0b98-d4b2-4a09-a5e3-20fedb440926	Primary Tumor	Not Reported	223.0	240.0	OCT	D7967904-FE4B-4BB5-92B2-5354404AC939	true	Solid Tissue	False	Tumor
TCGA-DD-AACY-01A	d884561b-5828-4c47-acd7-3f02e181b596	Adenomas and Adenocarcinomas	d884561b-5828-4c47-acd7-3f02e181b596	TCGA-DD-AACY	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	61.0	-22332.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1450.0	22332.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22332.0	61.18356164383562	['220a34de-1351-5db3-9edd-060908212f98', '33a82c86-eaa8-58c1-932a-6365312c7868']	['TCGA-DD-AACY_treatment', 'TCGA-DD-AACY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:24.746614-05:00']	['2019-07-31T21:11:47.252877-05:00', '2019-07-31T21:11:47.252877-05:00']	['released', 'released']	01	Primary	d99a9d3c-de04-454e-8aa8-2624fd07f2c3	Primary Tumor	Not Reported	1154.0	60.0	OCT	4FB4E64B-1E40-40D8-A90A-ECACC59657E3	true	Solid Tissue	False	Tumor
TCGA-BD-A3EP-01A	de302b98-250d-42fe-9945-11e1b2bbd3c6	Adenomas and Adenocarcinomas	de302b98-250d-42fe-9945-11e1b2bbd3c6	TCGA-BD-A3EP	Liver and intrahepatic bile ducts	Not Reported	black or african american	female	not hispanic or latino	Alive	75.0	-27756.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	86f2ecb2-6c8a-51da-943d-4acb6d72576d	BD	University of Pittsburgh	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	409.0	27756.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27756.0	76.04383561643836	['2355ea39-b633-5b37-af84-95e9f59cd968', '47b407a1-18eb-5505-b45f-0ccf1a6bbe10']	['TCGA-BD-A3EP_treatment_1', 'TCGA-BD-A3EP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:29.815491-05:00', '']	['2019-07-31T21:11:53.001118-05:00', '2019-07-31T21:11:53.001118-05:00']	['released', 'released']	01	Primary	553dfa2d-c496-4982-8ba1-32d5054864be	Primary Tumor	Not Reported	398.0	140.0	OCT	4560D451-6F7E-4F3F-8AF7-F393DB000ABD	true	Solid Tissue	False	Tumor
TCGA-BD-A3EP-11A	de302b98-250d-42fe-9945-11e1b2bbd3c6	Adenomas and Adenocarcinomas	de302b98-250d-42fe-9945-11e1b2bbd3c6	TCGA-BD-A3EP	Liver and intrahepatic bile ducts	Not Reported	black or african american	female	not hispanic or latino	Alive	75.0	-27756.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	86f2ecb2-6c8a-51da-943d-4acb6d72576d	BD	University of Pittsburgh	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	409.0	27756.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27756.0	76.04383561643836	['2355ea39-b633-5b37-af84-95e9f59cd968', '47b407a1-18eb-5505-b45f-0ccf1a6bbe10']	['TCGA-BD-A3EP_treatment_1', 'TCGA-BD-A3EP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:29.815491-05:00', '']	['2019-07-31T21:11:53.001118-05:00', '2019-07-31T21:11:53.001118-05:00']	['released', 'released']	11	Not Applicable	708114ce-2aa0-48f9-a23f-780add9da784	Solid Tissue Normal	Not Reported	398.0	120.0	OCT		true	Solid Tissue	False	Normal
TCGA-CC-A123-01A	e2f6d3aa-b817-4193-a550-8e53265aa336	Adenomas and Adenocarcinomas	e2f6d3aa-b817-4193-a550-8e53265aa336	TCGA-CC-A123	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	24.0	-9107.0	1986.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	219.0	9107.0	Hepatocellular carcinoma, NOS	no	2010.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	9107.0	24.95068493150685	['8b35eae4-98bd-5c73-a8b1-a12689ed3090', 'ec5e7357-2062-55e0-a233-ffc894ed0dea']	['TCGA-CC-A123_treatment_1', 'TCGA-CC-A123_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T09:25:08.473500-05:00', '']	['2019-07-31T16:14:01.984813-05:00', '2019-07-31T16:14:01.984813-05:00']	['released', 'released']	01	Primary	98eeca7b-4918-4176-927d-0ac1e48c5d7e	Primary Tumor	Not Reported	49.0	280.0	OCT	65D669CE-291F-489A-9B25-AD619B906900	true	Solid Tissue	False	Tumor
TCGA-DD-AADY-01A	e42e4244-dce8-453a-b5e0-7593a9b5af61	Adenomas and Adenocarcinomas	e42e4244-dce8-453a-b5e0-7593a9b5af61	TCGA-DD-AADY	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	55.0	-20233.0	1958.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	555.0	20233.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20233.0	55.43287671232877	['24514ac5-bd1b-5f99-a3b8-4ae29ffef9d3', 'cb308217-0501-5fe5-8dfc-a05519a5d280']	['TCGA-DD-AADY_treatment', 'TCGA-DD-AADY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:41.976421-05:00']	['2019-07-31T21:12:08.747964-05:00', '2019-07-31T21:12:08.747964-05:00']	['released', 'released']	01	Primary	a6a4b393-f67d-4b53-a5d0-3407fa71b9f1	Primary Tumor	Not Reported	308.0	20.0	OCT	49B92F18-C6E7-4704-A6DD-F098A4B74DDA	true	Solid Tissue	False	Tumor
TCGA-UB-AA0V-01A	ea214f79-0f6b-403f-8693-c844bf4b77cb	Adenomas and Adenocarcinomas	ea214f79-0f6b-403f-8693-c844bf4b77cb	TCGA-UB-AA0V	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25340.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	314.0	25340.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th		8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25340.0	69.42465753424658	['111f0e7b-f2cb-5763-9a83-681e98dfe1fd', '892406cf-8e08-59ba-8c20-41c9ebb72281']	['TCGA-UB-AA0V_treatment', 'TCGA-UB-AA0V_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:51.728883-05:00']	['2019-07-31T21:12:20.739084-05:00', '2019-07-31T21:12:20.739084-05:00']	['released', 'released']	01	Primary	04a89fe8-95fd-4c44-95ef-7953a6aaf304	Primary Tumor	Not Reported	7.0	110.0	OCT	0BEA5A64-9DDE-45A8-A788-5EE2CEC6F6E4	true	Solid Tissue	False	Tumor
TCGA-DD-AACC-01A	ed8c0d53-5db0-4b77-95ec-15971926e313	Adenomas and Adenocarcinomas	ed8c0d53-5db0-4b77-95ec-15971926e313	TCGA-DD-AACC	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	61.0	-22499.0	1947.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1685.0															No	Stage I	0.0	not reported	Liver		22499.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22499.0	61.64109589041096	['d01b2b71-da71-5dd6-a69c-c7af822f71cc', 'f6363b60-2f08-555d-b53f-ae49420da6f9']	['TCGA-DD-AACC_treatment_1', 'TCGA-DD-AACC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:59.439131-05:00', '']	['2019-07-31T21:12:29.807925-05:00', '2019-07-31T21:12:29.807925-05:00']	['released', 'released']	01	Primary	9e4d2c81-e63b-4807-bdd5-f3192b95b3ad	Primary Tumor	Not Reported	2029.0	40.0	OCT	0093FD02-9219-4901-8DA2-D98AEBDCF1D5	true	Solid Tissue	False	Tumor
TCGA-EP-A3RK-11A	f15279dd-5d12-460b-9bd1-b4f95681ca65	Adenomas and Adenocarcinomas	f15279dd-5d12-460b-9bd1-b4f95681ca65	TCGA-EP-A3RK	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	73.0	-26985.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	363.0	26985.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T3a	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26985.0	73.93150684931507	['3b1f506e-b45f-51a6-93ce-81c1b56520c0', '7f37cad4-ce75-5a7c-bd1c-fb1030dfed52']	['TCGA-EP-A3RK_treatment', 'TCGA-EP-A3RK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:28:13.734830-05:00']	['2019-07-31T21:12:48.454462-05:00', '2019-07-31T21:12:48.454462-05:00']	['released', 'released']	11	Not Applicable	13576f15-4fba-4ea4-b682-32271d2768b5	Solid Tissue Normal	Not Reported	14.0	880.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EP-A3RK-01A	f15279dd-5d12-460b-9bd1-b4f95681ca65	Adenomas and Adenocarcinomas	f15279dd-5d12-460b-9bd1-b4f95681ca65	TCGA-EP-A3RK	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	73.0	-26985.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	363.0	26985.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T3a	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26985.0	73.93150684931507	['3b1f506e-b45f-51a6-93ce-81c1b56520c0', '7f37cad4-ce75-5a7c-bd1c-fb1030dfed52']	['TCGA-EP-A3RK_treatment', 'TCGA-EP-A3RK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:28:13.734830-05:00']	['2019-07-31T21:12:48.454462-05:00', '2019-07-31T21:12:48.454462-05:00']	['released', 'released']	01	Primary	253da6ee-8786-4a20-a0dc-58816a8a9c39	Primary Tumor	Not Reported	14.0	1040.0	Unknown	49F4E752-EFBE-458F-85C0-1B81B9506D91	false	Solid Tissue	False	Tumor
TCGA-BC-A8YO-01A	f53a70d9-a774-4969-896e-2dcdd4d02a7a	Adenomas and Adenocarcinomas	f53a70d9-a774-4969-896e-2dcdd4d02a7a	TCGA-BC-A8YO	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	66.0	-24189.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage IIIC	0.0	not reported	Liver	562.0	24189.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24189.0	66.27123287671233	['25b08923-3377-52f2-aeea-046e8ecfaad2', '9c23e7df-1c0c-5382-90aa-6471d31d7861']	['TCGA-BC-A8YO_treatment_1', 'TCGA-BC-A8YO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T09:25:11.061966-05:00', '']	['2019-07-31T16:14:04.913651-05:00', '2019-07-31T16:14:04.913651-05:00']	['released', 'released']	01	Primary	4218932d-170a-41f0-89ec-92a71a7b13dd	Primary Tumor	Not Reported	141.0	680.0	Unknown	BF3E21AE-D9DC-4011-908A-32C6C1FE10FB	false	Solid Tissue	False	Tumor
TCGA-UB-A7MC-01A	f82aff25-0725-48d1-aefd-d60800f7d1ab	Adenomas and Adenocarcinomas	f82aff25-0725-48d1-aefd-d60800f7d1ab	TCGA-UB-A7MC	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	59.0	-21733.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	500.0	21733.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	21733.0	59.54246575342466	['00045c7d-6e29-5aa4-b580-9e7e4a8df49d', '4bb9bb43-c4f3-5735-887c-6a824d8a527a']	['TCGA-UB-A7MC_treatment_1', 'TCGA-UB-A7MC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'yes']	['2019-04-28T13:28:28.286772-05:00', '']	['2019-07-31T21:13:07.232301-05:00', '2019-07-31T21:13:07.232301-05:00']	['released', 'released']	01	Primary	208fa54c-b09d-421b-bacd-fe9e91fca556	Primary Tumor	Not Reported	88.0	540.0	OCT	B391B6EA-425D-411D-AA4C-EE43B861E807	true	Solid Tissue	False	Tumor
TCGA-GJ-A3OU-01A	fb2abc2a-ecf1-4184-912f-26a649f861ff	Adenomas and Adenocarcinomas	fb2abc2a-ecf1-4184-912f-26a649f861ff	TCGA-GJ-A3OU	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	59.0	-21671.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	cf12df24-06a9-523f-ab6c-234ab95cf1c9	GJ	ABS - IUPUI	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	879.0	21671.0	Hepatocellular carcinoma, clear cell type	no	2011.0	No	7th	T1	8174/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21671.0	59.37260273972603	['50017a4f-56e6-559a-a23c-f45d374d8484', 'b46c5aac-5dd9-55ad-b05f-9427824c13ce']	['TCGA-GJ-A3OU_treatment_1', 'TCGA-GJ-A3OU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:28:30.761401-05:00', '']	['2019-07-31T21:13:10.158131-05:00', '2019-07-31T21:13:10.158131-05:00']	['released', 'released']	01	Primary	fe863395-3ebb-45c5-aab9-b0181906c89c	Primary Tumor	Not Reported	69.0	130.0	Unknown	4ABC92BD-6D5C-462D-8DDC-2A3CEE065C13	false	Solid Tissue	False	Tumor
TCGA-ZP-A9D2-01A	cbb89556-d783-4e70-8db4-ef53e9a45922	Adenomas and Adenocarcinomas	cbb89556-d783-4e70-8db4-ef53e9a45922	TCGA-ZP-A9D2	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	51.0	-18717.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH	765.0															No		0.0	not reported	Liver	743.0	18717.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18717.0	51.27945205479452	['b9035034-9b24-52d0-af52-796d364da9cd', 'c56e12b3-a265-5734-b51e-ba3b4bb89cba']	['TCGA-ZP-A9D2_treatment', 'TCGA-ZP-A9D2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:36.164107-05:00']	['2019-07-31T21:10:47.467734-05:00', '2019-07-31T21:10:47.467734-05:00']	['released', 'released']	01	Primary	44ab8403-654c-49cd-9577-090448c1d9eb	Primary Tumor	Not Reported	654.0	60.0	Unknown	260D67D7-9E8C-4A3B-B031-8AB4A05BC688	false	Solid Tissue	False	Tumor
TCGA-DD-AACP-01A	7ad77384-0946-4fb5-9b10-bdc8a5fc8d87	Adenomas and Adenocarcinomas	7ad77384-0946-4fb5-9b10-bdc8a5fc8d87	TCGA-DD-AACP	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	64.0	-23728.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	415.0	23728.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23728.0	65.00821917808219	['b94c010d-4cef-564f-93fa-45e60a0dc6f8', 'f5b3eb78-ac5a-5ac9-8f0e-136807fa61be']	['TCGA-DD-AACP_treatment_1', 'TCGA-DD-AACP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:42.106397-05:00', '']	['2019-07-31T21:04:45.976838-05:00', '2019-07-31T21:04:45.976838-05:00']	['released', 'released']	01	Primary	2fb00cd2-6470-42f1-83bb-2c89e170fbd9	Primary Tumor	Not Reported	1625.0	20.0	OCT	7FDD120A-A5AD-4209-B167-34BA2289A784	true	Solid Tissue	False	Tumor
TCGA-CC-5261-01A	1ad7f17e-b3b8-40e9-aab8-5a17e0aec408	Adenomas and Adenocarcinomas	1ad7f17e-b3b8-40e9-aab8-5a17e0aec408	TCGA-CC-5261	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	44.0	-16373.0	1966.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	97.0															No	Stage II	0.0	not reported	Liver	12.0	16373.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16373.0	44.85753424657534	['140ffd01-28f7-528c-a71d-bb013387cf94', 'f07403e4-54ac-5513-966a-3d6bb3b85390']	['TCGA-CC-5261_treatment_1', 'TCGA-CC-5261_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:31.984191-05:00', '']	['2019-07-31T20:57:05.715232-05:00', '2019-07-31T20:57:05.715232-05:00']	['released', 'released']	01	Primary	538998f3-5230-4963-8b67-d34de695e97d	Primary Tumor	Not Reported	110.0	450.0	OCT	30B90892-0231-450E-8A93-28F387047463	true	Solid Tissue	False	Tumor
TCGA-ZS-A9CD-01A	9197ca4c-e48c-43af-ba61-d894faf3cc24	Adenomas and Adenocarcinomas	9197ca4c-e48c-43af-ba61-d894faf3cc24	TCGA-ZS-A9CD	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	73.0	-26915.0	1937.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33a38997-77be-52dc-b79d-890d8d4b792b	ZS	Tayside Tissue Bank	Liver hepatocellular carcinoma	NCH	1386.0															No	Stage II	0.0	not reported	Liver		26915.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26915.0	73.73972602739725	['283a3b0b-e2d6-5d1a-b72c-cd771b4601e5', '4dc9899e-b05f-5da7-86a4-a69e24a5adfe']	['TCGA-ZS-A9CD_treatment', 'TCGA-ZS-A9CD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:11.029260-05:00']	['2019-07-31T21:06:39.014696-05:00', '2019-07-31T21:06:39.014696-05:00']	['released', 'released']	01	Primary	e7570871-e848-416e-b84c-19c052a10a78	Primary Tumor	Not Reported	1268.0	30.0	OCT	11C6E09D-89C3-43B9-B884-247278242067	true	Solid Tissue	False	Tumor
TCGA-UB-A7MD-01A	c49b41bf-0025-4682-966b-cfe8fb2b2546	Adenomas and Adenocarcinomas	c49b41bf-0025-4682-966b-cfe8fb2b2546	TCGA-UB-A7MD	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	67.0	-24717.0	1946.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH	52.0															No	Stage I	0.0	not reported	Liver		24717.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	24717.0	67.71780821917808	['6bceb6d5-fc2b-5ce1-b2ec-f08b4e880fdc', 'f362047f-df82-5003-adb6-c85051d3cd08']	['TCGA-UB-A7MD_treatment', 'TCGA-UB-A7MD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:06.433564-05:00']	['2019-07-31T21:10:11.781498-05:00', '2019-07-31T21:10:11.781498-05:00']	['released', 'released']	01	Primary	2a293fef-70c7-4884-98ba-a5fea95bf541	Primary Tumor	Not Reported	128.0	140.0	OCT	DF3145A4-6311-4DCD-914F-3B3AABE4DAE7	true	Solid Tissue	False	Tumor
TCGA-2Y-A9HA-01A	a25a714e-c142-482b-91c8-4fea763e0254	Adenomas and Adenocarcinomas	a25a714e-c142-482b-91c8-4fea763e0254	TCGA-2Y-A9HA	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	70.0	-25892.0	1942.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	36.0															No	Stage II	0.0	not reported	Liver		25892.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25892.0	70.93698630136986	['1af75d93-12ab-5b1e-8116-1f14300cb5f0', 'ad55f0d9-30a5-5c2f-a398-9557e12bbbb1']	['TCGA-2Y-A9HA_treatment_1', 'TCGA-2Y-A9HA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:56.091685-05:00', '']	['2019-07-31T21:07:30.979365-05:00', '2019-07-31T21:07:30.979365-05:00']	['released', 'released']	01	Primary	40ec7948-f54b-4888-a0c2-df47f32a85f4	Primary Tumor	Not Reported	713.0	90.0	OCT	C07BBEDC-59CE-41B9-9D47-EDFD8AEB26B9	true	Solid Tissue	False	Tumor
TCGA-RC-A6M3-01A	c6a74db2-cf97-4c7b-be8c-557ee27e1d43	Adenomas and Adenocarcinomas	c6a74db2-cf97-4c7b-be8c-557ee27e1d43	TCGA-RC-A6M3	Liver and intrahepatic bile ducts	Not Reported	american indian or alaska native	male	not reported	Alive	24.0	-8899.0	1985.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	0.0	8899.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	8899.0	24.38082191780822	['2be29f8b-f81e-5514-9116-92abd4285ed6', '62310fe4-e1f1-5311-82ab-12d4edad5681']	['TCGA-RC-A6M3_treatment', 'TCGA-RC-A6M3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:26:18.930725-05:00']	['2019-07-31T21:10:26.750843-05:00', '2019-07-31T21:10:26.750843-05:00']	['released', 'released']	01	Primary	642ac714-e100-4da6-a696-0cf9465a10b4	Primary Tumor	Not Reported	1539.0	50.0	OCT	E01BF72F-DD73-46D9-8767-A90593DB371B	true	Solid Tissue	False	Tumor
TCGA-ZP-A9CY-01A	34fd27ce-930a-4f29-8a6e-dae4949d92eb	Adenomas and Adenocarcinomas	34fd27ce-930a-4f29-8a6e-dae4949d92eb	TCGA-ZP-A9CY	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	66.0	-24223.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	782.0	24223.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24223.0	66.36438356164383	['132b5d02-ce9b-586c-91e4-31185f2ecf30', 'd121fa52-ba66-59eb-a858-0e952cbcff60']	['TCGA-ZP-A9CY_treatment_1', 'TCGA-ZP-A9CY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:11.133877-05:00', '']	['2019-07-31T20:59:10.658899-05:00', '2019-07-31T20:59:10.658899-05:00']	['released', 'released']	01	Primary	ab63fd64-07e1-432c-b904-57adbc7b95db	Primary Tumor	Not Reported	839.0	30.0	Unknown	849947D6-678A-4536-A5FB-9A56489C8D3E	false	Solid Tissue	False	Tumor
TCGA-DD-AAVZ-01A	11f69d9f-a67d-41fa-95a9-baa194b3fcfb	Adenomas and Adenocarcinomas	11f69d9f-a67d-41fa-95a9-baa194b3fcfb	TCGA-DD-AAVZ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	38.0	-14005.0	1971.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1900.0	14005.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	14005.0	38.36986301369863	['bdef9f0e-6978-51d5-a807-555a37630009', 'd5018c8d-4fa5-57a9-a87f-66c58bcb2e6c']	['TCGA-DD-AAVZ_treatment', 'TCGA-DD-AAVZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:02.838394-05:00']	['2019-07-31T20:56:29.150010-05:00', '2019-07-31T20:56:29.150010-05:00']	['released', 'released']	01	Primary	d04de415-140d-4600-8586-4f5ff51f043e	Primary Tumor	Not Reported	1777.0	80.0	OCT	1146563E-D472-4EFF-8753-7CEEE2F74C12	true	Solid Tissue	False	Tumor
TCGA-DD-A1EC-01A	520a709a-87f6-4f3d-b2a2-9192e3b65c5b	Adenomas and Adenocarcinomas	520a709a-87f6-4f3d-b2a2-9192e3b65c5b	TCGA-DD-A1EC	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	20.0	-7363.0	1984.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	602.0	7363.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	7363.0	20.172602739726027	['bb893238-0303-5d04-881b-78667891847d', 'f20704ad-8aeb-544d-a47f-693fc103fdf1']	['TCGA-DD-A1EC_treatment', 'TCGA-DD-A1EC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:19:16.070813-05:00']	['2019-07-31T21:01:45.685993-05:00', '2019-07-31T21:01:45.685993-05:00']	['released', 'released']	01	Primary	1a0498cb-07d9-418a-8d88-cf52a373d9f0	Primary Tumor	Not Reported	2254.0	110.0	OCT	7CF5361C-34F3-496F-A7FC-AF4E9F2BD859	true	Solid Tissue	False	Tumor
TCGA-DD-A1EC-11A	520a709a-87f6-4f3d-b2a2-9192e3b65c5b	Adenomas and Adenocarcinomas	520a709a-87f6-4f3d-b2a2-9192e3b65c5b	TCGA-DD-A1EC	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	20.0	-7363.0	1984.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	602.0	7363.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	7363.0	20.172602739726027	['bb893238-0303-5d04-881b-78667891847d', 'f20704ad-8aeb-544d-a47f-693fc103fdf1']	['TCGA-DD-A1EC_treatment', 'TCGA-DD-A1EC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:19:16.070813-05:00']	['2019-07-31T21:01:45.685993-05:00', '2019-07-31T21:01:45.685993-05:00']	['released', 'released']	11	Not Applicable	d41b3e1e-885e-4e68-b6e7-d2ce582e9c2b	Solid Tissue Normal	Not Reported	2254.0	170.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-AADN-01A	32e39c1d-b8e8-4efe-b451-8efb112d3518	Adenomas and Adenocarcinomas	32e39c1d-b8e8-4efe-b451-8efb112d3518	TCGA-DD-AADN	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	59.0	-21632.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	898.0	21632.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21632.0	59.26575342465753	['32d009e1-841f-5adf-afcb-95ebc48007dc', 'e0175f2e-1c20-5408-a0ed-27a7e5d304ee']	['TCGA-DD-AADN_treatment', 'TCGA-DD-AADN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:01.883357-05:00']	['2019-07-31T20:58:58.811966-05:00', '2019-07-31T20:58:58.811966-05:00']	['released', 'released']	01	Primary	cb0f3b50-8342-4d9f-9810-98eba5ae6a8f	Primary Tumor	Not Reported	602.0	70.0	OCT	043E7A50-2122-42D4-BB6F-9AAC61FE8CBE	true	Solid Tissue	False	Tumor
TCGA-DD-A1EB-11A	68015cc7-d3a1-4c90-b8fb-5d14143d9960	Adenomas and Adenocarcinomas	68015cc7-d3a1-4c90-b8fb-5d14143d9960	TCGA-DD-A1EB	Liver and intrahepatic bile ducts	Not Reported	not reported	female	not reported	Alive	72.0	-26471.0	1929.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2017.0	26471.0	Hepatocellular carcinoma, NOS	no	2001.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26471.0	72.52328767123288	['f542dc46-8865-5c98-b14b-a0023c3d6b22', 'fd246f91-7036-598e-9fdc-0a29308fffab']	['TCGA-DD-A1EB_treatment', 'TCGA-DD-A1EB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:51.093481-05:00']	['2019-07-31T21:03:41.407668-05:00', '2019-07-31T21:03:41.407668-05:00']	['released', 'released']	11	Not Applicable	759a494f-c699-4dd6-9553-45265c667dae	Solid Tissue Normal	Not Reported	3538.0	160.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-A1EB-01A	68015cc7-d3a1-4c90-b8fb-5d14143d9960	Adenomas and Adenocarcinomas	68015cc7-d3a1-4c90-b8fb-5d14143d9960	TCGA-DD-A1EB	Liver and intrahepatic bile ducts	Not Reported	not reported	female	not reported	Alive	72.0	-26471.0	1929.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2017.0	26471.0	Hepatocellular carcinoma, NOS	no	2001.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26471.0	72.52328767123288	['f542dc46-8865-5c98-b14b-a0023c3d6b22', 'fd246f91-7036-598e-9fdc-0a29308fffab']	['TCGA-DD-A1EB_treatment', 'TCGA-DD-A1EB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:51.093481-05:00']	['2019-07-31T21:03:41.407668-05:00', '2019-07-31T21:03:41.407668-05:00']	['released', 'released']	01	Primary	fee48a64-cf2f-4ae9-b3cf-315410d8e8ae	Primary Tumor	Not Reported	3538.0	180.0	OCT	40ABAF02-60C0-4997-AB0F-2B9A90F1FE3B	true	Solid Tissue	False	Tumor
TCGA-G3-A25T-01A	f6e5979d-d6a9-4408-bd1b-1b37d1064e83	Adenomas and Adenocarcinomas	f6e5979d-d6a9-4408-bd1b-1b37d1064e83	TCGA-G3-A25T	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	45.0	-16461.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	1553.0	16461.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16461.0	45.0986301369863	['3c6e3996-aaa4-52d0-b74e-551d07db5f9a', 'e078ae58-907f-577a-8569-ffcb090e9403']	['TCGA-G3-A25T_treatment_1', 'TCGA-G3-A25T_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:28:25.829022-05:00', '']	['2019-07-31T21:13:03.598079-05:00', '2019-07-31T21:13:03.598079-05:00']	['released', 'released']	01	Primary	d42d6e07-8e0e-4345-b1b9-1b8b4574d042	Primary Tumor	Not Reported	1224.0	70.0	OCT	BC6447AE-5740-437A-987E-5ECB891667FE	true	Solid Tissue	False	Tumor
TCGA-DD-AACA-02A	d6486001-240a-455a-980c-e06c25c61fa5	Adenomas and Adenocarcinomas	d6486001-240a-455a-980c-e06c25c61fa5	TCGA-DD-AACA	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	65.0	-23973.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2301.0	23973.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23973.0	65.67945205479452	['0e3a9cdd-81fd-5550-9b68-21bb92403187', '5461b32f-dcf8-5a05-a379-cfc643b417d4']	['TCGA-DD-AACA_treatment', 'TCGA-DD-AACA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:10.147446-05:00']	['2019-07-31T21:11:29.168558-05:00', '2019-07-31T21:11:29.168558-05:00']	['released', 'released']	02	Recurrence	3410a3fc-aa65-4302-a800-315f0f723fc5	Recurrent Tumor	Not Reported	2057.0	20.0	OCT	C4260237-1E27-45C7-ADE8-41939D1324A8	true	Solid Tissue	False	Tumor
TCGA-DD-AACA-01A	d6486001-240a-455a-980c-e06c25c61fa5	Adenomas and Adenocarcinomas	d6486001-240a-455a-980c-e06c25c61fa5	TCGA-DD-AACA	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	65.0	-23973.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2301.0	23973.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23973.0	65.67945205479452	['0e3a9cdd-81fd-5550-9b68-21bb92403187', '5461b32f-dcf8-5a05-a379-cfc643b417d4']	['TCGA-DD-AACA_treatment', 'TCGA-DD-AACA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:10.147446-05:00']	['2019-07-31T21:11:29.168558-05:00', '2019-07-31T21:11:29.168558-05:00']	['released', 'released']	01	Primary	df383057-c8c2-4691-b040-609377773e2a	Primary Tumor	Not Reported	2057.0	120.0	OCT	6600D758-13D7-4925-BC34-F2A90EE0CFE5	true	Solid Tissue	False	Tumor
TCGA-DD-AACA-02B	d6486001-240a-455a-980c-e06c25c61fa5	Adenomas and Adenocarcinomas	d6486001-240a-455a-980c-e06c25c61fa5	TCGA-DD-AACA	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	65.0	-23973.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2301.0	23973.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23973.0	65.67945205479452	['0e3a9cdd-81fd-5550-9b68-21bb92403187', '5461b32f-dcf8-5a05-a379-cfc643b417d4']	['TCGA-DD-AACA_treatment', 'TCGA-DD-AACA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:10.147446-05:00']	['2019-07-31T21:11:29.168558-05:00', '2019-07-31T21:11:29.168558-05:00']	['released', 'released']	02	Recurrence	e31d2354-a883-4685-b750-f1738e07051d	Recurrent Tumor	Not Reported	2057.0	1.0	OCT	E3836223-B3ED-46C6-B257-6909E26D0F09	true	Solid Tissue	False	Tumor
TCGA-CC-A8HT-01A	95408571-9d4e-412b-8ee8-7992e0270b0f	Adenomas and Adenocarcinomas	95408571-9d4e-412b-8ee8-7992e0270b0f	TCGA-CC-A8HT	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	74.0	-27334.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	140.0															No	Stage IIIA	0.0	not reported	Liver	0.0	27334.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27334.0	74.88767123287671	['36d1a7e9-0d89-501b-b72f-4bd6bb6e6c7a', 'd36719a1-342d-524d-ac6e-44e193948ba6']	['TCGA-CC-A8HT_treatment_1', 'TCGA-CC-A8HT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:23.616245-05:00', '']	['2019-07-31T21:06:53.997373-05:00', '2019-07-31T21:06:53.997373-05:00']	['released', 'released']	01	Primary	5f78bf91-e73d-4b78-9cd7-ec6502e764aa	Primary Tumor	Not Reported	197.0	170.0	OCT	0D2B4676-F045-4259-A18C-47EA5DF8E7A2	true	Solid Tissue	False	Tumor
TCGA-K7-A5RG-01A	4fd3ed02-7b66-47bf-8b92-31fee1093a87	Adenomas and Adenocarcinomas	4fd3ed02-7b66-47bf-8b92-31fee1093a87	TCGA-K7-A5RG	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	66.0	-24218.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	f9ebb17f-fdca-5a0e-b026-dcb173867634	K7	ABS - Lahey Clinic	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	519.0	24218.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24218.0	66.35068493150685	['e1cd84f2-9763-5f2c-8d73-94c7c05cb10b', 'ed7a4afe-2562-5204-aaf7-371310605d78']	['TCGA-K7-A5RG_treatment_1', 'TCGA-K7-A5RG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:06.688853-05:00', '']	['2019-07-31T21:01:33.392122-05:00', '2019-07-31T21:01:33.392122-05:00']	['released', 'released']	01	Primary	3add537e-0692-4d5c-9c32-1341adcb3bfa	Primary Tumor	Not Reported	100.0	630.0	OCT	AADEAE33-3867-4F77-AAA6-072471B5A397	true	Solid Tissue	False	Tumor
TCGA-CC-A3MC-01A	0277f393-3743-47d6-a96f-155baec9eb49	Adenomas and Adenocarcinomas	0277f393-3743-47d6-a96f-155baec9eb49	TCGA-CC-A3MC	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	54.0	-20067.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	363.0	20067.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20067.0	54.97808219178082	['b31e6299-91ab-541a-972f-673e343d9901', 'b79bb429-6370-5d94-a1cf-3e052c92edd5']	['TCGA-CC-A3MC_treatment', 'TCGA-CC-A3MC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:00.991766-05:00']	['2019-07-31T20:55:13.410080-05:00', '2019-07-31T20:55:13.410080-05:00']	['released', 'released']	01	Primary	38e9689a-3698-45cd-a7a4-d2c4f0af11c6	Primary Tumor	Not Reported	268.0	400.0	OCT	3D0D4B1A-1340-488C-B231-F18CC1BC3783	true	Solid Tissue	False	Tumor
TCGA-WJ-A86L-01A	63d475ef-8f26-45ed-ae80-cfa87e68b2f5	Adenomas and Adenocarcinomas	63d475ef-8f26-45ed-ae80-cfa87e68b2f5	TCGA-WJ-A86L	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25018.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	73d67bfc-0459-5e54-8bf1-ebcd1c12a4c7	WJ	Greenville Health System	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	345.0	25018.0	Clear cell adenocarcinoma, NOS	no	2013.0	No	7th	T1	8310/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25018.0	68.54246575342465	['14131cc2-5348-5a93-8257-33ba44995a5e', '67798971-aa46-5dec-a5d5-466e267119ee']	['TCGA-WJ-A86L_treatment_1', 'TCGA-WJ-A86L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:33.896518-05:00', '']	['2019-07-31T21:03:20.401572-05:00', '2019-07-31T21:03:20.401572-05:00']	['released', 'released']	01	Primary	ab5ccf89-2c0d-4b45-be11-5c859c1cf427	Primary Tumor	Not Reported	95.0	270.0	Unknown	2C93F65E-88FD-405F-86F1-0E35C7F46DC2	false	Solid Tissue	False	Tumor
TCGA-DD-AACT-01A	3ea084c5-3783-4fde-b341-5914d2edb977	Adenomas and Adenocarcinomas	3ea084c5-3783-4fde-b341-5914d2edb977	TCGA-DD-AACT	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	69.0	-25292.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1562.0	25292.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25292.0	69.2931506849315	['40109fa7-49a5-55fb-a2f6-3fb5ddccfe51', 'c7de235b-032d-5487-8e3a-f5f7af8a53b9']	['TCGA-DD-AACT_treatment', 'TCGA-DD-AACT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:49.780163-05:00']	['2019-07-31T21:00:00.198401-05:00', '2019-07-31T21:00:00.198401-05:00']	['released', 'released']	01	Primary	d1cdc76a-e306-44a0-b509-8ddef84ddfdf	Primary Tumor	Not Reported	1317.0	60.0	OCT	0A9193A6-4600-44F8-88AD-264F8F2D7B4E	true	Solid Tissue	False	Tumor
TCGA-XR-A8TE-01A	ec4b4d34-2576-4412-b036-7460e64f4398	Adenomas and Adenocarcinomas	ec4b4d34-2576-4412-b036-7460e64f4398	TCGA-XR-A8TE	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Alive	16.0	-5862.0	1996.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	04898289-8edf-590e-8640-35e36365de75	XR	University of Sao Paulo	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	925.0	5862.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T3	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	5862.0	16.06027397260274	['166921ed-5cf4-5676-ac3b-9359656f8c40', 'dd3a0e6f-5eb8-5fc4-a875-04bb6281b6be']	['TCGA-XR-A8TE_treatment_1', 'TCGA-XR-A8TE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:27:57.051772-05:00', '']	['2019-07-31T21:12:26.546464-05:00', '2019-07-31T21:12:26.546464-05:00']	['released', 'released']	01	Primary	14f227ac-51c0-46bf-9194-d4406a10482a	Primary Tumor	Not Reported	487.0	90.0	OCT	D020A2B1-03B7-490C-AFA4-BBE3EB661CA3	true	Solid Tissue	False	Tumor
TCGA-FV-A4ZQ-01A	65e430e1-0c9a-4045-83a9-653b7cff811d	Adenomas and Adenocarcinomas	65e430e1-0c9a-4045-83a9-653b7cff811d	TCGA-FV-A4ZQ	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	52.0	-19090.0	1960.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	12.0	19090.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	19090.0	52.3013698630137	['38363b80-1958-5b5a-bf40-33348e09c32f', '7c188d40-3e7d-56a8-bb0d-ef10f3746770']	['TCGA-FV-A4ZQ_treatment_1', 'TCGA-FV-A4ZQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:20:41.074772-05:00', '']	['2019-07-31T21:03:29.527685-05:00', '2019-07-31T21:03:29.527685-05:00']	['released', 'released']	01	Primary	56daad30-a336-4311-9feb-26cf3e48c734	Primary Tumor	Not Reported	224.0	160.0	Unknown	C0B03F38-09C0-4B87-94BC-E2E8D9F7F922	false	Solid Tissue	False	Tumor
TCGA-DD-A39X-11A	0d0a10b4-7b99-4043-a129-89844f258156	Adenomas and Adenocarcinomas	0d0a10b4-7b99-4043-a129-89844f258156	TCGA-DD-A39X	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	78.0	-28528.0	1920.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1694.0															No	Stage I	0.0	not reported	Liver		28528.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28528.0	78.15890410958905	['21ec3225-d38b-5553-b8da-600fa798c93d', 'f84bf328-9e82-57c1-9f91-0136dcd101c1']	['TCGA-DD-A39X_treatment_1', 'TCGA-DD-A39X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:35.955179-05:00', '']	['2019-07-31T20:55:55.494064-05:00', '2019-07-31T20:55:55.494064-05:00']	['released', 'released']	11	Not Applicable	4b14715b-84e2-4ff9-9db6-998f42fe9fa8	Solid Tissue Normal	Not Reported	4705.0	230.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A39X-01A	0d0a10b4-7b99-4043-a129-89844f258156	Adenomas and Adenocarcinomas	0d0a10b4-7b99-4043-a129-89844f258156	TCGA-DD-A39X	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	78.0	-28528.0	1920.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1694.0															No	Stage I	0.0	not reported	Liver		28528.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28528.0	78.15890410958905	['21ec3225-d38b-5553-b8da-600fa798c93d', 'f84bf328-9e82-57c1-9f91-0136dcd101c1']	['TCGA-DD-A39X_treatment_1', 'TCGA-DD-A39X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:35.955179-05:00', '']	['2019-07-31T20:55:55.494064-05:00', '2019-07-31T20:55:55.494064-05:00']	['released', 'released']	01	Primary	75148cc5-ac7b-408c-b14f-595763e494eb	Primary Tumor	Not Reported	4705.0	120.0	Unknown	B9919D23-7D65-4295-84D5-6678B26BEA01	false	Solid Tissue	False	Tumor
TCGA-DD-AAD5-01A	6312d5b5-68ad-4d4f-a0a9-03d895ae30f9	Adenomas and Adenocarcinomas	6312d5b5-68ad-4d4f-a0a9-03d895ae30f9	TCGA-DD-AAD5	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	54.0	-19748.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1345.0	19748.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19748.0	54.104109589041094	['661f1e62-c1a6-5150-b172-c9669d6d04b8', 'd89db2ae-992c-5517-a073-1a0f7f04d4ee']	['TCGA-DD-AAD5_treatment_1', 'TCGA-DD-AAD5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:28.993926-05:00', '']	['2019-07-31T21:03:14.087455-05:00', '2019-07-31T21:03:14.087455-05:00']	['released', 'released']	01	Primary	3a5f387a-a6c4-479f-a172-ee734fbbb365	Primary Tumor	Not Reported	1058.0	70.0	OCT	7F74E08A-C14B-413E-9D75-FCDBFC2F67C5	true	Solid Tissue	False	Tumor
TCGA-WQ-AB4B-01A	d5471a2b-f14c-44de-9142-5a5fb07b6fc2	Adenomas and Adenocarcinomas	d5471a2b-f14c-44de-9142-5a5fb07b6fc2	TCGA-WQ-AB4B	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	62.0	-22769.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2deb19ef-f2aa-5861-87c8-f5c755f8800b	WQ	University of Kansas	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	395.0	22769.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	22769.0	62.38082191780822	['13640a67-f633-52ba-a529-ae9de1e57e26', '4f633d2f-aa39-5b55-88ef-af16a2f9013b']	['TCGA-WQ-AB4B_treatment_1', 'TCGA-WQ-AB4B_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:07.602708-05:00', '']	['2019-07-31T21:11:26.338346-05:00', '2019-07-31T21:11:26.338346-05:00']	['released', 'released']	01	Primary	0ee59a68-ae0f-4421-9805-d4c48c64b613	Primary Tumor	Not Reported	107.0	80.0	Unknown	A0DBAC80-0D07-41BD-9AD2-E73D2DE2FBC7	false	Solid Tissue	False	Tumor
TCGA-LG-A9QD-01A	948a9bbc-60b0-4fb7-a707-76bc41294217	Adenomas and Adenocarcinomas	948a9bbc-60b0-4fb7-a707-76bc41294217	TCGA-LG-A9QD	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Alive	68.0	-24969.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ef6a28c0-1733-5c00-be40-0ea911305be8	LG	Hartford Hospital	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	366.0	24969.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24969.0	68.40821917808219	['627ce4f3-300f-5e40-8148-1416bca09c74', 'a2f33670-dde0-5bba-8bdc-b769565b65d6']	['TCGA-LG-A9QD_treatment', 'TCGA-LG-A9QD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T09:25:23.670440-05:00']	['2019-07-31T16:14:20.959836-05:00', '2019-07-31T16:14:20.959836-05:00']	['released', 'released']	01	Primary	3b829cbd-1abb-41f8-9633-597e6b79e362	Primary Tumor	Not Reported	28.0	1580.0	OCT	D5BAD949-7001-4FAC-A7B4-E9B426A53A76	true	Solid Tissue	False	Tumor
TCGA-LG-A9QC-01A	8c2783ef-aa41-44c9-be87-fa4c84108f1e	Adenomas and Adenocarcinomas	8c2783ef-aa41-44c9-be87-fa4c84108f1e	TCGA-LG-A9QC	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	48.0	-17842.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ef6a28c0-1733-5c00-be40-0ea911305be8	LG	Hartford Hospital	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	425.0	17842.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	17842.0	48.88219178082192	['aa76128f-dc82-5101-9bd9-f19b6621f5e4', 'e827466e-bc70-5683-84a6-7eff003d0501']	['TCGA-LG-A9QC_treatment_1', 'TCGA-LG-A9QC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T09:25:21.167222-05:00', '']	['2019-07-31T16:14:17.536678-05:00', '2019-07-31T16:14:17.536678-05:00']	['released', 'released']	01	Primary	c8b18401-ab61-4925-a022-62b5f7190139	Primary Tumor	Not Reported	62.0	1080.0	OCT	AD8045A1-61EA-4713-9C8D-9AF200DB1424	true	Solid Tissue	False	Tumor
TCGA-CC-A1HT-01A	670c1cbc-4494-45f1-bb8b-18db82d4f7e0	Adenomas and Adenocarcinomas	670c1cbc-4494-45f1-bb8b-18db82d4f7e0	TCGA-CC-A1HT	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	50.0	-18553.0	1960.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	101.0															No	Stage IIIA	0.0	not reported	Liver	0.0	18553.0	Hepatocellular carcinoma, NOS	no	2010.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18553.0	50.83013698630137	['2e997d7d-8957-507d-9dcc-d098acfab4c2', '5eb9cd9f-2996-5aa3-a0f2-630bfb3e7e0e']	['TCGA-CC-A1HT_treatment', 'TCGA-CC-A1HT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:46.325336-05:00']	['2019-07-31T21:03:35.483120-05:00', '2019-07-31T21:03:35.483120-05:00']	['released', 'released']	01	Primary	96f911ed-2064-4745-ad07-6c47b0a0c7cd	Primary Tumor	Not Reported	86.0	470.0	OCT	81F0F911-C2C1-48AD-A67F-FD455503CB46	true	Solid Tissue	False	Tumor
TCGA-DD-AADL-01A	a7f7e313-4636-4c54-b2b7-f5928a8368e4	Adenomas and Adenocarcinomas	a7f7e313-4636-4c54-b2b7-f5928a8368e4	TCGA-DD-AADL	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	58.0	-21512.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	636.0	21512.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21512.0	58.93698630136986	['d85163cf-1c96-5aed-972c-ea5757a92b7f', 'e666b8fb-c952-566b-a1f5-1d363cdc3439']	['TCGA-DD-AADL_treatment_1', 'TCGA-DD-AADL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:25.037990-05:00', '']	['2019-07-31T21:08:05.005204-05:00', '2019-07-31T21:08:05.005204-05:00']	['released', 'released']	01	Primary	3299e2bc-db36-4b1d-ad37-f0e10cf11338	Primary Tumor	Not Reported	720.0	20.0	OCT	248AF6DC-85A7-4334-B282-B7B0102C4596	true	Solid Tissue	False	Tumor
TCGA-DD-AADS-01A	460a3cbd-c63c-4e6f-b670-2619687ac5a0	Adenomas and Adenocarcinomas	460a3cbd-c63c-4e6f-b670-2619687ac5a0	TCGA-DD-AADS	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	63.0	-23227.0	1950.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	474.0	23227.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23227.0	63.635616438356166	['9737bd8c-b1ed-5644-9139-ad50f30f92d2', 'b56fbd5f-3705-5064-a358-69ed7472d1d8']	['TCGA-DD-AADS_treatment', 'TCGA-DD-AADS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:32.583014-05:00']	['2019-07-31T21:00:52.092695-05:00', '2019-07-31T21:00:52.092695-05:00']	['released', 'released']	01	Primary	31a1acbe-df1c-42b1-817a-da0e805c7fb3	Primary Tumor	Not Reported	230.0	40.0	OCT	130967AE-5D29-406B-A410-1908D8B086FC	true	Solid Tissue	False	Tumor
TCGA-K7-A5RF-01A	3134f7d1-3359-497a-b8be-1f317d8ddaaa	Adenomas and Adenocarcinomas	3134f7d1-3359-497a-b8be-1f317d8ddaaa	TCGA-K7-A5RF	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	64.0	-23557.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	f9ebb17f-fdca-5a0e-b026-dcb173867634	K7	ABS - Lahey Clinic	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	631.0	23557.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23557.0	64.53972602739726	['6c193c4b-ba22-5a32-8819-0050976d4b26', '7cde9c2f-caa8-5b3f-a113-7767d771bee8']	['TCGA-K7-A5RF_treatment', 'TCGA-K7-A5RF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:52.326291-05:00']	['2019-07-31T20:58:46.966930-05:00', '2019-07-31T20:58:46.966930-05:00']	['released', 'released']	01	Primary	2fa93cb3-45bd-492c-b254-64bb0c9dddd9	Primary Tumor	Not Reported	102.0	1350.0	OCT	04C26B7B-66EE-4F20-A059-52E19557C268	true	Solid Tissue	False	Tumor
TCGA-DD-A4NF-01A	1043bc90-72c9-48c9-ae24-f617d0485e78	Adenomas and Adenocarcinomas	1043bc90-72c9-48c9-ae24-f617d0485e78	TCGA-DD-A4NF	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	72.0	-26330.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	942.0	26330.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26330.0	72.13698630136986	['7906d2ba-5ef6-5172-be06-3ecd7ccd6b7e', 'efde49fe-4c38-570d-88af-fcc778eec5cd']	['TCGA-DD-A4NF_treatment_1', 'TCGA-DD-A4NF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'yes']	['2019-04-28T13:14:53.118184-05:00', '']	['2019-07-31T20:56:17.207174-05:00', '2019-07-31T20:56:17.207174-05:00']	['released', 'released']	01	Primary	64150fa1-b4bf-4918-a801-e6a2cc70e5c7	Primary Tumor	Not Reported	364.0	200.0	OCT	7381633C-866A-4440-93B1-BC7102B59C93	true	Solid Tissue	False	Tumor
TCGA-DD-AADA-01A	e50edba1-8ec4-47e7-a01e-9f1b2cd75fd7	Adenomas and Adenocarcinomas	e50edba1-8ec4-47e7-a01e-9f1b2cd75fd7	TCGA-DD-AADA	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	66.0	-24288.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1233.0	24288.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24288.0	66.54246575342465	['03292b91-31e8-520d-a8a2-e5f932de0398', 'ec534a5e-34e9-5f33-a288-fb26edbd0b26']	['TCGA-DD-AADA_treatment', 'TCGA-DD-AADA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:46.698935-05:00']	['2019-07-31T21:12:14.812764-05:00', '2019-07-31T21:12:14.812764-05:00']	['released', 'released']	01	Primary	3065d32f-2852-4478-a6e7-c8129a2acf0b	Primary Tumor	Not Reported	959.0	40.0	OCT	624DA15E-ADC6-4F09-9DCB-3B4C42F3B453	true	Solid Tissue	False	Tumor
TCGA-MI-A75I-01A	55e53229-c58f-4922-8869-0f5e2f6c2d7d	Adenomas and Adenocarcinomas	55e53229-c58f-4922-8869-0f5e2f6c2d7d	TCGA-MI-A75I	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	61.0	-22341.0	1950.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2b1c1097-fa63-5d15-b5d3-c54f5eacb9c8	MI	BLN - Baylor	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	630.0	22341.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22341.0	61.20821917808219	['00498a18-72e7-55e5-8926-0829e3ac9cf4', 'f927f0a8-2656-5e01-bafd-d5ff431ec98b']	['TCGA-MI-A75I_treatment_1', 'TCGA-MI-A75I_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:32.944077-05:00', '']	['2019-07-31T21:02:06.432888-05:00', '2019-07-31T21:02:06.432888-05:00']	['released', 'released']	01	Primary	f43f95a7-29d8-499a-b8ea-f2a2edd906f9	Primary Tumor	Not Reported	665.0	50.0	OCT	4630A897-45DC-4122-BB86-A2943FE27CEA	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GU-01A	b27720a2-e240-413c-a0f1-0b1af3621de2	Adenomas and Adenocarcinomas	b27720a2-e240-413c-a0f1-0b1af3621de2	TCGA-2Y-A9GU	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20187.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1939.0	20187.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20187.0	55.30684931506849	['0ae23cae-0896-50ec-8e69-3bafc57451e6', 'e7822130-c7a8-5b25-b4ab-889e2d15c206']	['TCGA-2Y-A9GU_treatment_1', 'TCGA-2Y-A9GU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:06.080066-05:00', '']	['2019-07-31T21:08:57.977366-05:00', '2019-07-31T21:08:57.977366-05:00']	['released', 'released']	01	Primary	6477af21-e833-4b46-8658-5da593030fed	Primary Tumor	Not Reported	1752.0	120.0	OCT	5585C485-B57A-4CA8-A3E3-F093A7E6AC76	true	Solid Tissue	False	Tumor
TCGA-ED-A7PX-01A	470d52b8-3d74-4789-b714-b9869a96657b	Adenomas and Adenocarcinomas	470d52b8-3d74-4789-b714-b9869a96657b	TCGA-ED-A7PX	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	48.0	-17638.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	6.0	17638.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	17638.0	48.323287671232876	['b5a8058e-0cfb-5d7d-b1cb-a3a2d67951ce', 'cc3de161-2289-57b1-824d-f81cd04fcd68']	['TCGA-ED-A7PX_treatment', 'TCGA-ED-A7PX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'not reported']	['', '2019-04-28T13:18:35.040645-05:00']	['2019-07-31T21:00:55.078979-05:00', '2019-07-31T21:00:55.078979-05:00']	['released', 'released']	01	Primary	35600f0a-effb-40a5-a608-d60a42f3a43d	Primary Tumor	Not Reported	86.0	830.0	OCT	AF42396C-2DC9-4885-B7B1-D59BA1D2949A	true	Solid Tissue	False	Tumor
TCGA-FV-A23B-11A	c95ed407-bcc2-44aa-bc59-bf7549f2d665	Adenomas and Adenocarcinomas	c95ed407-bcc2-44aa-bc59-bf7549f2d665	TCGA-FV-A23B	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	70.0	-25788.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	1852.0															No	Stage II	0.0	not reported	Liver	987.0	25788.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25788.0	70.65205479452055	['0e47ee6f-8c69-533d-b353-950707df1beb', '3ad4075c-3a40-523b-9165-942db42b66c6']	['TCGA-FV-A23B_treatment', 'TCGA-FV-A23B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:26.406557-05:00']	['2019-07-31T21:10:36.012953-05:00', '2019-07-31T21:10:36.012953-05:00']	['released', 'released']	11	Not Applicable	cf3e04fe-9fc4-4293-a7c0-b46510f590e9	Solid Tissue Normal	Not Reported	2030.0	50.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FV-A23B-01A	c95ed407-bcc2-44aa-bc59-bf7549f2d665	Adenomas and Adenocarcinomas	c95ed407-bcc2-44aa-bc59-bf7549f2d665	TCGA-FV-A23B	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	70.0	-25788.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	1852.0															No	Stage II	0.0	not reported	Liver	987.0	25788.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25788.0	70.65205479452055	['0e47ee6f-8c69-533d-b353-950707df1beb', '3ad4075c-3a40-523b-9165-942db42b66c6']	['TCGA-FV-A23B_treatment', 'TCGA-FV-A23B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:26.406557-05:00']	['2019-07-31T21:10:36.012953-05:00', '2019-07-31T21:10:36.012953-05:00']	['released', 'released']	01	Primary	d056433d-c3e2-467a-8151-ddf2a6d8683a	Primary Tumor	Not Reported	2030.0	110.0	Unknown	82010944-23DA-4FC5-934B-05AB3C238467	false	Solid Tissue	False	Tumor
TCGA-DD-AACO-01A	34413807-07be-4204-b095-5e1dd1ed87dc	Adenomas and Adenocarcinomas	34413807-07be-4204-b095-5e1dd1ed87dc	TCGA-DD-AACO	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	40.0	-14796.0	1969.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1876.0	14796.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	14796.0	40.536986301369865	['28212fc8-07b3-5c9d-8ac7-e6722ce6fe16', '45cfb94f-b857-5ad0-b6be-8edce899dbcb']	['TCGA-DD-AACO_treatment_1', 'TCGA-DD-AACO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:06.463136-05:00', '']	['2019-07-31T20:59:04.783517-05:00', '2019-07-31T20:59:04.783517-05:00']	['released', 'released']	01	Primary	c71f310e-5777-4e78-aafa-64a5510b45c1	Primary Tumor	Not Reported	1637.0	110.0	OCT	B5BE83AC-C974-422B-91E7-A69057BA26C9	true	Solid Tissue	False	Tumor
TCGA-G3-A7M7-01A	3d048a45-3d5d-4563-acc8-3c662861f18a	Adenomas and Adenocarcinomas	3d048a45-3d5d-4563-acc8-3c662861f18a	TCGA-G3-A7M7	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	65.0	-24002.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	361.0	24002.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24002.0	65.75890410958904	['75e1b36d-cffb-5c65-bec0-17e7f27cdcf4', 'f5104981-d9b0-559c-bc4a-5fede4a515dd']	['TCGA-G3-A7M7_treatment_1', 'TCGA-G3-A7M7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:42.751928-05:00', '']	['2019-07-31T20:59:51.048157-05:00', '2019-07-31T20:59:51.048157-05:00']	['released', 'released']	01	Primary	fd7c8159-102b-4af5-ae93-4e468e54ec10	Primary Tumor	Not Reported	112.0	750.0	OCT	9EC72408-F4C7-4D95-ACE3-3BF44E10FF8C	true	Solid Tissue	False	Tumor
TCGA-MR-A8JO-01A	8574d285-e02a-4d2b-931b-73556a9fda02	Adenomas and Adenocarcinomas	8574d285-e02a-4d2b-931b-73556a9fda02	TCGA-MR-A8JO	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Alive	34.0	-12669.0	1979.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2e3c05db-a4a5-5563-9933-a10940cec98b	MR	University of Minnesota	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	330.0	12669.0	Hepatocellular carcinoma, fibrolamellar	no	2013.0	No	7th	T1	8171/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	12669.0	34.70958904109589	['c814a15b-aa4b-5211-9985-48492ffca1df', 'c8532952-3674-520b-8d57-2bc5ff77f166']	['TCGA-MR-A8JO_treatment', 'TCGA-MR-A8JO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:23.012360-05:00']	['2019-07-31T21:05:37.638154-05:00', '2019-07-31T21:05:37.638154-05:00']	['released', 'released']	01	Primary	f2b89e54-ec4d-4c0a-95db-2435412a7254	Primary Tumor	Not Reported	184.0	350.0	OCT	DA03F6F5-2579-45B7-954B-8C0F8EFD0F75	true	Solid Tissue	False	Tumor
TCGA-CC-5262-01A	1b428ada-eb3f-40c2-b4bf-1bbf6b61729d	Adenomas and Adenocarcinomas	1b428ada-eb3f-40c2-b4bf-1bbf6b61729d	TCGA-CC-5262	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	67.0	-24787.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	103.0															No	Stage IIIC	0.0	not reported	Liver	0.0	24787.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24787.0	67.90958904109588	['577f2bd3-8f75-5537-8647-8f8c6b28f798', 'b5290952-3cba-5ff9-a9b3-135f8e4ffc16']	['TCGA-CC-5262_treatment_1', 'TCGA-CC-5262_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:39.442749-05:00', '']	['2019-07-31T20:57:14.329808-05:00', '2019-07-31T20:57:14.329808-05:00']	['released', 'released']	01	Primary	dc595eed-d459-40fd-8417-6a1c56759ec8	Primary Tumor	Not Reported	97.0	800.0	OCT	B09509A2-A902-4298-AEDF-66BA21C584BB	true	Solid Tissue	False	Tumor
TCGA-DD-AADK-01A	40f30ffb-51de-4786-a88f-16c170aac207	Adenomas and Adenocarcinomas	40f30ffb-51de-4786-a88f-16c170aac207	TCGA-DD-AADK	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	68.0	-25046.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1049.0	25046.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25046.0	68.61917808219178	['11ac98e5-c00c-5e62-a46b-c7dc0bbe5a08', 'dae955fe-b389-5943-bc47-eac4a6d76960']	['TCGA-DD-AADK_treatment_1', 'TCGA-DD-AADK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:57.079068-05:00', '']	['2019-07-31T21:00:08.933891-05:00', '2019-07-31T21:00:08.933891-05:00']	['released', 'released']	01	Primary	c7352d50-28d0-4284-a54a-df0f9629efdc	Primary Tumor	Not Reported	763.0	50.0	OCT	DD514735-20C6-49AE-BD02-5D08C6C61523	true	Solid Tissue	False	Tumor
TCGA-DD-AAE1-01A	3bbff405-dae4-4dc9-985a-33e7ac9cb2dd	Adenomas and Adenocarcinomas	3bbff405-dae4-4dc9-985a-33e7ac9cb2dd	TCGA-DD-AAE1	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	52.0	-19073.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	552.0	19073.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19073.0	52.25479452054795	['5fe2df73-af0b-5555-833a-34c043f8223e', 'af9ef590-26cc-5fc6-beef-eaaaccce4c84']	['TCGA-DD-AAE1_treatment', 'TCGA-DD-AAE1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:35.490966-05:00']	['2019-07-31T20:59:40.815271-05:00', '2019-07-31T20:59:40.815271-05:00']	['released', 'released']	01	Primary	d949102d-e461-4c1f-b168-d41027d9a1fc	Primary Tumor	Not Reported	321.0	50.0	OCT	5357FFD7-B4B7-49A5-A2E3-FE9751DF6A30	true	Solid Tissue	False	Tumor
TCGA-DD-AAEH-01A	fbb0e4bc-5398-4a7e-963c-86ea1108a2de	Adenomas and Adenocarcinomas	fbb0e4bc-5398-4a7e-963c-86ea1108a2de	TCGA-DD-AAEH	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	73.0	-26894.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	784.0	26894.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26894.0	73.68219178082192	['41ac2ffb-6a50-570a-8394-43453254834b', '8fa71a7c-15a5-5548-87e8-d12c0a6a5093']	['TCGA-DD-AAEH_treatment', 'TCGA-DD-AAEH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:34.282989-05:00']	['2019-07-31T21:13:13.164558-05:00', '2019-07-31T21:13:13.164558-05:00']	['released', 'released']	01	Primary	4f20bdec-deac-4529-8e2f-823cfa8341e2	Primary Tumor	Not Reported	553.0	10.0	OCT	D6F3E1F8-27F3-47F9-88CC-F4145C983073	true	Solid Tissue	False	Tumor
TCGA-DD-AAE9-01A	4c960eee-e4b5-499d-a596-238aa78745a4	Adenomas and Adenocarcinomas	4c960eee-e4b5-499d-a596-238aa78745a4	TCGA-DD-AAE9	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	69.0	-25451.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	722.0	25451.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25451.0	69.72876712328767	['2e3df80a-8e7d-52fe-a12c-4bd277b843ba', '7a2a8f75-6073-5be4-b7a6-b2454b007778']	['TCGA-DD-AAE9_treatment_1', 'TCGA-DD-AAE9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:59.724805-05:00', '']	['2019-07-31T21:01:24.974652-05:00', '2019-07-31T21:01:24.974652-05:00']	['released', 'released']	01	Primary	0a21720b-c36f-402b-b0f4-69570fce8976	Primary Tumor	Not Reported	419.0	40.0	OCT	64700E97-F031-49DE-83F0-8CCDBDEE23AF	true	Solid Tissue	False	Tumor
TCGA-2Y-A9H1-01A	9c5e2438-f587-4935-92f0-4bfd57468eaa	Adenomas and Adenocarcinomas	9c5e2438-f587-4935-92f0-4bfd57468eaa	TCGA-2Y-A9H1	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	58.0	-21222.0	1952.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	1229.0															No	Stage I	0.0	not reported	Liver		21222.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21222.0	58.14246575342466	['b93dee1d-8bf7-5730-9dc9-4a79dc8cb2c8', 'e9972ac2-3391-5e9f-938c-1ae37baaf4f9']	['TCGA-2Y-A9H1_treatment_1', 'TCGA-2Y-A9H1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:46.349908-05:00', '']	['2019-07-31T21:07:19.462693-05:00', '2019-07-31T21:07:19.462693-05:00']	['released', 'released']	01	Primary	379fce58-0772-41bb-9153-dc00ecc30cec	Primary Tumor	Not Reported	1445.0	110.0	OCT	04B342FC-F63A-4C81-BFF7-556C0424BF97	true	Solid Tissue	False	Tumor
TCGA-BC-A10U-11A	23103931-cc29-4f89-ae9c-79d53401ecea	Adenomas and Adenocarcinomas	23103931-cc29-4f89-ae9c-79d53401ecea	TCGA-BC-A10U	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	69.0	-25305.0	1931.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	837.0															No		0.0	not reported	Liver		25305.0	Hepatocellular carcinoma, NOS	no	2000.0	No	5th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25305.0	69.32876712328768	['0daad81b-336e-5a44-9d3b-06de833bb922', '4f127b23-b5ee-5474-8426-53a25e1f5359']	['TCGA-BC-A10U_treatment', 'TCGA-BC-A10U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T08:36:47.504617-05:00']	['2019-07-31T15:16:01.493889-05:00', '2019-07-31T15:16:01.493889-05:00']	['released', 'released']	11	Not Applicable	e0fd6db2-23ce-44eb-87a2-1f8e3cee2d64	Solid Tissue Normal	Not Reported	3645.0	1130.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A10U-01A	23103931-cc29-4f89-ae9c-79d53401ecea	Adenomas and Adenocarcinomas	23103931-cc29-4f89-ae9c-79d53401ecea	TCGA-BC-A10U	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	69.0	-25305.0	1931.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	837.0															No		0.0	not reported	Liver		25305.0	Hepatocellular carcinoma, NOS	no	2000.0	No	5th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25305.0	69.32876712328768	['0daad81b-336e-5a44-9d3b-06de833bb922', '4f127b23-b5ee-5474-8426-53a25e1f5359']	['TCGA-BC-A10U_treatment', 'TCGA-BC-A10U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T08:36:47.504617-05:00']	['2019-07-31T15:16:01.493889-05:00', '2019-07-31T15:16:01.493889-05:00']	['released', 'released']	01	Primary	f948e99c-22ba-4037-8a69-34b15f9fa557	Primary Tumor	Not Reported	3645.0	510.0	Unknown	57EB75F3-6F48-4CFB-86CF-F694C390C86A	false	Solid Tissue	False	Tumor
TCGA-FV-A4ZP-01A	5c08008d-5ed4-4480-bd00-c8a2d8c787dc	Adenomas and Adenocarcinomas	5c08008d-5ed4-4480-bd00-c8a2d8c787dc	TCGA-FV-A4ZP	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	78.0	-28771.0	1927.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	2486.0															Not Reported	Stage IIIA	0.0	not reported	Liver	1836.0	28771.0	Hepatocellular carcinoma, NOS	yes	2005.0	No	6th	T3	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28771.0	78.82465753424657	['adbb9ae1-956a-5e54-ab03-fd25bb6c2ec2', 'df8f358b-5fa8-571d-af32-a02b8758b0e6']	['TCGA-FV-A4ZP_treatment', 'TCGA-FV-A4ZP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:19:59.673477-05:00']	['2019-07-31T21:02:39.530001-05:00', '2019-07-31T21:02:39.530001-05:00']	['released', 'released']	01	Primary	856ae98c-ce7b-4436-922b-bf76456a5edd	Primary Tumor	Not Reported	2519.0	210.0	Unknown	B6B41E65-9EFD-4F60-A4F0-68270AC39D15	false	Solid Tissue	False	Tumor
TCGA-DD-AAVP-01A	0004d251-3f70-4395-b175-c94c2f5b1b81	Adenomas and Adenocarcinomas	0004d251-3f70-4395-b175-c94c2f5b1b81	TCGA-DD-AAVP	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	48.0	-17833.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2752.0	17833.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17833.0	48.85753424657534	['13241640-0112-5ec0-bcbe-15fafe7c6634', '28d698d5-b9d7-5897-b2ff-c1e36cd4bcf7']	['TCGA-DD-AAVP_treatment_1', 'TCGA-DD-AAVP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:13:44.149411-05:00', '']	['2019-07-31T20:54:52.590036-05:00', '2019-07-31T20:54:52.590036-05:00']	['released', 'released']	01	Primary	9259e9ee-7279-4b62-8512-509cb705029c	Primary Tumor	Not Reported	2467.0	100.0	OCT	E930F87E-767F-4413-909E-97F7ABAD3D51	true	Solid Tissue	False	Tumor
TCGA-DD-A4NP-01A	001887aa-36d0-463f-8bca-dec7043b4f2e	Adenomas and Adenocarcinomas	001887aa-36d0-463f-8bca-dec7043b4f2e	TCGA-DD-A4NP	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	32.0	-11838.0	1973.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	3308.0	11838.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	11838.0	32.43287671232877	['875b2306-10d8-5eaa-937a-f92607f454a5', 'cd87c95c-ec58-564d-b7a9-46b54f014a69']	['TCGA-DD-A4NP_treatment', 'TCGA-DD-A4NP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:13:46.816725-05:00']	['2019-07-31T20:54:55.471937-05:00', '2019-07-31T20:54:55.471937-05:00']	['released', 'released']	01	Primary	8d3e521b-6df4-4633-bb44-7647ded94130	Primary Tumor	Not Reported	2736.0	160.0	OCT	6C7AE628-1BC9-453D-A1C2-5F2F63A295FC	true	Solid Tissue	False	Tumor
TCGA-BC-4073-01B	00f209c3-041a-4c6e-8b0f-6383eb3c85fc	Adenomas and Adenocarcinomas	00f209c3-041a-4c6e-8b0f-6383eb3c85fc	TCGA-BC-4073	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	73.0	-26795.0	1936.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	849.0	26795.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T3	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	26795.0	73.41095890410959	['2ce8d7ed-dcd3-584f-acd3-b26c519e7238', 'd00cf74f-7c87-5b2d-8c0a-1d2e6cffb59a']	['TCGA-BC-4073_treatment', 'TCGA-BC-4073_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:13:49.359789-05:00']	['2019-07-31T20:54:58.500435-05:00', '2019-07-31T20:54:58.500435-05:00']	['released', 'released']	01	Primary	9c101575-699b-4629-8a69-e57fe2d0c727	Primary Tumor	Not Reported	398.0	230.0	OCT	1C53BF2E-0AA8-477F-8281-63455E0D36E2	true	Solid Tissue	False	Tumor
TCGA-MI-A75E-01A	010d5817-9a3f-4a06-8643-653116c044ff	Adenomas and Adenocarcinomas	010d5817-9a3f-4a06-8643-653116c044ff	TCGA-MI-A75E	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	61.0	-22457.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2b1c1097-fa63-5d15-b5d3-c54f5eacb9c8	MI	BLN - Baylor	Liver hepatocellular carcinoma	NCH																No	Stage IIIC	0.0	not reported	Liver	507.0	22457.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22457.0	61.52602739726027	['3aa684b0-f064-5bef-b1da-8eec30967b07', 'bb2736c2-24c4-541a-a002-6bb150325556']	['TCGA-MI-A75E_treatment_1', 'TCGA-MI-A75E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:13:51.777199-05:00', '']	['2019-07-31T20:55:01.442696-05:00', '2019-07-31T20:55:01.442696-05:00']	['released', 'released']	01	Primary	63552745-eb7f-4948-a552-05b77f645de4	Primary Tumor	Not Reported	157.0	80.0	OCT	F88435AB-695B-4481-BE6C-93FEE7954465	true	Solid Tissue	False	Tumor
TCGA-G3-A7M8-01A	01cc571c-a47c-4548-9c14-5e51c79b095b	Adenomas and Adenocarcinomas	01cc571c-a47c-4548-9c14-5e51c79b095b	TCGA-G3-A7M8	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	31.0	-11527.0	1982.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	430.0	11527.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	11527.0	31.58082191780822	['3592b23f-5715-5e0f-9677-3a228395c475', '5aa27821-9025-5a44-9cc7-12931991b659']	['TCGA-G3-A7M8_treatment', 'TCGA-G3-A7M8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:13:53.977493-05:00']	['2019-07-31T20:55:04.437111-05:00', '2019-07-31T20:55:04.437111-05:00']	['released', 'released']	01	Primary	957cbaf2-52d1-4102-a87e-f1d0d5687c17	Primary Tumor	Not Reported	97.0	180.0	OCT	77483096-0271-4EBD-BC39-2232A3DEFF69	true	Solid Tissue	False	Tumor
TCGA-DD-A11C-01A	023a1ad1-fb16-437e-9806-5063b47f76bd	Adenomas and Adenocarcinomas	023a1ad1-fb16-437e-9806-5063b47f76bd	TCGA-DD-A11C	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	69.0	-25403.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	662.0	25403.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25403.0	69.59726027397261	['0c6b43df-dc04-5911-b332-f93bb65f9033', '887d1b13-ac90-58e7-b142-dccce184a967']	['TCGA-DD-A11C_treatment', 'TCGA-DD-A11C_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:13:56.227072-05:00']	['2019-07-31T20:55:07.382493-05:00', '2019-07-31T20:55:07.382493-05:00']	['released', 'released']	01	Primary	bf79978c-a9c7-429e-bb78-20eea5f16fdf	Primary Tumor	Not Reported	1703.0	220.0	Unknown	35CD5B20-BF61-4D28-AC7F-2CDC959382CD	false	Solid Tissue	False	Tumor
TCGA-DD-A11C-11A	023a1ad1-fb16-437e-9806-5063b47f76bd	Adenomas and Adenocarcinomas	023a1ad1-fb16-437e-9806-5063b47f76bd	TCGA-DD-A11C	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	69.0	-25403.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	662.0	25403.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25403.0	69.59726027397261	['0c6b43df-dc04-5911-b332-f93bb65f9033', '887d1b13-ac90-58e7-b142-dccce184a967']	['TCGA-DD-A11C_treatment', 'TCGA-DD-A11C_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:13:56.227072-05:00']	['2019-07-31T20:55:07.382493-05:00', '2019-07-31T20:55:07.382493-05:00']	['released', 'released']	11	Not Applicable	f115356f-bccb-4718-9fd1-73bca239cbe4	Solid Tissue Normal	Not Reported	1703.0	180.0	Unknown		false	Solid Tissue	False	Normal
TCGA-CC-A9FW-01A	027322f0-d720-41f8-897c-a10e5c1424c5	Adenomas and Adenocarcinomas	027322f0-d720-41f8-897c-a10e5c1424c5	TCGA-CC-A9FW	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	68.0	-24891.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	248.0	24891.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24891.0	68.1945205479452	['3f92d3a6-9246-5db0-8900-d074edb45bf1', 'f38ec6d8-1f29-5aee-b8a9-10e4f9f46cd0']	['TCGA-CC-A9FW_treatment', 'TCGA-CC-A9FW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:13:58.664163-05:00']	['2019-07-31T20:55:10.295481-05:00', '2019-07-31T20:55:10.295481-05:00']	['released', 'released']	01	Primary	3aabe8f1-7f16-4e31-973a-3289dec74ba7	Primary Tumor	Not Reported	125.0	300.0	OCT	81241A65-A7E2-4783-944C-58BB6BDA3F5F	true	Solid Tissue	False	Tumor
TCGA-DD-A114-01A	02931491-f56b-4233-a079-812e08bc0c59	Adenomas and Adenocarcinomas	02931491-f56b-4233-a079-812e08bc0c59	TCGA-DD-A114	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	42.0	-15410.0	1963.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1149.0															No	Stage II	0.0	not reported	Liver		15410.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T2	8170/3		M0	not reported	C22.0	Liver	Not Reported	not reported	15410.0	42.21917808219178	['0e12e16a-26cb-5e60-9c10-a1d6cb790835', '5800c4cd-2cf0-57f0-9478-4f746568bcec']	['TCGA-DD-A114_treatment', 'TCGA-DD-A114_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:03.350002-05:00']	['2019-07-31T20:55:16.348804-05:00', '2019-07-31T20:55:16.348804-05:00']	['released', 'released']	01	Primary	8659e0b1-4c44-41e6-b1df-85ae143f40ae	Primary Tumor	Not Reported	2063.0	250.0	Unknown	BACAFF9B-FAC1-49A8-8C56-A0A26794AA1E	false	Solid Tissue	False	Tumor
TCGA-DD-A114-11A	02931491-f56b-4233-a079-812e08bc0c59	Adenomas and Adenocarcinomas	02931491-f56b-4233-a079-812e08bc0c59	TCGA-DD-A114	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	42.0	-15410.0	1963.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1149.0															No	Stage II	0.0	not reported	Liver		15410.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T2	8170/3		M0	not reported	C22.0	Liver	Not Reported	not reported	15410.0	42.21917808219178	['0e12e16a-26cb-5e60-9c10-a1d6cb790835', '5800c4cd-2cf0-57f0-9478-4f746568bcec']	['TCGA-DD-A114_treatment', 'TCGA-DD-A114_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:03.350002-05:00']	['2019-07-31T20:55:16.348804-05:00', '2019-07-31T20:55:16.348804-05:00']	['released', 'released']	11	Not Applicable	f7b6ba23-4351-406d-a6a6-59bf8616184a	Solid Tissue Normal	Not Reported	2063.0	300.0	Unknown		false	Solid Tissue	False	Normal
TCGA-WX-AA46-01A	02c41e28-cf14-42e2-9e15-f43248ae16e0	Adenomas and Adenocarcinomas	02c41e28-cf14-42e2-9e15-f43248ae16e0	TCGA-WX-AA46	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	61.0	-22639.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	39c0854e-a35b-56ba-ae48-3d0f45b5c305	WX	Yale University	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	756.0	22639.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22639.0	62.02465753424657	['2890b424-9da5-5bd4-a7fe-fa4ca13ef8fe', '4d2efd8f-1bb4-56bc-a3c8-4bcba702e477']	['TCGA-WX-AA46_treatment_1', 'TCGA-WX-AA46_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:05.656868-05:00', '']	['2019-07-31T20:55:19.146623-05:00', '2019-07-31T20:55:19.146623-05:00']	['released', 'released']	01	Primary	3117e503-dd64-4fbe-8ea6-406637d39c5f	Primary Tumor	Not Reported	456.0	80.0	OCT	A767B73F-5C51-47E8-A569-E112DBB987FF	true	Solid Tissue	False	Tumor
TCGA-DD-AAW2-01A	03df105e-a005-4577-bfdb-9644758d778e	Adenomas and Adenocarcinomas	03df105e-a005-4577-bfdb-9644758d778e	TCGA-DD-AAW2	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	69.0	-25420.0	1940.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1855.0	25420.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25420.0	69.64383561643835	['9bd0e639-14db-5b89-b0a4-f4784e34bc2e', 'a4ac4bf7-2759-5302-91d3-a0b1d7324c02']	['TCGA-DD-AAW2_treatment', 'TCGA-DD-AAW2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:14:08.134677-05:00']	['2019-07-31T20:55:22.002007-05:00', '2019-07-31T20:55:22.002007-05:00']	['released', 'released']	01	Primary	6af93255-f2a0-43b1-b78f-2e8f53bf6764	Primary Tumor	Not Reported	1575.0	70.0	OCT	74C2D5FA-1FDF-424A-BEE2-DE602A4F6DA7	true	Solid Tissue	False	Tumor
TCGA-DD-AAD2-01A	03f5de7d-45a9-4a73-8c61-ed816d4a3ac5	Adenomas and Adenocarcinomas	03f5de7d-45a9-4a73-8c61-ed816d4a3ac5	TCGA-DD-AAD2	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	66.0	-24221.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	658.0	24221.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24221.0	66.35890410958905	['21226f75-25fd-5ff7-ba75-7e5edec32730', 'a1ea9839-08b7-5bae-a81f-85bb55d0c4ed']	['TCGA-DD-AAD2_treatment_1', 'TCGA-DD-AAD2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:10.419728-05:00', '']	['2019-07-31T20:55:24.948701-05:00', '2019-07-31T20:55:24.948701-05:00']	['released', 'released']	01	Primary	51cd88e1-b32b-41b4-b971-eef962f15720	Primary Tumor	Not Reported	1105.0	30.0	OCT	3F50DE59-F830-4D51-90C6-7B275AF0876F	true	Solid Tissue	False	Tumor
TCGA-5C-A9VG-01A	073e51f9-fb79-4a5f-9ba0-2c9af03c0b85	Adenomas and Adenocarcinomas	073e51f9-fb79-4a5f-9ba0-2c9af03c0b85	TCGA-5C-A9VG	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	58.0	-21273.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	994ff94f-5d44-5de6-908b-dea33dca2a3d	5C	Cureline	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	328.0	21273.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21273.0	58.28219178082192	['8b7cabfd-f835-5ec8-aab5-b8d7bdecbd18', 'b98a532e-fbf2-52ca-acbf-125e68b933d7']	['TCGA-5C-A9VG_treatment', 'TCGA-5C-A9VG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:15.466124-05:00']	['2019-07-31T20:55:30.854355-05:00', '2019-07-31T20:55:30.854355-05:00']	['released', 'released']	01	Primary	c8a68467-9ea9-437d-b79e-62df8e25695b	Primary Tumor	Not Reported	133.0	170.0	OCT	9C941E66-614A-49E4-8C60-2C040C591A11	true	Solid Tissue	False	Tumor
TCGA-BC-A3KF-01A	07dd49fc-8a76-41e8-9eb3-107336f68701	Adenomas and Adenocarcinomas	07dd49fc-8a76-41e8-9eb3-107336f68701	TCGA-BC-A3KF	Liver and intrahepatic bile ducts	Not Reported	white	female	not reported	Alive	66.0	-24328.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	8.0	24328.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	24328.0	66.65205479452055	['057b05d5-8895-54b4-b3a0-ddf20993b7b5', '87afc6a8-5ec2-53ea-8c00-54ee73b29e2f']	['TCGA-BC-A3KF_treatment', 'TCGA-BC-A3KF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T09:02:13.241645-05:00']	['2019-07-31T15:45:33.074043-05:00', '2019-07-31T15:45:33.074043-05:00']	['released', 'released']	01	Primary	ece7aff8-7303-4d9a-b5ef-abb871571686	Primary Tumor	Not Reported	91.0	340.0	Unknown	AFBED89A-FA3F-45E9-9824-AEE5F891C5B2	false	Solid Tissue	False	Tumor
TCGA-G3-A25X-11A	08428220-abd4-484e-85ca-3673454c837e	Adenomas and Adenocarcinomas	08428220-abd4-484e-85ca-3673454c837e	TCGA-G3-A25X	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	73.0	-26988.0	1934.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1779.0	26988.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26988.0	73.93972602739726	['2ee4d32f-3aeb-5d21-af8a-47d260ad2501', 'c47632cb-ffab-59bc-921b-c65d91fd72f5']	['TCGA-G3-A25X_treatment', 'TCGA-G3-A25X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:18.127694-05:00']	['2019-07-31T20:55:34.097949-05:00', '2019-07-31T20:55:34.097949-05:00']	['released', 'released']	11	Not Applicable	02081a6a-2c8f-431e-a6ee-91501046981f	Solid Tissue Normal	Not Reported	1346.0	220.0	OCT		true	Solid Tissue	False	Normal
TCGA-G3-A25X-01A	08428220-abd4-484e-85ca-3673454c837e	Adenomas and Adenocarcinomas	08428220-abd4-484e-85ca-3673454c837e	TCGA-G3-A25X	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	73.0	-26988.0	1934.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1779.0	26988.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26988.0	73.93972602739726	['2ee4d32f-3aeb-5d21-af8a-47d260ad2501', 'c47632cb-ffab-59bc-921b-c65d91fd72f5']	['TCGA-G3-A25X_treatment', 'TCGA-G3-A25X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:18.127694-05:00']	['2019-07-31T20:55:34.097949-05:00', '2019-07-31T20:55:34.097949-05:00']	['released', 'released']	01	Primary	5ff97822-0520-45b7-a28a-a1c68c5ac324	Primary Tumor	Not Reported	1346.0	160.0	OCT	7DF1A9E2-3A8F-4A9B-B918-4133D60E4F0A	true	Solid Tissue	False	Tumor
TCGA-RG-A7D4-01A	08cbbb39-d05a-48b0-a966-5212c5923c8b	Adenomas and Adenocarcinomas	08cbbb39-d05a-48b0-a966-5212c5923c8b	TCGA-RG-A7D4	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	69.0	-25302.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	426f3759-b687-5b34-98fc-7b6e44c9c540	RG	Montefiore Medical Center	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1098.0	25302.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25302.0	69.32054794520548	['290f3c72-d366-5928-9d3d-8eaa9558fcbb', 'a27f5587-6615-5bba-95b7-6110473f7c3f']	['TCGA-RG-A7D4_treatment', 'TCGA-RG-A7D4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:20.954683-05:00']	['2019-07-31T20:55:37.291887-05:00', '2019-07-31T20:55:37.291887-05:00']	['released', 'released']	01	Primary	20a2b10b-b7e3-4fe3-b8b6-ecbd4e91c5eb	Primary Tumor	Not Reported	530.0	250.0	OCT	C8724B8E-5FC3-419B-9CC8-E6046D671D96	true	Solid Tissue	False	Tumor
TCGA-DD-AADE-01A	0904fd43-e25c-4d0f-acee-29faa3fd933b	Adenomas and Adenocarcinomas	0904fd43-e25c-4d0f-acee-29faa3fd933b	TCGA-DD-AADE	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	50.0	-18482.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1202.0	18482.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18482.0	50.635616438356166	['20da5aa1-9490-5806-8777-03f95470e52c', 'ba14bbc9-7f6f-5fd6-b8c0-2b0ce9cd5317']	['TCGA-DD-AADE_treatment_1', 'TCGA-DD-AADE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:23.289250-05:00', '']	['2019-07-31T20:55:40.365499-05:00', '2019-07-31T20:55:40.365499-05:00']	['released', 'released']	01	Primary	64bcb18b-1287-4e57-8851-d83b3e2757f3	Primary Tumor	Not Reported	930.0	80.0	OCT	826E81E3-8D51-425F-B514-C0BBCDFA5E1F	true	Solid Tissue	False	Tumor
TCGA-G3-AAV4-01A	0955d871-5413-4ab2-8fdf-b4feb3aeef5d	Adenomas and Adenocarcinomas	0955d871-5413-4ab2-8fdf-b4feb3aeef5d	TCGA-G3-AAV4	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	83.0	-30466.0	1929.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	27.0															No	Stage I	0.0	not reported	Liver		30466.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	30466.0	83.46849315068494	['8802ff0d-ec6b-5b91-83de-5669f961a69c', 'b1d40e4e-d4d5-5896-8fce-2305e62b0323']	['TCGA-G3-AAV4_treatment_1', 'TCGA-G3-AAV4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:25.558763-05:00', '']	['2019-07-31T20:55:43.667304-05:00', '2019-07-31T20:55:43.667304-05:00']	['released', 'released']	01	Primary	076a7d31-e804-4637-b23e-d0e30d32bed4	Primary Tumor	Not Reported	423.0	470.0	OCT	85CCE331-652C-4D5B-9ED6-ECA8B57AE1AF	true	Solid Tissue	False	Tumor
TCGA-DD-AAD0-01A	09790a9b-cc2f-4d7e-a971-8fb4ecd9f791	Adenomas and Adenocarcinomas	09790a9b-cc2f-4d7e-a971-8fb4ecd9f791	TCGA-DD-AAD0	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	73.0	-26781.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	137.0	26781.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26781.0	73.37260273972603	['007c76f6-bda0-55ce-8d6d-86f4c2c47912', '94689096-704a-5224-92e0-e6c64e7ec071']	['TCGA-DD-AAD0_treatment_1', 'TCGA-DD-AAD0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:28.234274-05:00', '']	['2019-07-31T20:55:46.817247-05:00', '2019-07-31T20:55:46.817247-05:00']	['released', 'released']	01	Primary	387f3824-23a9-4acb-b330-ea2573f8dc0d	Primary Tumor	Not Reported	1134.0	40.0	OCT	7A0FAFC9-DB9A-4648-8184-D0A03EFCF16D	true	Solid Tissue	False	Tumor
TCGA-DD-AACN-01A	0afd4283-7311-4d69-a2f5-779628da45fc	Adenomas and Adenocarcinomas	0afd4283-7311-4d69-a2f5-779628da45fc	TCGA-DD-AACN	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	32.0	-12007.0	1977.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1302.0	12007.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	12007.0	32.895890410958906	['3c6b1028-4ccb-5fd2-a79f-ae71f07087a0', '9188136b-c61d-5f22-a05c-3edcbad09118']	['TCGA-DD-AACN_treatment', 'TCGA-DD-AACN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:30.878300-05:00']	['2019-07-31T20:55:49.960330-05:00', '2019-07-31T20:55:49.960330-05:00']	['released', 'released']	01	Primary	a118a851-65b2-4604-8b33-b731410cc205	Primary Tumor	Not Reported	1644.0	40.0	OCT	449B3C67-3530-4728-9F38-F44F4D8EC027	true	Solid Tissue	False	Tumor
TCGA-BC-A10R-11A	0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c	Adenomas and Adenocarcinomas	0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c	TCGA-BC-A10R	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24274.0	1933.0	1999.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	308.0															No		0.0	not reported	Liver		24274.0	Hepatocellular carcinoma, NOS	no	1999.0	No	5th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24274.0	66.5041095890411	['24a8cc47-7c40-5dab-9d5f-49bedfba3f87', 'f9d9cd5a-71ca-5f74-9510-d6b65aa9dde0']	['TCGA-BC-A10R_treatment_1', 'TCGA-BC-A10R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:14:33.412794-05:00', '']	['2019-07-31T20:55:52.737128-05:00', '2019-07-31T20:55:52.737128-05:00']	['released', 'released']	11	Not Applicable	1ea00561-3d1d-49d0-a3f7-d34eb8fec235	Solid Tissue Normal	Not Reported	4316.0	1620.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A10R-01A	0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c	Adenomas and Adenocarcinomas	0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c	TCGA-BC-A10R	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24274.0	1933.0	1999.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	308.0															No		0.0	not reported	Liver		24274.0	Hepatocellular carcinoma, NOS	no	1999.0	No	5th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24274.0	66.5041095890411	['24a8cc47-7c40-5dab-9d5f-49bedfba3f87', 'f9d9cd5a-71ca-5f74-9510-d6b65aa9dde0']	['TCGA-BC-A10R_treatment_1', 'TCGA-BC-A10R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:14:33.412794-05:00', '']	['2019-07-31T20:55:52.737128-05:00', '2019-07-31T20:55:52.737128-05:00']	['released', 'released']	01	Primary	995180f2-5aa7-47b9-bb3f-585f94b2457a	Primary Tumor	Not Reported	4316.0	180.0	Unknown	65BE2C95-CADA-44FC-9313-14529AFF773E	false	Solid Tissue	False	Tumor
TCGA-DD-AAD3-01A	0d13229a-304a-48a6-a761-12e68e94a4b4	Adenomas and Adenocarcinomas	0d13229a-304a-48a6-a761-12e68e94a4b4	TCGA-DD-AAD3	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	43.0	-15706.0	1968.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1295.0	15706.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	15706.0	43.03013698630137	['4be1f0af-dbf9-50c3-9af4-50dc420972c9', '69199fab-a68b-52ec-a4f1-65e572f1e5fd']	['TCGA-DD-AAD3_treatment', 'TCGA-DD-AAD3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:38.545766-05:00']	['2019-07-31T20:55:58.427147-05:00', '2019-07-31T20:55:58.427147-05:00']	['released', 'released']	01	Primary	bfc24617-ab7b-494e-b404-ab0c1934b5b3	Primary Tumor	Not Reported	1072.0	20.0	OCT	03056B3E-B81F-44C0-B21E-6C850D67DB43	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GZ-01A	0e8c3831-def9-4efa-9f93-8942072d6a77	Adenomas and Adenocarcinomas	0e8c3831-def9-4efa-9f93-8942072d6a77	TCGA-2Y-A9GZ	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	82.0	-30082.0	1925.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	848.0															No	Stage II	0.0	not reported	Liver		30082.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	30082.0	82.41643835616438	['2e637e2b-6f22-5a1c-91cf-c925926755a0', 'fae58ba4-ab4b-5145-8e0f-be4a51af8e7d']	['TCGA-2Y-A9GZ_treatment', 'TCGA-2Y-A9GZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:14:41.005191-05:00']	['2019-07-31T20:56:02.399071-05:00', '2019-07-31T20:56:02.399071-05:00']	['released', 'released']	01	Primary	dd954cb4-abf3-417f-a1e1-ca745b60750c	Primary Tumor	Not Reported	2337.0	80.0	OCT	C389FDD7-0981-46EB-B51A-1BF6FCEC047F	true	Solid Tissue	False	Tumor
TCGA-DD-A11D-11A	0ef95351-0133-4f34-a59c-90934fb161f8	Adenomas and Adenocarcinomas	0ef95351-0133-4f34-a59c-90934fb161f8	TCGA-DD-A11D	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	57.0	-21003.0	1949.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1560.0															No	Stage I	0.0	not reported	Liver		21003.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21003.0	57.54246575342466	['f5207d73-bec6-5e3e-87e4-b24351ee7b57', 'f6811cde-dd6d-54f1-9a1d-ab1adc193bfb']	['TCGA-DD-A11D_treatment_1', 'TCGA-DD-A11D_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:14:43.660878-05:00', '']	['2019-07-31T20:56:05.447417-05:00', '2019-07-31T20:56:05.447417-05:00']	['released', 'released']	11	Not Applicable	2969dd04-f315-48ae-b92c-995bd3fc59c4	Solid Tissue Normal	Not Reported	1731.0	240.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A11D-01A	0ef95351-0133-4f34-a59c-90934fb161f8	Adenomas and Adenocarcinomas	0ef95351-0133-4f34-a59c-90934fb161f8	TCGA-DD-A11D	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	57.0	-21003.0	1949.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1560.0															No	Stage I	0.0	not reported	Liver		21003.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21003.0	57.54246575342466	['f5207d73-bec6-5e3e-87e4-b24351ee7b57', 'f6811cde-dd6d-54f1-9a1d-ab1adc193bfb']	['TCGA-DD-A11D_treatment_1', 'TCGA-DD-A11D_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:14:43.660878-05:00', '']	['2019-07-31T20:56:05.447417-05:00', '2019-07-31T20:56:05.447417-05:00']	['released', 'released']	01	Primary	f1fa4bcc-bcac-4174-984c-f057af2b9826	Primary Tumor	Not Reported	1731.0	300.0	Unknown	8D1A74F7-E6C3-4557-917A-CA7273929ADF	false	Solid Tissue	False	Tumor
TCGA-DD-AACQ-01A	0f34d654-8984-4b8b-b345-67066d611513	Adenomas and Adenocarcinomas	0f34d654-8984-4b8b-b345-67066d611513	TCGA-DD-AACQ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	50.0	-18429.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	432.0															No	Stage II	0.0	not reported	Liver	429.0	18429.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18429.0	50.49041095890411	['13bc7a95-a31d-5204-9d87-32b84c94012f', 'ae4a768c-d123-5822-a2dc-6e2d6a19286c']	['TCGA-DD-AACQ_treatment', 'TCGA-DD-AACQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:14:46.069566-05:00']	['2019-07-31T20:56:08.393750-05:00', '2019-07-31T20:56:08.393750-05:00']	['released', 'released']	01	Primary	9f0fa2f5-a595-4ba1-a42f-e2079c71c750	Primary Tumor	Not Reported	1665.0	40.0	OCT	3BBE2BEA-D346-4EA8-82CB-9305EC49A331	true	Solid Tissue	False	Tumor
TCGA-DD-A1ED-01A	0ff6364a-e6f4-47ca-a7e7-14705bf0a8df	Adenomas and Adenocarcinomas	0ff6364a-e6f4-47ca-a7e7-14705bf0a8df	TCGA-DD-A1ED	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	68.0	-25039.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2301.0	25039.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25039.0	68.6	['4786c2df-532c-5aaa-9115-dc35b73a75ba', 'fe15090d-3fc6-5b3d-9c23-b59ba63d8990']	['TCGA-DD-A1ED_treatment', 'TCGA-DD-A1ED_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:48.484261-05:00']	['2019-07-31T20:56:11.205063-05:00', '2019-07-31T20:56:11.205063-05:00']	['released', 'released']	01	Primary	1cf84c3e-e7e2-43a6-b9af-e0042312f02f	Primary Tumor	Not Reported	1525.0	60.0	OCT	6C4C27E3-EB96-48E4-BDF8-6E93C1557707	true	Solid Tissue	False	Tumor
TCGA-DD-A1ED-11A	0ff6364a-e6f4-47ca-a7e7-14705bf0a8df	Adenomas and Adenocarcinomas	0ff6364a-e6f4-47ca-a7e7-14705bf0a8df	TCGA-DD-A1ED	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	68.0	-25039.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2301.0	25039.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25039.0	68.6	['4786c2df-532c-5aaa-9115-dc35b73a75ba', 'fe15090d-3fc6-5b3d-9c23-b59ba63d8990']	['TCGA-DD-A1ED_treatment', 'TCGA-DD-A1ED_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:48.484261-05:00']	['2019-07-31T20:56:11.205063-05:00', '2019-07-31T20:56:11.205063-05:00']	['released', 'released']	11	Not Applicable	f744bf5d-cf9c-430d-9ae1-5f58a9586615	Solid Tissue Normal	Not Reported	1525.0	170.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-AAW0-01A	109436aa-a655-429b-8d3b-1a43385c9016	Adenomas and Adenocarcinomas	109436aa-a655-429b-8d3b-1a43385c9016	TCGA-DD-AAW0	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	54.0	-19981.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2015.0	19981.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19981.0	54.74246575342466	['34a5a14d-59c9-5469-9be9-8e137e3986c1', 'd5b57cbb-f13e-5b53-96e0-3467ef3fc6cf']	['TCGA-DD-AAW0_treatment', 'TCGA-DD-AAW0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:14:55.634127-05:00']	['2019-07-31T20:56:20.055448-05:00', '2019-07-31T20:56:20.055448-05:00']	['released', 'released']	01	Primary	c7da1402-2958-469e-9956-395c03833125	Primary Tumor	Not Reported	1737.0	70.0	OCT	75F8B93A-4839-4A9B-92CD-98147D025D31	true	Solid Tissue	False	Tumor
TCGA-G3-A7M9-01A	115b754d-8559-4f1d-af44-fcd8c2cef86a	Adenomas and Adenocarcinomas	115b754d-8559-4f1d-af44-fcd8c2cef86a	TCGA-G3-A7M9	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	70.0	-25588.0	1943.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	56.0															Not Reported	Stage IIIB	0.0	not reported	Liver		25588.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T3b	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25588.0	70.1041095890411	['8f6c1705-f8a0-5da4-aa2a-43298f233cd7', 'a8b6a378-7376-5256-99c5-68d82b033d4b']	['TCGA-G3-A7M9_treatment_1', 'TCGA-G3-A7M9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:57.982674-05:00', '']	['2019-07-31T20:56:22.935533-05:00', '2019-07-31T20:56:22.935533-05:00']	['released', 'released']	01	Primary	0ffdd482-a87e-45bc-a39b-09f5c4f23b55	Primary Tumor	Not Reported	86.0	1500.0	OCT	0759EEFA-E337-43A5-A6B8-7FDB5FE579EB	true	Solid Tissue	False	Tumor
TCGA-DD-AAVW-01A	11823a8a-194f-4e6b-a373-ef5a3fc7d2b9	Adenomas and Adenocarcinomas	11823a8a-194f-4e6b-a373-ef5a3fc7d2b9	TCGA-DD-AAVW	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	35.0	-12986.0	1973.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2317.0	12986.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	12986.0	35.57808219178082	['9cb7ec80-d03e-55dd-a964-3176e3305cb4', 'f0f4bfd8-2400-5967-a631-67efd81b7594']	['TCGA-DD-AAVW_treatment', 'TCGA-DD-AAVW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:00.346227-05:00']	['2019-07-31T20:56:26.145570-05:00', '2019-07-31T20:56:26.145570-05:00']	['released', 'released']	01	Primary	aaee0b65-c176-431d-a2d5-4912c8281a7c	Primary Tumor	Not Reported	2156.0	20.0	OCT	922707E9-9F68-458F-B1FC-E95CA2876420	true	Solid Tissue	False	Tumor
TCGA-BD-A2L6-11A	13a97cee-76b0-46a1-b728-d87b2248311e	Adenomas and Adenocarcinomas	13a97cee-76b0-46a1-b728-d87b2248311e	TCGA-BD-A2L6	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Alive	69.0	-25489.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	86f2ecb2-6c8a-51da-943d-4acb6d72576d	BD	University of Pittsburgh	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	1363.0	25489.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25489.0	69.83287671232877	['3c88b7c6-5a66-5208-a63a-772cdb17d7a9', '4d2ad91a-b2e5-5896-a429-8e45238063b5']	['TCGA-BD-A2L6_treatment', 'TCGA-BD-A2L6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:15:05.220740-05:00']	['2019-07-31T20:56:32.360370-05:00', '2019-07-31T20:56:32.360370-05:00']	['released', 'released']	11	Not Applicable	6049cd94-d7bf-4d5e-8f78-6aab65c58fa4	Solid Tissue Normal	Not Reported	148.0	310.0	OCT		true	Solid Tissue	False	Normal
TCGA-BD-A2L6-01A	13a97cee-76b0-46a1-b728-d87b2248311e	Adenomas and Adenocarcinomas	13a97cee-76b0-46a1-b728-d87b2248311e	TCGA-BD-A2L6	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Alive	69.0	-25489.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	86f2ecb2-6c8a-51da-943d-4acb6d72576d	BD	University of Pittsburgh	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	1363.0	25489.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	25489.0	69.83287671232877	['3c88b7c6-5a66-5208-a63a-772cdb17d7a9', '4d2ad91a-b2e5-5896-a429-8e45238063b5']	['TCGA-BD-A2L6_treatment', 'TCGA-BD-A2L6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:15:05.220740-05:00']	['2019-07-31T20:56:32.360370-05:00', '2019-07-31T20:56:32.360370-05:00']	['released', 'released']	01	Primary	7a489d88-3ae5-40f5-9126-92664b250fd6	Primary Tumor	Not Reported	148.0	480.0	OCT	6E795E68-4CFC-4DC9-A072-9A78C59CE10A	true	Solid Tissue	False	Tumor
TCGA-G3-A5SI-01A	14201da5-4446-47be-af72-120b7780c6bf	Adenomas and Adenocarcinomas	14201da5-4446-47be-af72-120b7780c6bf	TCGA-G3-A5SI	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	44.0	-16126.0	1967.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	768.0															No	Stage II	0.0	not reported	Liver	447.0	16126.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16126.0	44.18082191780822	['bfc561a4-5693-5348-b6bd-ab6754029450', 'dd3f4e6b-8725-5fde-875b-2f943742d78b']	['TCGA-G3-A5SI_treatment_1', 'TCGA-G3-A5SI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:07.609473-05:00', '']	['2019-07-31T20:56:35.503774-05:00', '2019-07-31T20:56:35.503774-05:00']	['released', 'released']	01	Primary	81ade549-b8a5-4cbe-9970-1be85c005002	Primary Tumor	Not Reported	418.0	660.0	OCT	C3CB3D42-9123-4D51-9FA8-D272D5F62F7B	true	Solid Tissue	False	Tumor
TCGA-DD-AAVU-01A	146c5332-1af5-4c49-b740-9a9edc795f24	Adenomas and Adenocarcinomas	146c5332-1af5-4c49-b740-9a9edc795f24	TCGA-DD-AAVU	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	46.0	-16889.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	2202.0	16889.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16889.0	46.271232876712325	['1c2a424f-cfcb-5864-b3b4-2165c21a53d8', '53ce2171-53c9-5c98-8441-f0a0c119066b']	['TCGA-DD-AAVU_treatment', 'TCGA-DD-AAVU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:09.869297-05:00']	['2019-07-31T20:56:39.066243-05:00', '2019-07-31T20:56:39.066243-05:00']	['released', 'released']	01	Primary	7b4920a8-a742-4065-bad4-14473fe429a1	Primary Tumor	Not Reported	1938.0	40.0	OCT	08C1D8EA-E936-45D8-961D-02670FAD82CC	true	Solid Tissue	False	Tumor
TCGA-G3-AAV2-01A	1724c96a-2aa3-43d4-992a-08af948c0f45	Adenomas and Adenocarcinomas	1724c96a-2aa3-43d4-992a-08af948c0f45	TCGA-G3-AAV2	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	50.0	-18363.0	1963.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	372.0	18363.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18363.0	50.30958904109589	['3e2c6ad2-f325-5a3a-9a58-7d8052de06f5', 'a00f5416-643a-5b06-a00a-065a4a7f453c']	['TCGA-G3-AAV2_treatment_1', 'TCGA-G3-AAV2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:12.174985-05:00', '']	['2019-07-31T20:56:41.958737-05:00', '2019-07-31T20:56:41.958737-05:00']	['released', 'released']	01	Primary	a82bc212-23ad-4e9b-af92-653f4b3c9df4	Primary Tumor	Not Reported	136.0	500.0	OCT	A323CDD5-4022-486C-B77E-F0552FB9076B	true	Solid Tissue	False	Tumor
TCGA-DD-AACM-01A	173088ed-6bc0-4ccf-80e7-c647028cccd6	Adenomas and Adenocarcinomas	173088ed-6bc0-4ccf-80e7-c647028cccd6	TCGA-DD-AACM	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	48.0	-17590.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1769.0	17590.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17590.0	48.19178082191781	['e3e9ef51-9cce-5333-8fad-12d1b93ec32c', 'efce1219-65c7-58d2-87aa-b3e2004df13c']	['TCGA-DD-AACM_treatment_1', 'TCGA-DD-AACM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:14.619199-05:00', '']	['2019-07-31T20:56:44.659959-05:00', '2019-07-31T20:56:44.659959-05:00']	['released', 'released']	01	Primary	66a01b18-fcb1-466d-aebf-401816b17ec2	Primary Tumor	Not Reported	1777.0	90.0	OCT	ADABA595-4FA3-4D34-BB61-6B1EB345331C	true	Solid Tissue	False	Tumor
TCGA-2Y-A9H7-01A	18602ec8-aed1-4515-b0d1-0db6d1cbb2c4	Adenomas and Adenocarcinomas	18602ec8-aed1-4515-b0d1-0db6d1cbb2c4	TCGA-2Y-A9H7	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	81.0	-29752.0	1930.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	1168.0	29752.0	Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	29752.0	81.5123287671233	['40212afb-a9da-52ac-816d-70bbcde9b7e8', 'd0114d8a-4971-5d0c-ab40-88978b912d20']	['TCGA-2Y-A9H7_treatment_1', 'TCGA-2Y-A9H7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:19.724487-05:00', '']	['2019-07-31T20:56:50.806908-05:00', '2019-07-31T20:56:50.806908-05:00']	['released', 'released']	01	Primary	47b918da-fc82-40f9-a6f3-e8b2df75188b	Primary Tumor	Not Reported	846.0	140.0	OCT	80E07DD4-2925-4F58-B4DA-07041673A13F	true	Solid Tissue	False	Tumor
TCGA-EP-A2KB-01A	18c08546-bed3-4ed9-b223-479afe633c8e	Adenomas and Adenocarcinomas	18c08546-bed3-4ed9-b223-479afe633c8e	TCGA-EP-A2KB	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	46.0	-16835.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH	596.0															No	Stage I	0.0	not reported	Liver	334.0	16835.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	16835.0	46.12328767123287	['16127f9c-b088-51e7-8b8a-b7a606972a3f', 'f6eca0e4-a762-50b1-ae7f-f9ed18f4e09c']	['TCGA-EP-A2KB_treatment_1', 'TCGA-EP-A2KB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:22.372778-05:00', '']	['2019-07-31T20:56:53.722032-05:00', '2019-07-31T20:56:53.722032-05:00']	['released', 'released']	01	Primary	e2895132-da4f-4db5-b417-510e99fce776	Primary Tumor	Not Reported	50.0	1210.0	Unknown	DF650AE0-E9E8-48A7-8D39-88A3F7EC2AC7	false	Solid Tissue	False	Tumor
TCGA-CC-A8HU-01A	1943ff2c-ca53-4e3c-acc1-5ae84f4ba230	Adenomas and Adenocarcinomas	1943ff2c-ca53-4e3c-acc1-5ae84f4ba230	TCGA-CC-A8HU	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	39.0	-14367.0	1974.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	344.0															No	Stage IIIA	0.0	not reported	Liver	0.0	14367.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	14367.0	39.36164383561644	['8c17d60b-1485-5e83-a96e-70795322baa9', 'fc7e9440-9c13-5635-911a-fbcb253ccea0']	['TCGA-CC-A8HU_treatment_1', 'TCGA-CC-A8HU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:24.907594-05:00', '']	['2019-07-31T20:56:56.697621-05:00', '2019-07-31T20:56:56.697621-05:00']	['released', 'released']	01	Primary	78dfb76e-4ca8-4b43-b967-eeef66d0f676	Primary Tumor	Not Reported	141.0	360.0	OCT	CBCE823C-E6F5-4718-97F0-2705BE3C855A	true	Solid Tissue	False	Tumor
TCGA-DD-A4NB-01A	1983fade-44f1-41e0-8983-f2ce8d649655	Adenomas and Adenocarcinomas	1983fade-44f1-41e0-8983-f2ce8d649655	TCGA-DD-A4NB	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	25.0	-9426.0	1986.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	989.0	9426.0	Hepatocellular carcinoma, fibrolamellar	no	2011.0	No	7th	T1	8171/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	9426.0	25.824657534246576	['7332d8dd-b85b-5878-938f-3b218a22ad8e', 'ff4e2c05-8eb6-505d-8f80-8ed847522887']	['TCGA-DD-A4NB_treatment', 'TCGA-DD-A4NB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:27.276138-05:00']	['2019-07-31T20:56:59.778898-05:00', '2019-07-31T20:56:59.778898-05:00']	['released', 'released']	01	Primary	0a79c3ee-9dd0-4ff7-b079-c9a0aeb08e1f	Primary Tumor	Not Reported	464.0	180.0	OCT	963CA9F8-DA47-4E2E-892E-14E7AB0EB76E	true	Solid Tissue	False	Tumor
TCGA-PD-A5DF-01A	1987b453-f97d-45c7-9c89-b9a33313d645	Adenomas and Adenocarcinomas	1987b453-f97d-45c7-9c89-b9a33313d645	TCGA-PD-A5DF	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	58.0	-21414.0	1949.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	de3a3fc3-2a44-5862-abc9-ab271401aba1	PD	Fox Chase	Liver hepatocellular carcinoma	NCH	639.0															No	Stage IIIB	0.0	not reported	Liver		21414.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21414.0	58.66849315068493	['b31f5b33-983d-5d1d-981e-034557651e74', 'df1a49c5-df21-5522-a5ee-0f6406c7165c']	['TCGA-PD-A5DF_treatment', 'TCGA-PD-A5DF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:15:29.685663-05:00']	['2019-07-31T20:57:02.837478-05:00', '2019-07-31T20:57:02.837478-05:00']	['released', 'released']	01	Primary	0b88d087-50fb-4893-ae37-2fc5990a5b15	Primary Tumor	Not Reported	1906.0	140.0	OCT	8D63D119-DC81-45FE-9F02-8228A7160C55	true	Solid Tissue	False	Tumor
TCGA-DD-A11B-11A	1b1b1af0-b19b-4086-b1b7-669fa0b88235	Adenomas and Adenocarcinomas	1b1b1af0-b19b-4086-b1b7-669fa0b88235	TCGA-DD-A11B	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	73.0	-26857.0	1932.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	14.0															No	Stage I	0.0	not reported	Liver		26857.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26857.0	73.58082191780822	['43f9345b-7292-5ae8-b845-058559c8b552', '5535be87-9766-5be3-b0d9-3e0d48af6973']	['TCGA-DD-A11B_treatment', 'TCGA-DD-A11B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:34.492944-05:00']	['2019-07-31T20:57:08.301969-05:00', '2019-07-31T20:57:08.301969-05:00']	['released', 'released']	11	Not Applicable	8a77f4b1-8b1d-419b-8d1e-73bf2041303a	Solid Tissue Normal	Not Reported	1975.0	320.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A11B-01A	1b1b1af0-b19b-4086-b1b7-669fa0b88235	Adenomas and Adenocarcinomas	1b1b1af0-b19b-4086-b1b7-669fa0b88235	TCGA-DD-A11B	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	73.0	-26857.0	1932.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	14.0															No	Stage I	0.0	not reported	Liver		26857.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26857.0	73.58082191780822	['43f9345b-7292-5ae8-b845-058559c8b552', '5535be87-9766-5be3-b0d9-3e0d48af6973']	['TCGA-DD-A11B_treatment', 'TCGA-DD-A11B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:34.492944-05:00']	['2019-07-31T20:57:08.301969-05:00', '2019-07-31T20:57:08.301969-05:00']	['released', 'released']	01	Primary	cc6197e4-ec24-4cc7-a69d-e20d4bf14c62	Primary Tumor	Not Reported	1975.0	280.0	Unknown	B53C4282-5266-43FE-A958-19097FD20290	false	Solid Tissue	False	Tumor
TCGA-GJ-A6C0-01A	1b326242-4be6-4f05-b5fb-07ed76b49850	Adenomas and Adenocarcinomas	1b326242-4be6-4f05-b5fb-07ed76b49850	TCGA-GJ-A6C0	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	75.0	-27626.0	1937.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	cf12df24-06a9-523f-ab6c-234ab95cf1c9	GJ	ABS - IUPUI	Liver hepatocellular carcinoma	NCH	31.0															No	Stage II	0.0	not reported	Liver		27626.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27626.0	75.68767123287671	['d223999e-ba1a-56ab-aa07-cd0d8f1d9da3', 'fa5f5673-9c53-54a4-a131-726dbd8aa50c']	['TCGA-GJ-A6C0_treatment', 'TCGA-GJ-A6C0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:36.839535-05:00']	['2019-07-31T20:57:11.107070-05:00', '2019-07-31T20:57:11.107070-05:00']	['released', 'released']	01	Primary	9d33dab1-ce73-42c6-b504-42e127839882	Primary Tumor	Not Reported	310.0	170.0	Unknown	D9F106D7-C163-46C5-8DDC-FF60ED1CF17B	false	Solid Tissue	False	Tumor
TCGA-DD-AADW-01A	1bcf1762-7926-45f6-a367-d45fc3af7bc3	Adenomas and Adenocarcinomas	1bcf1762-7926-45f6-a367-d45fc3af7bc3	TCGA-DD-AADW	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	48.0	-17781.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	587.0	17781.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17781.0	48.71506849315068	['5e223092-3c32-534e-85ff-f39962e14c14', 'c42c3aef-9203-52b9-ae51-b3a040847f2d']	['TCGA-DD-AADW_treatment_1', 'TCGA-DD-AADW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'yes']	['2019-04-28T13:15:41.881037-05:00', '']	['2019-07-31T20:57:17.378936-05:00', '2019-07-31T20:57:17.378936-05:00']	['released', 'released']	01	Primary	db312a8d-28b5-4828-9731-5a175eb2c517	Primary Tumor	Not Reported	287.0	30.0	OCT	18DA1A83-81E4-462C-AA58-FBB1298F86F9	true	Solid Tissue	False	Tumor
TCGA-DD-A1EF-11A	1c1e8987-676f-417b-b3b4-e0321367df55	Adenomas and Adenocarcinomas	1c1e8987-676f-417b-b3b4-e0321367df55	TCGA-DD-A1EF	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	57.0	-21165.0	1950.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	394.0															No	Stage I	0.0	not reported	Liver		21165.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21165.0	57.986301369863014	['24e5dc72-a173-555d-a62e-6468ca46383a', '68ce6c1e-2136-52ae-a4d9-415edee39a05']	['TCGA-DD-A1EF_treatment', 'TCGA-DD-A1EF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:15:44.368642-05:00']	['2019-07-31T20:57:20.291410-05:00', '2019-07-31T20:57:20.291410-05:00']	['released', 'released']	11	Not Applicable	e0887353-33a9-45ed-a326-a184cdc0adc9	Solid Tissue Normal	Not Reported	1382.0	70.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-A1EF-01A	1c1e8987-676f-417b-b3b4-e0321367df55	Adenomas and Adenocarcinomas	1c1e8987-676f-417b-b3b4-e0321367df55	TCGA-DD-A1EF	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	57.0	-21165.0	1950.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	394.0															No	Stage I	0.0	not reported	Liver		21165.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21165.0	57.986301369863014	['24e5dc72-a173-555d-a62e-6468ca46383a', '68ce6c1e-2136-52ae-a4d9-415edee39a05']	['TCGA-DD-A1EF_treatment', 'TCGA-DD-A1EF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:15:44.368642-05:00']	['2019-07-31T20:57:20.291410-05:00', '2019-07-31T20:57:20.291410-05:00']	['released', 'released']	01	Primary	f11e2b07-2848-4601-b19f-eed188aa4c3b	Primary Tumor	Not Reported	1382.0	190.0	OCT	002B24F9-22DB-4504-A048-BF9790A4837E	true	Solid Tissue	False	Tumor
TCGA-XR-A8TG-01A	1d7d5166-6582-4ea1-b242-37c2c3919a3c	Adenomas and Adenocarcinomas	1d7d5166-6582-4ea1-b242-37c2c3919a3c	TCGA-XR-A8TG	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Alive	58.0	-21544.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	04898289-8edf-590e-8640-35e36365de75	XR	University of Sao Paulo	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	898.0	21544.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	21544.0	59.02465753424657	['4b5da898-0794-5780-bf4a-c6a689d9e572', '5f49af80-0a97-579c-b466-7ea1ea9eb310']	['TCGA-XR-A8TG_treatment', 'TCGA-XR-A8TG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:15:46.786864-05:00']	['2019-07-31T20:57:23.121571-05:00', '2019-07-31T20:57:23.121571-05:00']	['released', 'released']	01	Primary	e96bf364-973c-4282-b3eb-a445b4bc59b6	Primary Tumor	Not Reported	439.0	20.0	OCT	B6CBB321-E73F-4A24-8557-E10E94B2B8C6	true	Solid Tissue	False	Tumor
TCGA-DD-AADJ-01A	1d880aea-9efe-4a43-8a6a-6a81801da9e0	Adenomas and Adenocarcinomas	1d880aea-9efe-4a43-8a6a-6a81801da9e0	TCGA-DD-AADJ	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	70.0	-25863.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1066.0	25863.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25863.0	70.85753424657534	['b71cce13-1da8-5a0d-bce2-7b5eb3ebe979', 'be0e100c-2b57-5ded-993e-7d14142eab8c']	['TCGA-DD-AADJ_treatment_1', 'TCGA-DD-AADJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:49.208119-05:00', '']	['2019-07-31T20:57:26.024828-05:00', '2019-07-31T20:57:26.024828-05:00']	['released', 'released']	01	Primary	5733ea09-3aae-4aea-9828-00104bea3be1	Primary Tumor	Not Reported	804.0	30.0	OCT	D087E915-C5DB-40B1-9EDA-B10EA2D6754B	true	Solid Tissue	False	Tumor
TCGA-XR-A8TF-01A	1e9f910c-82c0-4222-a62f-b656839307fc	Adenomas and Adenocarcinomas	1e9f910c-82c0-4222-a62f-b656839307fc	TCGA-XR-A8TF	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Dead	74.0	-27145.0	1938.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	04898289-8edf-590e-8640-35e36365de75	XR	University of Sao Paulo	Liver hepatocellular carcinoma	NCH	693.0															No	Stage I	0.0	not reported	Liver		27145.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27145.0	74.36986301369863	['5f59483f-8578-5bbd-84a3-09b1a1bf2e93', '9c8c22f5-2e92-531a-b6b6-b0d3f9d44a47']	['TCGA-XR-A8TF_treatment', 'TCGA-XR-A8TF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:51.603581-05:00']	['2019-07-31T20:57:28.906490-05:00', '2019-07-31T20:57:28.906490-05:00']	['released', 'released']	01	Primary	6ddbc513-b220-4814-835c-274365f30040	Primary Tumor	Not Reported	481.0	250.0	OCT	A0557F82-3ACC-43E5-9ED3-902BEDD36939	true	Solid Tissue	False	Tumor
TCGA-K7-AAU7-01A	1eacfcc0-1d05-4441-b3d8-b0790e1c40f1	Adenomas and Adenocarcinomas	1eacfcc0-1d05-4441-b3d8-b0790e1c40f1	TCGA-K7-AAU7	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	61.0	-22476.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	f9ebb17f-fdca-5a0e-b026-dcb173867634	K7	ABS - Lahey Clinic	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	359.0	22476.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2013.0	No	7th	T2a	8180/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22476.0	61.57808219178082	['77941f1b-7a0e-5dba-abf4-f595fcd0f5a7', 'b5427a67-b6e9-5061-ab40-6f0619d42dfd']	['TCGA-K7-AAU7_treatment_1', 'TCGA-K7-AAU7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:15:54.075130-05:00', '']	['2019-07-31T20:57:32.224345-05:00', '2019-07-31T20:57:32.224345-05:00']	['released', 'released']	01	Primary	6e0902dd-f307-4354-9f61-47a9d97fa77f	Primary Tumor	Not Reported	9.0	160.0	OCT	AE0DD792-F1D5-4340-A521-FC814E08C0CB	true	Solid Tissue	False	Tumor
TCGA-DD-AAD1-01A	1f482810-433a-4d46-b81b-f7909fff8c09	Adenomas and Adenocarcinomas	1f482810-433a-4d46-b81b-f7909fff8c09	TCGA-DD-AAD1	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	51.0	-18794.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	564.0	18794.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18794.0	51.49041095890411	['12e352e9-2a1d-5f2c-a0e5-ab7dde6984e3', '3e3754e3-7fe0-51f3-834c-f89117e3ce43']	['TCGA-DD-AAD1_treatment_1', 'TCGA-DD-AAD1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:15:56.343125-05:00', '']	['2019-07-31T20:57:35.147459-05:00', '2019-07-31T20:57:35.147459-05:00']	['released', 'released']	01	Primary	a727f2ad-4d22-4d42-a8ce-37e5cfaf75c8	Primary Tumor	Not Reported	1114.0	10.0	OCT	D0035DF7-2E83-44E0-8FF1-C9A057E11AE3	true	Solid Tissue	False	Tumor
TCGA-ED-A7XO-01A	20bb3855-66e2-46d4-b189-006b4b254c2e	Adenomas and Adenocarcinomas	20bb3855-66e2-46d4-b189-006b4b254c2e	TCGA-ED-A7XO	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	29.0	-10828.0	1984.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	427.0	10828.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	10828.0	29.665753424657535	['08587143-8cf0-55be-b2a8-9bd33b4e4fdc', '199a9fda-e082-5ddb-9c80-27af195da7e5']	['TCGA-ED-A7XO_treatment', 'TCGA-ED-A7XO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:15:58.754462-05:00']	['2019-07-31T20:57:38.315179-05:00', '2019-07-31T20:57:38.315179-05:00']	['released', 'released']	01	Primary	8ae44ec9-741c-484b-a784-a0cb2f02aaa0	Primary Tumor	Not Reported	77.0	1430.0	OCT	3FC3BB34-8E4A-4422-BFEF-58B15947F032	true	Solid Tissue	False	Tumor
TCGA-DD-AACH-01A	219b067c-522f-4971-b0d0-86f9971d369d	Adenomas and Adenocarcinomas	219b067c-522f-4971-b0d0-86f9971d369d	TCGA-DD-AACH	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	69.0	-25544.0	1939.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	195.0															No	Stage II	0.0	not reported	Liver		25544.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25544.0	69.98356164383561	['390a389c-ecb2-51c8-963b-1c37770f536d', '535e59a2-4074-544e-8a52-4840b0cb5b3e']	['TCGA-DD-AACH_treatment_1', 'TCGA-DD-AACH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:01.092280-05:00', '']	['2019-07-31T20:57:41.133028-05:00', '2019-07-31T20:57:41.133028-05:00']	['released', 'released']	01	Primary	31dfd0a9-31c4-4665-adad-3cbe49c1c5eb	Primary Tumor	Not Reported	1919.0	220.0	OCT	573AD8A4-3D0A-4128-BAD8-2FDC5B480DE5	true	Solid Tissue	False	Tumor
TCGA-ZP-A9CZ-01A	22077056-067d-4db5-98e5-106778ceca56	Adenomas and Adenocarcinomas	22077056-067d-4db5-98e5-106778ceca56	TCGA-ZP-A9CZ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	72.0	-26403.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	706.0	26403.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26403.0	72.33698630136986	['05d504e0-b8c2-53c6-9a1e-42314bb7a620', 'c410eb3b-f090-5278-9cbb-790513fb0fe8']	['TCGA-ZP-A9CZ_treatment_1', 'TCGA-ZP-A9CZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:03.611151-05:00', '']	['2019-07-31T20:57:44.136779-05:00', '2019-07-31T20:57:44.136779-05:00']	['released', 'released']	01	Primary	6e118e72-6654-42fc-92f5-c7a39e44bb15	Primary Tumor	Not Reported	797.0	50.0	Unknown	C3F4669C-9E5D-4A46-84A8-E78BF2D5EA92	false	Solid Tissue	False	Tumor
TCGA-CC-A7IE-01A	220f75d7-08a4-4936-b4b2-0750e87ccdf5	Adenomas and Adenocarcinomas	220f75d7-08a4-4936-b4b2-0750e87ccdf5	TCGA-CC-A7IE	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	57.0	-20985.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	217.0															No	Stage IIIA	0.0	not reported	Liver	0.0	20985.0	Hepatocellular carcinoma, NOS	no	2012.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20985.0	57.49315068493151	['95697307-934b-5779-91cf-fddd4a1cf3bf', 'eed112c7-6efe-5028-b495-96da9e078409']	['TCGA-CC-A7IE_treatment', 'TCGA-CC-A7IE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:05.980056-05:00']	['2019-07-31T20:57:47.408809-05:00', '2019-07-31T20:57:47.408809-05:00']	['released', 'released']	01	Primary	b58106e6-417f-41f7-88ec-2e9e51495631	Primary Tumor	Not Reported	243.0	290.0	OCT	2858A435-0C78-468B-B2B0-DB9EBB4CA545	true	Solid Tissue	False	Tumor
TCGA-MI-A75G-01A	22dd3876-1f2c-4ddd-8fae-f5fb820993ba	Adenomas and Adenocarcinomas	22dd3876-1f2c-4ddd-8fae-f5fb820993ba	TCGA-MI-A75G	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	63.0	-23284.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2b1c1097-fa63-5d15-b5d3-c54f5eacb9c8	MI	BLN - Baylor	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	698.0	23284.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23284.0	63.79178082191781	['30db3b01-eb72-5b0d-beae-55d32d7e0e72', 'd851b88e-9d58-57dd-a5ca-a255d0690744']	['TCGA-MI-A75G_treatment_1', 'TCGA-MI-A75G_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:08.275617-05:00', '']	['2019-07-31T20:57:50.254905-05:00', '2019-07-31T20:57:50.254905-05:00']	['released', 'released']	01	Primary	688494f9-f573-4d02-a4a1-11341076e1fb	Primary Tumor	Not Reported	427.0	80.0	OCT	30FAEBBF-0EEE-40F5-9463-50FDDE258D4B	true	Solid Tissue	False	Tumor
TCGA-G3-A25Y-01A	239b4298-b090-480a-a19f-9758a827aa30	Adenomas and Adenocarcinomas	239b4298-b090-480a-a19f-9758a827aa30	TCGA-G3-A25Y	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	52.0	-19055.0	1954.0	2007.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	452.0															No	Stage I	0.0	not reported	Liver		19055.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19055.0	52.205479452054796	['4dc8a81c-3c8f-5c3c-ad9c-a9d65aae46ad', '70a205ad-ac4e-5c67-ba60-f12644bfa070']	['TCGA-G3-A25Y_treatment', 'TCGA-G3-A25Y_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:10.681380-05:00']	['2019-07-31T20:57:53.128801-05:00', '2019-07-31T20:57:53.128801-05:00']	['released', 'released']	01	Primary	433df923-691a-41f8-8718-6f9783f59873	Primary Tumor	Not Reported	1595.0	440.0	OCT	5AEEF060-BA18-416A-BE3F-604891A9A6D2	true	Solid Tissue	False	Tumor
TCGA-CC-A5UE-01A	23d8e6a0-fa79-4323-a0a6-2dea2a319667	Adenomas and Adenocarcinomas	23d8e6a0-fa79-4323-a0a6-2dea2a319667	TCGA-CC-A5UE	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	48.0	-17805.0	1964.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	272.0															No	Stage IIIB	0.0	not reported	Liver	0.0	17805.0	Hepatocellular carcinoma, NOS	no	2012.0	No	6th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17805.0	48.78082191780822	['045bac88-fa67-59db-994e-ac10c2226921', 'ba02e258-e10c-5fb7-bf98-3cc4a7c52d5b']	['TCGA-CC-A5UE_treatment', 'TCGA-CC-A5UE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:12.905319-05:00']	['2019-07-31T20:57:56.340084-05:00', '2019-07-31T20:57:56.340084-05:00']	['released', 'released']	01	Primary	e8a5ec1d-b962-4b48-8eae-d49bd6291b6b	Primary Tumor	Not Reported	85.0	300.0	OCT	3D729315-DE44-441D-9CB2-3CFB827C2808	true	Solid Tissue	False	Tumor
TCGA-DD-A73D-01A	24170a77-94e0-4002-9d3e-a46c84e84fca	Adenomas and Adenocarcinomas	24170a77-94e0-4002-9d3e-a46c84e84fca	TCGA-DD-A73D	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24941.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	693.0	24941.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24941.0	68.33150684931506	['0c327217-62b9-5e99-87a7-eb39e331886c', 'e80e8a22-ed16-5f03-81f1-b504f32684c4']	['TCGA-DD-A73D_treatment_1', 'TCGA-DD-A73D_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:15.343829-05:00', '']	['2019-07-31T20:57:59.115027-05:00', '2019-07-31T20:57:59.115027-05:00']	['released', 'released']	01	Primary	294d514d-43dd-4fda-852a-792a8999493a	Primary Tumor	Not Reported	313.0	250.0	Unknown	6C9BA4B3-78FD-4D16-A420-5C98BCEFD55D	false	Solid Tissue	False	Tumor
TCGA-G3-A5SK-01A	24259d55-20ac-4359-861f-dcad7ad88cee	Adenomas and Adenocarcinomas	24259d55-20ac-4359-861f-dcad7ad88cee	TCGA-G3-A5SK	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	58.0	-21320.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	744.0	21320.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	21320.0	58.41095890410959	['2c1481fa-312c-590a-9c28-43b88b677a55', '6cd8db22-5113-5541-9b37-ce2ead44858c']	['TCGA-G3-A5SK_treatment', 'TCGA-G3-A5SK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:17.758457-05:00']	['2019-07-31T20:58:02.269004-05:00', '2019-07-31T20:58:02.269004-05:00']	['released', 'released']	01	Primary	b245c6c9-405b-48c9-bcaa-02bcdf11bd2e	Primary Tumor	Not Reported	251.0	650.0	OCT	6FB76663-58FA-48DD-A0F8-136C975FE067	true	Solid Tissue	False	Tumor
TCGA-DD-AAD8-01A	24b66729-242b-4771-819d-77c9a1fcbb10	Adenomas and Adenocarcinomas	24b66729-242b-4771-819d-77c9a1fcbb10	TCGA-DD-AAD8	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	73.0	-26781.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1219.0	26781.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26781.0	73.37260273972603	['57cbba23-ac57-540a-991d-392295efd446', '7f505856-33f2-5b76-b13c-1d5f3e731839']	['TCGA-DD-AAD8_treatment_1', 'TCGA-DD-AAD8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:20.136847-05:00', '']	['2019-07-31T20:58:05.406467-05:00', '2019-07-31T20:58:05.406467-05:00']	['released', 'released']	01	Primary	a4847550-1a54-489f-a533-79b159cdb8cd	Primary Tumor	Not Reported	981.0	30.0	OCT	5536ED7C-6CC3-442D-A8FD-5EE91C98F358	true	Solid Tissue	False	Tumor
TCGA-MR-A520-01A	25e893ad-a0fd-45ae-9aa9-9bcd7c2ec8e5	Adenomas and Adenocarcinomas	25e893ad-a0fd-45ae-9aa9-9bcd7c2ec8e5	TCGA-MR-A520	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	58.0	-21398.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2e3c05db-a4a5-5563-9933-a10940cec98b	MR	University of Minnesota	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	229.0	21398.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21398.0	58.62465753424657	['e318f368-87c5-5de7-8ca3-c799aeeb0cdd', 'e4c42bee-c60c-55e3-ab8a-b0466b7800d3']	['TCGA-MR-A520_treatment', 'TCGA-MR-A520_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:22.558732-05:00']	['2019-07-31T20:58:08.481278-05:00', '2019-07-31T20:58:08.481278-05:00']	['released', 'released']	01	Primary	d7f0e432-c20b-4b2b-8d73-2a235f339be7	Primary Tumor	Not Reported	106.0	270.0	OCT	FA4ACC09-F22B-4253-8667-6C04369E5DCA	true	Solid Tissue	False	Tumor
TCGA-G3-A7M6-01A	2681f83d-233f-4ea2-b5e6-3c05af81f123	Adenomas and Adenocarcinomas	2681f83d-233f-4ea2-b5e6-3c05af81f123	TCGA-G3-A7M6	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22205.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	632.0	22205.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22205.0	60.83561643835616	['39c9aa4f-c6ca-51a3-bd03-436ae3248906', '8cff3e69-b900-52f8-b61f-f78aafa07792']	['TCGA-G3-A7M6_treatment_1', 'TCGA-G3-A7M6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:24.663653-05:00', '']	['2019-07-31T20:58:12.012556-05:00', '2019-07-31T20:58:12.012556-05:00']	['released', 'released']	01	Primary	33b4c69a-230a-4d4b-9d6b-5f1c28d7d25b	Primary Tumor	Not Reported	212.0	680.0	OCT	BE9902BC-2818-4A37-AF40-768208EA15B9	true	Solid Tissue	False	Tumor
TCGA-RC-A7SB-01A	26d93d77-ab66-45aa-a162-98d091221afb	Adenomas and Adenocarcinomas	26d93d77-ab66-45aa-a162-98d091221afb	TCGA-RC-A7SB	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	53.0	-19698.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	588.0	19698.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19698.0	53.967123287671235	['7f0b39f5-adfb-51f0-8213-687b7d95dfc7', 'ccdf1f2a-fb1e-55a0-875f-b65847ea9601']	['TCGA-RC-A7SB_treatment_1', 'TCGA-RC-A7SB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:27.066854-05:00', '']	['2019-07-31T20:58:15.115306-05:00', '2019-07-31T20:58:15.115306-05:00']	['released', 'released']	01	Primary	a3f87572-a82e-4cd9-821d-a1ea2caf867c	Primary Tumor	Not Reported	343.0	110.0	OCT	5B9D93C9-3051-4E0C-97B1-25E9CDD9CFE1	true	Solid Tissue	False	Tumor
TCGA-DD-A1EL-01A	2854ffe8-1f77-497a-bf49-11e0189fee35	Adenomas and Adenocarcinomas	2854ffe8-1f77-497a-bf49-11e0189fee35	TCGA-DD-A1EL	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	23.0	-8573.0	1986.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	415.0															No	Stage II	0.0	not reported	Liver		8573.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	8573.0	23.487671232876714	['37b16fdb-a34c-5118-a19a-2e7aaee0a907', 'fbf872de-b76c-5875-a098-d3941bf17268']	['TCGA-DD-A1EL_treatment', 'TCGA-DD-A1EL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:30.005712-05:00']	['2019-07-31T20:58:18.240185-05:00', '2019-07-31T20:58:18.240185-05:00']	['released', 'released']	01	Primary	5a756b40-6c08-47e8-9b25-9b3ffff39606	Primary Tumor	Not Reported	577.0	130.0	OCT	C8A1098A-0717-4801-A3E5-C13C42C65936	true	Solid Tissue	False	Tumor
TCGA-DD-A1EL-11A	2854ffe8-1f77-497a-bf49-11e0189fee35	Adenomas and Adenocarcinomas	2854ffe8-1f77-497a-bf49-11e0189fee35	TCGA-DD-A1EL	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	23.0	-8573.0	1986.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	415.0															No	Stage II	0.0	not reported	Liver		8573.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	8573.0	23.487671232876714	['37b16fdb-a34c-5118-a19a-2e7aaee0a907', 'fbf872de-b76c-5875-a098-d3941bf17268']	['TCGA-DD-A1EL_treatment', 'TCGA-DD-A1EL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:30.005712-05:00']	['2019-07-31T20:58:18.240185-05:00', '2019-07-31T20:58:18.240185-05:00']	['released', 'released']	11	Not Applicable	8c47698b-2797-4343-9a22-7f5094fddd72	Solid Tissue Normal	Not Reported	577.0	220.0	OCT		true	Solid Tissue	False	Normal
TCGA-5R-AA1C-01A	290890eb-321c-45dc-9cd1-45676c6e5e96	Adenomas and Adenocarcinomas	290890eb-321c-45dc-9cd1-45676c6e5e96	TCGA-5R-AA1C	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	57.0	-21073.0	1956.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9a7a9c39-f289-5594-972a-ff9157a187f0	5R	Proteogenex, Inc	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	520.0	21073.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21073.0	57.73424657534247	['9045ac44-9bdb-5c69-89b2-6b3da2b7ba71', '96792a7f-d28a-54dc-9b12-e0fa68c48a6a']	['TCGA-5R-AA1C_treatment_1', 'TCGA-5R-AA1C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:32.412407-05:00', '']	['2019-07-31T20:58:22.502958-05:00', '2019-07-31T20:58:22.502958-05:00']	['released', 'released']	01	Primary	59c12b57-2eea-4f8b-bbd7-6e504c1034d6	Primary Tumor	Not Reported	60.0	750.0	Unknown	AF0BACCE-3975-4E9F-9272-404229EC77C9	false	Solid Tissue	False	Tumor
TCGA-ED-A8O5-01A	2bea076b-c923-4a91-a37b-c6615fec021c	Adenomas and Adenocarcinomas	2bea076b-c923-4a91-a37b-c6615fec021c	TCGA-ED-A8O5	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	59.0	-21648.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	406.0	21648.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21648.0	59.30958904109589	['21679b43-281f-5263-b567-a2c2c25fec6a', '4912876b-3904-5065-a895-4b16910a83f2']	['TCGA-ED-A8O5_treatment_1', 'TCGA-ED-A8O5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:34.942637-05:00', '']	['2019-07-31T20:58:25.558790-05:00', '2019-07-31T20:58:25.558790-05:00']	['released', 'released']	01	Primary	384d3f50-c931-45e4-bd65-bcfed8e1c602	Primary Tumor	Not Reported	100.0	950.0	OCT	6C198F5C-9B63-45D9-A83D-4CFEC01DDC8C	true	Solid Tissue	False	Tumor
TCGA-2V-A95S-01A	2c041473-eaaa-4b7c-9b2e-b9da3543ad18	Adenomas and Adenocarcinomas	2c041473-eaaa-4b7c-9b2e-b9da3543ad18	TCGA-2V-A95S	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive					Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	08ca7e8a-4c6f-5134-b202-078784e8e0e4	2V	University of California San Diego	Liver hepatocellular carcinoma	NCH																No	Stage II		not reported	Liver			Hepatocellular carcinoma, NOS	no		No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported			['0a79774f-a25f-5425-b83c-004e4b752701', 'd88b47ad-02d9-5dbf-92c6-36cdbe3bfa24']	['TCGA-2V-A95S_treatment_1', 'TCGA-2V-A95S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:37.754023-05:00', '']	['2019-07-31T20:58:28.373210-05:00', '2019-07-31T20:58:28.373210-05:00']	['released', 'released']	01	Primary	d7873cbc-8d52-4869-b11a-4a23cb213dbd	Primary Tumor	Not Reported		170.0	Unknown	BE263DC7-2250-42E2-8AD6-D99A6DF679B6	false	Solid Tissue	False	Tumor
TCGA-CC-A3MB-01A	2c53d48d-e3bc-49f3-bbe0-2eee24252b4c	Adenomas and Adenocarcinomas	2c53d48d-e3bc-49f3-bbe0-2eee24252b4c	TCGA-CC-A3MB	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	36.0	-13255.0	1975.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	315.0															No	Stage IIIA	0.0	not reported	Liver	3.0	13255.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	13255.0	36.31506849315068	['146ff9ae-1d18-5ac0-bd6d-5903d5cdd830', 'b5978097-00e7-5737-b3a6-6058063d49ea']	['TCGA-CC-A3MB_treatment_1', 'TCGA-CC-A3MB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:40.169407-05:00', '']	['2019-07-31T20:58:31.515378-05:00', '2019-07-31T20:58:31.515378-05:00']	['released', 'released']	01	Primary	0466f2a2-3e22-4bde-907d-82d963ea9746	Primary Tumor	Not Reported	205.0	460.0	OCT	62A01956-C6F4-4FCB-AC43-052EEC8AE7AE	true	Solid Tissue	False	Tumor
TCGA-G3-A5SJ-01A	2c8a1e74-33de-453f-8d1e-e226185e52fc	Adenomas and Adenocarcinomas	2c8a1e74-33de-453f-8d1e-e226185e52fc	TCGA-G3-A5SJ	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	59.0	-21848.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	698.0	21848.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	21848.0	59.85753424657534	['6b8c68cf-b75b-57d1-a4af-454428933b64', '9c8f8d3d-8761-58d5-a98e-8d860910c2d1']	['TCGA-G3-A5SJ_treatment_1', 'TCGA-G3-A5SJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:42.835356-05:00', '']	['2019-07-31T20:58:34.584983-05:00', '2019-07-31T20:58:34.584983-05:00']	['released', 'released']	01	Primary	74a3b091-f6de-49fe-be1d-7e091348da2c	Primary Tumor	Not Reported	285.0	290.0	OCT	5237C744-2C11-4340-BC70-9AD10238F1E6	true	Solid Tissue	False	Tumor
TCGA-HP-A5MZ-01A	2d00f09f-0074-46c8-b357-b5f33567762a	Adenomas and Adenocarcinomas	2d00f09f-0074-46c8-b357-b5f33567762a	TCGA-HP-A5MZ	Liver and intrahepatic bile ducts	Not Reported	not reported	male	not reported	Dead	78.0	-22702.0			Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	b521e8d8-2b93-5a14-9fd0-ece883fd1327	HP	Ontario Institute for Cancer Research (OICR)	Liver hepatocellular carcinoma	NCH	91.0															No	Stage I	0.0	not reported	Liver		22702.0	Hepatocellular carcinoma, NOS	no		No	6th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	22702.0	62.1972602739726	['8aa7d4da-596f-517f-9ba0-90993487214c', 'cb549ddf-e9f1-560d-b364-7a905770e1ab']	['TCGA-HP-A5MZ_treatment_1', 'TCGA-HP-A5MZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:16:45.398852-05:00', '']	['2019-07-31T20:58:37.571866-05:00', '2019-07-31T20:58:37.571866-05:00']	['released', 'released']	01	Primary	9ec5013e-aabb-487a-87d7-49b4b6bd0f6a	Primary Tumor	Not Reported		160.0	Unknown	BD5F2C9B-16EE-42B2-B09B-F9BE4FCB2F75	false	Solid Tissue	False	Tumor
TCGA-RC-A6M4-01A	2d1dc64d-27de-4c83-a7fa-88da5b48bf24	Adenomas and Adenocarcinomas	2d1dc64d-27de-4c83-a7fa-88da5b48bf24	TCGA-RC-A6M4	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27327.0	1936.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	22.0	27327.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27327.0	74.86849315068493	['2025d5ea-e9fe-5170-aaf3-b0588009a7ef', '990c9dee-e5f2-5410-b2e8-6c5f20d98a90']	['TCGA-RC-A6M4_treatment_1', 'TCGA-RC-A6M4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:16:47.629296-05:00', '']	['2019-07-31T20:58:40.514254-05:00', '2019-07-31T20:58:40.514254-05:00']	['released', 'released']	01	Primary	81585e57-7e85-44bb-88be-f2764e35269d	Primary Tumor	Not Reported	1077.0	70.0	OCT	EE8C11B9-C9E3-4940-86A0-08C388EB8C1A	true	Solid Tissue	False	Tumor
TCGA-G3-A25Z-01A	2f3d22ad-6917-4189-89d9-2a06c2d2de0a	Adenomas and Adenocarcinomas	2f3d22ad-6917-4189-89d9-2a06c2d2de0a	TCGA-G3-A25Z	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	58.0	-21509.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	655.0	21509.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21509.0	58.92876712328767	['5e63027f-2085-5120-9c48-9ce3771e3341', 'a8184d23-1591-598d-aad2-fd7f102a2a40']	['TCGA-G3-A25Z_treatment', 'TCGA-G3-A25Z_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:49.974196-05:00']	['2019-07-31T20:58:43.682145-05:00', '2019-07-31T20:58:43.682145-05:00']	['released', 'released']	01	Primary	6fa5e58b-6bc3-4b13-b76d-92bcb28dc908	Primary Tumor	Not Reported	233.0	300.0	OCT	001A2553-3F5F-4A74-88E6-03B42C061E6D	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GT-01A	31a2ecc5-2d45-4823-8187-dc701dd412a8	Adenomas and Adenocarcinomas	31a2ecc5-2d45-4823-8187-dc701dd412a8	TCGA-2Y-A9GT	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	51.0	-18768.0	1955.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	1624.0															No	Stage I	0.0	not reported	Liver		18768.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18768.0	51.41917808219178	['9a317b44-5ad2-555e-b47c-7e2146b5e970', 'c927c519-f7ac-57a1-a577-1f783f6372b8']	['TCGA-2Y-A9GT_treatment', 'TCGA-2Y-A9GT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:54.813154-05:00']	['2019-07-31T20:58:49.734928-05:00', '2019-07-31T20:58:49.734928-05:00']	['released', 'released']	01	Primary	d249fffe-46a4-428c-b433-08949432ded9	Primary Tumor	Not Reported	2603.0	60.0	OCT	AC6F0803-6F8E-4708-80DE-DFC708B2217D	true	Solid Tissue	False	Tumor
TCGA-DD-AAW1-01A	31c7d56b-4af7-4fdb-ba83-63bf615fcc3d	Adenomas and Adenocarcinomas	31c7d56b-4af7-4fdb-ba83-63bf615fcc3d	TCGA-DD-AAW1	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	55.0	-20288.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	1989.0	20288.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20288.0	55.583561643835615	['b90fdec3-c9b3-5eda-b661-4bbaf55ccc47', 'be308cbc-ce2b-561a-a372-0f7831d580ce']	['TCGA-DD-AAW1_treatment', 'TCGA-DD-AAW1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:16:56.960049-05:00']	['2019-07-31T20:58:52.670205-05:00', '2019-07-31T20:58:52.670205-05:00']	['released', 'released']	01	Primary	6396d448-e089-4406-9b7b-d0710c48ed1d	Primary Tumor	Not Reported	1703.0	40.0	OCT	3ED5891B-FD39-4F88-94AA-D040867A51B5	true	Solid Tissue	False	Tumor
TCGA-RC-A7SH-01A	32a98b3d-4cbd-4dcc-ac71-428fafc5e1c3	Adenomas and Adenocarcinomas	32a98b3d-4cbd-4dcc-ac71-428fafc5e1c3	TCGA-RC-A7SH	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	42.0	-15560.0	1970.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	468.0	15560.0	Hepatocellular carcinoma, clear cell type	no	2012.0	No	7th	T2	8174/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	15560.0	42.63013698630137	['8fcae704-3ad3-560b-85f6-e57d1334d0a2', 'abc07694-9dce-5863-a7c6-6008ad0ef0a8']	['TCGA-RC-A7SH_treatment_1', 'TCGA-RC-A7SH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:16:59.406028-05:00', '']	['2019-07-31T20:58:55.709551-05:00', '2019-07-31T20:58:55.709551-05:00']	['released', 'released']	01	Primary	4006aaa4-b2ec-47fe-b35a-319d16e30dd0	Primary Tumor	Not Reported	271.0	10.0	OCT	F862582D-03E2-41AB-85C8-B637C2573E74	true	Solid Tissue	False	Tumor
TCGA-ED-A66Y-01A	34303cdd-c31c-4b95-9965-2a5513dc322d	Adenomas and Adenocarcinomas	34303cdd-c31c-4b95-9965-2a5513dc322d	TCGA-ED-A66Y	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	51.0	-18797.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH	296.0															No	Stage IIIA	0.0	not reported	Liver	7.0	18797.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18797.0	51.4986301369863	['542f49ce-745f-56c3-9462-fa7afb90094b', 'cf217fcf-041d-5f7a-9be7-c225a68600c6']	['TCGA-ED-A66Y_treatment_1', 'TCGA-ED-A66Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:04.143320-05:00', '']	['2019-07-31T20:59:01.861586-05:00', '2019-07-31T20:59:01.861586-05:00']	['released', 'released']	01	Primary	bc90ead3-1a92-49c8-9d97-ef4a8751833a	Primary Tumor	Not Reported	75.0	1670.0	OCT	14F29317-F7B9-49D4-B215-EF489A4283CA	true	Solid Tissue	False	Tumor
TCGA-DD-AAEI-01A	34416be6-b6d6-4029-b899-9ba685e39590	Adenomas and Adenocarcinomas	34416be6-b6d6-4029-b899-9ba685e39590	TCGA-DD-AAEI	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	72.0	-26465.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1531.0	26465.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26465.0	72.5068493150685	['92bb6d24-3c13-54b8-a36b-ab6476b40c9d', 'a1287a49-26d1-5f77-bae5-93d9f29b6079']	['TCGA-DD-AAEI_treatment_1', 'TCGA-DD-AAEI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'yes']	['2019-04-28T13:17:08.921645-05:00', '']	['2019-07-31T20:59:07.605717-05:00', '2019-07-31T20:59:07.605717-05:00']	['released', 'released']	01	Primary	dcc6d13a-31e3-495a-8d63-5c897fc3c4a0	Primary Tumor	Not Reported	1238.0	10.0	OCT	405C1F31-C46C-4288-83BA-9BBFA4F7DF2E	true	Solid Tissue	False	Tumor
TCGA-2Y-A9H8-01A	3528dd91-1a6d-4d41-a3ee-829c857cc904	Adenomas and Adenocarcinomas	3528dd91-1a6d-4d41-a3ee-829c857cc904	TCGA-2Y-A9H8	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	85.0	-31322.0	1926.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	633.0															No		0.0	not reported	Liver		31322.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	31322.0	85.81369863013698	['44a71d05-a5b3-54eb-8ec6-ce237c9d31d3', '8ca8c863-cb24-5179-9999-caaa21f31fb1']	['TCGA-2Y-A9H8_treatment_1', 'TCGA-2Y-A9H8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:17:13.609317-05:00', '']	['2019-07-31T20:59:13.482789-05:00', '2019-07-31T20:59:13.482789-05:00']	['released', 'released']	01	Primary	aaaecdc1-bf19-4208-89db-57e2feb355fc	Primary Tumor	Not Reported	792.0	80.0	OCT	61B5E3D4-727D-45ED-BAC3-9125A0E03F40	true	Solid Tissue	False	Tumor
TCGA-DD-A3A2-01A	357c1c08-f368-4cae-8f20-9be241b30479	Adenomas and Adenocarcinomas	357c1c08-f368-4cae-8f20-9be241b30479	TCGA-DD-A3A2	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	76.0	-27930.0	1922.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2131.0															No	Stage I	0.0	not reported	Liver		27930.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27930.0	76.52054794520548	['e8e11166-5d08-517a-93c0-a6f78dd7282d', 'eb96e3e2-a930-5945-9c10-0d75aa9be49e']	['TCGA-DD-A3A2_treatment_1', 'TCGA-DD-A3A2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:16.035452-05:00', '']	['2019-07-31T20:59:16.407238-05:00', '2019-07-31T20:59:16.407238-05:00']	['released', 'released']	01	Primary	8deaa382-46df-4f30-b6ee-c2cacf762eb3	Primary Tumor	Not Reported	4962.0	250.0	Unknown	91B547FA-DAB2-4B65-9AC4-5151D4524001	false	Solid Tissue	False	Tumor
TCGA-DD-A3A2-11A	357c1c08-f368-4cae-8f20-9be241b30479	Adenomas and Adenocarcinomas	357c1c08-f368-4cae-8f20-9be241b30479	TCGA-DD-A3A2	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	76.0	-27930.0	1922.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2131.0															No	Stage I	0.0	not reported	Liver		27930.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27930.0	76.52054794520548	['e8e11166-5d08-517a-93c0-a6f78dd7282d', 'eb96e3e2-a930-5945-9c10-0d75aa9be49e']	['TCGA-DD-A3A2_treatment_1', 'TCGA-DD-A3A2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:16.035452-05:00', '']	['2019-07-31T20:59:16.407238-05:00', '2019-07-31T20:59:16.407238-05:00']	['released', 'released']	11	Not Applicable	b25d09df-dc59-4a79-8e1b-38e525232901	Solid Tissue Normal	Not Reported	4962.0	160.0	Unknown		false	Solid Tissue	False	Normal
TCGA-CC-A5UD-01A	3837c8ac-6c9e-499b-a4e7-d42c870bcb49	Adenomas and Adenocarcinomas	3837c8ac-6c9e-499b-a4e7-d42c870bcb49	TCGA-CC-A5UD	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	45.0	-16702.0	1967.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	304.0															No	Stage IIIA	0.0	not reported	Liver	0.0	16702.0	Hepatocellular carcinoma, NOS	no	2012.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16702.0	45.75890410958904	['35aff3b8-7457-5c65-8c12-418ebadaebc4', 'f4aafad1-6a32-5efb-8f9d-0688f074d57a']	['TCGA-CC-A5UD_treatment', 'TCGA-CC-A5UD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:18.404526-05:00']	['2019-07-31T20:59:19.196856-05:00', '2019-07-31T20:59:19.196856-05:00']	['released', 'released']	01	Primary	24fb408b-5259-4928-ad19-02b8add76539	Primary Tumor	Not Reported	92.0	310.0	OCT	77BF208C-F5ED-4A05-BFDE-36063F43E022	true	Solid Tissue	False	Tumor
TCGA-ZP-A9D0-01A	396ef7c2-343e-4d5c-9b20-adc0a52c1978	Adenomas and Adenocarcinomas	396ef7c2-343e-4d5c-9b20-adc0a52c1978	TCGA-ZP-A9D0	Liver and intrahepatic bile ducts	Not Reported	black or african american	female	not hispanic or latino	Alive	67.0	-24525.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	1091.0	24525.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24525.0	67.1917808219178	['3c063594-2a80-5184-9124-c1b4efd5bc3f', '66e7c254-7bb8-5350-a603-1381bc0786b6']	['TCGA-ZP-A9D0_treatment_1', 'TCGA-ZP-A9D0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:20.851446-05:00', '']	['2019-07-31T20:59:22.161216-05:00', '2019-07-31T20:59:22.161216-05:00']	['released', 'released']	01	Primary	89213a53-9609-47e5-a4ab-af534237caac	Primary Tumor	Not Reported	723.0	100.0	Unknown	38325470-AA90-4CA4-A8C0-8BF1A9D595F9	false	Solid Tissue	False	Tumor
TCGA-BC-A10W-01A	39baf24a-4032-4c23-b3fe-2c50df1881f6	Adenomas and Adenocarcinomas	39baf24a-4032-4c23-b3fe-2c50df1881f6	TCGA-BC-A10W	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	50.0	-18562.0	1952.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	91.0															No		0.0	not reported	Liver		18562.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T4	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18562.0	50.85479452054795	['ac6b67a0-6c22-5cc6-abcf-45286d3c78d3', 'fb32dc68-3776-5c36-bdef-71c5952f281e']	['TCGA-BC-A10W_treatment', 'TCGA-BC-A10W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T09:25:03.751958-05:00']	['2019-07-31T16:13:55.897525-05:00', '2019-07-31T16:13:55.897525-05:00']	['released', 'released']	01	Primary	18fd84d2-dda5-4916-b42b-5ee6ac00496f	Primary Tumor	Not Reported	3100.0	460.0	Unknown	A7F79765-5038-47AA-87B0-40E2D802E535	false	Solid Tissue	False	Tumor
TCGA-BC-A10W-11A	39baf24a-4032-4c23-b3fe-2c50df1881f6	Adenomas and Adenocarcinomas	39baf24a-4032-4c23-b3fe-2c50df1881f6	TCGA-BC-A10W	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	50.0	-18562.0	1952.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	91.0															No		0.0	not reported	Liver		18562.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T4	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18562.0	50.85479452054795	['ac6b67a0-6c22-5cc6-abcf-45286d3c78d3', 'fb32dc68-3776-5c36-bdef-71c5952f281e']	['TCGA-BC-A10W_treatment', 'TCGA-BC-A10W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T09:25:03.751958-05:00']	['2019-07-31T16:13:55.897525-05:00', '2019-07-31T16:13:55.897525-05:00']	['released', 'released']	11	Not Applicable	dc9a2f36-3f59-4744-a2f8-f2017c16f3d9	Solid Tissue Normal	Not Reported	3100.0	390.0	Unknown		false	Solid Tissue	False	Normal
TCGA-WX-AA47-01A	39e147c9-2acb-4ba8-a991-e43e1719b2d8	Adenomas and Adenocarcinomas	39e147c9-2acb-4ba8-a991-e43e1719b2d8	TCGA-WX-AA47	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	33.0	-12056.0	1979.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	39c0854e-a35b-56ba-ae48-3d0f45b5c305	WX	Yale University	Liver hepatocellular carcinoma	NCH	556.0															No	Stage IIIA	0.0	not reported	Liver		12056.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T3a	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	12056.0	33.03013698630137	['902caf48-8153-5066-8055-a347dbc45e78', 'd77d941f-675e-51ed-b764-3d28a5cc30f7']	['TCGA-WX-AA47_treatment', 'TCGA-WX-AA47_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:17:25.529230-05:00']	['2019-07-31T20:59:28.309000-05:00', '2019-07-31T20:59:28.309000-05:00']	['released', 'released']	01	Primary	45f1a40f-b2c2-45a2-aec8-954945857c31	Primary Tumor	Not Reported	626.0	60.0	OCT	473868C8-CFDF-42E6-B6DC-48A737697D07	true	Solid Tissue	False	Tumor
TCGA-G3-A3CK-01A	39eb1db0-2722-4af4-8254-d0e10256c64d	Adenomas and Adenocarcinomas	39eb1db0-2722-4af4-8254-d0e10256c64d	TCGA-G3-A3CK	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	61.0	-22462.0	1950.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	585.0	22462.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22462.0	61.53972602739726	['bb110c0e-df9d-537c-887f-dd5742c1234e', 'd0c824c1-f5fa-5bde-8233-985e059e261d']	['TCGA-G3-A3CK_treatment_1', 'TCGA-G3-A3CK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:27.895137-05:00', '']	['2019-07-31T20:59:31.508142-05:00', '2019-07-31T20:59:31.508142-05:00']	['released', 'released']	01	Primary	2f38c711-639f-4611-9076-dc99a1db8239	Primary Tumor	Not Reported	132.0	520.0	OCT	ED5E5458-1E88-4126-B46B-96297F5A0FFF	true	Solid Tissue	False	Tumor
TCGA-G3-A3CH-01A	3a2d7482-c246-411e-841f-71d96e353328	Adenomas and Adenocarcinomas	3a2d7482-c246-411e-841f-71d96e353328	TCGA-G3-A3CH	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	53.0	-19473.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	780.0	19473.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19473.0	53.35068493150685	['20625b24-dc47-5bfc-bd01-a2541f771ddb', '56bd90cc-9bfb-57fc-8950-e858523aabb7']	['TCGA-G3-A3CH_treatment_1', 'TCGA-G3-A3CH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:17:30.208597-05:00', '']	['2019-07-31T20:59:34.772689-05:00', '2019-07-31T20:59:34.772689-05:00']	['released', 'released']	01	Primary	4621932d-aa60-4886-8ed4-3a34edd8baf4	Primary Tumor	Not Reported	296.0	120.0	Unknown	735AAE4A-21E1-4481-9D86-385CCE5712D1	false	Solid Tissue	False	Tumor
TCGA-G3-A3CH-11A	3a2d7482-c246-411e-841f-71d96e353328	Adenomas and Adenocarcinomas	3a2d7482-c246-411e-841f-71d96e353328	TCGA-G3-A3CH	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	53.0	-19473.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	780.0	19473.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19473.0	53.35068493150685	['20625b24-dc47-5bfc-bd01-a2541f771ddb', '56bd90cc-9bfb-57fc-8950-e858523aabb7']	['TCGA-G3-A3CH_treatment_1', 'TCGA-G3-A3CH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:17:30.208597-05:00', '']	['2019-07-31T20:59:34.772689-05:00', '2019-07-31T20:59:34.772689-05:00']	['released', 'released']	11	Not Applicable	6b915dde-b8ac-4cc6-839b-e226e914b499	Solid Tissue Normal	Not Reported	444.0	330.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-A1EI-11A	3acf7438-fd65-442c-8a30-68b6714537f3	Adenomas and Adenocarcinomas	3acf7438-fd65-442c-8a30-68b6714537f3	TCGA-DD-A1EI	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	46.0	-17097.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	183.0	17097.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17097.0	46.84109589041096	['29c8bab7-c749-525c-bfca-6a78513a2a38', '765a9c3a-9481-5177-a0f4-a6fd2b625d35']	['TCGA-DD-A1EI_treatment', 'TCGA-DD-A1EI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:17:32.613226-05:00']	['2019-07-31T20:59:37.735041-05:00', '2019-07-31T20:59:37.735041-05:00']	['released', 'released']	11	Not Applicable	48f02d39-0821-4a45-87a1-11349283e105	Solid Tissue Normal	Not Reported	926.0	190.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-A1EI-01A	3acf7438-fd65-442c-8a30-68b6714537f3	Adenomas and Adenocarcinomas	3acf7438-fd65-442c-8a30-68b6714537f3	TCGA-DD-A1EI	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	46.0	-17097.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	183.0	17097.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17097.0	46.84109589041096	['29c8bab7-c749-525c-bfca-6a78513a2a38', '765a9c3a-9481-5177-a0f4-a6fd2b625d35']	['TCGA-DD-A1EI_treatment', 'TCGA-DD-A1EI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:17:32.613226-05:00']	['2019-07-31T20:59:37.735041-05:00', '2019-07-31T20:59:37.735041-05:00']	['released', 'released']	01	Primary	65fb618a-9296-47ad-bba9-a93fc3f88e68	Primary Tumor	Not Reported	926.0	80.0	OCT	C253EB16-129F-4442-8C88-8A132E610E8C	true	Solid Tissue	False	Tumor
TCGA-DD-AAEE-01A	3c51fee0-da54-40e9-a954-dfe30f6f075c	Adenomas and Adenocarcinomas	3c51fee0-da54-40e9-a954-dfe30f6f075c	TCGA-DD-AAEE	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	55.0	-20396.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	810.0	20396.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20396.0	55.87945205479452	['252fbca6-d8f3-519e-afe2-10f4b6cfbc24', '754a8efd-261f-51fb-a55f-c80503771367']	['TCGA-DD-AAEE_treatment', 'TCGA-DD-AAEE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:17:37.908785-05:00']	['2019-07-31T20:59:43.841663-05:00', '2019-07-31T20:59:43.841663-05:00']	['released', 'released']	01	Primary	2df88392-7502-4dfe-8f51-7334f363883e	Primary Tumor	Not Reported	509.0	40.0	OCT	D857BF5A-E2C6-4A6E-88CA-E8707E6FF3D9	true	Solid Tissue	False	Tumor
TCGA-DD-AAE3-01A	3c969bdf-cae8-44f5-839f-5abd4cba0ec8	Adenomas and Adenocarcinomas	3c969bdf-cae8-44f5-839f-5abd4cba0ec8	TCGA-DD-AAE3	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	50.0	-18271.0	1963.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	566.0	18271.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18271.0	50.057534246575344	['a9dcf727-f048-5392-a33e-727dd5511b9d', 'cfabb0cc-e976-568b-82d1-2e500f738b6b']	['TCGA-DD-AAE3_treatment', 'TCGA-DD-AAE3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:40.380177-05:00']	['2019-07-31T20:59:47.921980-05:00', '2019-07-31T20:59:47.921980-05:00']	['released', 'released']	01	Primary	45f03983-5591-49d2-a555-43279e78cc07	Primary Tumor	Not Reported	342.0	30.0	OCT	FED7CE87-1B13-4035-A76B-CEC1045B93C4	true	Solid Tissue	False	Tumor
TCGA-DD-AACL-01A	3da3cfec-5464-4dd8-9757-a0cdfe3536f8	Adenomas and Adenocarcinomas	3da3cfec-5464-4dd8-9757-a0cdfe3536f8	TCGA-DD-AACL	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	66.0	-24355.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	107.0															No	Stage I	0.0	not reported	Liver	58.0	24355.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24355.0	66.72602739726027	['4b371915-15d0-5243-96f0-8e8cea13cd83', 'ed6d528b-838c-5a51-acd9-4e91b2f74014']	['TCGA-DD-AACL_treatment', 'TCGA-DD-AACL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:23.122061-05:00']	['2019-07-31T20:59:25.305728-05:00', '2019-07-31T20:59:25.305728-05:00']	['released', 'released']	01	Primary	bfa0e9b2-6a36-4865-9455-0a942dc9ca44	Primary Tumor	Not Reported	1826.0	280.0	OCT	E390B088-3CB5-45A7-B679-7995BE7B00F7	true	Solid Tissue	False	Tumor
TCGA-BC-A10X-01A	3dc48ea9-a3c6-437f-af5a-88feb300cc5f	Adenomas and Adenocarcinomas	3dc48ea9-a3c6-437f-af5a-88feb300cc5f	TCGA-BC-A10X	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	52.0	-19140.0	1950.0	2004.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	770.0															No	Stage IIIA	0.0	not reported	Liver		19140.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T3a	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	19140.0	52.43835616438356	['25163168-47a2-58f6-8d2b-0eab41970f89', 'f80a1377-df50-5e86-ab3c-a9ee271a388b']	['TCGA-BC-A10X_treatment_1', 'TCGA-BC-A10X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T09:25:06.149821-05:00', '']	['2019-07-31T16:13:58.989583-05:00', '2019-07-31T16:13:58.989583-05:00']	['released', 'released']	01	Primary	1ae03bc9-de5a-417c-a617-7256c8d2d9b8	Primary Tumor	Not Reported	3080.0	520.0	Unknown	671F5D97-36F3-40BA-9E28-1B65B21EF3D4	false	Solid Tissue	False	Tumor
TCGA-BC-A10X-11A	3dc48ea9-a3c6-437f-af5a-88feb300cc5f	Adenomas and Adenocarcinomas	3dc48ea9-a3c6-437f-af5a-88feb300cc5f	TCGA-BC-A10X	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	52.0	-19140.0	1950.0	2004.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	770.0															No	Stage IIIA	0.0	not reported	Liver		19140.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T3a	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	19140.0	52.43835616438356	['25163168-47a2-58f6-8d2b-0eab41970f89', 'f80a1377-df50-5e86-ab3c-a9ee271a388b']	['TCGA-BC-A10X_treatment_1', 'TCGA-BC-A10X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T09:25:06.149821-05:00', '']	['2019-07-31T16:13:58.989583-05:00', '2019-07-31T16:13:58.989583-05:00']	['released', 'released']	11	Not Applicable	d746f333-a5dd-4464-a091-84e9cf9665b8	Solid Tissue Normal	Not Reported	3080.0	430.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FV-A3R3-01A	3dd7c93d-8194-44ee-8014-10dd81ef6441	Adenomas and Adenocarcinomas	3dd7c93d-8194-44ee-8014-10dd81ef6441	TCGA-FV-A3R3	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	38.0	-14231.0	1974.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	366.0															No	Stage I	0.0	not reported	Liver	4.0	14231.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	14231.0	38.989041095890414	['891a4ec4-00cb-5c61-9052-e426fe54a527', 'beabe03c-36b9-5aca-b913-cf892e3c07e7']	['TCGA-FV-A3R3_treatment', 'TCGA-FV-A3R3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:45.099869-05:00']	['2019-07-31T20:59:53.893388-05:00', '2019-07-31T20:59:53.893388-05:00']	['released', 'released']	01	Primary	8abda02f-aedf-4599-9407-e253207d5d4c	Primary Tumor	Not Reported	28.0	90.0	OCT	FF0E1601-BC87-4E61-95BE-1776C9F85002	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GW-01A	3e1920b3-3bd4-4506-a0cf-567257154bcf	Adenomas and Adenocarcinomas	3e1920b3-3bd4-4506-a0cf-567257154bcf	TCGA-2Y-A9GW	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	64.0	-23587.0	1943.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	1271.0															No	Stage I	0.0	not reported	Liver		23587.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	23587.0	64.62191780821918	['3b993486-e97c-5dc4-8a73-e2d2f788a8ea', '4b8db2c5-888e-5209-8afe-cdd47eef4842']	['TCGA-2Y-A9GW_treatment', 'TCGA-2Y-A9GW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:47.412830-05:00']	['2019-07-31T20:59:56.952493-05:00', '2019-07-31T20:59:56.952493-05:00']	['released', 'released']	01	Primary	5243430a-7662-4858-85ed-a0c95fd1ecdd	Primary Tumor	Not Reported	2375.0	80.0	OCT	5846FA3D-E3AD-4530-8A5F-5D90CD17F539	true	Solid Tissue	False	Tumor
TCGA-ZS-A9CG-01A	3f6a6891-c6d5-447b-ad32-325fd46ec32b	Adenomas and Adenocarcinomas	3f6a6891-c6d5-447b-ad32-325fd46ec32b	TCGA-ZS-A9CG	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	55.0	-20100.0	1958.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33a38997-77be-52dc-b79d-890d8d4b792b	ZS	Tayside Tissue Bank	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	341.0	20100.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20100.0	55.06849315068493	['19cb2baa-6823-57f3-a619-d7c0aa9b05fb', '32abbbeb-4b83-5c8c-8c85-9c3439d8db2b']	['TCGA-ZS-A9CG_treatment', 'TCGA-ZS-A9CG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:17:52.072018-05:00']	['2019-07-31T21:00:03.108035-05:00', '2019-07-31T21:00:03.108035-05:00']	['released', 'released']	01	Primary	a31bfe51-1193-49d8-b469-1b8d0c1f1cee	Primary Tumor	Not Reported	201.0	50.0	OCT	8A0E7BA8-7262-4832-89DA-61893BE4B458	true	Solid Tissue	False	Tumor
TCGA-DD-A4NH-01A	4012ea90-5768-4acc-af3a-ba954f493db4	Adenomas and Adenocarcinomas	4012ea90-5768-4acc-af3a-ba954f493db4	TCGA-DD-A4NH	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	65.0	-23865.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIB	0.0	not reported	Liver	917.0	23865.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23865.0	65.38356164383562	['61928a7f-1608-5b09-8d4e-80863ad7dcce', '67841aa9-4cfb-5efd-8190-f56b218af7c0']	['TCGA-DD-A4NH_treatment_1', 'TCGA-DD-A4NH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:17:54.726119-05:00', '']	['2019-07-31T21:00:05.798836-05:00', '2019-07-31T21:00:05.798836-05:00']	['released', 'released']	01	Primary	493270aa-eb7d-4047-b438-c4e056e626ee	Primary Tumor	Not Reported	335.0	270.0	OCT	C9179EC7-2990-4581-B652-60289CC895F5	true	Solid Tissue	False	Tumor
TCGA-DD-AADC-01A	4100fd8b-cf37-4e63-a73d-95c9c392d606	Adenomas and Adenocarcinomas	4100fd8b-cf37-4e63-a73d-95c9c392d606	TCGA-DD-AADC	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	53.0	-19527.0	1958.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	425.0															No	Stage I	0.0	not reported	Liver		19527.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19527.0	53.4986301369863	['9ba60424-ba84-5a0e-9238-9df4116dbb64', 'eb3d29f0-0443-52fc-95ab-9c9b3acfe33d']	['TCGA-DD-AADC_treatment_1', 'TCGA-DD-AADC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:17:59.870170-05:00', '']	['2019-07-31T21:00:12.116293-05:00', '2019-07-31T21:00:12.116293-05:00']	['released', 'released']	01	Primary	874df34f-4b31-4201-8537-6572ca07a130	Primary Tumor	Not Reported	945.0	40.0	OCT	2A33A2FB-4491-43AA-8C6D-8173FB1D2179	true	Solid Tissue	False	Tumor
TCGA-DD-AAD6-01A	418e79d1-51c7-4cef-a1b6-e291fb13c2a5	Adenomas and Adenocarcinomas	418e79d1-51c7-4cef-a1b6-e291fb13c2a5	TCGA-DD-AAD6	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	66.0	-24185.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	672.0	24185.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24185.0	66.26027397260275	['7532446f-4e23-5b4d-b2cc-2d14f19c137c', 'da9ba4d6-293a-5d31-9ccd-90974c9eeaa3']	['TCGA-DD-AAD6_treatment', 'TCGA-DD-AAD6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:02.261627-05:00']	['2019-07-31T21:00:15.082388-05:00', '2019-07-31T21:00:15.082388-05:00']	['released', 'released']	01	Primary	873e2132-94ee-426a-9f9a-6488373ab2ad	Primary Tumor	Not Reported	1035.0	70.0	OCT	B246AEB4-8035-4114-9F1E-3E076809A896	true	Solid Tissue	False	Tumor
TCGA-DD-AACD-01A	41fb30aa-63b4-4cc6-a275-b77048612fa0	Adenomas and Adenocarcinomas	41fb30aa-63b4-4cc6-a275-b77048612fa0	TCGA-DD-AACD	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	48.0	-17828.0	1960.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	381.0															No	Stage I	0.0	not reported	Liver		17828.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17828.0	48.843835616438355	['74713e86-2ab5-59cf-8a38-a160e35a3152', 'c676d933-1b03-5ae1-95dc-24fea6500136']	['TCGA-DD-AACD_treatment', 'TCGA-DD-AACD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:18:04.564689-05:00']	['2019-07-31T21:00:17.994248-05:00', '2019-07-31T21:00:17.994248-05:00']	['released', 'released']	01	Primary	3c6d6d34-3bed-49ef-8737-5c96a6e79e16	Primary Tumor	Not Reported	2015.0	230.0	OCT	0494EF97-6D76-4DC7-8642-880C889C2C24	true	Solid Tissue	False	Tumor
TCGA-NI-A8LF-01A	420dc176-e9a8-484b-bfa3-1b84e039c26b	Adenomas and Adenocarcinomas	420dc176-e9a8-484b-bfa3-1b84e039c26b	TCGA-NI-A8LF	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	74.0	-27162.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	1ba22d72-8f0f-55c1-a40a-1d56ddb5f5a6	NI	Roswell Park	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	799.0	27162.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27162.0	74.41643835616438	['17f41b78-8357-5a6a-813c-054a8f0b9938', 'e8ca9118-d072-5c22-8b33-69d582ff5b7a']	['TCGA-NI-A8LF_treatment_1', 'TCGA-NI-A8LF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:07.068471-05:00', '']	['2019-07-31T21:00:20.902632-05:00', '2019-07-31T21:00:20.902632-05:00']	['released', 'released']	01	Primary	74f6a3da-57d7-4b32-8ef2-186bd131f3b0	Primary Tumor	Not Reported	422.0	240.0	OCT	5B4751DF-719F-4F2B-8D27-D69E480F6881	true	Solid Tissue	False	Tumor
TCGA-ZP-A9D4-01A	4244912d-8527-410c-a084-a56c55eb1f82	Adenomas and Adenocarcinomas	4244912d-8527-410c-a084-a56c55eb1f82	TCGA-ZP-A9D4	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23656.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	395.0	23656.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23656.0	64.81095890410958	['44a4d44e-d41e-59d7-8735-7c4d4d4aa336', 'b5bbe886-025f-5e6e-9b5e-783e71e33feb']	['TCGA-ZP-A9D4_treatment_1', 'TCGA-ZP-A9D4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:09.471305-05:00', '']	['2019-07-31T21:00:23.706809-05:00', '2019-07-31T21:00:23.706809-05:00']	['released', 'released']	01	Primary	545da348-26c6-4e80-90c0-d9422797b8fd	Primary Tumor	Not Reported	472.0	50.0	Unknown	8BD8A06B-4C20-4EF9-950D-AFED27C1303F	false	Solid Tissue	False	Tumor
TCGA-DD-AAE7-01A	427fdbf8-1603-466f-a5c6-963bb2ec3dac	Adenomas and Adenocarcinomas	427fdbf8-1603-466f-a5c6-963bb2ec3dac	TCGA-DD-AAE7	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	72.0	-26568.0	1940.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	644.0	26568.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26568.0	72.78904109589041	['0db20ea4-c802-57b9-9786-0078ef3ebce1', '1434cf1b-6b05-574e-b037-1ffaad2294c5']	['TCGA-DD-AAE7_treatment_1', 'TCGA-DD-AAE7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:11.860316-05:00', '']	['2019-07-31T21:00:26.645398-05:00', '2019-07-31T21:00:26.645398-05:00']	['released', 'released']	01	Primary	974eae11-2dfb-4f80-8aa7-338076d54204	Primary Tumor	Not Reported	410.0	20.0	OCT	1861F2A9-334D-4C4E-A7D0-D010712D6096	true	Solid Tissue	False	Tumor
TCGA-DD-A39Z-01A	42cb60f0-1a9e-4f59-8e2e-50c25e85cb98	Adenomas and Adenocarcinomas	42cb60f0-1a9e-4f59-8e2e-50c25e85cb98	TCGA-DD-A39Z	Liver and intrahepatic bile ducts	Not Reported	not reported	female	not reported	Dead	43.0	-15930.0	1953.0	1997.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	601.0															No	Stage II	0.0	not reported	Liver		15930.0	Hepatocellular carcinoma, NOS	no	1996.0	No	4th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	15930.0	43.64383561643836	['5e2cda53-665c-54b9-8b62-b22d2bdb150f', '6b9076cc-5c08-5fa6-af8a-aa5280add163']	['TCGA-DD-A39Z_treatment_1', 'TCGA-DD-A39Z_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:18:14.402254-05:00', '']	['2019-07-31T21:00:29.952409-05:00', '2019-07-31T21:00:29.952409-05:00']	['released', 'released']	01	Primary	02d27600-4857-4316-974d-0cf70c4c7056	Primary Tumor	Not Reported	5728.0	250.0	Unknown	1976B0D8-E1F2-468F-9AB0-242E9507AB0D	false	Solid Tissue	False	Tumor
TCGA-DD-A39Z-11A	42cb60f0-1a9e-4f59-8e2e-50c25e85cb98	Adenomas and Adenocarcinomas	42cb60f0-1a9e-4f59-8e2e-50c25e85cb98	TCGA-DD-A39Z	Liver and intrahepatic bile ducts	Not Reported	not reported	female	not reported	Dead	43.0	-15930.0	1953.0	1997.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	601.0															No	Stage II	0.0	not reported	Liver		15930.0	Hepatocellular carcinoma, NOS	no	1996.0	No	4th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	15930.0	43.64383561643836	['5e2cda53-665c-54b9-8b62-b22d2bdb150f', '6b9076cc-5c08-5fa6-af8a-aa5280add163']	['TCGA-DD-A39Z_treatment_1', 'TCGA-DD-A39Z_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:18:14.402254-05:00', '']	['2019-07-31T21:00:29.952409-05:00', '2019-07-31T21:00:29.952409-05:00']	['released', 'released']	11	Not Applicable	7da50944-297e-46ab-8e8e-20631c68d010	Solid Tissue Normal	Not Reported	5728.0	210.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-AACX-01A	431a72e1-ea03-4e40-89c4-2f02d454c897	Adenomas and Adenocarcinomas	431a72e1-ea03-4e40-89c4-2f02d454c897	TCGA-DD-AACX	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	66.0	-24329.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	170.0	24329.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24329.0	66.65479452054795	['3873ea08-b9b9-54c0-872e-c6e7f42513b5', '4653729e-a8ae-5f9c-ab10-8f31daef6043']	['TCGA-DD-AACX_treatment', 'TCGA-DD-AACX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:18:16.870649-05:00']	['2019-07-31T21:00:33.179143-05:00', '2019-07-31T21:00:33.179143-05:00']	['released', 'released']	01	Primary	373ca39a-ac3e-4129-95ae-18eed3237cac	Primary Tumor	Not Reported	1183.0	30.0	OCT	0911F16A-EA5A-45F4-906E-4F2163096A78	true	Solid Tissue	False	Tumor
TCGA-EP-A2KA-01A	440375d7-cdcd-418a-8992-0a8ca42d290d	Adenomas and Adenocarcinomas	440375d7-cdcd-418a-8992-0a8ca42d290d	TCGA-EP-A2KA	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	52.0	-19214.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH	627.0															No	Stage IIIA	0.0	not reported	Liver	357.0	19214.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3a	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	19214.0	52.64109589041096	['096e7caf-e17a-55e6-94e6-3bcb9693fab2', '851e1ec8-1170-5137-890f-13c36ec806b6']	['TCGA-EP-A2KA_treatment_1', 'TCGA-EP-A2KA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'yes']	['2019-04-28T13:18:19.229240-05:00', '']	['2019-07-31T21:00:36.002415-05:00', '2019-07-31T21:00:36.002415-05:00']	['released', 'released']	01	Primary	e6e1bf11-da29-4052-85a1-584401f0fa3d	Primary Tumor	Not Reported	106.0	400.0	Unknown	CCEFF8C5-E949-4F3F-93DA-67ECF5503C1C	false	Solid Tissue	False	Tumor
TCGA-ZP-A9D1-01A	447ac9e3-0533-461a-bc92-906a7b2180c3	Adenomas and Adenocarcinomas	447ac9e3-0533-461a-bc92-906a7b2180c3	TCGA-ZP-A9D1	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20584.0	1956.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH																Not Reported		0.0	not reported	Liver	21.0	20584.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20584.0	56.394520547945206	['5726833d-b730-54ee-a2cd-2dd7e2028805', 'afa7109f-49cc-5552-a1cd-bc7dda963e3a']	['TCGA-ZP-A9D1_treatment', 'TCGA-ZP-A9D1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:21.615831-05:00']	['2019-07-31T21:00:38.991936-05:00', '2019-07-31T21:00:38.991936-05:00']	['released', 'released']	01	Primary	d64641fe-43f3-4251-8332-72c6af236178	Primary Tumor	Not Reported	699.0	70.0	Unknown	2FA60C52-0164-432D-BB08-A8638AAF2C2F	false	Solid Tissue	False	Tumor
TCGA-DD-A3A9-01A	457cca7c-a8b4-414e-a3c0-7fccf0ee2034	Adenomas and Adenocarcinomas	457cca7c-a8b4-414e-a3c0-7fccf0ee2034	TCGA-DD-A3A9	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23526.0	1937.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	931.0															No	Stage IVB	0.0	not reported	Liver		23526.0	Hepatocellular carcinoma, NOS	no	2001.0	No	5th	T4	8170/3	N0	M1	not reported	C22.0	Liver	Not Reported	not reported	23526.0	64.45479452054795	['533721df-d5e9-5398-8f77-5c0e4b2bdd2b', 'b198d796-ea76-573c-8c9c-4b2f5b8ea677']	['TCGA-DD-A3A9_treatment', 'TCGA-DD-A3A9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:18:24.033300-05:00']	['2019-07-31T21:00:42.282893-05:00', '2019-07-31T21:00:42.282893-05:00']	['released', 'released']	01	Primary	9bfbc85e-86e0-4ac5-9304-84b1eb32b9cc	Primary Tumor	Not Reported	3584.0	230.0	Unknown	59B64E76-42CB-421D-B8A7-36F7050BA5E5	false	Solid Tissue	False	Tumor
TCGA-DD-A115-01A	45b566d7-f120-471c-a94a-be7936889f2d	Adenomas and Adenocarcinomas	45b566d7-f120-471c-a94a-be7936889f2d	TCGA-DD-A115	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Dead	53.0	-19697.0	1949.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2542.0															No	Stage IIIA	0.0	not reported	Liver		19697.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19697.0	53.964383561643835	['41000d11-ee33-52a0-a8c1-6c80f5e5c0be', 'bddd0c26-e678-5b1f-91a8-25b3315aaa09']	['TCGA-DD-A115_treatment_1', 'TCGA-DD-A115_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:18:27.408988-05:00', '']	['2019-07-31T21:00:45.382589-05:00', '2019-07-31T21:00:45.382589-05:00']	['released', 'released']	01	Primary	670ffb57-959a-496a-bd9f-d04f71b0c357	Primary Tumor	Not Reported	3198.0	230.0	Unknown	C0EAB9A6-AAA3-48D5-AE3F-A428D828D63C	false	Solid Tissue	False	Tumor
TCGA-DD-A115-11A	45b566d7-f120-471c-a94a-be7936889f2d	Adenomas and Adenocarcinomas	45b566d7-f120-471c-a94a-be7936889f2d	TCGA-DD-A115	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Dead	53.0	-19697.0	1949.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	2542.0															No	Stage IIIA	0.0	not reported	Liver		19697.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19697.0	53.964383561643835	['41000d11-ee33-52a0-a8c1-6c80f5e5c0be', 'bddd0c26-e678-5b1f-91a8-25b3315aaa09']	['TCGA-DD-A115_treatment_1', 'TCGA-DD-A115_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:18:27.408988-05:00', '']	['2019-07-31T21:00:45.382589-05:00', '2019-07-31T21:00:45.382589-05:00']	['released', 'released']	11	Not Applicable	980db62f-5d6d-4cc2-9ffb-ff0c5377ff39	Solid Tissue Normal	Not Reported	3198.0	170.0	Unknown		false	Solid Tissue	False	Normal
TCGA-GJ-A9DB-01A	45f00f00-d793-4dca-aeb9-7626d4575c90	Adenomas and Adenocarcinomas	45f00f00-d793-4dca-aeb9-7626d4575c90	TCGA-GJ-A9DB	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	68.0	-25020.0	1945.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	cf12df24-06a9-523f-ab6c-234ab95cf1c9	GJ	ABS - IUPUI	Liver hepatocellular carcinoma	NCH	67.0															No	Stage I	0.0	not reported	Liver		25020.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	25020.0	68.54794520547945	['06cdfc78-398d-50a7-93e2-6a921d63e308', 'c5b98fc3-f70d-5456-a49f-e90e859344fd']	['TCGA-GJ-A9DB_treatment', 'TCGA-GJ-A9DB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:29.880805-05:00']	['2019-07-31T21:00:48.848756-05:00', '2019-07-31T21:00:48.848756-05:00']	['released', 'released']	01	Primary	ee280cfa-626f-4d7b-a51f-c5dd82635d43	Primary Tumor	Not Reported	132.0	540.0	Unknown	8B2D3FA5-D673-4B70-B153-7EACE17A50E0	false	Solid Tissue	False	Tumor
TCGA-DD-A73G-01A	4774367c-5d8f-4b23-934a-e6d33a89dca8	Adenomas and Adenocarcinomas	4774367c-5d8f-4b23-934a-e6d33a89dca8	TCGA-DD-A73G	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	73.0	-26949.0	1932.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	3478.0	26949.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26949.0	73.83287671232877	['6cc92718-ee3f-54d4-98f2-7569a17c302a', '6f026ef1-336f-5498-82c0-134418cc73db']	['TCGA-DD-A73G_treatment', 'TCGA-DD-A73G_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:37.373040-05:00']	['2019-07-31T21:00:57.791296-05:00', '2019-07-31T21:00:57.791296-05:00']	['released', 'released']	01	Primary	985f2e16-e330-4896-b5e7-971fb8be57ed	Primary Tumor	Not Reported	3045.0	240.0	Unknown	C7A70BE1-34F6-4500-8C6C-A0D4FBBBD251	false	Solid Tissue	False	Tumor
TCGA-5R-AAAM-01A	477affb9-7c8b-4895-a4f3-6cc6ef8ec5e4	Adenomas and Adenocarcinomas	477affb9-7c8b-4895-a4f3-6cc6ef8ec5e4	TCGA-5R-AAAM	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	65.0	-24020.0	1948.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9a7a9c39-f289-5594-972a-ff9157a187f0	5R	Proteogenex, Inc	Liver hepatocellular carcinoma	NCH	46.0															No	Stage II	0.0	not reported	Liver		24020.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24020.0	65.8082191780822	['7818fa2a-ea58-52de-a182-d187937551ad', 'c013192f-ed49-5205-a687-ac6a69c17afc']	['TCGA-5R-AAAM_treatment_1', 'TCGA-5R-AAAM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:39.915933-05:00', '']	['2019-07-31T21:01:00.915076-05:00', '2019-07-31T21:01:00.915076-05:00']	['released', 'released']	01	Primary	e4e33aac-7fd7-4c43-ae92-c0eb7af07183	Primary Tumor	Not Reported	35.0	730.0	OCT	B07C5DBA-634E-4028-A32D-61FE7445BDEE	true	Solid Tissue	False	Tumor
TCGA-DD-AADQ-01A	485d283a-552c-485a-84fb-3abdb98dc797	Adenomas and Adenocarcinomas	485d283a-552c-485a-84fb-3abdb98dc797	TCGA-DD-AADQ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	59.0	-21756.0	1954.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	436.0	21756.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21756.0	59.605479452054794	['1cc25911-88ca-5952-93ce-2f470964b055', 'eb5ad258-996e-5fc9-be89-3a7e322c5878']	['TCGA-DD-AADQ_treatment_1', 'TCGA-DD-AADQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:42.293199-05:00', '']	['2019-07-31T21:01:04.552384-05:00', '2019-07-31T21:01:04.552384-05:00']	['released', 'released']	01	Primary	b2060a24-43d9-48f2-8a45-1db926042938	Primary Tumor	Not Reported	169.0	70.0	OCT	EE21BA4A-FA71-4432-9A1F-CFCB991F48C2	true	Solid Tissue	False	Tumor
TCGA-DD-A39W-01A	48d33449-b969-423a-b4e7-541809109617	Adenomas and Adenocarcinomas	48d33449-b969-423a-b4e7-541809109617	TCGA-DD-A39W	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	29.0	-10699.0	1966.0	1997.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	827.0															No	Stage III	0.0	not reported	Liver		10699.0	Hepatocellular carcinoma, NOS	no	1995.0	No	4th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	10699.0	29.312328767123287	['4cd9b99e-b04a-52b0-b9fa-3db02eb300e2', 'fc2fd4d1-6729-53fa-b628-a5f0526a77b6']	['TCGA-DD-A39W_treatment_1', 'TCGA-DD-A39W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:18:44.837909-05:00', '']	['2019-07-31T21:01:07.518428-05:00', '2019-07-31T21:01:07.518428-05:00']	['released', 'released']	01	Primary	88dd13c0-6e32-4a07-8250-620e85dc1f40	Primary Tumor	Not Reported	6014.0	180.0	Unknown	3EE9248B-64B4-4B76-A427-73C254D6489D	false	Solid Tissue	False	Tumor
TCGA-DD-A39W-11A	48d33449-b969-423a-b4e7-541809109617	Adenomas and Adenocarcinomas	48d33449-b969-423a-b4e7-541809109617	TCGA-DD-A39W	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	29.0	-10699.0	1966.0	1997.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	827.0															No	Stage III	0.0	not reported	Liver		10699.0	Hepatocellular carcinoma, NOS	no	1995.0	No	4th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	10699.0	29.312328767123287	['4cd9b99e-b04a-52b0-b9fa-3db02eb300e2', 'fc2fd4d1-6729-53fa-b628-a5f0526a77b6']	['TCGA-DD-A39W_treatment_1', 'TCGA-DD-A39W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:18:44.837909-05:00', '']	['2019-07-31T21:01:07.518428-05:00', '2019-07-31T21:01:07.518428-05:00']	['released', 'released']	11	Not Applicable	b24629ef-b23a-4c2b-879c-6a8a2fd58973	Solid Tissue Normal	Not Reported	6014.0	160.0	Unknown		false	Solid Tissue	False	Normal
TCGA-WQ-A9G7-01A	491a3734-dcb8-4779-b098-0b5567f13f87	Adenomas and Adenocarcinomas	491a3734-dcb8-4779-b098-0b5567f13f87	TCGA-WQ-A9G7	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	71.0		1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2deb19ef-f2aa-5861-87c8-f5c755f8800b	WQ	University of Kansas	Liver hepatocellular carcinoma	NCH																No		0.0	not reported	Liver	30.0		Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported			['285291fa-2fb2-5cae-9bbe-08b11aef531d', 'c4fbe2f2-6247-5cfe-baa4-9f6d8815fe17']	['TCGA-WQ-A9G7_treatment', 'TCGA-WQ-A9G7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:47.199757-05:00']	['2019-07-31T21:01:10.323396-05:00', '2019-07-31T21:01:10.323396-05:00']	['released', 'released']	01	Primary	59c5fc11-a9e1-4a62-9565-8a1dcc5b27aa	Primary Tumor	Not Reported	165.0	160.0	Unknown	211B2C4B-7DEB-4031-A3D2-5464A7386245	false	Solid Tissue	False	Tumor
TCGA-2Y-A9H0-01A	492ff93f-432b-4b73-8706-632fb2c83eb4	Adenomas and Adenocarcinomas	492ff93f-432b-4b73-8706-632fb2c83eb4	TCGA-2Y-A9H0	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Alive	49.0	-18109.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	3675.0	18109.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18109.0	49.61369863013699	['431e0018-b050-5b5d-bb79-bc3279b345e9', 'f640d0bc-bcbf-518f-a6bb-b464572ce690']	['TCGA-2Y-A9H0_treatment_1', 'TCGA-2Y-A9H0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:49.526697-05:00', '']	['2019-07-31T21:01:13.326717-05:00', '2019-07-31T21:01:13.326717-05:00']	['released', 'released']	01	Primary	605ef0eb-ebc3-4123-a952-1d1beacba4cd	Primary Tumor	Not Reported	3538.0	130.0	OCT	33EB4235-F58D-4AB6-8944-F2B59374A5F0	true	Solid Tissue	False	Tumor
TCGA-DD-AAC8-01A	496beef9-80d9-4734-a23d-334ae1b6aaab	Adenomas and Adenocarcinomas	496beef9-80d9-4734-a23d-334ae1b6aaab	TCGA-DD-AAC8	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	72.0	-26322.0	1936.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	16.0															No	Stage I	0.0	not reported	Liver		26322.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26322.0	72.11506849315069	['08d90b3b-5cd0-5d0b-9357-ba9d81309012', 'b9e5e085-a9c7-5165-a0d1-182840a14e6b']	['TCGA-DD-AAC8_treatment', 'TCGA-DD-AAC8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T08:58:28.393775-05:00']	['2019-07-31T15:41:09.490551-05:00', '2019-07-31T15:41:09.490551-05:00']	['released', 'released']	01	Primary	3e29928b-b802-4eb8-bfcc-a88e3edf1806	Primary Tumor	Not Reported	2080.0	570.0	OCT	2751F570-A1CE-4F6A-98CD-56C8B31AB0FF	true	Solid Tissue	False	Tumor
TCGA-KR-A7K8-01A	4b0e544c-4090-4ebb-b3e5-2623aa91356c	Adenomas and Adenocarcinomas	4b0e544c-4090-4ebb-b3e5-2623aa91356c	TCGA-KR-A7K8	Liver and intrahepatic bile ducts	Not Reported	not reported	male	not reported	Alive	57.0	-20914.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	72165b47-b0b5-5107-b0be-b5a74bc3e249	KR	University Of Michigan	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	906.0	20914.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20914.0	57.298630136986304	['5bcd6913-4137-58f3-88fa-6636b5e48c57', '5d00b529-0e89-581c-b51e-6a0223e8699f']	['TCGA-KR-A7K8_treatment_1', 'TCGA-KR-A7K8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:18:51.969934-05:00', '']	['2019-07-31T21:01:16.225989-05:00', '2019-07-31T21:01:16.225989-05:00']	['released', 'released']	01	Primary	30f43a40-040f-4c42-a84e-0ba7ec9c8945	Primary Tumor	Not Reported	435.0	80.0	Unknown	9B449A83-1172-4EE0-9337-27BD5D3ECF4D	false	Solid Tissue	False	Tumor
TCGA-BC-A216-11A	4bbdbe77-f3cb-4b64-9826-72debb734784	Adenomas and Adenocarcinomas	4bbdbe77-f3cb-4b64-9826-72debb734784	TCGA-BC-A216	Liver and intrahepatic bile ducts	Not Reported	white	female	not reported	Alive	62.0	-22968.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	1351.0	22968.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T3	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	22968.0	62.92602739726028	['14b781f8-693f-5dfb-b8f8-ab36bc298115', '92b6c0e1-c6bc-50ec-aa21-f3c1b4821ca7']	['TCGA-BC-A216_treatment', 'TCGA-BC-A216_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:54.354037-05:00']	['2019-07-31T21:01:19.056005-05:00', '2019-07-31T21:01:19.056005-05:00']	['released', 'released']	11	Not Applicable	b3ddee9b-04d5-4fa3-94c1-754bcc2a0f5d	Solid Tissue Normal	Not Reported	1052.0	120.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A216-01A	4bbdbe77-f3cb-4b64-9826-72debb734784	Adenomas and Adenocarcinomas	4bbdbe77-f3cb-4b64-9826-72debb734784	TCGA-BC-A216	Liver and intrahepatic bile ducts	Not Reported	white	female	not reported	Alive	62.0	-22968.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	1351.0	22968.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T3	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	22968.0	62.92602739726028	['14b781f8-693f-5dfb-b8f8-ab36bc298115', '92b6c0e1-c6bc-50ec-aa21-f3c1b4821ca7']	['TCGA-BC-A216_treatment', 'TCGA-BC-A216_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:54.354037-05:00']	['2019-07-31T21:01:19.056005-05:00', '2019-07-31T21:01:19.056005-05:00']	['released', 'released']	01	Primary	f8b5247f-5276-4189-9041-2d914482d539	Primary Tumor	Not Reported	1052.0	100.0	Unknown	28CDABB8-3172-4676-8F4A-8B91F2B8D85F	false	Solid Tissue	False	Tumor
TCGA-DD-AADV-01A	4c78b999-4797-4e19-8bc5-9ffd01cf768a	Adenomas and Adenocarcinomas	4c78b999-4797-4e19-8bc5-9ffd01cf768a	TCGA-DD-AADV	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	50.0	-18300.0	1963.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	574.0	18300.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18300.0	50.136986301369866	['10246dd2-3101-5b91-b5cb-92bf89f1ba6f', 'ce3b7c8d-1ad4-56d2-98de-4a054082ad52']	['TCGA-DD-AADV_treatment', 'TCGA-DD-AADV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:18:57.078851-05:00']	['2019-07-31T21:01:22.052866-05:00', '2019-07-31T21:01:22.052866-05:00']	['released', 'released']	01	Primary	bbe36805-117d-4923-92de-64b83dd318f0	Primary Tumor	Not Reported	286.0	20.0	OCT	750CC634-8874-488C-B20D-6B636978156A	true	Solid Tissue	False	Tumor
TCGA-DD-A3A3-11A	516c8594-2973-41e5-a5ce-76d177edfa48	Adenomas and Adenocarcinomas	516c8594-2973-41e5-a5ce-76d177edfa48	TCGA-DD-A3A3	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	45.0	-16708.0	1954.0	2000.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	535.0															No	Stage I	0.0	not reported	Liver		16708.0	Hepatocellular carcinoma, NOS	no	1999.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16708.0	45.775342465753425	['689e8856-5619-503a-9dfd-330eab43c631', 'c8734913-6072-5814-8106-4c5aa436bafc']	['TCGA-DD-A3A3_treatment_1', 'TCGA-DD-A3A3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:19:09.052475-05:00', '']	['2019-07-31T21:01:36.316118-05:00', '2019-07-31T21:01:36.316118-05:00']	['released', 'released']	11	Not Applicable	1079b0a9-f74e-4d0a-bed0-22aad6ea64e2	Solid Tissue Normal	Not Reported	4397.0	190.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A3A3-01A	516c8594-2973-41e5-a5ce-76d177edfa48	Adenomas and Adenocarcinomas	516c8594-2973-41e5-a5ce-76d177edfa48	TCGA-DD-A3A3	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	45.0	-16708.0	1954.0	2000.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	535.0															No	Stage I	0.0	not reported	Liver		16708.0	Hepatocellular carcinoma, NOS	no	1999.0	No	5th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16708.0	45.775342465753425	['689e8856-5619-503a-9dfd-330eab43c631', 'c8734913-6072-5814-8106-4c5aa436bafc']	['TCGA-DD-A3A3_treatment_1', 'TCGA-DD-A3A3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:19:09.052475-05:00', '']	['2019-07-31T21:01:36.316118-05:00', '2019-07-31T21:01:36.316118-05:00']	['released', 'released']	01	Primary	94306c6e-490a-4681-b61e-6a9e935065bc	Primary Tumor	Not Reported	4397.0	250.0	Unknown	A37A1F44-D2AD-457C-8292-3E7A6667268D	false	Solid Tissue	False	Tumor
TCGA-2Y-A9H5-01A	51810579-e20d-4f08-93e7-891d645931db	Adenomas and Adenocarcinomas	51810579-e20d-4f08-93e7-891d645931db	TCGA-2Y-A9H5	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	59.0	-21818.0	1951.0	2011.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	555.0															No	Stage I	0.0	not reported	Liver		21818.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	21818.0	59.775342465753425	['d3800426-d919-55de-958e-323ab2403a61', 'e9f866f0-e917-5366-bd65-f14114e2dc7f']	['TCGA-2Y-A9H5_treatment_1', 'TCGA-2Y-A9H5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:11.449722-05:00', '']	['2019-07-31T21:01:39.403163-05:00', '2019-07-31T21:01:39.403163-05:00']	['released', 'released']	01	Primary	45ce6d64-65d7-4bdd-8444-ffe9af6f5df4	Primary Tumor	Not Reported	1101.0	30.0	OCT	99FC2CC9-19F1-4BCB-81E6-5FED4619B331	true	Solid Tissue	False	Tumor
TCGA-DD-A4NI-01A	518aa9cc-71cf-4734-9d55-b435da99d300	Adenomas and Adenocarcinomas	518aa9cc-71cf-4734-9d55-b435da99d300	TCGA-DD-A4NI	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	67.0	-24516.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage II	0.0	not reported	Liver	816.0	24516.0	Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	24516.0	67.16712328767123	['3fc89ab8-5262-534b-9461-2257166a7aa4', '5817df91-7d5e-5162-854c-dacc8e1b4bbd']	['TCGA-DD-A4NI_treatment_1', 'TCGA-DD-A4NI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:13.546556-05:00', '']	['2019-07-31T21:01:42.848088-05:00', '2019-07-31T21:01:42.848088-05:00']	['released', 'released']	01	Primary	453e3da6-a1b3-4303-9a08-17d99027910f	Primary Tumor	Not Reported	357.0	130.0	OCT	7D4F801A-187C-4B20-96B3-98313D5252E3	true	Solid Tissue	False	Tumor
TCGA-DD-A1EJ-01A	52292ffc-0902-4d97-b461-20723987a177	Adenomas and Adenocarcinomas	52292ffc-0902-4d97-b461-20723987a177	TCGA-DD-A1EJ	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	71.0	-26009.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1005.0															No	Stage IIIC	0.0	not reported	Liver	887.0	26009.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N1	M0	not reported	C22.0	Liver	Not Reported	not reported	26009.0	71.25753424657535	['7e06f6cc-c8ab-58db-bcb9-f3e32d3adc80', 'ba842480-3ef3-5544-b3f4-6dbda2c440ce']	['TCGA-DD-A1EJ_treatment_1', 'TCGA-DD-A1EJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:19:18.338331-05:00', '']	['2019-07-31T21:01:48.715081-05:00', '2019-07-31T21:01:48.715081-05:00']	['released', 'released']	01	Primary	2d549bb0-9e98-40c7-8b33-545c481dd105	Primary Tumor	Not Reported	909.0	290.0	OCT	A34C7F12-5EB1-4B7C-890C-FD2DFF41E85C	true	Solid Tissue	False	Tumor
TCGA-DD-A1EJ-11A	52292ffc-0902-4d97-b461-20723987a177	Adenomas and Adenocarcinomas	52292ffc-0902-4d97-b461-20723987a177	TCGA-DD-A1EJ	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	71.0	-26009.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1005.0															No	Stage IIIC	0.0	not reported	Liver	887.0	26009.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N1	M0	not reported	C22.0	Liver	Not Reported	not reported	26009.0	71.25753424657535	['7e06f6cc-c8ab-58db-bcb9-f3e32d3adc80', 'ba842480-3ef3-5544-b3f4-6dbda2c440ce']	['TCGA-DD-A1EJ_treatment_1', 'TCGA-DD-A1EJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:19:18.338331-05:00', '']	['2019-07-31T21:01:48.715081-05:00', '2019-07-31T21:01:48.715081-05:00']	['released', 'released']	11	Not Applicable	617875bb-9eaf-4436-ac52-7b23e526df90	Solid Tissue Normal	Not Reported	909.0	130.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-AAED-01A	527d2bc3-7fdd-4b08-839d-67e2f246db04	Adenomas and Adenocarcinomas	527d2bc3-7fdd-4b08-839d-67e2f246db04	TCGA-DD-AAED	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18722.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	763.0	18722.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18722.0	51.293150684931504	['03fb6b5d-f5b7-506e-a302-0637bccbc5b0', '89e36e64-481a-52d8-a6f4-7b837b04a133']	['TCGA-DD-AAED_treatment', 'TCGA-DD-AAED_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:19:20.492059-05:00']	['2019-07-31T21:01:51.751417-05:00', '2019-07-31T21:01:51.751417-05:00']	['released', 'released']	01	Primary	4d6702b7-c774-466f-9c42-dde5c4c422d0	Primary Tumor	Not Reported	489.0	60.0	OCT	EEA08FBB-E73F-4DC8-91D8-DE3FBDFCA0F6	true	Solid Tissue	False	Tumor
TCGA-DD-A4NR-01A	52a7f734-da07-49c5-861d-c70da37ff959	Adenomas and Adenocarcinomas	52a7f734-da07-49c5-861d-c70da37ff959	TCGA-DD-A4NR	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	85.0	-31386.0	1920.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	9.0															No	Stage I	0.0	not reported	Liver		31386.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	31386.0	85.98904109589041	['138a2a4d-9b7f-5a38-90fa-6d8443abe872', '691d98be-9aa9-5be9-8437-1eb53e3e3450']	['TCGA-DD-A4NR_treatment_1', 'TCGA-DD-A4NR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:22.900615-05:00', '']	['2019-07-31T21:01:54.544116-05:00', '2019-07-31T21:01:54.544116-05:00']	['released', 'released']	01	Primary	71bc4fd0-374f-423e-a8b4-ae1bceceda83	Primary Tumor	Not Reported	2652.0	240.0	OCT	93133C58-B1BF-4A5C-8EFC-AE17EC6A0B64	true	Solid Tissue	False	Tumor
TCGA-CC-A7IG-01A	534a7b11-3abd-4581-a9c9-d984d6aa33a0	Adenomas and Adenocarcinomas	534a7b11-3abd-4581-a9c9-d984d6aa33a0	TCGA-CC-A7IG	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	47.0	-17453.0	1966.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	299.0															No	Stage II	0.0	not reported	Liver	0.0	17453.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17453.0	47.81643835616438	['754bc5cf-b7b7-572a-8ff0-e16eb29f09a1', 'b1fcce1c-b695-5780-a83f-b6fa37cb96a7']	['TCGA-CC-A7IG_treatment_1', 'TCGA-CC-A7IG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:25.402795-05:00', '']	['2019-07-31T21:01:57.542563-05:00', '2019-07-31T21:01:57.542563-05:00']	['released', 'released']	01	Primary	642a133c-371d-4c40-a0e5-6568313de439	Primary Tumor	Not Reported	239.0	210.0	OCT	FF015D7F-02CD-485E-83B6-8C533DE83B2A	true	Solid Tissue	False	Tumor
TCGA-WX-AA44-01A	5436fafb-bc16-4450-ac8b-568e1e5ee5fe	Adenomas and Adenocarcinomas	5436fafb-bc16-4450-ac8b-568e1e5ee5fe	TCGA-WX-AA44	Liver and intrahepatic bile ducts	Not Reported	white	female	hispanic or latino	Alive	64.0	-23654.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	39c0854e-a35b-56ba-ae48-3d0f45b5c305	WX	Yale University	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	615.0	23654.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23654.0	64.8054794520548	['4f8dbc80-f7cd-53b1-b3bf-3e2193019723', 'ade694fa-f7ab-5582-8bd0-28d792d7adf4']	['TCGA-WX-AA44_treatment', 'TCGA-WX-AA44_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:19:28.009519-05:00']	['2019-07-31T21:02:00.777009-05:00', '2019-07-31T21:02:00.777009-05:00']	['released', 'released']	01	Primary	faf5de3b-b8b2-43d9-89c4-1a6b2ee207a5	Primary Tumor	Not Reported	924.0	90.0	OCT	759F0B44-92DC-4E47-BA10-7B19C4272485	true	Solid Tissue	False	Tumor
TCGA-DD-A73B-01A	5449c232-56f1-4e03-9421-aba3ae180107	Adenomas and Adenocarcinomas	5449c232-56f1-4e03-9421-aba3ae180107	TCGA-DD-A73B	Liver and intrahepatic bile ducts	Not Reported	white	female	hispanic or latino	Dead	72.0	-26390.0	1940.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	283.0															No	Stage I	0.0	not reported	Liver		26390.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26390.0	72.3013698630137	['5954a18c-d3d2-5c4b-8366-07b5c4cdc96d', '9c5e8b3d-d5e0-5b6d-9c32-569e08f9b59f']	['TCGA-DD-A73B_treatment', 'TCGA-DD-A73B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:19:30.414205-05:00']	['2019-07-31T21:02:03.675008-05:00', '2019-07-31T21:02:03.675008-05:00']	['released', 'released']	01	Primary	7a4f8926-1472-4a9b-b0f6-e28bd7ceb6e8	Primary Tumor	Not Reported	345.0	150.0	Unknown	B1C57A75-7C86-49D9-B143-09E60824F508	false	Solid Tissue	False	Tumor
TCGA-ED-A459-01A	56403463-1727-4c23-a709-de5f168c4073	Adenomas and Adenocarcinomas	56403463-1727-4c23-a709-de5f168c4073	TCGA-ED-A459	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	47.0	-17402.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	910.0	17402.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17402.0	47.676712328767124	['138043d4-12b8-5e1c-ab7a-0a80b90b48ae', 'd814e751-83ba-5ed9-8fe8-58883fd5f73d']	['TCGA-ED-A459_treatment', 'TCGA-ED-A459_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:19:35.227030-05:00']	['2019-07-31T21:02:09.402059-05:00', '2019-07-31T21:02:09.402059-05:00']	['released', 'released']	01	Primary	97fa4d8b-1c05-41a6-97c4-0b27dc70eb4c	Primary Tumor	Not Reported	87.0	1800.0	OCT	289EC60C-0AAB-4E61-A8AB-A199D4663AE6	true	Solid Tissue	False	Tumor
TCGA-DD-AAE2-01A	56447eb8-c50c-4e31-a29e-bde6bfd31af4	Adenomas and Adenocarcinomas	56447eb8-c50c-4e31-a29e-bde6bfd31af4	TCGA-DD-AAE2	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18695.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	638.0	18695.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18695.0	51.21917808219178	['a1182797-f11b-5f11-b6ed-bf280738a28c', 'e7f280e6-bda3-5454-966a-0d4d7bd0a9f2']	['TCGA-DD-AAE2_treatment', 'TCGA-DD-AAE2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:19:37.463900-05:00']	['2019-07-31T21:02:12.243514-05:00', '2019-07-31T21:02:12.243514-05:00']	['released', 'released']	01	Primary	6fdfd765-bbf7-4094-b5f9-3332e9514873	Primary Tumor	Not Reported	337.0	20.0	OCT	C70F898B-E3C1-42C1-BF50-38E126A5B708	true	Solid Tissue	False	Tumor
TCGA-DD-AAW3-01A	564b4f4d-3c18-40d5-9d95-916774df600c	Adenomas and Adenocarcinomas	564b4f4d-3c18-40d5-9d95-916774df600c	TCGA-DD-AAW3	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	69.0	-25254.0	1940.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1633.0	25254.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25254.0	69.18904109589042	['3b2bf89c-d479-5b23-8fa1-6c2c2149445e', 'fcfb6d92-4761-5a9d-b6a0-1153f0bf381c']	['TCGA-DD-AAW3_treatment_1', 'TCGA-DD-AAW3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:40.113809-05:00', '']	['2019-07-31T21:02:15.119961-05:00', '2019-07-31T21:02:15.119961-05:00']	['released', 'released']	01	Primary	95c763b1-759b-47a3-8009-de916d6d457e	Primary Tumor	Not Reported	1507.0	60.0	OCT	882E141C-D3AB-4EF8-A26E-D5D3F75443B6	true	Solid Tissue	False	Tumor
TCGA-BW-A5NP-01A	56a82a56-0241-4d3d-9de2-696b0c36df91	Adenomas and Adenocarcinomas	56a82a56-0241-4d3d-9de2-696b0c36df91	TCGA-BW-A5NP	Liver and intrahepatic bile ducts	Not Reported	white	female	hispanic or latino	Alive	26.0	-9809.0	1984.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	0e691470-b18b-5803-9e4a-ee2cfbaae7b4	BW	St. Joseph's Medical Center-(MD)	Liver hepatocellular carcinoma	NCH																No	Stage IV	0.0	not reported	Liver	0.0	9809.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	N0	M1	not reported	C22.0	Liver	Not Reported	not reported	9809.0	26.873972602739727	['4bdb7727-68cd-5b6b-9222-4c26dcb18061', 'ce8e9e44-2a0b-5054-a394-33aecadacccd']	['TCGA-BW-A5NP_treatment', 'TCGA-BW-A5NP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:19:42.515475-05:00']	['2019-07-31T21:02:18.295222-05:00', '2019-07-31T21:02:18.295222-05:00']	['released', 'released']	01	Primary	c13884b6-eaef-4e1c-8fa7-5fe76548d32f	Primary Tumor	Not Reported	1057.0	290.0	Unknown	D13029B5-B160-48FC-A556-9FBF8CAF4EDB	false	Solid Tissue	False	Tumor
TCGA-DD-AA3A-01A	56abd1c1-8f22-4856-8b0a-73d7e092bdb3	Adenomas and Adenocarcinomas	56abd1c1-8f22-4856-8b0a-73d7e092bdb3	TCGA-DD-AA3A	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	81.0	-29712.0	1928.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	410.0															No	Stage I	0.0	not reported	Liver		29712.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2009.0	No	6th	T1	8180/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	29712.0	81.40273972602739	['9c2aca84-03c0-5fd3-8436-c21c6ca0cf2a', 'e34f8022-1500-5485-ad29-9ff9667bc910']	['TCGA-DD-AA3A_treatment_1', 'TCGA-DD-AA3A_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:45.056119-05:00', '']	['2019-07-31T21:02:21.569360-05:00', '2019-07-31T21:02:21.569360-05:00']	['released', 'released']	01	Primary	3a71a328-228a-4609-b162-f38c825503b7	Primary Tumor	Not Reported	1559.0	100.0	OCT	F1055545-91C4-4397-BD34-FE995A3E9B05	true	Solid Tissue	False	Tumor
TCGA-XR-A8TD-01A	574ba00b-fee6-4aab-ac01-6ffaf8fdc0c5	Adenomas and Adenocarcinomas	574ba00b-fee6-4aab-ac01-6ffaf8fdc0c5	TCGA-XR-A8TD	Liver and intrahepatic bile ducts	Not Reported	white	female	hispanic or latino	Alive	49.0	-17908.0	1963.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	04898289-8edf-590e-8640-35e36365de75	XR	University of Sao Paulo	Liver hepatocellular carcinoma	NCH																No	Stage IIIB	0.0	not reported	Liver	1030.0	17908.0	Hepatocellular carcinoma, clear cell type	no	2012.0	No	7th	T3	8174/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17908.0	49.06301369863014	['4db4af1b-ea26-5d05-8d6f-c5a45a5ca950', 'b5511a48-3b59-575a-9627-5e7cfde75526']	['TCGA-XR-A8TD_treatment_1', 'TCGA-XR-A8TD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:47.282794-05:00', '']	['2019-07-31T21:02:24.611776-05:00', '2019-07-31T21:02:24.611776-05:00']	['released', 'released']	01	Primary	4ef6344b-e31c-425e-96c8-97daa428f5bc	Primary Tumor	Not Reported	585.0	320.0	OCT	DA6BFBB1-CD64-4996-8D5C-73600EBDFE34	true	Solid Tissue	False	Tumor
TCGA-BC-A10S-01A	592ef526-176a-42e0-bbeb-fb62d369a343	Adenomas and Adenocarcinomas	592ef526-176a-42e0-bbeb-fb62d369a343	TCGA-BC-A10S	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	81.0	-29842.0	1918.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	1423.0															No		0.0	not reported	Liver		29842.0	Hepatocellular carcinoma, NOS	no	1999.0	No	5th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29842.0	81.75890410958904	['302bae4b-6b10-59bf-be24-537eba141fd1', 'd96dbff7-8ca4-5035-9974-a3c72e0448a5']	['TCGA-BC-A10S_treatment', 'TCGA-BC-A10S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T09:25:01.372569-05:00']	['2019-07-31T16:13:53.103181-05:00', '2019-07-31T16:13:53.103181-05:00']	['released', 'released']	01	Primary	ade2df15-2ed2-4dee-a710-e2814de6e4ef	Primary Tumor	Not Reported	4284.0	550.0	Unknown	A0F69833-CBDD-492D-9564-AE8FB2F9CE3B	false	Solid Tissue	False	Tumor
TCGA-BC-A10S-11A	592ef526-176a-42e0-bbeb-fb62d369a343	Adenomas and Adenocarcinomas	592ef526-176a-42e0-bbeb-fb62d369a343	TCGA-BC-A10S	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	81.0	-29842.0	1918.0	2002.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	1423.0															No		0.0	not reported	Liver		29842.0	Hepatocellular carcinoma, NOS	no	1999.0	No	5th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29842.0	81.75890410958904	['302bae4b-6b10-59bf-be24-537eba141fd1', 'd96dbff7-8ca4-5035-9974-a3c72e0448a5']	['TCGA-BC-A10S_treatment', 'TCGA-BC-A10S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T09:25:01.372569-05:00']	['2019-07-31T16:13:53.103181-05:00', '2019-07-31T16:13:53.103181-05:00']	['released', 'released']	11	Not Applicable	e68d61e9-5b70-49c0-bdaf-f4bef849155a	Solid Tissue Normal	Not Reported	4284.0	680.0	Unknown		false	Solid Tissue	False	Normal
TCGA-KR-A7K0-01A	5a7706ba-3cea-41eb-b78a-fd69206daa93	Adenomas and Adenocarcinomas	5a7706ba-3cea-41eb-b78a-fd69206daa93	TCGA-KR-A7K0	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Dead	65.0	-23974.0	1948.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	72165b47-b0b5-5107-b0be-b5a74bc3e249	KR	University Of Michigan	Liver hepatocellular carcinoma	NCH	65.0															Not Reported	Stage I	0.0	not reported	Liver		23974.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23974.0	65.68219178082192	['79cf58d9-c6a1-529a-b7b6-b096383919e9', '7a449f64-d7eb-542f-b6e2-73ce8d874de0']	['TCGA-KR-A7K0_treatment', 'TCGA-KR-A7K0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:19:52.512958-05:00']	['2019-07-31T21:02:30.713707-05:00', '2019-07-31T21:02:30.713707-05:00']	['released', 'released']	01	Primary	cbd70f3d-2af2-4645-bd83-aed0d0857083	Primary Tumor	Not Reported	126.0	90.0	Unknown	34BFDBBD-A66F-4436-AD51-D6AA979F2CD3	false	Solid Tissue	False	Tumor
TCGA-CC-A8HV-01A	5b32d3f4-9b88-42de-aaac-22d1d2f5cde0	Adenomas and Adenocarcinomas	5b32d3f4-9b88-42de-aaac-22d1d2f5cde0	TCGA-CC-A8HV	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	51.0	-18935.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	279.0															No	Stage II	0.0	not reported	Liver	0.0	18935.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18935.0	51.87671232876713	['0899a3d5-a830-5bcb-8636-121a48767ddc', 'c8eed5e9-10f6-5135-9a73-e5cd5d1f384b']	['TCGA-CC-A8HV_treatment_1', 'TCGA-CC-A8HV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:19:54.986361-05:00', '']	['2019-07-31T21:02:33.663326-05:00', '2019-07-31T21:02:33.663326-05:00']	['released', 'released']	01	Primary	0633d181-7845-4578-9778-daa6d1c128cb	Primary Tumor	Not Reported	140.0	230.0	OCT	8C178CD4-7D29-4584-B41B-BAE67890DBEB	true	Solid Tissue	False	Tumor
TCGA-DD-A4NK-01A	5b8d04b2-ef40-4216-a3bb-42520efbe863	Adenomas and Adenocarcinomas	5b8d04b2-ef40-4216-a3bb-42520efbe863	TCGA-DD-A4NK	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	80.0	-29244.0	1924.0	2007.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1210.0															No	Stage IIIA	0.0	not reported	Liver		29244.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	29244.0	80.12054794520547	['7075eac5-bd31-5619-9ff6-4b9a3d4bc13c', 'ebc03980-6c6f-5377-97cd-803506f202c9']	['TCGA-DD-A4NK_treatment', 'TCGA-DD-A4NK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:19:57.292785-05:00']	['2019-07-31T21:02:36.681107-05:00', '2019-07-31T21:02:36.681107-05:00']	['released', 'released']	01	Primary	089d93c5-5e66-4227-8b04-7e4c665148e6	Primary Tumor	Not Reported	3143.0	130.0	OCT	0521278C-B2AC-4D7D-BC1F-5003B630808E	true	Solid Tissue	False	Tumor
TCGA-BC-4072-01B	5c9a21a3-d471-401a-9568-59dc84245d28	Adenomas and Adenocarcinomas	5c9a21a3-d471-401a-9568-59dc84245d28	TCGA-BC-4072	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27162.0	1931.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	1490.0															No	Stage IIIA	0.0	not reported	Liver		27162.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27162.0	74.41643835616438	['b89f5c85-714b-54cd-b049-e7e6bee3d097', 'd0bc2878-2cc7-593e-8463-f910f8457e6b']	['TCGA-BC-4072_treatment', 'TCGA-BC-4072_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:02.213210-05:00']	['2019-07-31T21:02:42.806478-05:00', '2019-07-31T21:02:42.806478-05:00']	['released', 'released']	01	Primary	b390716a-8160-464f-9a7f-a9d7e3ce99b4	Primary Tumor	Not Reported	2256.0	270.0	Unknown	CF0E1E81-A89B-4D33-A02E-C77DAE5E8E30	false	Solid Tissue	False	Tumor
TCGA-G3-AAV7-01A	5d259f26-3bef-4fe4-948b-495183f5f8be	Adenomas and Adenocarcinomas	5d259f26-3bef-4fe4-948b-495183f5f8be	TCGA-G3-AAV7	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	38.0	-14229.0	1975.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	361.0	14229.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	14229.0	38.983561643835614	['ab033923-b297-5c02-8522-5d79b7708ddb', 'e9293923-7b50-510a-a28d-959a94cf7723']	['TCGA-G3-AAV7_treatment', 'TCGA-G3-AAV7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:04.605942-05:00']	['2019-07-31T21:02:45.840893-05:00', '2019-07-31T21:02:45.840893-05:00']	['released', 'released']	01	Primary	5cdd976b-bb2b-47a9-a745-ad446797ac34	Primary Tumor	Not Reported	52.0	120.0	OCT	0F368084-04F6-4DCE-9ADF-6B3B94D274AB	true	Solid Tissue	False	Tumor
TCGA-CC-A9FU-01A	5e2a99a1-41c1-49ca-97d6-69f9b9938d24	Adenomas and Adenocarcinomas	5e2a99a1-41c1-49ca-97d6-69f9b9938d24	TCGA-CC-A9FU	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	52.0	-19326.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	0.0	19326.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19326.0	52.94794520547945	['13af4dcd-0644-5f24-a6e0-aa12830a0133', '85cf2106-ab87-53ba-b463-c02949c49037']	['TCGA-CC-A9FU_treatment', 'TCGA-CC-A9FU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:20:06.923901-05:00']	['2019-07-31T21:02:48.784792-05:00', '2019-07-31T21:02:48.784792-05:00']	['released', 'released']	01	Primary	ca56e355-4821-4169-b069-aea16c5b456b	Primary Tumor	Not Reported	205.0	220.0	OCT	95F22F75-89A6-4B67-BDF2-A357825453EF	true	Solid Tissue	False	Tumor
TCGA-DD-AAE0-01A	5e4136e4-ddd8-4faf-8a8e-5f836fd97f49	Adenomas and Adenocarcinomas	5e4136e4-ddd8-4faf-8a8e-5f836fd97f49	TCGA-DD-AAE0	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	45.0	-16732.0	1968.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	555.0	16732.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16732.0	45.84109589041096	['13ba8d27-2a79-5d78-9c25-998ad6a1cb3e', '64f2abe3-fc37-560d-b3e7-e0a19df52465']	['TCGA-DD-AAE0_treatment', 'TCGA-DD-AAE0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:09.981608-05:00']	['2019-07-31T21:02:51.606497-05:00', '2019-07-31T21:02:51.606497-05:00']	['released', 'released']	01	Primary	29ef7722-025a-458b-aa60-1ca9c3e70ada	Primary Tumor	Not Reported	314.0	40.0	OCT	C8EB705D-E9F9-4101-9B7F-EE4968CA5781	true	Solid Tissue	False	Tumor
TCGA-DD-AADB-01A	5eaaf7ae-36af-4fb4-8940-e0861983ceb0	Adenomas and Adenocarcinomas	5eaaf7ae-36af-4fb4-8940-e0861983ceb0	TCGA-DD-AADB	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18728.0	1960.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1242.0	18728.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18728.0	51.30958904109589	['545e15dd-2a3c-58c9-b7ac-0285cf6743ed', 'ee7b1fd4-99ac-5c0c-aa1e-9f2b98d04fe9']	['TCGA-DD-AADB_treatment_1', 'TCGA-DD-AADB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:12.407668-05:00', '']	['2019-07-31T21:02:54.516725-05:00', '2019-07-31T21:02:54.516725-05:00']	['released', 'released']	01	Primary	d7116164-d537-4b2d-b699-ec091c094363	Primary Tumor	Not Reported	946.0	20.0	OCT	3963D999-C204-45C2-8515-B922BEBA7C9D	true	Solid Tissue	False	Tumor
TCGA-DD-A11A-11A	609c82fd-eb3a-46d7-8c09-0cde281a50b3	Adenomas and Adenocarcinomas	609c82fd-eb3a-46d7-8c09-0cde281a50b3	TCGA-DD-A11A	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Not Reported	67.0	-24646.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	79.0	24646.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24646.0	67.52328767123288	['339501de-3a0b-5b9c-b7a6-e7175c2b1f88', 'f44ad2d1-7794-5942-9e06-239049fca86a']	['TCGA-DD-A11A_treatment_1', 'TCGA-DD-A11A_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:20:14.717632-05:00', '']	['2019-07-31T21:02:57.494692-05:00', '2019-07-31T21:02:57.494692-05:00']	['released', 'released']	11	Not Applicable	0cfc44e7-7450-4815-ac7c-414003a7d6df	Solid Tissue Normal	Not Reported	2184.0	240.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A11A-01A	609c82fd-eb3a-46d7-8c09-0cde281a50b3	Adenomas and Adenocarcinomas	609c82fd-eb3a-46d7-8c09-0cde281a50b3	TCGA-DD-A11A	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Not Reported	67.0	-24646.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	79.0	24646.0	Hepatocellular carcinoma, NOS	no	2004.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24646.0	67.52328767123288	['339501de-3a0b-5b9c-b7a6-e7175c2b1f88', 'f44ad2d1-7794-5942-9e06-239049fca86a']	['TCGA-DD-A11A_treatment_1', 'TCGA-DD-A11A_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:20:14.717632-05:00', '']	['2019-07-31T21:02:57.494692-05:00', '2019-07-31T21:02:57.494692-05:00']	['released', 'released']	01	Primary	b614fd23-a9ba-420d-9c01-1e82b721e1e8	Primary Tumor	Not Reported	2184.0	260.0	Unknown	E1571DB1-B1B2-4B0E-9A0A-01A4470353DF	false	Solid Tissue	False	Tumor
TCGA-5C-A9VH-01A	60fcd491-0170-46c0-ab14-d71f88267a14	Adenomas and Adenocarcinomas	60fcd491-0170-46c0-ab14-d71f88267a14	TCGA-5C-A9VH	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	70.0	-25608.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	994ff94f-5d44-5de6-908b-dea33dca2a3d	5C	Cureline	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	322.0	25608.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25608.0	70.15890410958905	['21f1153a-c25b-5e3a-a04e-b5f7c3bd4630', 'cbf6f8a9-0da8-5b65-baac-046dfffce3a2']	['TCGA-5C-A9VH_treatment', 'TCGA-5C-A9VH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:17.305483-05:00']	['2019-07-31T21:03:00.321601-05:00', '2019-07-31T21:03:00.321601-05:00']	['released', 'released']	01	Primary	4fd4d1c8-64f9-4463-970e-6b5409e36807	Primary Tumor	Not Reported	127.0	90.0	OCT	938BCE76-BF7D-4470-A409-805FD012D05D	true	Solid Tissue	False	Tumor
TCGA-CC-A3MA-01A	613ddb95-14d7-4941-b374-fb5cd344d1bb	Adenomas and Adenocarcinomas	613ddb95-14d7-4941-b374-fb5cd344d1bb	TCGA-CC-A3MA	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	61.0	-22375.0	1950.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	303.0															No	Stage IIIA	0.0	not reported	Liver	2.0	22375.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22375.0	61.3013698630137	['3211ef1e-4cf3-59e7-81fc-25a5653b9f8d', '9c105fe9-f28a-5e89-98ea-99dbf7f8d006']	['TCGA-CC-A3MA_treatment', 'TCGA-CC-A3MA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:19.800627-05:00']	['2019-07-31T21:03:03.239694-05:00', '2019-07-31T21:03:03.239694-05:00']	['released', 'released']	01	Primary	6955889c-d216-44ca-be25-70fb7d00bc64	Primary Tumor	Not Reported	177.0	530.0	OCT	B631A61B-4550-47DE-9240-0FCFAEF47BC6	true	Solid Tissue	False	Tumor
TCGA-DD-A3A7-01A	614c0ecf-6a84-4c86-8706-79be5bb00991	Adenomas and Adenocarcinomas	614c0ecf-6a84-4c86-8706-79be5bb00991	TCGA-DD-A3A7	Liver and intrahepatic bile ducts	Not Reported	not reported	male	not reported	Dead	67.0	-24599.0	1931.0	1999.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	419.0															No	Stage IIIB	0.0	not reported	Liver		24599.0	Hepatocellular carcinoma, NOS	no	1998.0	No	7th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24599.0	67.3945205479452	['dfe42dec-89d9-5ca9-adba-b4ecf333432b', 'e14aa50f-cf7e-59ee-8d9a-1891bc506184']	['TCGA-DD-A3A7_treatment', 'TCGA-DD-A3A7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:20:22.001576-05:00']	['2019-07-31T21:03:06.268769-05:00', '2019-07-31T21:03:06.268769-05:00']	['released', 'released']	01	Primary	1ef290a3-d054-4e3a-9683-8f99a2010e3e	Primary Tumor	Not Reported	4772.0	130.0	Unknown	B520F88D-4004-4DFA-BF8D-7CE96777C5A3	false	Solid Tissue	False	Tumor
TCGA-CC-5264-01A	61902cb6-b041-48ac-aacc-483a28949865	Adenomas and Adenocarcinomas	61902cb6-b041-48ac-aacc-483a28949865	TCGA-CC-5264	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	71.0	-25979.0	1939.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	102.0															No	Stage IIIA	0.0	not reported	Liver	0.0	25979.0	Hepatocellular carcinoma, NOS	no	2010.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25979.0	71.17534246575343	['4e69a169-a045-55e6-94bb-31dc3bcd77b8', 'd60e1bbf-b6f5-5df7-9066-8816fdf8c6ec']	['TCGA-CC-5264_treatment_1', 'TCGA-CC-5264_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:24.403892-05:00', '']	['2019-07-31T21:03:08.786684-05:00', '2019-07-31T21:03:08.786684-05:00']	['released', 'released']	01	Primary	ec67465b-dc08-4e09-8af2-3b489bd15393	Primary Tumor	Not Reported	84.0	550.0	OCT	4D5CD8E8-DAD7-4392-A44C-BBDF3DAD872F	true	Solid Tissue	False	Tumor
TCGA-DD-AADM-01A	62c02da8-e4b4-4294-9923-8992d187fc7b	Adenomas and Adenocarcinomas	62c02da8-e4b4-4294-9923-8992d187fc7b	TCGA-DD-AADM	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	58.0	-21349.0	1954.0	2012.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	12.0															No	Stage II	0.0	not reported	Liver		21349.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21349.0	58.49041095890411	['d2011ad3-bbca-5f2a-a646-4c39ab7f6e50', 'fa555b9e-bfc5-5c0e-9e23-c71a219985cc']	['TCGA-DD-AADM_treatment', 'TCGA-DD-AADM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:26.737322-05:00']	['2019-07-31T21:03:11.446845-05:00', '2019-07-31T21:03:11.446845-05:00']	['released', 'released']	01	Primary	96ff95cf-c5d9-4a58-b252-74859c1a8103	Primary Tumor	Not Reported	704.0	20.0	OCT	36839A87-47E6-4E63-8683-A1549549AECE	true	Solid Tissue	False	Tumor
TCGA-XR-A8TC-01A	4db9de75-9297-46e5-acc5-9275f52a642a	Adenomas and Adenocarcinomas	4db9de75-9297-46e5-acc5-9275f52a642a	TCGA-XR-A8TC	Liver and intrahepatic bile ducts	Not Reported	white	female	hispanic or latino	Alive	43.0	-15817.0	1968.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	04898289-8edf-590e-8640-35e36365de75	XR	University of Sao Paulo	Liver hepatocellular carcinoma	NCH		TCGA-XR-A8TC	During enrollment, the TSS found the patient had surgery 2 months prior to the TCGA cancer procurement.	28719	Notification	4db9de75-9297-46e5-acc5-9275f52a642a	2015-07-17T00:00:00	0461d977-252b-5b50-bf3b-34672d1a94d6	case	2018-08-23T16:36:27.780612-05:00	4db9de75-9297-46e5-acc5-9275f52a642a	released	Case submitted is found to be a recurrence after submission	Approved	TCGA-XR-A8TC	Not Reported	Stage I	0.0	not reported	Liver	1339.0	15817.0	Hepatocellular carcinoma, NOS	yes	2011.0	Yes	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	15817.0	43.33424657534247	['4917aff5-3678-5705-bd65-303140e3380b', 'e350e78c-ebd3-5810-8967-ee7d5bda845a']	['TCGA-XR-A8TC_treatment_1', 'TCGA-XR-A8TC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:19:02.362606-05:00', '']	['2019-07-31T21:01:27.538251-05:00', '2019-07-31T21:01:27.538251-05:00']	['released', 'released']	01	Primary	607a26fb-b0af-4de3-982d-b8b557e84175	Primary Tumor	Not Reported	908.0	110.0	OCT	681B14A0-98E6-4F74-89B0-3DFB3A97C0E1	true	Solid Tissue	False	Tumor
TCGA-BC-A10Q-11A	dfa15fbe-bb14-40ce-afc6-70694112e3e2	Adenomas and Adenocarcinomas	dfa15fbe-bb14-40ce-afc6-70694112e3e2	TCGA-BC-A10Q	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	72.0	-26400.0	1926.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	1135.0	TCGA-BC-A10Q	Case originally accepted in the liver study, but is not a hepatocellular. This is a Cholangiocarcinoma and will not be removed or change studies, but will be analyzed in the CHOL study and not in the LIHC study.	25379	Observation	dfa15fbe-bb14-40ce-afc6-70694112e3e2	2015-01-30T00:00:00	0a6862a9-1804-54e8-b7f8-5e8d4c123886	case	2018-08-23T16:36:27.780612-05:00	dfa15fbe-bb14-40ce-afc6-70694112e3e2	released	General	Approved	TCGA-BC-A10Q	No		0.0	not reported	Liver		26400.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26400.0	72.32876712328768	['c6950321-e76b-5549-abc5-e7154dde561e', 'd9102f8a-3bf6-5a47-8576-86445b93a832']	['TCGA-BC-A10Q_treatment', 'TCGA-BC-A10Q_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:27:32.103048-05:00']	['2019-07-31T21:11:55.959683-05:00', '2019-07-31T21:11:55.959683-05:00']	['released', 'released']	11	Not Applicable	5d3bf988-3331-4412-bc17-b8f4650a8623	Solid Tissue Normal	Not Reported	4437.0	340.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A10Q-01A	dfa15fbe-bb14-40ce-afc6-70694112e3e2	Adenomas and Adenocarcinomas	dfa15fbe-bb14-40ce-afc6-70694112e3e2	TCGA-BC-A10Q	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	72.0	-26400.0	1926.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	1135.0	TCGA-BC-A10Q	Case originally accepted in the liver study, but is not a hepatocellular. This is a Cholangiocarcinoma and will not be removed or change studies, but will be analyzed in the CHOL study and not in the LIHC study.	25379	Observation	dfa15fbe-bb14-40ce-afc6-70694112e3e2	2015-01-30T00:00:00	0a6862a9-1804-54e8-b7f8-5e8d4c123886	case	2018-08-23T16:36:27.780612-05:00	dfa15fbe-bb14-40ce-afc6-70694112e3e2	released	General	Approved	TCGA-BC-A10Q	No		0.0	not reported	Liver		26400.0	Hepatocellular carcinoma, NOS	no	1998.0	No	5th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26400.0	72.32876712328768	['c6950321-e76b-5549-abc5-e7154dde561e', 'd9102f8a-3bf6-5a47-8576-86445b93a832']	['TCGA-BC-A10Q_treatment', 'TCGA-BC-A10Q_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:27:32.103048-05:00']	['2019-07-31T21:11:55.959683-05:00', '2019-07-31T21:11:55.959683-05:00']	['released', 'released']	01	Primary	bf225dc1-4309-4304-849e-cbcc23c8442c	Primary Tumor	Not Reported	4437.0	340.0	Unknown	10117C34-85C2-49DE-B2AD-F8D0D4570DA9	false	Solid Tissue	False	Tumor
TCGA-FV-A3R2-01A	17833039-0d7e-47f0-90e6-8cabae94c124	Adenomas and Adenocarcinomas	17833039-0d7e-47f0-90e6-8cabae94c124	TCGA-FV-A3R2	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	75.0	-27530.0	1930.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	194.0	TCGA-FV-A3R2	Patient had a prior papillary transitional cell bladder cancer. No systemic chemotherapy or radiation.	15996	Notification	17833039-0d7e-47f0-90e6-8cabae94c124	2013-04-25T00:00:00	0e4b110c-89fe-5cba-802c-7b6fc5946962	case	2018-08-23T16:36:27.780612-05:00	17833039-0d7e-47f0-90e6-8cabae94c124	released	Prior malignancy	Approved	TCGA-FV-A3R2	Not Reported	Stage I	0.0	not reported	Liver		27530.0	Hepatocellular carcinoma, NOS	yes	2005.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27530.0	75.42465753424658	['648f8a7b-298a-5307-ab34-e287544ee7b4', 'c0b9c23f-7323-5e0d-993c-a5cac4f6e6ca']	['TCGA-FV-A3R2_treatment_1', 'TCGA-FV-A3R2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:15:17.254685-05:00', '']	['2019-07-31T20:56:47.640333-05:00', '2019-07-31T20:56:47.640333-05:00']	['released', 'released']	01	Primary	04beca9f-830c-4ca8-a947-1bf2d7df1b26	Primary Tumor	Not Reported	2555.0	120.0	OCT	6F330991-CD7E-4387-AFE8-B9C6C8D98396	true	Solid Tissue	False	Tumor
TCGA-FV-A3R2-11A	17833039-0d7e-47f0-90e6-8cabae94c124	Adenomas and Adenocarcinomas	17833039-0d7e-47f0-90e6-8cabae94c124	TCGA-FV-A3R2	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	75.0	-27530.0	1930.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	194.0	TCGA-FV-A3R2	Patient had a prior papillary transitional cell bladder cancer. No systemic chemotherapy or radiation.	15996	Notification	17833039-0d7e-47f0-90e6-8cabae94c124	2013-04-25T00:00:00	0e4b110c-89fe-5cba-802c-7b6fc5946962	case	2018-08-23T16:36:27.780612-05:00	17833039-0d7e-47f0-90e6-8cabae94c124	released	Prior malignancy	Approved	TCGA-FV-A3R2	Not Reported	Stage I	0.0	not reported	Liver		27530.0	Hepatocellular carcinoma, NOS	yes	2005.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27530.0	75.42465753424658	['648f8a7b-298a-5307-ab34-e287544ee7b4', 'c0b9c23f-7323-5e0d-993c-a5cac4f6e6ca']	['TCGA-FV-A3R2_treatment_1', 'TCGA-FV-A3R2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:15:17.254685-05:00', '']	['2019-07-31T20:56:47.640333-05:00', '2019-07-31T20:56:47.640333-05:00']	['released', 'released']	11	Not Applicable	50d807b1-a8cb-4299-a597-0d3f8dd98692	Solid Tissue Normal	Not Reported	2555.0	80.0	OCT		true	Solid Tissue	False	Normal
TCGA-G3-A3CG-01A	8a14d153-bbf7-4512-a067-976edfb65f91	Adenomas and Adenocarcinomas	8a14d153-bbf7-4512-a067-976edfb65f91	TCGA-G3-A3CG	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	80.0	-29432.0	1931.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH		['TCGA-G3-A3CG', 'TCGA-G3-A3CG', 'TCGA-G3-A3CG']	['Patient had a prior sigmoid colon adenocarcinoma. No systemic chemotherapy or radiation.', 'Patient had peroperative neoadjuvant therapy for the TCGA tumor.', 'Patient had a prior prostate adenocarcinoma treated wtih systemic chemotherapy and locoregional radiation.']	['15999', '16000', '15998']	['Notification', 'Notification', 'Notification']	['8a14d153-bbf7-4512-a067-976edfb65f91', '8a14d153-bbf7-4512-a067-976edfb65f91', '8a14d153-bbf7-4512-a067-976edfb65f91']	['2013-04-25T00:00:00', '2013-04-25T00:00:00', '2013-04-25T00:00:00']	['1dee4812-8610-5309-8ea4-7055c6bd346f', '65db5c5b-b807-550a-958d-4ac5dbd47418', 'f57ac228-8fb6-55c7-b71b-52812a57e28e']	['case', 'case', 'case']	['2018-08-23T16:36:27.780612-05:00', '2018-08-23T16:36:27.780612-05:00', '2018-08-23T16:36:27.780612-05:00']	['8a14d153-bbf7-4512-a067-976edfb65f91', '8a14d153-bbf7-4512-a067-976edfb65f91', '8a14d153-bbf7-4512-a067-976edfb65f91']	['released', 'released', 'released']	['Prior malignancy', 'Neoadjuvant therapy', 'History of unacceptable prior treatment related to a prior/other malignancy']	['Approved', 'Approved', 'Approved']	['TCGA-G3-A3CG', 'TCGA-G3-A3CG', 'TCGA-G3-A3CG']	Not Reported	Stage I	0.0	not reported	Liver	673.0	29432.0	Hepatocellular carcinoma, NOS	yes	2011.0	Yes	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	29432.0	80.63561643835617	['52954d33-7a49-5a10-a855-9fe1d01e332e', 'c37753b0-3705-5c80-aadd-92e3a64ea2a3']	['TCGA-G3-A3CG_treatment_1', 'TCGA-G3-A3CG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:22:49.037898-05:00', '']	['2019-07-31T21:06:11.348184-05:00', '2019-07-31T21:06:11.348184-05:00']	['released', 'released']	01	Primary	d02deece-d8bc-4614-ac26-60a4282fdb07	Primary Tumor	Not Reported	261.0	270.0	Unknown	6E2F9CE1-6D48-42DF-8737-64ED53BF8646	false	Solid Tissue	False	Tumor
TCGA-FV-A3I0-11A	a8c2aa08-9156-4845-ad77-5e060858c757	Adenomas and Adenocarcinomas	a8c2aa08-9156-4845-ad77-5e060858c757	TCGA-FV-A3I0	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	76.0	-28101.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH		TCGA-FV-A3I0	Case originally accepted in the liver study, but is not a hepatocellular. This is a Cholangiocarcinoma and will not be removed or change studies, but will be analyzed in the CHOL study and not in the LIHC study.	25380	Observation	a8c2aa08-9156-4845-ad77-5e060858c757	2015-01-30T00:00:00	33b3d6c9-961d-5fb6-8ab2-5dc40eed47b5	case	2018-08-23T16:36:27.780612-05:00	a8c2aa08-9156-4845-ad77-5e060858c757	released	General	Approved	TCGA-FV-A3I0	No	Stage II	0.0	not reported	Liver	848.0	28101.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2011.0	No	7th	T2	8180/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28101.0	76.98904109589041	['9b33ca58-cb03-5830-befe-59d6294d30e2', 'fd77d012-571f-52b7-99e5-08c735992e89']	['TCGA-FV-A3I0_treatment', 'TCGA-FV-A3I0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:24:27.527700-05:00']	['2019-07-31T21:08:07.893672-05:00', '2019-07-31T21:08:07.893672-05:00']	['released', 'released']	11	Not Applicable	52bca35c-ecf3-4e3c-8e98-596622b4adfd	Solid Tissue Normal	Not Reported	70.0	40.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FV-A3I0-01A	a8c2aa08-9156-4845-ad77-5e060858c757	Adenomas and Adenocarcinomas	a8c2aa08-9156-4845-ad77-5e060858c757	TCGA-FV-A3I0	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	76.0	-28101.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH		TCGA-FV-A3I0	Case originally accepted in the liver study, but is not a hepatocellular. This is a Cholangiocarcinoma and will not be removed or change studies, but will be analyzed in the CHOL study and not in the LIHC study.	25380	Observation	a8c2aa08-9156-4845-ad77-5e060858c757	2015-01-30T00:00:00	33b3d6c9-961d-5fb6-8ab2-5dc40eed47b5	case	2018-08-23T16:36:27.780612-05:00	a8c2aa08-9156-4845-ad77-5e060858c757	released	General	Approved	TCGA-FV-A3I0	No	Stage II	0.0	not reported	Liver	848.0	28101.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2011.0	No	7th	T2	8180/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	28101.0	76.98904109589041	['9b33ca58-cb03-5830-befe-59d6294d30e2', 'fd77d012-571f-52b7-99e5-08c735992e89']	['TCGA-FV-A3I0_treatment', 'TCGA-FV-A3I0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:24:27.527700-05:00']	['2019-07-31T21:08:07.893672-05:00', '2019-07-31T21:08:07.893672-05:00']	['released', 'released']	01	Primary	810d65b3-59d9-4815-aa41-0c21a0d17ac2	Primary Tumor	Not Reported	70.0	190.0	Unknown	B4DB59E9-FFBB-4716-9235-90A1DF17455B	false	Solid Tissue	False	Tumor
TCGA-G3-AAV5-01A	4dff4242-4a53-4f46-b200-7ed83f6b7808	Adenomas and Adenocarcinomas	4dff4242-4a53-4f46-b200-7ed83f6b7808	TCGA-G3-AAV5	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	67.0	-24655.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH		TCGA-G3-AAV5	TSS confirmed during enrollment that patient had chemoembolization prior to cancer procurement.	21917	Notification	4dff4242-4a53-4f46-b200-7ed83f6b7808	2014-09-02T00:00:00	5f9b54d8-38cb-5f07-b391-71cf2aef0f08	case	2018-08-23T16:36:27.780612-05:00	4dff4242-4a53-4f46-b200-7ed83f6b7808	released	Neoadjuvant therapy	Approved	TCGA-G3-AAV5	No	Stage II	0.0	not reported	Liver	354.0	24655.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24655.0	67.54794520547945	['51618b1f-49ea-5dc4-b906-431c25caf79b', '73ecec3b-43ca-5cf5-896b-0bd7be0b58e5']	['TCGA-G3-AAV5_treatment_1', 'TCGA-G3-AAV5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'yes']	['2019-04-28T13:19:04.503850-05:00', '']	['2019-07-31T21:01:30.268131-05:00', '2019-07-31T21:01:30.268131-05:00']	['released', 'released']	01	Primary	4e8b5c38-4e61-4f34-9255-da81ff5db4b7	Primary Tumor	Not Reported	62.0	450.0	OCT	A578503A-47F1-4DD4-B3E8-C1642EF89190	true	Solid Tissue	False	Tumor
TCGA-BC-A112-11A	a2c17e87-d8bc-4160-88ae-e3e894d013e4	Adenomas and Adenocarcinomas	a2c17e87-d8bc-4160-88ae-e3e894d013e4	TCGA-BC-A112	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	80.0	-29511.0	1929.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	153.0	TCGA-BC-A112	Patient had a prior prostate adenocarcinoma and received regional radiation. No systemic chemotherapy.	15991	Notification	a2c17e87-d8bc-4160-88ae-e3e894d013e4	2013-04-25T00:00:00	6690cc82-a939-5327-9247-6cebec2b5dfd	case	2018-08-23T16:36:27.780612-05:00	a2c17e87-d8bc-4160-88ae-e3e894d013e4	released	History of acceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BC-A112	Not Reported		0.0	not reported	Liver		29511.0	Hepatocellular carcinoma, NOS	yes	2009.0	No	6th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29511.0	80.85205479452055	['233f016d-5a41-581f-9f1d-111e025860e2', 'ba1c046f-bc74-5540-8d31-0e56a1a65c48']	['TCGA-BC-A112_treatment', 'TCGA-BC-A112_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:58.551396-05:00']	['2019-07-31T21:07:34.156175-05:00', '2019-07-31T21:07:34.156175-05:00']	['released', 'released']	11	Not Applicable	675a507a-0d99-4b2c-8ee3-6cd19cc7ba5e	Solid Tissue Normal	Not Reported	538.0	100.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A112-01A	a2c17e87-d8bc-4160-88ae-e3e894d013e4	Adenomas and Adenocarcinomas	a2c17e87-d8bc-4160-88ae-e3e894d013e4	TCGA-BC-A112	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	80.0	-29511.0	1929.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	153.0	TCGA-BC-A112	Patient had a prior prostate adenocarcinoma and received regional radiation. No systemic chemotherapy.	15991	Notification	a2c17e87-d8bc-4160-88ae-e3e894d013e4	2013-04-25T00:00:00	6690cc82-a939-5327-9247-6cebec2b5dfd	case	2018-08-23T16:36:27.780612-05:00	a2c17e87-d8bc-4160-88ae-e3e894d013e4	released	History of acceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BC-A112	Not Reported		0.0	not reported	Liver		29511.0	Hepatocellular carcinoma, NOS	yes	2009.0	No	6th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29511.0	80.85205479452055	['233f016d-5a41-581f-9f1d-111e025860e2', 'ba1c046f-bc74-5540-8d31-0e56a1a65c48']	['TCGA-BC-A112_treatment', 'TCGA-BC-A112_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:58.551396-05:00']	['2019-07-31T21:07:34.156175-05:00', '2019-07-31T21:07:34.156175-05:00']	['released', 'released']	01	Primary	6b3da272-71dc-4aec-ab4c-42bf93523bb4	Primary Tumor	Not Reported	538.0	70.0	Unknown	284ECD8D-E19C-4042-9C8E-EAA003D2C69D	false	Solid Tissue	False	Tumor
TCGA-EP-A3JL-01A	a196a937-b17d-4d4a-965b-8af0f4f41367	Adenomas and Adenocarcinomas	a196a937-b17d-4d4a-965b-8af0f4f41367	TCGA-EP-A3JL	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	76.0	-27886.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05	EP	Christiana Healthcare	Liver hepatocellular carcinoma	NCH		TCGA-EP-A3JL	Patient had a prior tumor in the back. No systemic chemotherapy or radiation.	15993	Notification	a196a937-b17d-4d4a-965b-8af0f4f41367	2013-04-25T00:00:00	67cae150-0bdc-51af-926e-7c14d5b6e1dc	case	2018-08-23T16:36:27.780612-05:00	a196a937-b17d-4d4a-965b-8af0f4f41367	released	Prior malignancy	Approved	TCGA-EP-A3JL	Not Reported	Stage I	0.0	not reported	Liver	303.0	27886.0	Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27886.0	76.4	['64b7e03d-b69a-58c5-9355-de436007053d', 'e600f138-7e34-546b-99e1-5cc0c31f28f2']	['TCGA-EP-A3JL_treatment', 'TCGA-EP-A3JL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:53.530990-05:00']	['2019-07-31T21:07:27.825341-05:00', '2019-07-31T21:07:27.825341-05:00']	['released', 'released']	01	Primary	93612bcd-f1d2-44dd-8abf-7da2865878ce	Primary Tumor	Not Reported	22.0	570.0	Unknown	B277ACF9-B233-474B-975A-52FDE44F27E3	false	Solid Tissue	False	Tumor
TCGA-ES-A2HS-01A	728aedb3-551a-4c16-9be3-7733a9539e9e	Adenomas and Adenocarcinomas	728aedb3-551a-4c16-9be3-7733a9539e9e	TCGA-ES-A2HS	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	80.0	-29268.0	1928.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	29bb87f7-7e08-54b6-9bf8-b321a9926f80	ES	University of Florida	Liver hepatocellular carcinoma	NCH	688.0	TCGA-ES-A2HS	Patient had a prior prostate adenocarcinoma treated with locoregional radiation. No systemic chemotherapy	15994	Notification	728aedb3-551a-4c16-9be3-7733a9539e9e	2013-04-25T00:00:00	79c23a9f-227f-5a22-80d0-d065000b6216	case	2018-08-23T16:36:27.780612-05:00	728aedb3-551a-4c16-9be3-7733a9539e9e	released	History of acceptable prior treatment related to a prior/other malignancy	Approved	TCGA-ES-A2HS	Not Reported	Stage I	0.0	not reported	Liver		29268.0	Hepatocellular carcinoma, NOS	yes	2008.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29268.0	80.18630136986302	['0c6132d7-2dd7-5a52-8016-3e58a895e260', 'c635775b-a557-5f40-a3d8-4ceba8b33402']	['TCGA-ES-A2HS_treatment_1', 'TCGA-ES-A2HS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:21:19.604584-05:00', '']	['2019-07-31T21:04:18.493535-05:00', '2019-07-31T21:04:18.493535-05:00']	['released', 'released']	01	Primary	a06fe860-8d5f-4ed0-b7fc-72f74567fb7e	Primary Tumor	Not Reported	1113.0	320.0	OCT	53AB28EC-71C0-4AF0-93DA-FE72CD7FE19B	true	Solid Tissue	False	Tumor
TCGA-ES-A2HS-11A	728aedb3-551a-4c16-9be3-7733a9539e9e	Adenomas and Adenocarcinomas	728aedb3-551a-4c16-9be3-7733a9539e9e	TCGA-ES-A2HS	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	80.0	-29268.0	1928.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	29bb87f7-7e08-54b6-9bf8-b321a9926f80	ES	University of Florida	Liver hepatocellular carcinoma	NCH	688.0	TCGA-ES-A2HS	Patient had a prior prostate adenocarcinoma treated with locoregional radiation. No systemic chemotherapy	15994	Notification	728aedb3-551a-4c16-9be3-7733a9539e9e	2013-04-25T00:00:00	79c23a9f-227f-5a22-80d0-d065000b6216	case	2018-08-23T16:36:27.780612-05:00	728aedb3-551a-4c16-9be3-7733a9539e9e	released	History of acceptable prior treatment related to a prior/other malignancy	Approved	TCGA-ES-A2HS	Not Reported	Stage I	0.0	not reported	Liver		29268.0	Hepatocellular carcinoma, NOS	yes	2008.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	29268.0	80.18630136986302	['0c6132d7-2dd7-5a52-8016-3e58a895e260', 'c635775b-a557-5f40-a3d8-4ceba8b33402']	['TCGA-ES-A2HS_treatment_1', 'TCGA-ES-A2HS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:21:19.604584-05:00', '']	['2019-07-31T21:04:18.493535-05:00', '2019-07-31T21:04:18.493535-05:00']	['released', 'released']	11	Not Applicable	d263d674-cce4-4a57-b379-671fa9e5416e	Solid Tissue Normal	Not Reported	1113.0	230.0	OCT		true	Solid Tissue	False	Normal
TCGA-BC-A110-01A	cf028bce-d20d-42b8-8507-1ec94a391e85	Adenomas and Adenocarcinomas	cf028bce-d20d-42b8-8507-1ec94a391e85	TCGA-BC-A110	Liver and intrahepatic bile ducts	Not Reported	black or african american	female	not hispanic or latino	Dead	51.0	-18951.0	1952.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	2116.0	TCGA-BC-A110	Patient had a prior Wilms tumor. No systemic chemotherapy or radiation.	15990	Notification	cf028bce-d20d-42b8-8507-1ec94a391e85	2013-04-25T00:00:00	7da3ee04-df24-5faf-987f-6c27b7018bd0	case	2018-08-23T16:36:27.780612-05:00	cf028bce-d20d-42b8-8507-1ec94a391e85	released	Prior malignancy	Approved	TCGA-BC-A110	Not Reported		0.0	not reported	Liver		18951.0	Hepatocellular carcinoma, NOS	yes	2003.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18951.0	51.92054794520548	['ba00b738-75a1-582d-a257-92af67d21cc6', 'f1205624-ce42-5777-a069-7861c3da43c2']	['TCGA-BC-A110_treatment', 'TCGA-BC-A110_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:26:45.887914-05:00']	['2019-07-31T21:10:59.610501-05:00', '2019-07-31T21:10:59.610501-05:00']	['released', 'released']	01	Primary	4db99739-f0d5-4db9-a5fa-4445c7a61b4b	Primary Tumor	Not Reported	2629.0	280.0	Unknown	DCC8DAE3-E0AF-4B37-8E5F-A2004ACA1F9B	false	Solid Tissue	False	Tumor
TCGA-BC-A110-11A	cf028bce-d20d-42b8-8507-1ec94a391e85	Adenomas and Adenocarcinomas	cf028bce-d20d-42b8-8507-1ec94a391e85	TCGA-BC-A110	Liver and intrahepatic bile ducts	Not Reported	black or african american	female	not hispanic or latino	Dead	51.0	-18951.0	1952.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	2116.0	TCGA-BC-A110	Patient had a prior Wilms tumor. No systemic chemotherapy or radiation.	15990	Notification	cf028bce-d20d-42b8-8507-1ec94a391e85	2013-04-25T00:00:00	7da3ee04-df24-5faf-987f-6c27b7018bd0	case	2018-08-23T16:36:27.780612-05:00	cf028bce-d20d-42b8-8507-1ec94a391e85	released	Prior malignancy	Approved	TCGA-BC-A110	Not Reported		0.0	not reported	Liver		18951.0	Hepatocellular carcinoma, NOS	yes	2003.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18951.0	51.92054794520548	['ba00b738-75a1-582d-a257-92af67d21cc6', 'f1205624-ce42-5777-a069-7861c3da43c2']	['TCGA-BC-A110_treatment', 'TCGA-BC-A110_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:26:45.887914-05:00']	['2019-07-31T21:10:59.610501-05:00', '2019-07-31T21:10:59.610501-05:00']	['released', 'released']	11	Not Applicable	aa8d7157-7345-4255-84d4-c4b6747e3a72	Solid Tissue Normal	Not Reported	2629.0	90.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A3A6-11A	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	Adenomas and Adenocarcinomas	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	TCGA-DD-A3A6	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	72.0	-26319.0	1925.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	3258.0	TCGA-DD-A3A6	The EPC found that the diagnostic slides were not representative of a hepatocellular case, but is representative of the piece sent for TCGA.	25400	Observation	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	2015-02-05T00:00:00	9c92cb81-43d1-5d1a-9d27-66f233eef6e8	case	2018-08-23T16:36:27.780612-05:00	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	released	Item may not meet study protocol	Approved	TCGA-DD-A3A6	No	Stage II	0.0	not reported	Liver		26319.0	Hepatocellular carcinoma, NOS	no	1997.0	No	4th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26319.0	72.10684931506849	['313a790c-3282-598c-86e6-f90a880b90fd', 'fc18cfe5-ba14-52a8-a8d8-2fb296c85365']	['TCGA-DD-A3A6_treatment_1', 'TCGA-DD-A3A6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:08.972925-05:00', '']	['2019-07-31T21:10:14.782651-05:00', '2019-07-31T21:10:14.782651-05:00']	['released', 'released']	11	Not Applicable	88af1e79-aa6c-46fb-b087-bb4ce8aeb1ad	Solid Tissue Normal	Not Reported	5304.0	20.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A3A6-01A	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	Adenomas and Adenocarcinomas	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	TCGA-DD-A3A6	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	72.0	-26319.0	1925.0	2005.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	3258.0	TCGA-DD-A3A6	The EPC found that the diagnostic slides were not representative of a hepatocellular case, but is representative of the piece sent for TCGA.	25400	Observation	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	2015-02-05T00:00:00	9c92cb81-43d1-5d1a-9d27-66f233eef6e8	case	2018-08-23T16:36:27.780612-05:00	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9	released	Item may not meet study protocol	Approved	TCGA-DD-A3A6	No	Stage II	0.0	not reported	Liver		26319.0	Hepatocellular carcinoma, NOS	no	1997.0	No	4th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26319.0	72.10684931506849	['313a790c-3282-598c-86e6-f90a880b90fd', 'fc18cfe5-ba14-52a8-a8d8-2fb296c85365']	['TCGA-DD-A3A6_treatment_1', 'TCGA-DD-A3A6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:08.972925-05:00', '']	['2019-07-31T21:10:14.782651-05:00', '2019-07-31T21:10:14.782651-05:00']	['released', 'released']	01	Primary	8bbfeeab-ff99-4bd0-b407-e1e532bd04fc	Primary Tumor	Not Reported	5304.0	150.0	Unknown	EEA9EFFB-B5F9-42D9-B452-E165E018C33C	false	Solid Tissue	False	Tumor
TCGA-FV-A3I1-11A	bfd20d71-18a5-4f01-8d56-84378ad92359	Adenomas and Adenocarcinomas	bfd20d71-18a5-4f01-8d56-84378ad92359	TCGA-FV-A3I1	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	81.0		1930.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	247.0	TCGA-FV-A3I1	Patient had a prior colon adenocarcinoma. No systemic chemotherapy or radiation.	15995	Notification	bfd20d71-18a5-4f01-8d56-84378ad92359	2013-04-25T00:00:00	9fa52dd3-dfee-5230-b164-ddffc749ded6	case	2018-08-23T16:36:27.780612-05:00	bfd20d71-18a5-4f01-8d56-84378ad92359	released	Prior malignancy	Approved	TCGA-FV-A3I1	Not Reported	Stage II	0.0	not reported	Liver	0.0		Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T2	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported			['2208c7b6-c873-5343-b032-3ec71b9c5678', 'b8a9749c-6840-596d-a74e-bce11d8ef63c']	['TCGA-FV-A3I1_treatment', 'TCGA-FV-A3I1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:57.109783-05:00']	['2019-07-31T21:09:58.681084-05:00', '2019-07-31T21:09:58.681084-05:00']	['released', 'released']	11	Not Applicable	3811dc8f-a2bb-402f-a631-090773c27786	Solid Tissue Normal	Not Reported	76.0	70.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FV-A3I1-01A	bfd20d71-18a5-4f01-8d56-84378ad92359	Adenomas and Adenocarcinomas	bfd20d71-18a5-4f01-8d56-84378ad92359	TCGA-FV-A3I1	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	81.0		1930.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	247.0	TCGA-FV-A3I1	Patient had a prior colon adenocarcinoma. No systemic chemotherapy or radiation.	15995	Notification	bfd20d71-18a5-4f01-8d56-84378ad92359	2013-04-25T00:00:00	9fa52dd3-dfee-5230-b164-ddffc749ded6	case	2018-08-23T16:36:27.780612-05:00	bfd20d71-18a5-4f01-8d56-84378ad92359	released	Prior malignancy	Approved	TCGA-FV-A3I1	Not Reported	Stage II	0.0	not reported	Liver	0.0		Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T2	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported			['2208c7b6-c873-5343-b032-3ec71b9c5678', 'b8a9749c-6840-596d-a74e-bce11d8ef63c']	['TCGA-FV-A3I1_treatment', 'TCGA-FV-A3I1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:57.109783-05:00']	['2019-07-31T21:09:58.681084-05:00', '2019-07-31T21:09:58.681084-05:00']	['released', 'released']	01	Primary	a744be68-d008-4847-a11d-89918a419a5f	Primary Tumor	Not Reported	76.0	70.0	Unknown	B40A8E73-2904-4C68-B2AD-6FC27211654B	false	Solid Tissue	False	Tumor
TCGA-UB-A7MA-01A	10179efc-a091-4119-8ec2-30db6269d674	Adenomas and Adenocarcinomas	10179efc-a091-4119-8ec2-30db6269d674	TCGA-UB-A7MA	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22843.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH		TCGA-UB-A7MA	Case originally accepted in the liver study, but is a cholongio-liver mix. This case will not be removed or change studies, but will be analyzed in the CHOL study and not in the LIHC study.	26880	Observation	10179efc-a091-4119-8ec2-30db6269d674	2015-03-04T00:00:00	a1f76735-f482-5751-8706-db7527590eb9	case	2018-08-23T16:36:27.780612-05:00	10179efc-a091-4119-8ec2-30db6269d674	released	General	Approved	TCGA-UB-A7MA	No	Stage II	0.0	not reported	Liver	848.0	22843.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2013.0	No	7th	T2b	8180/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22843.0	62.583561643835615	['1d4f1903-4986-5782-aeb3-e4fda6cc95f3', 'd3966fad-6e2c-5cbd-b245-4e97caabba53']	['TCGA-UB-A7MA_treatment', 'TCGA-UB-A7MA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:14:50.830180-05:00']	['2019-07-31T20:56:14.124880-05:00', '2019-07-31T20:56:14.124880-05:00']	['released', 'released']	01	Primary	b9f894f9-7e61-4604-968e-2592642fc53b	Primary Tumor	Not Reported	109.0	500.0	OCT	82349CD5-39AA-42F8-80A1-B438B2300D09	true	Solid Tissue	False	Tumor
TCGA-BD-A3ER-01A	9457a9a1-3dd1-4d88-b1e1-d20aae4491dd	Adenomas and Adenocarcinomas	9457a9a1-3dd1-4d88-b1e1-d20aae4491dd	TCGA-BD-A3ER	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	62.0	-22657.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	86f2ecb2-6c8a-51da-943d-4acb6d72576d	BD	University of Pittsburgh	Liver hepatocellular carcinoma	NCH		TCGA-BD-A3ER	Patient had a prior prostate adenocarcinoma treated with systemic chemotherapy.	15992	Notification	9457a9a1-3dd1-4d88-b1e1-d20aae4491dd	2013-04-25T00:00:00	b0eb1b7f-6fce-51c7-ae99-bdfd06d24c21	case	2018-08-23T16:36:27.780612-05:00	9457a9a1-3dd1-4d88-b1e1-d20aae4491dd	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BD-A3ER	Not Reported	Stage II	0.0	not reported	Liver	1115.0	22657.0	Hepatocellular carcinoma, NOS	yes	2011.0	No	7th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	22657.0	62.07397260273972	['8e78ac06-e15e-5cd8-a290-36bb26d13cc3', 'ffa89772-1c7a-5723-a7bc-0b97a2e8797c']	['TCGA-BD-A3ER_treatment', 'TCGA-BD-A3ER_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:18.729192-05:00']	['2019-07-31T21:06:48.190213-05:00', '2019-07-31T21:06:48.190213-05:00']	['released', 'released']	01	Primary	7e3bb1d9-c3b4-4af8-85d3-f51f3b77d066	Primary Tumor	Not Reported	23.0	90.0	OCT	2CD158D7-48E7-43D6-8E0F-2D56FC6F5256	true	Solid Tissue	False	Tumor
TCGA-KR-A7K2-01A	fbb398fe-2ba8-4845-8083-6533ecb4a52e	Adenomas and Adenocarcinomas	fbb398fe-2ba8-4845-8083-6533ecb4a52e	TCGA-KR-A7K2	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Alive	64.0	-23699.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	72165b47-b0b5-5107-b0be-b5a74bc3e249	KR	University Of Michigan	Liver hepatocellular carcinoma	NCH		TCGA-KR-A7K2	Case originally accepted in the liver study, but is a cholongio-liver mix. This case will not be removed or change studies, but will be analyzed in the CHOL study and not in the LIHC study.	26879	Observation	fbb398fe-2ba8-4845-8083-6533ecb4a52e	2015-03-04T00:00:00	ba1d9597-7ba4-589a-8105-88bc96b9efdc	case	2018-08-23T16:36:27.780612-05:00	fbb398fe-2ba8-4845-8083-6533ecb4a52e	released	General	Approved	TCGA-KR-A7K2	No	Stage I	0.0	not reported	Liver	829.0	23699.0	Combined hepatocellular carcinoma and cholangiocarcinoma	no	2013.0	No	7th	T1	8180/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23699.0	64.92876712328767	['8f26c49f-72f5-5aa5-bef5-c9fd6d5f4be4', '9a53ec49-4d38-5c6d-a151-ccf9029eae8a']	['TCGA-KR-A7K2_treatment', 'TCGA-KR-A7K2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:36.600765-05:00']	['2019-07-31T21:13:16.604718-05:00', '2019-07-31T21:13:16.604718-05:00']	['released', 'released']	01	Primary	97843db5-32bd-4b54-8397-d5315d0922ec	Primary Tumor	Not Reported	85.0	70.0	Unknown	5121C5D6-3BCB-4A0F-B18A-51BA4E87778B	false	Solid Tissue	False	Tumor
TCGA-G3-A25W-11A	06ac44e9-1226-4202-828b-6f224766d7ac	Adenomas and Adenocarcinomas	06ac44e9-1226-4202-828b-6f224766d7ac	TCGA-G3-A25W	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	79.0	-29018.0	1931.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH		TCGA-G3-A25W	Patient had a prior papillary renal cell carcinoma. No systemic chemotherapy or radiation.	15997	Notification	06ac44e9-1226-4202-828b-6f224766d7ac	2013-04-25T00:00:00	cc095f24-6680-5dcb-a8a7-31e08b07c8d9	case	2018-08-23T16:36:27.780612-05:00	06ac44e9-1226-4202-828b-6f224766d7ac	released	Prior malignancy	Approved	TCGA-G3-A25W	Not Reported	Stage IIIB	0.0	not reported	Liver	935.0	29018.0	Hepatocellular carcinoma, NOS	yes	2010.0	No	7th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	29018.0	79.5013698630137	['8247a7e2-d4eb-5182-bcb2-1874bfb5d6d5', 'a9b1b9ee-b601-59cf-897c-226fce8ff92d']	['TCGA-G3-A25W_treatment_1', 'TCGA-G3-A25W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:12.879088-05:00', '']	['2019-07-31T20:55:27.747025-05:00', '2019-07-31T20:55:27.747025-05:00']	['released', 'released']	11	Not Applicable	1467d6a9-e66e-49dc-a1ef-161ba83c4432	Solid Tissue Normal	Not Reported	419.0	440.0	OCT		true	Solid Tissue	False	Normal
TCGA-G3-A25W-01A	06ac44e9-1226-4202-828b-6f224766d7ac	Adenomas and Adenocarcinomas	06ac44e9-1226-4202-828b-6f224766d7ac	TCGA-G3-A25W	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	79.0	-29018.0	1931.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH		TCGA-G3-A25W	Patient had a prior papillary renal cell carcinoma. No systemic chemotherapy or radiation.	15997	Notification	06ac44e9-1226-4202-828b-6f224766d7ac	2013-04-25T00:00:00	cc095f24-6680-5dcb-a8a7-31e08b07c8d9	case	2018-08-23T16:36:27.780612-05:00	06ac44e9-1226-4202-828b-6f224766d7ac	released	Prior malignancy	Approved	TCGA-G3-A25W	Not Reported	Stage IIIB	0.0	not reported	Liver	935.0	29018.0	Hepatocellular carcinoma, NOS	yes	2010.0	No	7th	T3b	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	29018.0	79.5013698630137	['8247a7e2-d4eb-5182-bcb2-1874bfb5d6d5', 'a9b1b9ee-b601-59cf-897c-226fce8ff92d']	['TCGA-G3-A25W_treatment_1', 'TCGA-G3-A25W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:14:12.879088-05:00', '']	['2019-07-31T20:55:27.747025-05:00', '2019-07-31T20:55:27.747025-05:00']	['released', 'released']	01	Primary	859cde68-b3bb-4867-bced-c016bfaffde9	Primary Tumor	Not Reported	419.0	260.0	OCT	F92FE7A0-15D4-45FD-BB39-E3022E30EB77	true	Solid Tissue	False	Tumor
TCGA-T1-A6J8-01A	59f163d2-6a7c-41b8-b4d6-f07174dafc6e	Adenomas and Adenocarcinomas	59f163d2-6a7c-41b8-b4d6-f07174dafc6e	TCGA-T1-A6J8	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	68.0	-24853.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d6f3ff9-3b72-5dfe-98b6-b9a65a51d5ce	T1	St. Joseph's Hospital Arizona	Liver hepatocellular carcinoma	NCH		TCGA-T1-A6J8	TSS confirmed the patient had a prior bladder and prostate cancer with an unknown treatment history which is unacceptable for TCGA cases.	23899	Notification	59f163d2-6a7c-41b8-b4d6-f07174dafc6e	2015-01-12T00:00:00	f08e1963-04e9-51a9-9911-081f386bba0e	case	2018-08-23T16:36:27.780612-05:00	59f163d2-6a7c-41b8-b4d6-f07174dafc6e	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-T1-A6J8	Not Reported		0.0	not reported	Liver	23.0	24853.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	24853.0	68.09041095890412	['45685885-5eb7-5603-8fe0-1e04f03bcede', 'e01e0b87-2f50-56e0-896f-b710711ef15a']	['TCGA-T1-A6J8_treatment_1', 'TCGA-T1-A6J8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:19:49.725324-05:00', '']	['2019-07-31T21:02:27.588828-05:00', '2019-07-31T21:02:27.588828-05:00']	['released', 'released']	01	Primary	44173ac6-a31d-4034-8e96-db1fd1daadbb	Primary Tumor	Not Reported	77.0	340.0	OCT	CEAA3A97-FE48-4408-9DCA-21D924287CAC	true	Solid Tissue	False	Tumor
TCGA-DD-A4NV-01A	8e5ce60b-2eda-482d-b109-210df1321aff	Adenomas and Adenocarcinomas	8e5ce60b-2eda-482d-b109-210df1321aff	TCGA-DD-A4NV	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	61.0	-22438.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	2398.0	22438.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22438.0	61.47397260273973	['1d857536-d1b9-5757-aba8-e11a5a752a04', 'bf571134-e2ad-54dc-b1c9-f785244c1da1']	['TCGA-DD-A4NV_treatment_1', 'TCGA-DD-A4NV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:55.919944-05:00', '']	['2019-07-31T21:06:20.594001-05:00', '2019-07-31T21:06:20.594001-05:00']	['released', 'released']	01	Primary	118f2987-8ab8-4e16-8010-94971faa29a0	Primary Tumor	Not Reported	1928.0	80.0	OCT	C65CD25A-D623-4793-B22F-567693666073	true	Solid Tissue	False	Tumor
TCGA-DD-AADF-01A	70bb26b8-b38b-4e79-90e7-033a38405b00	Adenomas and Adenocarcinomas	70bb26b8-b38b-4e79-90e7-033a38405b00	TCGA-DD-AADF	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	64.0	-23614.0	1947.0	2011.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	115.0															No	Stage I	0.0	not reported	Liver		23614.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23614.0	64.69589041095891	['05b453fa-5fb8-5420-8058-116ae03b2c00', '68541836-9dd3-5013-ae56-b9d01d0b034a']	['TCGA-DD-AADF_treatment_1', 'TCGA-DD-AADF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:11.990374-05:00', '']	['2019-07-31T21:04:09.216489-05:00', '2019-07-31T21:04:09.216489-05:00']	['released', 'released']	01	Primary	f38012cb-8922-4401-b2c1-05cc36c3c79f	Primary Tumor	Not Reported	865.0	30.0	OCT	046D3A59-FFB8-40B1-8ED2-6853F42CF611	true	Solid Tissue	False	Tumor
TCGA-DD-A1EE-01A	654af137-70d9-4ee4-9f69-793e352d30f8	Adenomas and Adenocarcinomas	654af137-70d9-4ee4-9f69-793e352d30f8	TCGA-DD-A1EE	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	73.0	-26858.0	1933.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	349.0															No	Stage IIIA	0.0	not reported	Liver	204.0	26858.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26858.0	73.58356164383562	['0adb4177-d2bd-5424-8265-cb55fd54d181', 'ddd209be-ca18-53cc-80a2-32d868821126']	['TCGA-DD-A1EE_treatment', 'TCGA-DD-A1EE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:38.695986-05:00']	['2019-07-31T21:03:26.335375-05:00', '2019-07-31T21:03:26.335375-05:00']	['released', 'released']	01	Primary	43879fcb-cf8f-4b51-a5a7-1232df941865	Primary Tumor	Not Reported	1521.0	110.0	OCT	EC55BB6D-4704-48D6-9C37-E82AADE685F7	true	Solid Tissue	False	Tumor
TCGA-DD-A1EE-11A	654af137-70d9-4ee4-9f69-793e352d30f8	Adenomas and Adenocarcinomas	654af137-70d9-4ee4-9f69-793e352d30f8	TCGA-DD-A1EE	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	73.0	-26858.0	1933.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	349.0															No	Stage IIIA	0.0	not reported	Liver	204.0	26858.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26858.0	73.58356164383562	['0adb4177-d2bd-5424-8265-cb55fd54d181', 'ddd209be-ca18-53cc-80a2-32d868821126']	['TCGA-DD-A1EE_treatment', 'TCGA-DD-A1EE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:38.695986-05:00']	['2019-07-31T21:03:26.335375-05:00', '2019-07-31T21:03:26.335375-05:00']	['released', 'released']	11	Not Applicable	d9fd7e08-27aa-4081-96fe-86b7ec06d3df	Solid Tissue Normal	Not Reported	1521.0	190.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-AACW-01A	67a00f5f-c753-48f9-bc24-8287f50ec776	Adenomas and Adenocarcinomas	67a00f5f-c753-48f9-bc24-8287f50ec776	TCGA-DD-AACW	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	43.0	-15872.0	1967.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1424.0	15872.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	15872.0	43.484931506849314	['4a4aa6e2-19d5-5f90-8292-a576441895bf', 'daa0ded0-9c64-500d-bac7-96c53cf260e7']	['TCGA-DD-AACW_treatment', 'TCGA-DD-AACW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:20:48.696174-05:00']	['2019-07-31T21:03:38.445979-05:00', '2019-07-31T21:03:38.445979-05:00']	['released', 'released']	01	Primary	32c40946-b067-48a5-8a7c-cd1923bd6d60	Primary Tumor	Not Reported	1184.0	40.0	OCT	04474C44-102B-4514-BC48-468B9ED478A2	true	Solid Tissue	False	Tumor
TCGA-DD-A3A8-01A	69d6881b-9e9a-407b-8b02-bad5fc2455bf	Adenomas and Adenocarcinomas	69d6881b-9e9a-407b-8b02-bad5fc2455bf	TCGA-DD-A3A8	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	75.0	-27524.0	1926.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	11.0															Not Reported	Stage II	0.0	not reported	Liver		27524.0	Hepatocellular carcinoma, NOS	yes	2001.0	No	5th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27524.0	75.40821917808219	['718868a8-94b5-50fd-bf82-d09c766354e8', 'a958aa64-dd4d-5a52-86f7-8737054ee861']	['TCGA-DD-A3A8_treatment_1', 'TCGA-DD-A3A8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:53.496426-05:00', '']	['2019-07-31T21:03:44.769801-05:00', '2019-07-31T21:03:44.769801-05:00']	['released', 'released']	01	Primary	93d007f8-84d9-427d-a1e9-54919605f7b3	Primary Tumor	Not Reported	3708.0	290.0	Unknown	5D143B3D-AC64-4C1C-A276-D12111750C67	false	Solid Tissue	False	Tumor
TCGA-DD-A3A8-11A	69d6881b-9e9a-407b-8b02-bad5fc2455bf	Adenomas and Adenocarcinomas	69d6881b-9e9a-407b-8b02-bad5fc2455bf	TCGA-DD-A3A8	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	75.0	-27524.0	1926.0	2001.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	11.0															Not Reported	Stage II	0.0	not reported	Liver		27524.0	Hepatocellular carcinoma, NOS	yes	2001.0	No	5th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	27524.0	75.40821917808219	['718868a8-94b5-50fd-bf82-d09c766354e8', 'a958aa64-dd4d-5a52-86f7-8737054ee861']	['TCGA-DD-A3A8_treatment_1', 'TCGA-DD-A3A8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:20:53.496426-05:00', '']	['2019-07-31T21:03:44.769801-05:00', '2019-07-31T21:03:44.769801-05:00']	['released', 'released']	11	Not Applicable	f070e7db-1215-4864-9293-c778f161ae68	Solid Tissue Normal	Not Reported	3708.0	240.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BC-A5W4-01A	6bb5d506-8fca-43f3-90a6-03c915d7ede2	Adenomas and Adenocarcinomas	6bb5d506-8fca-43f3-90a6-03c915d7ede2	TCGA-BC-A5W4	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	69.0	-25503.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	547.0															Not Reported	Stage IIIA	0.0	not reported	Liver	289.0	25503.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T3a	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	25503.0	69.87123287671233	['c855d99f-2649-5a39-a975-8aceeb053e34', 'd75cd02c-056a-5065-bcb4-cf0ea6d6eff5']	['TCGA-BC-A5W4_treatment', 'TCGA-BC-A5W4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:00.681739-05:00']	['2019-07-31T21:03:53.971068-05:00', '2019-07-31T21:03:53.971068-05:00']	['released', 'released']	01	Primary	7b9c40bf-6ad0-491e-84fc-f835fe3589c5	Primary Tumor	Not Reported	224.0	540.0	Unknown	6BCF821F-1993-4BA9-A9D2-EB4DEACD402C	false	Solid Tissue	False	Tumor
TCGA-BC-A217-01A	6dcfc418-ab28-4365-95ea-c1ae254f2341	Adenomas and Adenocarcinomas	6dcfc418-ab28-4365-95ea-c1ae254f2341	TCGA-BC-A217	Liver and intrahepatic bile ducts	Not Reported	white	female	not reported	Dead	75.0	-27411.0	1935.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH	1397.0															No	Stage II	0.0	not reported	Liver	421.0	27411.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	27411.0	75.0986301369863	['24e968fa-b55b-5cee-aee7-c995b2f8253d', 'c0d85091-0e52-5ef8-beb9-7e05cb843c7b']	['TCGA-BC-A217_treatment_1', 'TCGA-BC-A217_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:02.988662-05:00', '']	['2019-07-31T21:03:57.438512-05:00', '2019-07-31T21:03:57.438512-05:00']	['released', 'released']	01	Primary	c827a8b9-359c-4a6f-b950-839b3fb0c097	Primary Tumor	Not Reported	408.0	240.0	Unknown	FEA652A1-DD1E-4D78-87DF-FC2162267A96	false	Solid Tissue	False	Tumor
TCGA-DD-AAEK-01A	6ea0ef82-694d-492d-95da-a3bc8de99149	Adenomas and Adenocarcinomas	6ea0ef82-694d-492d-95da-a3bc8de99149	TCGA-DD-AAEK	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18757.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1067.0	18757.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18757.0	51.38904109589041	['1bea0b89-ba96-59da-97b9-f59e83400530', 'c2f43d9a-3a47-555f-a6a3-3885e0ee5fee']	['TCGA-DD-AAEK_treatment', 'TCGA-DD-AAEK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:05.151751-05:00']	['2019-07-31T21:04:00.534631-05:00', '2019-07-31T21:04:00.534631-05:00']	['released', 'released']	01	Primary	bda59599-c551-4e99-804b-c58af26a039b	Primary Tumor	Not Reported	1162.0	10.0	OCT	C174382E-E3FB-456E-B5B7-1949B3086967	true	Solid Tissue	False	Tumor
TCGA-BC-A69I-01A	70aecc90-17f0-4064-8ebb-be81f9b1d7fd	Adenomas and Adenocarcinomas	70aecc90-17f0-4064-8ebb-be81f9b1d7fd	TCGA-BC-A69I	Liver and intrahepatic bile ducts	Not Reported	white	male	not reported	Alive	69.0	-25370.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	387.0	25370.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25370.0	69.5068493150685	['4734b508-fc0a-5c51-842b-1a275371b841', '84e73d0f-22ef-52b3-8f2c-e8c74b7fba37']	['TCGA-BC-A69I_treatment', 'TCGA-BC-A69I_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:09.701720-05:00']	['2019-07-31T21:04:06.313959-05:00', '2019-07-31T21:04:06.313959-05:00']	['released', 'released']	01	Primary	e36d5a75-0bc8-480d-8458-e23cb453c279	Primary Tumor	Not Reported	80.0	500.0	Unknown	94F0B317-494A-4467-94A2-5004010E133F	false	Solid Tissue	False	Tumor
TCGA-RC-A7SF-01A	714a6878-ed2a-47f3-9755-b705ac144d68	Adenomas and Adenocarcinomas	714a6878-ed2a-47f3-9755-b705ac144d68	TCGA-RC-A7SF	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	66.0	-24432.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	579.0	24432.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24432.0	66.93698630136986	['1a92518d-600e-5bff-a064-cbd38dd03ec8', '288af713-648c-5f9c-9e0f-53f7189d2e7e']	['TCGA-RC-A7SF_treatment', 'TCGA-RC-A7SF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:14.615460-05:00']	['2019-07-31T21:04:12.270687-05:00', '2019-07-31T21:04:12.270687-05:00']	['released', 'released']	01	Primary	ffaa3256-0dc7-4e99-9ed5-cac165f3750e	Primary Tumor	Not Reported	285.0	20.0	OCT	D4F398CC-0003-4C08-989F-3C60762B100F	true	Solid Tissue	False	Tumor
TCGA-CC-5259-01A	7444eea6-90e8-42dd-a7b5-0afc6d96e1e8	Adenomas and Adenocarcinomas	7444eea6-90e8-42dd-a7b5-0afc6d96e1e8	TCGA-CC-5259	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	60.0	-21946.0	1950.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIC	0.0	not reported	Liver	250.0	21946.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21946.0	60.12602739726027	['bf203f71-eca5-595b-a8b1-be4fcd38f833', 'e8427baa-d2b2-5b7f-8878-40f13e8ffe57']	['TCGA-CC-5259_treatment', 'TCGA-CC-5259_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:22.179911-05:00']	['2019-07-31T21:04:21.382517-05:00', '2019-07-31T21:04:21.382517-05:00']	['released', 'released']	01	Primary	e5587496-5655-4b18-82e3-e00593a1c64c	Primary Tumor	Not Reported	106.0	400.0	OCT	BE330AF3-7D80-4588-80D1-2C24F0158BFB	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GY-01A	75030b63-59af-4705-86e7-3a431b7cf65a	Adenomas and Adenocarcinomas	75030b63-59af-4705-86e7-3a431b7cf65a	TCGA-2Y-A9GY	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23435.0	1943.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	757.0															No	Stage II	0.0	not reported	Liver		23435.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	23435.0	64.20547945205479	['664622da-fa94-5053-8b47-683f1f85dffc', 'daa0a695-ef27-59d5-9200-d09348d895b1']	['TCGA-2Y-A9GY_treatment_1', 'TCGA-2Y-A9GY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:24.846050-05:00', '']	['2019-07-31T21:04:24.660158-05:00', '2019-07-31T21:04:24.660158-05:00']	['released', 'released']	01	Primary	8a3626bf-811b-4a1c-8e68-999b6fe7bc0e	Primary Tumor	Not Reported	2340.0	140.0	OCT	A58D47E8-EB89-4267-830A-6EE9782D28EC	true	Solid Tissue	False	Tumor
TCGA-BC-A3KG-01A	75f43fca-200a-48b0-bb67-0693d7b91119	Adenomas and Adenocarcinomas	75f43fca-200a-48b0-bb67-0693d7b91119	TCGA-BC-A3KG	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25061.0	1943.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	735fda57-1a46-5afd-a1c0-99af9115c0af	BC	UNC	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	680.0	25061.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25061.0	68.66027397260274	['160d377f-e29b-55e0-a034-3535f48d9a21', 'd3fbd640-1d6d-5287-a86a-ad048e4d6193']	['TCGA-BC-A3KG_treatment_1', 'TCGA-BC-A3KG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:21:27.313849-05:00', '']	['2019-07-31T21:04:27.546851-05:00', '2019-07-31T21:04:27.546851-05:00']	['released', 'released']	01	Primary	da632ff7-e6b4-4ecd-ab72-a08461588b44	Primary Tumor	Not Reported	140.0	790.0	Unknown	67A81454-06A8-451D-B855-F9D146CC0348	false	Solid Tissue	False	Tumor
TCGA-DD-A4NO-01A	75f78c38-6854-4390-ad11-789b4e549d63	Adenomas and Adenocarcinomas	75f78c38-6854-4390-ad11-789b4e549d63	TCGA-DD-A4NO	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	65.0	-24090.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2245.0	24090.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24090.0	66.0	['21b377c8-e29c-5465-872e-a00e37c87925', '22110c9d-1abf-515c-9e74-2d058f527a7c']	['TCGA-DD-A4NO_treatment_1', 'TCGA-DD-A4NO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:29.803861-05:00', '']	['2019-07-31T21:04:30.427841-05:00', '2019-07-31T21:04:30.427841-05:00']	['released', 'released']	01	Primary	4ef18704-c08f-4f69-a5ae-09ade360650e	Primary Tumor	Not Reported	1879.0	190.0	OCT	0B108361-E361-4A8B-9F5C-FC3ACB992DB9	true	Solid Tissue	False	Tumor
TCGA-O8-A75V-01A	76cc9c06-0827-465e-bab3-5f4115295ebe	Adenomas and Adenocarcinomas	76cc9c06-0827-465e-bab3-5f4115295ebe	TCGA-O8-A75V	Liver and intrahepatic bile ducts	Not Reported	not reported	male	hispanic or latino	Alive	54.0	-19850.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	908d67b1-6836-521b-94a0-23d4ff8f2ccb	O8	Saint Mary's Health Care	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	538.0	19850.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	19850.0	54.38356164383562	['6960831a-8c7c-5731-83cb-a7e2f12a6794', 'ca0b871f-8094-5d0b-b5a9-90b31607d57a']	['TCGA-O8-A75V_treatment', 'TCGA-O8-A75V_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:32.276495-05:00']	['2019-07-31T21:04:33.491842-05:00', '2019-07-31T21:04:33.491842-05:00']	['released', 'released']	01	Primary	2953eefa-b97d-4328-90e1-5f991e2c2713	Primary Tumor	Not Reported	142.0	270.0	OCT	F3642560-1DE2-43D1-A8B5-06308AFF325E	true	Solid Tissue	False	Tumor
TCGA-KR-A7K7-01A	7ba3d8f1-0c26-4c49-8d6b-0f2875b58daf	Adenomas and Adenocarcinomas	7ba3d8f1-0c26-4c49-8d6b-0f2875b58daf	TCGA-KR-A7K7	Liver and intrahepatic bile ducts	Not Reported	white	female	not reported	Alive	61.0	-22587.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	72165b47-b0b5-5107-b0be-b5a74bc3e249	KR	University Of Michigan	Liver hepatocellular carcinoma	NCH																Not Reported	Stage II	0.0	not reported	Liver	951.0	22587.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22587.0	61.88219178082192	['a0a8f6ce-d47f-5e22-b66d-a4e05fde74d6', 'c186a898-6f36-5160-bb94-1025065712df']	['TCGA-KR-A7K7_treatment', 'TCGA-KR-A7K7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:21:44.534476-05:00']	['2019-07-31T21:04:49.065503-05:00', '2019-07-31T21:04:49.065503-05:00']	['released', 'released']	01	Primary	f178cc5c-525a-418b-a868-fa6e7c50947c	Primary Tumor	Not Reported	461.0	140.0	Unknown	8CE97410-9210-4B15-97FE-E61722535975	false	Solid Tissue	False	Tumor
TCGA-DD-A118-01A	7d914d07-f250-4c7a-8fa2-df14e708936e	Adenomas and Adenocarcinomas	7d914d07-f250-4c7a-8fa2-df14e708936e	TCGA-DD-A118	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28406.0	1926.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	3437.0	28406.0	Hepatocellular carcinoma, NOS	no	2003.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	28406.0	77.82465753424657	['0b306b4e-2d9f-5afb-bf41-c0c766add590', '710010be-4a63-50b9-8129-2aca8f7ffbb3']	['TCGA-DD-A118_treatment', 'TCGA-DD-A118_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:49.279844-05:00']	['2019-07-31T21:04:55.158157-05:00', '2019-07-31T21:04:55.158157-05:00']	['released', 'released']	01	Primary	b1da5474-3d42-433c-918e-22cb5c353a13	Primary Tumor	Not Reported	2854.0	30.0	Unknown	74D4EB64-F12B-470D-8A7C-EDD24CD1448D	false	Solid Tissue	False	Tumor
TCGA-DD-A118-11A	7d914d07-f250-4c7a-8fa2-df14e708936e	Adenomas and Adenocarcinomas	7d914d07-f250-4c7a-8fa2-df14e708936e	TCGA-DD-A118	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28406.0	1926.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	3437.0	28406.0	Hepatocellular carcinoma, NOS	no	2003.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	28406.0	77.82465753424657	['0b306b4e-2d9f-5afb-bf41-c0c766add590', '710010be-4a63-50b9-8129-2aca8f7ffbb3']	['TCGA-DD-A118_treatment', 'TCGA-DD-A118_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:21:49.279844-05:00']	['2019-07-31T21:04:55.158157-05:00', '2019-07-31T21:04:55.158157-05:00']	['released', 'released']	11	Not Applicable	ba0e5d15-cdac-4fc0-97e7-ef81d921d5d4	Solid Tissue Normal	Not Reported	2854.0	60.0	Unknown		false	Solid Tissue	False	Normal
TCGA-ES-A2HT-11A	7dd3bda9-3a0a-46fa-b052-a6d24b847804	Adenomas and Adenocarcinomas	7dd3bda9-3a0a-46fa-b052-a6d24b847804	TCGA-ES-A2HT	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	54.0	-20023.0	1953.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	29bb87f7-7e08-54b6-9bf8-b321a9926f80	ES	University of Florida	Liver hepatocellular carcinoma	NCH	438.0															No	Stage I	0.0	not reported	Liver		20023.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20023.0	54.85753424657534	['08db6312-9201-5583-a74b-4d2de4bd4a12', 'db905dbf-466d-588c-b59a-20d6893aba0c']	['TCGA-ES-A2HT_treatment', 'TCGA-ES-A2HT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:21:51.524564-05:00']	['2019-07-31T21:04:58.088352-05:00', '2019-07-31T21:04:58.088352-05:00']	['released', 'released']	11	Not Applicable	723a470f-6855-409a-aad4-d6b933313239	Solid Tissue Normal	Not Reported	1392.0	430.0	OCT		true	Solid Tissue	False	Normal
TCGA-ES-A2HT-01A	7dd3bda9-3a0a-46fa-b052-a6d24b847804	Adenomas and Adenocarcinomas	7dd3bda9-3a0a-46fa-b052-a6d24b847804	TCGA-ES-A2HT	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Dead	54.0	-20023.0	1953.0	2008.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	29bb87f7-7e08-54b6-9bf8-b321a9926f80	ES	University of Florida	Liver hepatocellular carcinoma	NCH	438.0															No	Stage I	0.0	not reported	Liver		20023.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20023.0	54.85753424657534	['08db6312-9201-5583-a74b-4d2de4bd4a12', 'db905dbf-466d-588c-b59a-20d6893aba0c']	['TCGA-ES-A2HT_treatment', 'TCGA-ES-A2HT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:21:51.524564-05:00']	['2019-07-31T21:04:58.088352-05:00', '2019-07-31T21:04:58.088352-05:00']	['released', 'released']	01	Primary	9b68c72d-30d4-4a7a-ade7-a2bde50a84f2	Primary Tumor	Not Reported	1392.0	340.0	OCT	FF97C711-0686-480B-BC53-3CADCAA4C4C1	true	Solid Tissue	False	Tumor
TCGA-ED-A8O6-01A	7fb03840-5153-4dc6-a302-5a89aa4e1fb6	Adenomas and Adenocarcinomas	7fb03840-5153-4dc6-a302-5a89aa4e1fb6	TCGA-ED-A8O6	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	50.0	-18572.0	1963.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH	56.0															No	Stage IIIA	0.0	not reported	Liver	6.0	18572.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18572.0	50.88219178082192	['53927004-1a4e-53ec-a641-8fd8d9bd8555', '7f8ef37b-e29c-53a0-9f19-378b555ce2ca']	['TCGA-ED-A8O6_treatment_1', 'TCGA-ED-A8O6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:21:58.682851-05:00', '']	['2019-07-31T21:05:08.228133-05:00', '2019-07-31T21:05:08.228133-05:00']	['released', 'released']	01	Primary	7c3d43a4-d7b7-4988-8195-fbfcd14592fc	Primary Tumor	Not Reported	97.0	1030.0	OCT	0ABB9050-0248-42F0-AFEB-98FA5CE2DD55	true	Solid Tissue	False	Tumor
TCGA-2Y-A9H4-01A	801b1d2c-eb6f-4eef-a00b-83da939d755a	Adenomas and Adenocarcinomas	801b1d2c-eb6f-4eef-a00b-83da939d755a	TCGA-2Y-A9H4	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	68.0	-25096.0	1942.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1452.0	25096.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	25096.0	68.75616438356164	['5c4fd3b0-bb1b-5bd3-a607-0586402bf814', 'a8031b16-1b06-5f50-b2f5-39b6ff71f2c9']	['TCGA-2Y-A9H4_treatment', 'TCGA-2Y-A9H4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:03.678879-05:00']	['2019-07-31T21:05:13.793070-05:00', '2019-07-31T21:05:13.793070-05:00']	['released', 'released']	01	Primary	c53e6fd9-76e1-44c3-af36-d1d0dfc2802a	Primary Tumor	Not Reported	1210.0	100.0	OCT	8A93B07B-8DCC-4DF4-B792-212C80E203FB	true	Solid Tissue	False	Tumor
TCGA-DD-A4NJ-01A	815dffb0-0c22-4e05-868c-26e6c553980a	Adenomas and Adenocarcinomas	815dffb0-0c22-4e05-868c-26e6c553980a	TCGA-DD-A4NJ	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	54.0	-19964.0	1957.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	928.0	19964.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19964.0	54.6958904109589	['789d2746-dff2-5737-9ece-9e85c270fc5d', 'c0830ea5-192e-5c5b-91d7-7f5fdde768b1']	['TCGA-DD-A4NJ_treatment_1', 'TCGA-DD-A4NJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:13.188955-05:00', '']	['2019-07-31T21:05:25.704480-05:00', '2019-07-31T21:05:25.704480-05:00']	['released', 'released']	01	Primary	9620d434-5aff-4b60-bf5a-f1b80281f608	Primary Tumor	Not Reported	416.0	140.0	OCT	36C3150D-343E-4B3F-A5D7-1AE978246648	true	Solid Tissue	False	Tumor
TCGA-K7-A6G5-01A	81eddcda-0069-4652-9dc6-8aac89cba1ff	Adenomas and Adenocarcinomas	81eddcda-0069-4652-9dc6-8aac89cba1ff	TCGA-K7-A6G5	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	66.0	-24233.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	f9ebb17f-fdca-5a0e-b026-dcb173867634	K7	ABS - Lahey Clinic	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	512.0	24233.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	24233.0	66.3917808219178	['3acc798f-a10a-515b-918f-f34263e34ea3', 'f5edbb6f-1b63-5fa1-a866-55ae945deb71']	['TCGA-K7-A6G5_treatment_1', 'TCGA-K7-A6G5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:15.522360-05:00', '']	['2019-07-31T21:05:28.883770-05:00', '2019-07-31T21:05:28.883770-05:00']	['released', 'released']	01	Primary	63a726a2-46cd-48dc-bab7-195b16fb0f25	Primary Tumor	Not Reported	31.0	60.0	OCT	BA14915C-0D72-4A11-AAFA-DD51FC6309B2	true	Solid Tissue	False	Tumor
TCGA-DD-AACS-01A	82d6268a-de59-4a14-abd2-7492178fa5bd	Adenomas and Adenocarcinomas	82d6268a-de59-4a14-abd2-7492178fa5bd	TCGA-DD-AACS	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	39.0	-14473.0	1970.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1804.0	14473.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	14473.0	39.652054794520545	['30a8fd73-f7ed-51dd-85a3-1343ef2224b5', 'a8e09b62-cb42-59b4-8f91-28030aa6cf46']	['TCGA-DD-AACS_treatment_1', 'TCGA-DD-AACS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:17.954357-05:00', '']	['2019-07-31T21:05:31.685110-05:00', '2019-07-31T21:05:31.685110-05:00']	['released', 'released']	01	Primary	87bac135-bc68-4ced-bc5f-f36699c593c9	Primary Tumor	Not Reported	1532.0	20.0	OCT	EA952B6F-851C-4675-A933-80325945E7EC	true	Solid Tissue	False	Tumor
TCGA-G3-A7M5-01A	869f8a17-bced-4002-bd60-99df84a03b93	Adenomas and Adenocarcinomas	869f8a17-bced-4002-bd60-99df84a03b93	TCGA-G3-A7M5	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	76.0	-27963.0	1937.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	447.0	27963.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	27963.0	76.6109589041096	['b5083b7e-110d-5bf0-846c-e008d2dc55b6', 'b671e081-1e0a-5eb2-b819-eb55d371067f']	['TCGA-G3-A7M5_treatment', 'TCGA-G3-A7M5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:25.390983-05:00']	['2019-07-31T21:05:40.692365-05:00', '2019-07-31T21:05:40.692365-05:00']	['released', 'released']	01	Primary	738d9234-646f-431b-8ee3-661d2b3ca23b	Primary Tumor	Not Reported	217.0	720.0	OCT	9441C376-F0CE-4A84-A9C0-5FB1917216F2	true	Solid Tissue	False	Tumor
TCGA-ED-A7PZ-01A	87750e70-3af7-452a-9aa5-375acd3843ea	Adenomas and Adenocarcinomas	87750e70-3af7-452a-9aa5-375acd3843ea	TCGA-ED-A7PZ	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	61.0	-22601.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	6.0	22601.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	22601.0	61.92054794520548	['1869b0a5-847b-531c-8e07-80b6b12aba2f', '1a38ed35-9106-5001-af73-9e3f4c4d3a32']	['TCGA-ED-A7PZ_treatment_1', 'TCGA-ED-A7PZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:30.148874-05:00', '']	['2019-07-31T21:05:46.828768-05:00', '2019-07-31T21:05:46.828768-05:00']	['released', 'released']	01	Primary	6931e9f2-8dae-45cf-9fa3-dee9d629472a	Primary Tumor	Not Reported	78.0	1350.0	OCT	85F0B753-BB67-4836-92DC-81F602C0CC8C	true	Solid Tissue	False	Tumor
TCGA-DD-AACU-01A	88b6181c-1086-42df-8bb9-1069ec2dc675	Adenomas and Adenocarcinomas	88b6181c-1086-42df-8bb9-1069ec2dc675	TCGA-DD-AACU	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	59.0	-21606.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1567.0	21606.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21606.0	59.1945205479452	['3401be0d-e68b-59d4-9989-8b503b3ca74a', '7273b719-b04c-5246-8923-7a30e2bf4650']	['TCGA-DD-AACU_treatment_1', 'TCGA-DD-AACU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:22:39.651562-05:00', '']	['2019-07-31T21:05:58.902029-05:00', '2019-07-31T21:05:58.902029-05:00']	['released', 'released']	01	Primary	c43a96b1-db0b-481c-8d94-46155dc7cdda	Primary Tumor	Not Reported	1272.0	40.0	OCT	3CA9651B-35BE-4D1E-9C91-BF3029931F32	true	Solid Tissue	False	Tumor
TCGA-DD-AADR-01A	899d8ea5-49dc-4970-8848-ea6ea088a272	Adenomas and Adenocarcinomas	899d8ea5-49dc-4970-8848-ea6ea088a272	TCGA-DD-AADR	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	58.0	-21217.0	1951.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2028.0	21217.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21217.0	58.12876712328767	['28b2a771-2712-5e7e-ad03-86fcf134db66', 'e5953b63-a8c6-5e04-b722-2cb794f9ee92']	['TCGA-DD-AADR_treatment', 'TCGA-DD-AADR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:22:44.258889-05:00']	['2019-07-31T21:06:04.769564-05:00', '2019-07-31T21:06:04.769564-05:00']	['released', 'released']	01	Primary	44b29302-be2e-4e06-864a-44df6155250b	Primary Tumor	Not Reported	1754.0	90.0	OCT	1037C8D1-A07D-4FEA-84AF-364335AC37E9	true	Solid Tissue	False	Tumor
TCGA-FV-A496-01A	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	Adenomas and Adenocarcinomas	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	TCGA-FV-A496	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	84.0	-30950.0	1928.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	10.0	30950.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	30950.0	84.79452054794521	['d0250ac6-0b30-50f2-86e0-0ef22407445a', 'df7ace6e-3758-508b-bb6d-532bc4a24240']	['TCGA-FV-A496_treatment', 'TCGA-FV-A496_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:22:51.212088-05:00']	['2019-07-31T21:06:14.558460-05:00', '2019-07-31T21:06:14.558460-05:00']	['released', 'released']	01	Primary	fd1e3b28-c143-4ef6-a699-3a61cb20a5ed	Primary Tumor	Not Reported	51.0	70.0	Unknown	358A0018-5731-45D3-97B8-502A3BF95FA8	false	Solid Tissue	False	Tumor
TCGA-CC-A3M9-01A	8e938868-d992-47c4-becb-93b0f7fffe07	Adenomas and Adenocarcinomas	8e938868-d992-47c4-becb-93b0f7fffe07	TCGA-CC-A3M9	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	45.0	-16460.0	1966.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	300.0															No	Stage IIIA	0.0	not reported	Liver	3.0	16460.0	Hepatocellular carcinoma, spindle cell variant	no	2011.0	No	7th	T3	8173/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16460.0	45.0958904109589	['115fc97c-4a0d-528f-bf70-cc2ef6821a9b', '96dee378-438a-54f2-93f0-de542831335d']	['TCGA-CC-A3M9_treatment', 'TCGA-CC-A3M9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:01.049162-05:00']	['2019-07-31T21:06:26.999495-05:00', '2019-07-31T21:06:26.999495-05:00']	['released', 'released']	01	Primary	3319fcfb-a070-403e-bb86-cfd0d6da68e6	Primary Tumor	Not Reported	226.0	200.0	OCT	9529CF47-D435-4CA9-B8B4-069CA2FCD3CD	true	Solid Tissue	False	Tumor
TCGA-UB-A7MF-01A	8eef926b-f316-4fdb-b84a-262010258feb	Adenomas and Adenocarcinomas	8eef926b-f316-4fdb-b84a-262010258feb	TCGA-UB-A7MF	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	56.0	-20815.0	1957.0	2013.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH	214.0															Not Reported	Stage IIIA	0.0	not reported	Liver		20815.0	Hepatocellular carcinoma, NOS	yes	2013.0	No	7th	T3a	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	20815.0	57.02739726027397	['34a73d5a-76ad-5095-86ad-1c70dcf6688e', 'ba7e49e6-14b8-51d0-bbce-7d1d74b79a48']	['TCGA-UB-A7MF_treatment', 'TCGA-UB-A7MF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:03.570865-05:00']	['2019-07-31T21:06:30.386671-05:00', '2019-07-31T21:06:30.386671-05:00']	['released', 'released']	01	Primary	d421eeed-621f-4137-9d3f-1e06c8eb9606	Primary Tumor	Not Reported	240.0	380.0	OCT	7A3E5345-5272-4D82-8E97-40CCE9BAF330	true	Solid Tissue	False	Tumor
TCGA-ZP-A9CV-01A	91909c63-debc-42ad-b4be-56870195bdcb	Adenomas and Adenocarcinomas	91909c63-debc-42ad-b4be-56870195bdcb	TCGA-ZP-A9CV	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	59.0	-21633.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9063dd32-2419-5b6e-a800-67ea5f1f71f4	ZP	Medical College of Wisconsin	Liver hepatocellular carcinoma	NCH	1088.0															No		0.0	not reported	Liver	142.0	21633.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21633.0	59.26849315068493	['8dfd1467-49e5-5604-9622-d776631c7d2d', 'c491f678-c6b6-5906-9982-822e9767a83b']	['TCGA-ZP-A9CV_treatment', 'TCGA-ZP-A9CV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:08.585567-05:00']	['2019-07-31T21:06:36.114243-05:00', '2019-07-31T21:06:36.114243-05:00']	['released', 'released']	01	Primary	c8c067a3-f48a-4b5d-bf4c-0e1530618f1b	Primary Tumor	Not Reported	955.0	40.0	Unknown	382219F6-24AD-49BD-96D1-FC7A9B2CDFDB	false	Solid Tissue	False	Tumor
TCGA-3K-AAZ8-01A	94e387ae-b641-4e9f-bb53-22c7b2a9cccb	Adenomas and Adenocarcinomas	94e387ae-b641-4e9f-bb53-22c7b2a9cccb	TCGA-3K-AAZ8	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	65.0	-24046.0	1948.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	b7e5500b-b955-5cde-a867-d96d6a24bac9	3K	Boston Medical Center	Liver hepatocellular carcinoma	NCH																No	Stage IIIB	0.0	not reported	Liver	396.0	24046.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3b	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	24046.0	65.87945205479453	['0ab80814-8341-572a-8c39-3dc87adb2cc6', 'f1a89da8-55ec-5c61-bc52-3aa77be5e07d']	['TCGA-3K-AAZ8_treatment_1', 'TCGA-3K-AAZ8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:23:21.219676-05:00', '']	['2019-07-31T21:06:51.006194-05:00', '2019-07-31T21:06:51.006194-05:00']	['released', 'released']	01	Primary	bb485b2f-3a35-41e1-81b8-d6b0ba4f8a64	Primary Tumor	Not Reported	65.0	230.0	OCT	61B69388-FA7E-4AE5-A3F5-104BCE12284F	true	Solid Tissue	False	Tumor
TCGA-2Y-A9GS-01A	95b97198-1a1b-4f01-90f3-6c66638371d1	Adenomas and Adenocarcinomas	95b97198-1a1b-4f01-90f3-6c66638371d1	TCGA-2Y-A9GS	Liver and intrahepatic bile ducts	Not Reported	white	male	hispanic or latino	Dead	58.0	-21318.0	1948.0	2007.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH	724.0															No		0.0	not reported	Liver		21318.0	Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T2	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	21318.0	58.40547945205479	['c742cca9-d6d7-55c5-a8ab-c40287db9781', 'ec926521-7362-5d69-a254-637fb819657a']	['TCGA-2Y-A9GS_treatment_1', 'TCGA-2Y-A9GS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:23:28.813942-05:00', '']	['2019-07-31T21:06:59.809221-05:00', '2019-07-31T21:06:59.809221-05:00']	['released', 'released']	01	Primary	6ffc6d98-5f3c-4672-a390-98e0076d3e5a	Primary Tumor	Not Reported	2558.0	80.0	OCT	DAA3D158-0488-41C9-8B3F-BE6D05E036D8	true	Solid Tissue	False	Tumor
TCGA-DD-AADP-01A	96d42ecc-1157-453a-9661-9248ddf8f273	Adenomas and Adenocarcinomas	96d42ecc-1157-453a-9661-9248ddf8f273	TCGA-DD-AADP	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	45.0	-16760.0	1968.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	458.0	16760.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16760.0	45.917808219178085	['1c57bace-752c-543a-88b5-96c303ea66e3', '8e7bf341-3c97-5f33-a9c1-281bfd65de31']	['TCGA-DD-AADP_treatment', 'TCGA-DD-AADP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:23:31.311650-05:00']	['2019-07-31T21:07:02.885288-05:00', '2019-07-31T21:07:02.885288-05:00']	['released', 'released']	01	Primary	de29419c-e3db-4c0a-b2bc-1d73154e1e32	Primary Tumor	Not Reported	161.0	20.0	OCT	11B44F97-2332-4CB7-B57C-063B1C6127EF	true	Solid Tissue	False	Tumor
TCGA-DD-A116-01A	994347ba-3045-4ade-926f-06420fbd906c	Adenomas and Adenocarcinomas	994347ba-3045-4ade-926f-06420fbd906c	TCGA-DD-A116	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	68.0	-24934.0	1934.0	2006.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1622.0															No	Stage IIIA	0.0	not reported	Liver		24934.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24934.0	68.31232876712329	['16348e68-4add-5b48-bff1-036b32d33c06', '33576c92-165e-577c-bb0d-2fc2ad6b163d']	['TCGA-DD-A116_treatment_1', 'TCGA-DD-A116_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'yes']	['2019-04-28T13:23:36.515959-05:00', '']	['2019-07-31T21:07:08.601248-05:00', '2019-07-31T21:07:08.601248-05:00']	['released', 'released']	01	Primary	6be74119-a0bf-4f76-93b3-2433d07ce0d1	Primary Tumor	Not Reported	3208.0	170.0	Unknown	0914680E-B846-4370-920D-FEB06F609EE5	false	Solid Tissue	False	Tumor
TCGA-DD-A116-11A	994347ba-3045-4ade-926f-06420fbd906c	Adenomas and Adenocarcinomas	994347ba-3045-4ade-926f-06420fbd906c	TCGA-DD-A116	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	68.0	-24934.0	1934.0	2006.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	1622.0															No	Stage IIIA	0.0	not reported	Liver		24934.0	Hepatocellular carcinoma, NOS	no	2002.0	No	5th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24934.0	68.31232876712329	['16348e68-4add-5b48-bff1-036b32d33c06', '33576c92-165e-577c-bb0d-2fc2ad6b163d']	['TCGA-DD-A116_treatment_1', 'TCGA-DD-A116_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'yes']	['2019-04-28T13:23:36.515959-05:00', '']	['2019-07-31T21:07:08.601248-05:00', '2019-07-31T21:07:08.601248-05:00']	['released', 'released']	11	Not Applicable	bb746b3c-ef5d-405c-96c3-876207a965a2	Solid Tissue Normal	Not Reported	3208.0	170.0	Unknown		false	Solid Tissue	False	Normal
TCGA-NI-A4U2-01A	9aea3437-572a-48c6-beb9-9bdbcb243875	Adenomas and Adenocarcinomas	9aea3437-572a-48c6-beb9-9bdbcb243875	TCGA-NI-A4U2	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	71.0	-26011.0	1934.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	1ba22d72-8f0f-55c1-a40a-1d56ddb5f5a6	NI	Roswell Park	Liver hepatocellular carcinoma	NCH	1791.0															No	Stage IIIA	0.0	not reported	Liver		26011.0	Hepatocellular carcinoma, NOS	no	2005.0	No	6th	T3	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	26011.0	71.26301369863013	['2c3f0efd-5aec-5ebd-9ce2-66d25cef1a10', 'dc2353bf-0a54-597d-aadb-0b4a62c49b84']	['TCGA-NI-A4U2_treatment', 'TCGA-NI-A4U2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'yes']	['', '2019-04-28T13:23:41.353049-05:00']	['2019-07-31T21:07:14.002498-05:00', '2019-07-31T21:07:14.002498-05:00']	['released', 'released']	01	Primary	83e8cddf-0a86-4fed-96ea-0ea1c39ceec5	Primary Tumor	Not Reported	2802.0	320.0	Unknown	3AC56788-7CF9-4E6E-B1B8-7620A33E32A0	false	Solid Tissue	False	Tumor
TCGA-ED-A627-01A	a4af0084-edd4-4dcd-8975-4a59ee5da64c	Adenomas and Adenocarcinomas	a4af0084-edd4-4dcd-8975-4a59ee5da64c	TCGA-ED-A627	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	74.0	-27303.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	423.0	27303.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	27303.0	74.8027397260274	['a9820c81-226b-5ae1-8a94-9657a11f0df8', 'bf004a07-4655-514c-9971-db3c6719e3d1']	['TCGA-ED-A627_treatment_1', 'TCGA-ED-A627_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:04.488729-05:00', '']	['2019-07-31T21:07:40.315194-05:00', '2019-07-31T21:07:40.315194-05:00']	['released', 'released']	01	Primary	975ec176-7f4a-4bf2-85ea-df821b23865c	Primary Tumor	Not Reported	157.0	1140.0	OCT	104D5D1C-E6E3-4806-9E6C-4C949865F713	true	Solid Tissue	False	Tumor
TCGA-DD-A1EK-01A	a5e4412b-0e49-4d86-9cce-71f440a84048	Adenomas and Adenocarcinomas	a5e4412b-0e49-4d86-9cce-71f440a84048	TCGA-DD-A1EK	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23437.0	1944.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	558.0															No	Stage IVB	0.0	not reported	Liver		23437.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T4	8170/3	N0	M1	not reported	C22.0	Liver	Not Reported	not reported	23437.0	64.21095890410959	['21a3360f-2df3-53b6-8eda-dadfce3485b4', 'd0922097-f988-5994-bcc0-5d42595d001b']	['TCGA-DD-A1EK_treatment', 'TCGA-DD-A1EK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:24:07.960273-05:00']	['2019-07-31T21:07:43.524367-05:00', '2019-07-31T21:07:43.524367-05:00']	['released', 'released']	01	Primary	71ccf91a-f2af-4c6b-a22f-769f4cc96163	Primary Tumor	Not Reported	819.0	40.0	OCT	AE199A35-2585-4363-8896-9B55B12C1BDF	true	Solid Tissue	False	Tumor
TCGA-CC-5263-01A	a6af3061-1484-4f6c-bb4b-c8f4626b4161	Adenomas and Adenocarcinomas	a6af3061-1484-4f6c-bb4b-c8f4626b4161	TCGA-CC-5263	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	35.0	-12863.0	1975.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	129.0															No	Stage IIIA	0.0	not reported	Liver		12863.0	Hepatocellular carcinoma, NOS	no	2010.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	12863.0	35.24109589041096	['1ba0ee0e-74ce-5078-acf9-ab101d3e9b88', '4aa27359-8ced-561f-94ca-7dfd1d08594d']	['TCGA-CC-5263_treatment_1', 'TCGA-CC-5263_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:19.869068-05:00', '']	['2019-07-31T21:07:59.116946-05:00', '2019-07-31T21:07:59.116946-05:00']	['released', 'released']	01	Primary	efa9f768-cc58-4ce4-a47a-ed598797adc8	Primary Tumor	Not Reported	91.0	900.0	OCT	3136CA38-995E-4B6B-97F2-D37AF68EFA4C	true	Solid Tissue	False	Tumor
TCGA-CC-A7II-01A	aaf7c9b5-6cb7-42bf-a0d1-07975eae3be9	Adenomas and Adenocarcinomas	aaf7c9b5-6cb7-42bf-a0d1-07975eae3be9	TCGA-CC-A7II	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	54.0	-20079.0	1959.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	399.0	20079.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	20079.0	55.010958904109586	['f5133737-814c-527c-9fd0-effe1f860b03', 'fb8d3e2a-ac3f-5dce-b9fc-d0a35d046c51']	['TCGA-CC-A7II_treatment', 'TCGA-CC-A7II_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:24:32.412994-05:00']	['2019-07-31T21:08:13.770641-05:00', '2019-07-31T21:08:13.770641-05:00']	['released', 'released']	01	Primary	ad384cc4-8444-419f-a2e7-27dfc417ea82	Primary Tumor	Not Reported	169.0	400.0	OCT	A5E3C73D-B84B-4D1C-858F-4B4392341610	true	Solid Tissue	False	Tumor
TCGA-DD-AACE-01A	abbcf6bd-4683-45ac-947a-51ae6ef0a244	Adenomas and Adenocarcinomas	abbcf6bd-4683-45ac-947a-51ae6ef0a244	TCGA-DD-AACE	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	62.0	-22727.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	2184.0	22727.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22727.0	62.26575342465753	['794c6aa2-f140-5ab4-afb7-a02703b1a712', '928d50e2-1df7-5d90-bb4b-68bd02e78ad2']	['TCGA-DD-AACE_treatment_1', 'TCGA-DD-AACE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:37.376029-05:00', '']	['2019-07-31T21:08:22.037128-05:00', '2019-07-31T21:08:22.037128-05:00']	['released', 'released']	01	Primary	ffaf08d5-9193-45f3-91b3-b32a78dd6724	Primary Tumor	Not Reported	1973.0	170.0	OCT	63AE7F04-F180-486A-89FB-6E509AF91E0B	true	Solid Tissue	False	Tumor
TCGA-DD-AAEA-01A	ad9657aa-34e9-48b1-ba63-916fe7bd14bb	Adenomas and Adenocarcinomas	ad9657aa-34e9-48b1-ba63-916fe7bd14bb	TCGA-DD-AAEA	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	65.0	-24027.0	1947.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	575.0	24027.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24027.0	65.82739726027397	['ba385f27-7380-5226-bb93-9e6946edc638', 'd6b0f9dc-90a8-5fee-ab5d-4b605add8d74']	['TCGA-DD-AAEA_treatment_1', 'TCGA-DD-AAEA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:24:44.619517-05:00', '']	['2019-07-31T21:08:30.962157-05:00', '2019-07-31T21:08:30.962157-05:00']	['released', 'released']	01	Primary	3bf98906-2844-4070-9deb-3a792f19281b	Primary Tumor	Not Reported	461.0	50.0	OCT	E793074A-8F17-4698-9D99-BA2053E8E3C3	true	Solid Tissue	False	Tumor
TCGA-DD-A3A0-01A	ae99d9fd-1735-4217-b4ef-33b377fbd594	Adenomas and Adenocarcinomas	ae99d9fd-1735-4217-b4ef-33b377fbd594	TCGA-DD-A3A0	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	70.0	-25889.0	1931.0	2003.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	785.0															No	Stage I	0.0	not reported	Liver		25889.0	Hepatocellular carcinoma, NOS	no	2001.0	No	5th	T1	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	25889.0	70.92876712328767	['853c03e9-56a2-5fd8-a3de-2713d3ec4ea1', 'ce753f2d-7ed5-50f1-b690-8c273df6ffce']	['TCGA-DD-A3A0_treatment', 'TCGA-DD-A3A0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:24:49.516429-05:00']	['2019-07-31T21:08:36.858758-05:00', '2019-07-31T21:08:36.858758-05:00']	['released', 'released']	01	Primary	ef575b18-0cd6-40f0-ac36-076347748a05	Primary Tumor	Not Reported	3586.0	220.0	Unknown	C9E146D4-77FF-4877-8DA6-2E5D912F33C6	false	Solid Tissue	False	Tumor
TCGA-DD-AADD-01A	b44f664c-444c-4c64-a407-52fd9b55f178	Adenomas and Adenocarcinomas	b44f664c-444c-4c64-a407-52fd9b55f178	TCGA-DD-AADD	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18752.0	1960.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1231.0	18752.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18752.0	51.37534246575343	['3f44ef01-acec-5924-a81a-488d25fd090a', 'f15f1f24-0a27-5b52-bc11-4be3af5ae3a5']	['TCGA-DD-AADD_treatment', 'TCGA-DD-AADD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:08.549315-05:00']	['2019-07-31T21:09:01.339636-05:00', '2019-07-31T21:09:01.339636-05:00']	['released', 'released']	01	Primary	e5819156-d6d0-4295-9787-65ab37c3d900	Primary Tumor	Not Reported	931.0	30.0	OCT	DCDE4D46-AB4E-4C21-9F01-35A304FFF8D5	true	Solid Tissue	False	Tumor
TCGA-G3-A3CI-01A	b5465221-78fe-40a8-abec-bed600602dd4	Adenomas and Adenocarcinomas	b5465221-78fe-40a8-abec-bed600602dd4	TCGA-G3-A3CI	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	71.0	-26224.0	1940.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	180.0	26224.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	26224.0	71.84657534246575	['287ea99f-1ade-57e8-b11c-a94d9d8da37e', '8f72d4f6-26d8-56ee-a3f1-1ebe2bc832cd']	['TCGA-G3-A3CI_treatment', 'TCGA-G3-A3CI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['not reported', 'not reported']	['', '2019-04-28T13:25:11.094621-05:00']	['2019-07-31T21:09:04.193003-05:00', '2019-07-31T21:09:04.193003-05:00']	['released', 'released']	01	Primary	2c1ac52f-293b-4cc1-9c90-2870cc4b14e1	Primary Tumor	Not Reported	258.0	370.0	Unknown	42613B77-F014-4AE9-AEF8-C5E632125EFA	false	Solid Tissue	False	Tumor
TCGA-DD-AACG-01A	b5bef77a-f46c-406c-9aa8-55f7a61aa885	Adenomas and Adenocarcinomas	b5bef77a-f46c-406c-9aa8-55f7a61aa885	TCGA-DD-AACG	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Dead	52.0	-19174.0	1956.0	2009.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	469.0															No	Stage II	0.0	not reported	Liver		19174.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	19174.0	52.53150684931507	['46ba92d5-c58a-5037-a9a5-40ed42f6824d', '4cfa4385-9fd1-5eef-b183-1a2a99017762']	['TCGA-DD-AACG_treatment_1', 'TCGA-DD-AACG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:15.967491-05:00', '']	['2019-07-31T21:09:10.319924-05:00', '2019-07-31T21:09:10.319924-05:00']	['released', 'released']	01	Primary	503cf010-40b3-41b0-b4e9-5ca06b5afb95	Primary Tumor	Not Reported	1931.0	280.0	OCT	8B0FA2B9-F484-4D9C-AFAE-BDD90DA6A7A8	true	Solid Tissue	False	Tumor
TCGA-G3-A25S-01A	b865dec4-f051-4fbe-9405-f832ff2010d7	Adenomas and Adenocarcinomas	b865dec4-f051-4fbe-9405-f832ff2010d7	TCGA-G3-A25S	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	64.0	-23571.0	1945.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH	416.0															No	Stage I	0.0	not reported	Liver	37.0	23571.0	Hepatocellular carcinoma, NOS	no	2009.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23571.0	64.57808219178082	['3ff77e6b-c7e2-5b2f-a2ff-e61ae61f637b', 'ceaa1e19-f566-562d-af6c-b917e13be20d']	['TCGA-G3-A25S_treatment_1', 'TCGA-G3-A25S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'yes']	['2019-04-28T13:25:26.158600-05:00', '']	['2019-07-31T21:09:22.416594-05:00', '2019-07-31T21:09:22.416594-05:00']	['released', 'released']	01	Primary	d12be3f6-68bc-4583-9478-fc01a0eb9387	Primary Tumor	Not Reported	707.0	480.0	OCT	F4DAEF13-D4B0-4C12-9617-04878D3FC98D	true	Solid Tissue	False	Tumor
TCGA-DD-AAE8-01A	b929ece7-6caf-4081-83d3-9923306b4a8a	Adenomas and Adenocarcinomas	b929ece7-6caf-4081-83d3-9923306b4a8a	TCGA-DD-AAE8	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	45.0	-16549.0	1967.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	664.0	16549.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	16549.0	45.33972602739726	['13278c1b-edc0-5e87-996e-5ce2263c6d1a', 'b140399e-d1ab-5b12-9e87-1f5ca1f84058']	['TCGA-DD-AAE8_treatment_1', 'TCGA-DD-AAE8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:28.698005-05:00', '']	['2019-07-31T21:09:25.475026-05:00', '2019-07-31T21:09:25.475026-05:00']	['released', 'released']	01	Primary	99fcb09e-a7db-4218-983d-3f6df4872996	Primary Tumor	Not Reported	417.0	20.0	OCT	B94DC39D-E27E-488E-87F3-C1EB76445321	true	Solid Tissue	False	Tumor
TCGA-G3-A25U-01A	b9835dc5-bf31-4541-a973-e8ca802d80ba	Adenomas and Adenocarcinomas	b9835dc5-bf31-4541-a973-e8ca802d80ba	TCGA-G3-A25U	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	63.0	-23207.0	1944.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	addd7b04-91a3-5179-99a5-cbff20df6bb4	G3	Alberta Health Services	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	1636.0	23207.0	Hepatocellular carcinoma, NOS	no	2007.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23207.0	63.58082191780822	['41d65c25-cb42-53db-a40d-eafe1738d0b5', '5ac0628e-eb52-52e1-96bd-218a2b58f815']	['TCGA-G3-A25U_treatment_1', 'TCGA-G3-A25U_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:34.776900-05:00', '']	['2019-07-31T21:09:31.710774-05:00', '2019-07-31T21:09:31.710774-05:00']	['released', 'released']	01	Primary	824e95b4-5d35-4b11-b320-fcf96e78ad10	Primary Tumor	Not Reported	1281.0	350.0	OCT	2781ABF5-FC79-4973-BE15-037BC685FAFC	true	Solid Tissue	False	Tumor
TCGA-FV-A495-01A	bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd	Adenomas and Adenocarcinomas	bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd	TCGA-FV-A495	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	51.0	-18740.0	1961.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	1.0	18740.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	NX	M0	not reported	C22.0	Liver	Not Reported	not reported	18740.0	51.342465753424655	['6fc25754-e068-5055-9415-c5c4998833ea', '9e52e4f0-3539-5983-a4b4-9aad0cf91639']	['TCGA-FV-A495_treatment_1', 'TCGA-FV-A495_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:25:45.197711-05:00', '']	['2019-07-31T21:09:43.519037-05:00', '2019-07-31T21:09:43.519037-05:00']	['released', 'released']	01	Primary	b7fc877d-6055-4a28-bbdf-50ce7236b7bf	Primary Tumor	Not Reported	56.0	70.0	Unknown	99D80D8A-88F7-445D-9B87-9B4B96C3C010	false	Solid Tissue	False	Tumor
TCGA-DD-AAEG-01A	bd627786-31a8-46d9-b3e2-7f489d50f608	Adenomas and Adenocarcinomas	bd627786-31a8-46d9-b3e2-7f489d50f608	TCGA-DD-AAEG	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	59.0	-21853.0	1953.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																Not Reported	Stage I	0.0	not reported	Liver	719.0	21853.0	Hepatocellular carcinoma, NOS	yes	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21853.0	59.87123287671233	['339b26a8-2969-5d11-adf0-79a0cc497852', '41f36242-527f-5e61-b66d-7d5327ea37cc']	['TCGA-DD-AAEG_treatment', 'TCGA-DD-AAEG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:25:47.500702-05:00']	['2019-07-31T21:09:46.405628-05:00', '2019-07-31T21:09:46.405628-05:00']	['released', 'released']	01	Primary	e8159d19-97f4-4690-b60b-40080d1e83eb	Primary Tumor	Not Reported	529.0	20.0	OCT	B48B65B0-92F9-4B49-B8A8-563EA5AF70F1	true	Solid Tissue	False	Tumor
TCGA-UB-A7ME-01A	be1240f0-34dc-4205-b152-c26f11d28462	Adenomas and Adenocarcinomas	be1240f0-34dc-4205-b152-c26f11d28462	TCGA-UB-A7ME	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	51.0	-18846.0	1962.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c	UB	UCSF	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	486.0	18846.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18846.0	51.632876712328766	['094636cb-e5b4-53cc-92e2-48550f94816f', 'd4124cb5-b14a-525b-bda5-34e4e3b91b1b']	['TCGA-UB-A7ME_treatment_1', 'TCGA-UB-A7ME_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:25:49.898495-05:00', '']	['2019-07-31T21:09:49.325896-05:00', '2019-07-31T21:09:49.325896-05:00']	['released', 'released']	01	Primary	e473499a-00c0-47a4-8e1c-feae98a8df32	Primary Tumor	Not Reported	154.0	70.0	OCT	AAC76123-7B45-4C65-A90D-EEE823A0F84B	true	Unknown	False	Tumor
TCGA-CC-A9FV-01A	c4e6527a-8f58-4f6b-93b1-04abb5680ed0	Adenomas and Adenocarcinomas	c4e6527a-8f58-4f6b-93b1-04abb5680ed0	TCGA-CC-A9FV	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	57.0	-21044.0	1956.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	0.0	21044.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21044.0	57.654794520547945	['5065a843-4f2d-55d8-bfa1-8229d1575717', '92dddf8d-d3aa-56fc-aedc-45804a674929']	['TCGA-CC-A9FV_treatment_1', 'TCGA-CC-A9FV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['not reported', 'not reported']	['2019-04-28T13:26:11.469640-05:00', '']	['2019-07-31T21:10:17.801674-05:00', '2019-07-31T21:10:17.801674-05:00']	['released', 'released']	01	Primary	f268bd70-c419-4c38-8513-787aae53f337	Primary Tumor	Not Reported	184.0	420.0	OCT	01A31339-0FAD-4D49-ACD1-E357D32C887B	true	Solid Tissue	False	Tumor
TCGA-DD-AAE4-01A	c797d6ad-05d4-4322-bad2-29801a986b4e	Adenomas and Adenocarcinomas	c797d6ad-05d4-4322-bad2-29801a986b4e	TCGA-DD-AAE4	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	49.0	-18009.0	1964.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	608.0	18009.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	18009.0	49.33972602739726	['613b7601-e6f7-5b22-a7ad-cbbe2291b8fc', 'c0f7f3d0-1c2e-50fe-947d-301159d7bd9d']	['TCGA-DD-AAE4_treatment', 'TCGA-DD-AAE4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:21.297947-05:00']	['2019-07-31T21:10:29.853150-05:00', '2019-07-31T21:10:29.853150-05:00']	['released', 'released']	01	Primary	1cf2d738-51f7-4038-b07d-e66a1995c8ca	Primary Tumor	Not Reported	343.0	30.0	OCT	2DDF43C9-8728-4CD6-977C-ECCE8B0BD322	true	Solid Tissue	False	Tumor
TCGA-CC-5260-01A	ca8afb2c-be3d-41e8-8dbc-19fe7ab6154b	Adenomas and Adenocarcinomas	ca8afb2c-be3d-41e8-8dbc-19fe7ab6154b	TCGA-CC-5260	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	61.0	-22345.0	1949.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH	87.0															No	Stage IIIC	0.0	not reported	Liver	0.0	22345.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T4	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22345.0	61.21917808219178	['040e0320-c2de-55e7-b2be-2893207fe7c9', '5913487a-ec7b-53a2-8f8b-1d1c6736cd0e']	['TCGA-CC-5260_treatment', 'TCGA-CC-5260_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:26:28.814426-05:00']	['2019-07-31T21:10:38.981908-05:00', '2019-07-31T21:10:38.981908-05:00']	['released', 'released']	01	Primary	7f347680-cd4d-4289-8f8f-3b0541381a42	Primary Tumor	Not Reported	105.0	600.0	OCT	2E6A53F8-D019-4B4A-894F-CF21BEE91EDD	true	Solid Tissue	False	Tumor
TCGA-DD-A1EH-01A	cab5b264-abab-4bdb-816e-9d2c0ac30629	Adenomas and Adenocarcinomas	cab5b264-abab-4bdb-816e-9d2c0ac30629	TCGA-DD-A1EH	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	23.0	-8499.0	1985.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage III	0.0	not reported	Liver	1495.0	8499.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	8499.0	23.284931506849315	['111ffd20-041c-55e6-aa1c-f91c980a3dde', '6b5e772d-23b0-5638-bfad-4584009e25be']	['TCGA-DD-A1EH_treatment', 'TCGA-DD-A1EH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:26:31.317589-05:00']	['2019-07-31T21:10:41.939955-05:00', '2019-07-31T21:10:41.939955-05:00']	['released', 'released']	01	Primary	44c98b82-adcb-4597-a9db-83e7d2a0e2f9	Primary Tumor	Not Reported	933.0	220.0	OCT	951E7AFB-F380-4FA8-B213-CB766A60FF5B	true	Solid Tissue	False	Tumor
TCGA-DD-A1EH-11A	cab5b264-abab-4bdb-816e-9d2c0ac30629	Adenomas and Adenocarcinomas	cab5b264-abab-4bdb-816e-9d2c0ac30629	TCGA-DD-A1EH	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	23.0	-8499.0	1985.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage III	0.0	not reported	Liver	1495.0	8499.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	8499.0	23.284931506849315	['111ffd20-041c-55e6-aa1c-f91c980a3dde', '6b5e772d-23b0-5638-bfad-4584009e25be']	['TCGA-DD-A1EH_treatment', 'TCGA-DD-A1EH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'yes']	['', '2019-04-28T13:26:31.317589-05:00']	['2019-07-31T21:10:41.939955-05:00', '2019-07-31T21:10:41.939955-05:00']	['released', 'released']	11	Not Applicable	db3d6662-eebb-4396-93e3-b5f1022c90d2	Solid Tissue Normal	Not Reported	933.0	140.0	OCT		true	Solid Tissue	False	Normal
TCGA-DD-AACZ-01A	cce2bb32-84cb-4991-9628-1ea408a9b11a	Adenomas and Adenocarcinomas	cce2bb32-84cb-4991-9628-1ea408a9b11a	TCGA-DD-AACZ	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Dead	63.0	-23230.0	1947.0	2010.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	171.0															No	Stage I	0.0	not reported	Liver		23230.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	23230.0	63.64383561643836	['e3038a09-6d53-57c0-b427-0ea872d65316', 'e8650e5b-f1bf-5bb0-80d6-c1550c3453f4']	['TCGA-DD-AACZ_treatment_1', 'TCGA-DD-AACZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:41.052005-05:00', '']	['2019-07-31T21:10:53.144557-05:00', '2019-07-31T21:10:53.144557-05:00']	['released', 'released']	01	Primary	b67f0f40-26ed-4fa0-b9b4-94686c48c593	Primary Tumor	Not Reported	1147.0	60.0	OCT	8A8CB301-B3F2-469B-85D3-CAEA5A2F46ED	true	Solid Tissue	False	Tumor
TCGA-ED-A5KG-01A	cebdafee-8ffd-4ee2-8dd1-9225e06623c2	Adenomas and Adenocarcinomas	cebdafee-8ffd-4ee2-8dd1-9225e06623c2	TCGA-ED-A5KG	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	60.0	-22258.0	1952.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4	ED	Asterand	Liver hepatocellular carcinoma	NCH																No	Stage II	0.0	not reported	Liver	854.0	22258.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T2	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	22258.0	60.98082191780822	['616dc2a1-c1d8-5a97-9571-f9f75abdfc00', '61e120d0-3e8b-5d3a-a700-ef8b9107cf34']	['TCGA-ED-A5KG_treatment_1', 'TCGA-ED-A5KG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:26:43.489337-05:00', '']	['2019-07-31T21:10:56.050177-05:00', '2019-07-31T21:10:56.050177-05:00']	['released', 'released']	01	Primary	7e3298d1-7ee0-470d-be0f-fc638ea6c62e	Primary Tumor	Not Reported	112.0	1810.0	OCT	87394A2B-7AF7-49E0-9ED0-6FFCC899EC38	true	Solid Tissue	False	Tumor
TCGA-FV-A2QR-01A	d3a03f7a-3482-4548-957e-05c692b20101	Adenomas and Adenocarcinomas	d3a03f7a-3482-4548-957e-05c692b20101	TCGA-FV-A2QR	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	75.0		1931.0	2007.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	581.0															No	Stage I	0.0	not reported	Liver			Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported			['4e6e64ff-7899-594e-b4bd-a8530a3eb001', '8f1fda03-a220-5915-93db-f1c91371963e']	['TCGA-FV-A2QR_treatment', 'TCGA-FV-A2QR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:00.504498-05:00']	['2019-07-31T21:11:17.469356-05:00', '2019-07-31T21:11:17.469356-05:00']	['released', 'released']	01	Primary	5e6e2c83-3102-4130-98aa-167c8be39120	Primary Tumor	Not Reported	1764.0	100.0	Unknown	DE38B13D-FD4D-4077-ADBE-D034C2F5F003	false	Solid Tissue	False	Tumor
TCGA-FV-A2QR-11A	d3a03f7a-3482-4548-957e-05c692b20101	Adenomas and Adenocarcinomas	d3a03f7a-3482-4548-957e-05c692b20101	TCGA-FV-A2QR	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Dead	75.0		1931.0	2007.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH	581.0															No	Stage I	0.0	not reported	Liver			Hepatocellular carcinoma, NOS	no	2006.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported			['4e6e64ff-7899-594e-b4bd-a8530a3eb001', '8f1fda03-a220-5915-93db-f1c91371963e']	['TCGA-FV-A2QR_treatment', 'TCGA-FV-A2QR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:00.504498-05:00']	['2019-07-31T21:11:17.469356-05:00', '2019-07-31T21:11:17.469356-05:00']	['released', 'released']	11	Not Applicable	7029f596-0988-4b9a-9c87-56fd5ce60ea2	Solid Tissue Normal	Not Reported	1764.0	30.0	Unknown		false	Solid Tissue	False	Normal
TCGA-5R-AA1D-01A	d3d3dba9-139e-4f57-ac70-b741553d1687	Adenomas and Adenocarcinomas	d3d3dba9-139e-4f57-ac70-b741553d1687	TCGA-5R-AA1D	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Alive	17.0	-6545.0	1996.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	9a7a9c39-f289-5594-972a-ff9157a187f0	5R	Proteogenex, Inc	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	449.0	6545.0	Hepatocellular carcinoma, NOS	no	2013.0	No	7th	T3a	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	6545.0	17.931506849315067	['e2a68988-8477-5844-9536-cc65920b4ea6', 'fe3d5b60-a4d4-522b-8e44-7bf02f00ad72']	['TCGA-5R-AA1D_treatment', 'TCGA-5R-AA1D_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['yes', 'no']	['', '2019-04-28T13:27:02.839426-05:00']	['2019-07-31T21:11:20.486652-05:00', '2019-07-31T21:11:20.486652-05:00']	['released', 'released']	01	Primary	4b868f02-7246-49b7-b0bb-4efdded82daa	Primary Tumor	Not Reported	58.0	750.0	Unknown	59A41C0E-AEC6-49E3-BB91-ECFC1F7C4C80	false	Solid Tissue	False	Tumor
TCGA-FV-A2QQ-01A	d680df09-368e-42b5-b540-45c41ed31042	Adenomas and Adenocarcinomas	d680df09-368e-42b5-b540-45c41ed31042	TCGA-FV-A2QQ	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	80.0	-29354.0	1931.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	98428b7d-30e7-5283-b22d-450c17717d09	FV	International Genomics Consortium	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	729.0	29354.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	29354.0	80.42191780821918	['986cf184-7567-579a-8cde-0a913bb22b4c', 'bd23d434-8b58-545f-9f24-c7d6a6ee2747']	['TCGA-FV-A2QQ_treatment', 'TCGA-FV-A2QQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:12.678303-05:00']	['2019-07-31T21:11:32.241305-05:00', '2019-07-31T21:11:32.241305-05:00']	['released', 'released']	01	Primary	a0096af4-abd3-4f6e-a6ac-2cf2e57c7bd9	Primary Tumor	Not Reported	71.0	150.0	Unknown	350B10AF-C17B-41DA-BB21-A672DBB683B2	false	Solid Tissue	False	Tumor
TCGA-DD-AACK-01A	d7cd045a-0be2-4b6d-aefd-5d75e57bc6f6	Adenomas and Adenocarcinomas	d7cd045a-0be2-4b6d-aefd-5d75e57bc6f6	TCGA-DD-AACK	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	70.0	-25796.0	1938.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	9.0	25796.0	Hepatocellular carcinoma, NOS	no	2008.0	No	6th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	25796.0	70.67397260273972	['8d9ebbea-6bdb-54b9-bcbd-4528694b1f5b', 'd9f2b14b-2150-56c6-a8f9-e393a8dc75c5']	['TCGA-DD-AACK_treatment_1', 'TCGA-DD-AACK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:19.864378-05:00', '']	['2019-07-31T21:11:41.436122-05:00', '2019-07-31T21:11:41.436122-05:00']	['released', 'released']	01	Primary	9d81f1db-2a62-4ac1-b7d3-2f7b18f0ec1e	Primary Tumor	Not Reported	1828.0	140.0	OCT	B41B7C44-ED04-46EB-AD41-271456ECA762	true	Solid Tissue	False	Tumor
TCGA-DD-A3A5-01A	d8549d23-37d4-42bd-b472-f49bbebd09b0	Adenomas and Adenocarcinomas	d8549d23-37d4-42bd-b472-f49bbebd09b0	TCGA-DD-A3A5	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24288.0	1930.0	2004.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	3125.0															No	Stage III	0.0	not reported	Liver		24288.0	Hepatocellular carcinoma, NOS	no	1996.0	No	4th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24288.0	66.54246575342465	['07969d69-fdd5-57e2-8fa1-88bcbf5329ef', 'a96d6ef0-33f6-535b-ab02-966bab6a4fa3']	['TCGA-DD-A3A5_treatment', 'TCGA-DD-A3A5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:22.293186-05:00']	['2019-07-31T21:11:44.260967-05:00', '2019-07-31T21:11:44.260967-05:00']	['released', 'released']	01	Primary	2be2966f-d7be-4fb4-bee9-c00c47f7ab69	Primary Tumor	Not Reported	5538.0	250.0	Unknown	646F2FED-EA95-4758-B454-4B0E638553B4	false	Solid Tissue	False	Tumor
TCGA-DD-A3A5-11A	d8549d23-37d4-42bd-b472-f49bbebd09b0	Adenomas and Adenocarcinomas	d8549d23-37d4-42bd-b472-f49bbebd09b0	TCGA-DD-A3A5	Liver and intrahepatic bile ducts	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24288.0	1930.0	2004.0	Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH	3125.0															No	Stage III	0.0	not reported	Liver		24288.0	Hepatocellular carcinoma, NOS	no	1996.0	No	4th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24288.0	66.54246575342465	['07969d69-fdd5-57e2-8fa1-88bcbf5329ef', 'a96d6ef0-33f6-535b-ab02-966bab6a4fa3']	['TCGA-DD-A3A5_treatment', 'TCGA-DD-A3A5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:22.293186-05:00']	['2019-07-31T21:11:44.260967-05:00', '2019-07-31T21:11:44.260967-05:00']	['released', 'released']	11	Not Applicable	3e439275-1fcb-4bed-a34b-883baa5151e1	Solid Tissue Normal	Not Reported	5538.0	300.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DD-A73E-01A	e0863874-f7b8-49b6-a88b-5ae5f1ec2b15	Adenomas and Adenocarcinomas	e0863874-f7b8-49b6-a88b-5ae5f1ec2b15	TCGA-DD-A73E	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	66.0	-24377.0	1946.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8	DD	Mayo Clinic - Rochester	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	44.0	24377.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	24377.0	66.78630136986301	['1faf259f-be3a-512e-93a1-b3042c504838', 'a1334f3f-67aa-5de9-bfb6-d0709467ca58']	['TCGA-DD-A73E_treatment_1', 'TCGA-DD-A73E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:27:36.992050-05:00', '']	['2019-07-31T21:12:02.947647-05:00', '2019-07-31T21:12:02.947647-05:00']	['released', 'released']	01	Primary	d4fcbd8f-0b83-4b9d-ac2c-ce8c47412cc3	Primary Tumor	Not Reported	336.0	170.0	Unknown	10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9	false	Solid Tissue	False	Tumor
TCGA-CC-A7IH-01A	e4e0bc11-ad61-4419-857c-44fb5c7877a3	Adenomas and Adenocarcinomas	e4e0bc11-ad61-4419-857c-44fb5c7877a3	TCGA-CC-A7IH	Liver and intrahepatic bile ducts	Not Reported	asian	male	not hispanic or latino	Alive	58.0	-21381.0	1955.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	be652f28-50ec-5d4e-bc42-79a304ee03db	CC	ILSBio	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	365.0	21381.0	Hepatocellular carcinoma, NOS	no	2013.0	No	6th	T3	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	21381.0	58.57808219178082	['2f20bcb1-5503-5bb2-8dc6-5808fb931b3b', '8a533a39-1c61-57b2-9fe3-30132b00883b']	['TCGA-CC-A7IH_treatment', 'TCGA-CC-A7IH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:27:44.321300-05:00']	['2019-07-31T21:12:11.911648-05:00', '2019-07-31T21:12:11.911648-05:00']	['released', 'released']	01	Primary	40f9f3b1-545d-4743-912c-9c92aac5f396	Primary Tumor	Not Reported	181.0	190.0	OCT	643C84D1-C247-4CA6-84C3-38ED99E886F6	true	Solid Tissue	False	Tumor
TCGA-BW-A5NO-01A	ee63c44b-91f4-4004-8dea-192eab527036	Adenomas and Adenocarcinomas	ee63c44b-91f4-4004-8dea-192eab527036	TCGA-BW-A5NO	Liver and intrahepatic bile ducts	Not Reported	black or african american	male	not hispanic or latino	Alive	50.0	-18510.0	1960.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	0e691470-b18b-5803-9e4a-ee2cfbaae7b4	BW	St. Joseph's Medical Center-(MD)	Liver hepatocellular carcinoma	NCH																No	Stage IIIA	0.0	not reported	Liver	20.0	18510.0	Hepatocellular carcinoma, NOS	no	2010.0	No	7th	T3a	8170/3	NX	MX	not reported	C22.0	Liver	Not Reported	not reported	18510.0	50.71232876712329	['d1088ee3-d38c-5145-8d7c-c50a98900ed2', 'fd753998-490d-53dd-97b6-dce916e2d299']	['TCGA-BW-A5NO_treatment_1', 'TCGA-BW-A5NO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['no', 'no']	['2019-04-28T13:28:01.851536-05:00', '']	['2019-07-31T21:12:33.123400-05:00', '2019-07-31T21:12:33.123400-05:00']	['released', 'released']	01	Primary	3cbd785d-cad5-4299-8fe8-695ca8db726d	Primary Tumor	Not Reported	840.0	110.0	Unknown	39E090EF-9EA0-4362-BB47-432DE5AA1393	false	Solid Tissue	False	Tumor
TCGA-2Y-A9H9-01A	efc3e5e4-0d8e-4bef-a259-29f8ed21684f	Adenomas and Adenocarcinomas	efc3e5e4-0d8e-4bef-a259-29f8ed21684f	TCGA-2Y-A9H9	Liver and intrahepatic bile ducts	Not Reported	white	male	not hispanic or latino	Alive	70.0	-25670.0	1941.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	33e340f9-a97a-56eb-a3e6-aad831681cb4	2Y	Moffitt Cancer Center	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	697.0	25670.0	Hepatocellular carcinoma, NOS	no	2011.0	No	7th	T1	8170/3	N0	MX	not reported	C22.0	Liver	Not Reported	not reported	25670.0	70.32876712328768	['6ac7bded-7033-5085-80c4-0aa5c13f9df0', '982687d0-9c05-56dc-9122-ab994752b558']	['TCGA-2Y-A9H9_treatment_1', 'TCGA-2Y-A9H9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['yes', 'no']	['2019-04-28T13:28:06.383311-05:00', '']	['2019-07-31T21:12:39.591733-05:00', '2019-07-31T21:12:39.591733-05:00']	['released', 'released']	01	Primary	42d4cda4-bf55-41b5-9b91-04132a081e13	Primary Tumor	Not Reported	731.0	120.0	OCT	36C343AC-443B-4196-8B6D-7D9213F2DAE1	true	Solid Tissue	False	Tumor
TCGA-RC-A7S9-01A	f5de6712-4de4-43de-8eb5-ec2a798c8438	Adenomas and Adenocarcinomas	f5de6712-4de4-43de-8eb5-ec2a798c8438	TCGA-RC-A7S9	Liver and intrahepatic bile ducts	Not Reported	asian	female	not hispanic or latino	Alive	47.0	-17403.0	1965.0		Liver and intrahepatic bile ducts	TCGA-LIHC	Adenomas and Adenocarcinomas	Liver Hepatocellular Carcinoma	TCGA	ae9dc463-76e6-5b63-9123-f080997fdf85	RC	University of Utah	Liver hepatocellular carcinoma	NCH																No	Stage I	0.0	not reported	Liver	640.0	17403.0	Hepatocellular carcinoma, NOS	no	2012.0	No	7th	T1	8170/3	N0	M0	not reported	C22.0	Liver	Not Reported	not reported	17403.0	47.679452054794524	['171f32f0-8a10-5798-bd81-ecdd3cdb4f50', 'd2920470-e785-57da-9d46-4ac400c57539']	['TCGA-RC-A7S9_treatment', 'TCGA-RC-A7S9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['no', 'no']	['', '2019-04-28T13:28:20.709796-05:00']	['2019-07-31T21:12:57.429695-05:00', '2019-07-31T21:12:57.429695-05:00']	['released', 'released']	01	Primary	d70c86b2-d403-4cb3-a381-076819b5b414	Primary Tumor	Not Reported	383.0	20.0	OCT	A537996A-E747-4906-B488-43181F3C7E17	true	Solid Tissue	False	Tumor
